data_5o2y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5o2y _Structure_validation_residue.Date_analyzed 2017-10-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.56 0.219 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -61.72 -45.82 92.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.55 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.98 95.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.52 -47.38 73.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 37' ' ' VAL . 12.8 ptm85 -69.77 -34.77 74.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.465 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -61.07 -38.52 86.49 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.826 0.346 . . . . 0.0 110.688 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -62.4 -39.3 92.78 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 21.6 t -60.94 -47.52 93.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.801 175.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 33' ' ' ARG . 99.9 t -60.31 -38.84 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.996 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 m -59.02 -47.1 86.41 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 5.4 m-20 -70.41 -34.8 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.699 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.52 -44.95 93.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.423 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 37' ' ' VAL . 91.4 t -62.41 -41.34 91.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.288 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.04 90.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.085 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.487 ' O ' HD11 ' A' ' 47' ' ' LEU . 88.3 mt -60.25 -48.65 80.85 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.61 -36.05 81.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.166 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -61.73 -39.65 97.73 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.0 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.498 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -63.02 -39.81 95.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.232 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 43' ' ' LEU . 7.3 mp -60.76 -48.27 82.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.763 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.43 -36.83 85.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 24.6 mmt -68.02 -40.17 83.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.372 . . . . 0.0 110.628 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -63.63 -38.73 92.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.84 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.83 -32.72 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.96 -48.61 78.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 110.443 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.96 -46.56 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.43 HD21 ' HA ' ' A' ' 77' ' ' ALA . 38.5 m-80 -101.22 -0.67 35.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m 62.3 29.05 17.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.519 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -164.15 158.6 19.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -82.93 140.94 43.38 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.398 . . . . 0.0 110.952 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.43 157.91 44.75 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.105 2.537 . . . . 0.0 113.771 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.6 p -84.85 179.04 7.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.791 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.2 t -49.04 -44.78 41.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -171.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.17 -45.16 23.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.503 . . . . 0.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.434 HE21 ' NH2' ' A' ' 56' ' ' ARG . 48.2 mt-30 -64.12 -34.69 78.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.83 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' A' ' 100' ' ' LEU . . . -65.73 -48.84 63.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.922 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.54 -38.33 77.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.903 0.382 . . . . 0.0 111.036 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -72.08 -23.49 61.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.242 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.498 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 11.0 mt -79.4 -18.33 52.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.24 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.93 -59.14 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.125 0.488 . . . . 0.0 111.905 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -152.2 148.39 27.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.94 122.07 50.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.848 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.48 139.83 65.12 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.149 2.566 . . . . 0.0 112.529 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 p -81.18 -18.28 46.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.91 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.25 142.61 54.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.444 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.05 141.6 63.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.246 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 73.4 Cg_endo -76.99 143.72 76.42 Favored 'Cis proline' 0 C--N 1.344 0.294 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.588 -4.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -69.88 121.28 17.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.034 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -58.42 130.9 48.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.807 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -112.66 164.72 13.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.863 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 63.03 32.35 15.47 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.397 0.618 . . . . 0.0 110.658 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -88.86 144.05 32.46 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.896 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.33 139.99 43.13 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.37 2.047 . . . . 0.0 111.992 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.79 125.1 23.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.09 -9.41 60.67 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.789 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.09 -171.41 54.35 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.341 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -83.14 -32.68 26.53 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' A' ' 67' ' ' LEU . 9.5 tt -139.07 126.94 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.678 174.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -67.4 -20.59 65.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -128.82 157.82 40.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.65 123.69 72.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.737 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.38 142.95 97.35 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.444 2.096 . . . . 0.0 111.27 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -138.18 144.7 40.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.818 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.49 142.08 52.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.8 -18.72 13.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.349 2.699 . . . . 0.0 113.457 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.414 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 23.1 m-90 -81.65 -14.28 56.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.399 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.14 25.65 5.51 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.29 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 139.6 38.76 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.641 -0.329 . . . . 0.0 110.328 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.494 ' O ' HD23 ' A' ' 114' ' ' LEU . 6.9 m-20 -87.73 119.22 27.84 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.31 -0.244 . . . . 0.0 110.345 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HH ' ' HB2' ' A' ' 39' ' ' ASP . 50.1 m-85 -50.95 145.71 6.97 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.748 0.655 . . . . 0.0 111.839 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -121.33 143.97 48.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.287 0.565 . . . . 0.0 111.625 -175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.496 HD13 ' HB ' ' A' ' 109' ' ' VAL . 13.1 tp -122.48 142.27 50.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.741 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -128.08 112.57 14.74 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.555 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -107.4 131.22 21.88 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.438 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.44 143.64 64.9 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.055 -1.227 . . . . 0.0 111.431 -2.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.24 156.14 34.51 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.985 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -73.4 -27.09 61.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.074 0.464 . . . . 0.0 110.559 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -110.53 -27.01 9.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -147.51 -144.96 4.09 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.704 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -73.63 -43.17 60.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -140.64 128.38 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.301 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.82 127.37 54.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.0 111.23 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 pt -106.69 134.73 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.675 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.32 148.16 37.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 111.402 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 4.7 m -103.4 146.68 28.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.058 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 97' ' ' ASP . 1.8 mm? -88.3 -20.5 25.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.704 0.288 . . . . 0.0 111.197 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.26 -160.32 54.01 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.492 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.414 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 12.9 Cg_exo -69.95 -23.81 29.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.481 2.787 . . . . 0.0 112.38 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.487 ' OD2' HG23 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -91.9 -14.24 29.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.077 -173.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.01 5.84 62.77 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.357 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.7 ' O ' ' OG ' ' A' ' 122' ' ' SER . 22.8 m -93.58 118.79 67.56 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 117.548 0.674 . . . . 0.0 111.974 -175.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.49 148.06 29.28 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.38 2.72 . . . . 0.0 113.451 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 63.96 24.78 13.73 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.583 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.924 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.3 p -93.55 176.97 6.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.97 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -63.65 -41.88 98.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 0.0 110.405 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.51 -22.11 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.447 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.924 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.6 OUTLIER -56.94 104.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.689 0.618 . . . . 0.0 112.034 -171.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.18 103.66 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.437 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.12 178.6 19.2 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.89 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -68.21 -25.16 65.08 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.618 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -74.94 -31.3 61.47 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.6 m -66.99 -48.03 69.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.582 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 tp -75.75 -37.65 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.295 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 177.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.731 0.3 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -63.2 -37.94 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.285 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.93 70.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.871 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.88 -47.04 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.461 ' O ' HG22 ' A' ' 37' ' ' VAL . 16.8 ptm180 -62.66 -34.8 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.802 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.61 -39.12 83.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.718 0.295 . . . . 0.0 111.003 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.8 -36.2 77.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 110.035 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 68.2 t -60.36 -46.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.184 177.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 33' ' ' ARG . 89.2 t -60.04 -38.82 78.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.016 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -61.09 -46.72 89.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.81 -34.93 72.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.921 0.391 . . . . 0.0 110.629 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.62 -45.81 91.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 37' ' ' VAL . 29.3 m -65.32 -34.93 73.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.572 0.225 . . . . 0.0 110.539 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.81 94.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' O ' HD13 ' A' ' 47' ' ' LEU . 95.2 mt -61.0 -47.68 85.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.13 -43.02 73.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.952 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -65.21 -50.34 57.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.94 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.42 86.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.939 0.399 . . . . 0.0 110.851 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.4 mp -61.77 -50.26 73.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.417 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.9 -31.66 68.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.56 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.474 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.9 mtt -66.95 -42.45 85.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.727 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.42 -38.59 87.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 60.2 tttm -65.19 -32.88 74.79 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.0 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -65.71 -41.05 92.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.949 0.404 . . . . 0.0 109.952 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -76.61 -46.48 25.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.329 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' A' ' 77' ' ' ALA . 45.0 m-80 -111.43 13.56 21.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 28.8 p 49.81 35.46 9.25 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -167.08 156.34 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.491 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 38.0 m-85 -83.53 142.08 42.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 110.874 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.74 145.06 61.85 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.016 2.477 . . . . 0.0 112.891 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -75.87 177.81 6.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.622 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -50.55 -40.4 51.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.0 -45.58 26.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.512 . . . . 0.0 110.543 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -72.18 -28.11 63.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.273 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.43 -50.3 60.29 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.825 -0.703 . . . . 0.0 113.261 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -31.02 67.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.175 0.512 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -72.29 -23.44 61.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.776 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.44 68.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 HD12 ' CG2' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -97.86 -3.35 38.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.294 -0.563 . . . . 0.0 112.45 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 86.7 t -103.2 -62.83 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -139.58 141.86 37.16 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -57.38 121.16 45.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 135.76 71.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.532 2.155 . . . . 0.0 112.231 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.7 m -90.45 -9.24 48.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.866 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 128.8 33.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.931 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.82 139.43 76.99 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.097 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 15.3 Cg_exo -69.14 140.96 61.73 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 124.299 -1.125 . . . . 0.0 113.376 1.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -86.35 136.94 32.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.658 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.449 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -74.9 122.86 24.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.963 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -104.91 156.02 18.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.334 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 59.45 49.85 8.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.507 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.562 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 38.6 p90 -92.17 144.57 29.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.03 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.62 138.96 39.53 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.297 1.998 . . . . 0.0 111.663 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -64.93 125.27 24.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.191 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.45 2.19 90.4 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.997 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.72 -152.75 51.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.362 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.95 -26.94 13.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 9.1 tt -133.32 133.87 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.52 -25.82 57.55 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -130.45 172.48 11.84 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.607 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -55.58 124.01 53.85 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.68 141.08 58.67 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -140.04 139.19 35.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 43.2 m-20 -58.67 154.43 35.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.862 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.58 -25.01 24.3 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.735 2.29 . . . . 0.0 112.839 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -80.71 -12.8 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.403 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.11 33.05 5.6 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.628 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.501 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 38.8 m -102.48 133.97 46.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.862 0.363 . . . . 0.0 111.572 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.12 124.9 28.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.08 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -65.68 138.76 58.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.24 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -112.69 142.35 45.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.503 HD22 ' CG2' ' A' ' 111' ' ' ILE . 3.4 tm? -126.21 123.28 37.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.09 113.52 27.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.701 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -106.56 119.71 50.79 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.484 171.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.82 159.69 66.5 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 124.042 -1.233 . . . . 0.0 111.795 -3.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.51 163.89 39.28 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -96.1 -35.64 11.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.631 0.729 . . . . 0.0 109.522 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -95.69 14.07 24.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.39 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.8 -156.01 27.31 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -72.4 -34.92 68.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.423 0.611 . . . . 0.0 110.867 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.414 ' HB ' HD21 ' A' ' 100' ' ' LEU . 31.6 m -138.02 151.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -117.99 121.5 40.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.535 -176.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.503 ' CG2' HD22 ' A' ' 100' ' ' LEU . 7.6 pt -106.75 126.63 62.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.457 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 42.6 p90 -148.25 144.44 27.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.297 0.57 . . . . 0.0 111.647 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.3 m -92.16 138.26 31.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.409 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 73.8 mt -66.27 -16.36 63.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.179 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.6 -165.53 49.94 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.683 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.71 -34.54 24.52 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 123.528 2.819 . . . . 0.0 113.053 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -90.12 -10.93 42.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.646 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.94 87.48 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.908 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.729 ' O ' ' OG ' ' A' ' 122' ' ' SER . 89.4 t -86.72 116.1 64.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.737 0.268 . . . . 0.0 110.991 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 47.0 Cg_endo -71.47 153.81 60.61 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 11.9 pt-20 55.66 25.05 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.911 1.284 . . . . 0.0 111.869 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.8 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.6 OUTLIER -94.61 177.9 5.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.759 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.69 -27.4 62.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.991 0.424 . . . . 0.0 110.787 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.16 -17.22 58.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.622 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.8 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -62.74 121.9 14.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.098 -177.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 70.5 mt -91.76 105.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -112.0 179.63 19.61 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.078 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -58.47 -38.78 78.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.786 0.327 . . . . 0.0 111.181 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.784 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.6 m -64.04 -43.57 95.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -87.0 -38.69 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.959 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.176 177.542 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 8.1 tp10 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.713 0.292 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.77 -41.02 94.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.881 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.04 81.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.528 ' O ' HG23 ' A' ' 36' ' ' VAL . 67.7 m-20 -68.9 -48.11 64.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.197 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 12.3 ptm85 -66.9 -35.21 79.5 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.867 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -60.77 -37.81 83.13 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.094 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HD3' ' HG3' ' A' ' 93' ' ' PRO . 30.7 tttp -64.35 -41.94 96.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.669 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 60.9 t -61.1 -44.05 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.479 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 41' ' ' VAL . 77.4 t -62.91 -38.96 83.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 175.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -62.27 -46.01 90.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.438 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 64.4 m-20 -66.67 -36.31 82.24 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.306 0.574 . . . . 0.0 109.741 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.37 -42.76 99.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.98 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 37' ' ' VAL . 85.1 t -62.62 -38.11 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.441 . . . . 0.0 110.247 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.83 98.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.618 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 96.6 mt -64.47 -47.89 77.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.492 ' HG2' HD11 ' A' ' 111' ' ' ILE . 4.2 mm-40 -58.4 -44.95 89.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.281 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.25 -40.94 99.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.924 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -61.21 -42.38 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.791 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.27 -45.44 88.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.09 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.56 -43.68 98.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.02 -43.67 82.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.203 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -63.52 -41.15 98.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.446 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.65 -33.24 74.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.815 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.5 tp -67.55 -50.42 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.71 -44.75 32.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.888 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 36.6 m-80 -95.28 2.93 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.548 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m 68.67 3.78 4.05 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 171.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -159.58 165.52 32.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.727 0.298 . . . . 0.0 111.11 -178.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -74.12 142.02 78.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.572 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.49 143.28 42.4 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.189 2.592 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.538 HG21 ' H ' ' A' ' 60' ' ' THR . 1.4 m -72.35 176.82 4.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 175.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.538 ' H ' HG21 ' A' ' 59' ' ' THR . 8.8 t -51.34 -43.65 61.82 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.09 -38.97 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 110.348 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.82 -31.81 68.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.567 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -49.03 73.21 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.523 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.1 mp -69.58 -35.49 75.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.404 . . . . 0.0 111.093 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -72.54 -24.4 61.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.053 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.1 -29.38 67.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD22 ' H ' ' A' ' 67' ' ' LEU . 1.2 pt? -103.61 -1.92 27.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.672 0.272 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 74.9 t -109.49 -59.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.257 0.551 . . . . 0.0 111.074 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.0 p -156.68 136.03 12.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.05 121.57 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.459 0.474 . . . . 0.0 111.34 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.98 137.07 80.32 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.007 2.472 . . . . 0.0 112.598 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.0 m -89.76 3.84 51.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.23 148.88 22.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.046 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -77.37 137.06 64.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.19 131.77 24.56 Favored 'Cis proline' 0 C--O 1.235 0.34 0 C-N-CA 122.957 -1.684 . . . . 0.0 112.247 -0.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.6 126.27 26.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.159 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.76 132.32 53.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.685 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -118.07 149.94 40.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.228 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 59.49 44.23 15.13 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.687 0.617 . . . . 0.0 110.542 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -94.84 153.39 40.01 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.274 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.55 140.37 21.29 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.307 2.005 . . . . 0.0 111.222 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.77 125.03 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.06 10.32 86.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.615 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.39 -119.89 20.2 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -126.27 -37.44 2.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 13.8 tt -124.94 127.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.874 172.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -69.29 -21.67 63.86 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -129.39 165.03 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.5 mt -60.23 126.55 84.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 98' ' ' TYR . 37.9 Cg_endo -67.07 138.86 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.463 2.108 . . . . 0.0 111.511 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -133.4 138.51 46.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.762 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 4.4 p30 -67.28 152.95 95.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HG3' ' HD3' ' A' ' 35' ' ' LYS . 27.0 Cg_exo -59.27 -17.82 41.65 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.263 2.642 . . . . 0.0 113.169 -170.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.544 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.5 m-90 -81.27 -26.47 35.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.02 10.87 3.68 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.94 172.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.575 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 14.7 m -103.63 148.38 26.09 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.548 0.674 . . . . 0.0 111.038 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.19 133.71 34.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.104 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 78.4 m-85 -60.61 148.65 37.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.231 0.332 . . . . 0.0 110.312 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -130.4 143.21 50.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.15 0.5 . . . . 0.0 111.361 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.506 HD23 ' CG2' ' A' ' 111' ' ' ILE . 3.3 tm? -111.26 121.51 45.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -106.89 112.28 25.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.9 p -106.85 130.99 22.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.743 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.33 159.77 78.09 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.678 -1.384 . . . . 0.0 111.125 -4.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.96 159.24 53.86 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.136 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -96.2 -36.04 11.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -101.97 1.27 36.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.976 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.99 -155.88 13.26 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 11.9 mm100 -74.69 -29.32 61.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.271 0.535 . . . . 0.0 110.83 176.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.434 ' HB ' HD22 ' A' ' 100' ' ' LEU . 13.5 m -144.78 151.16 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.618 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.39 133.02 51.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.01 0.433 . . . . 0.0 111.614 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.506 ' CG2' HD23 ' A' ' 100' ' ' LEU . 6.7 pt -112.3 127.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.87 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -150.84 160.87 43.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.217 0.532 . . . . 0.0 111.884 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 6.2 p -106.85 146.68 30.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.651 175.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 7.3 mp -86.61 -20.31 28.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.544 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 76.53 -159.64 50.09 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.57 170.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.28 -23.79 32.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.64 2.893 . . . . 0.0 112.298 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -13.97 35.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.5 13.79 74.44 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.068 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 122' ' ' SER . 30.8 m -111.3 123.64 34.6 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-N 117.515 0.657 . . . . 0.0 112.194 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -78.13 157.01 30.15 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.503 2.802 . . . . 0.0 112.128 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 63.73 42.41 6.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.085 0.945 . . . . 0.0 109.497 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.669 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.6 p -120.86 177.26 5.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.881 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -73.73 -31.73 63.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.55 -28.42 67.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.753 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.669 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 3.5 m-20 -47.07 112.0 0.47 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 124.282 0.989 . . . . 0.0 112.131 -172.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.424 ' HB ' HG11 ' A' ' 36' ' ' VAL . 4.8 mp -84.62 105.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 130' ' ' THR . . . -130.4 -172.24 13.09 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -63.89 -37.62 88.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.898 0.38 . . . . 0.0 111.727 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -77.3 -19.82 55.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 127' ' ' GLY . 3.4 t -88.68 -22.33 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.951 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.78 -42.98 13.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.701 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.096 -178.553 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.661 0.267 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -59.92 -38.52 82.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.48 60.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.46 ' O ' HG22 ' A' ' 36' ' ' VAL . 62.5 m-20 -69.29 -42.53 75.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.459 ' O ' HG22 ' A' ' 37' ' ' VAL . 14.2 ptm180 -62.17 -34.48 76.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.093 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -58.78 -37.05 75.42 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.8 0.334 . . . . 0.0 111.082 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -68.58 -39.59 80.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 32' ' ' ASP . 46.7 t -61.37 -41.76 91.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.651 ' O ' HG21 ' A' ' 41' ' ' VAL . 96.2 t -60.52 -41.23 86.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.589 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.8 t -59.26 -48.23 82.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.003 0.43 . . . . 0.0 110.887 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -69.86 -34.26 73.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.13 -39.9 91.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.657 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.651 HG21 ' O ' ' A' ' 37' ' ' VAL . 52.2 t -63.5 -37.73 80.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.205 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.06 -35.63 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.596 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.455 ' O ' HD11 ' A' ' 47' ' ' LEU . 9.0 mp -64.08 -47.68 79.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.465 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -56.29 -37.4 69.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.999 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.49 -45.46 85.17 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.969 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -61.32 -44.62 96.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.793 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 43' ' ' LEU . 7.9 mp -62.93 -41.88 99.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.653 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.11 -44.77 94.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.447 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.438 ' HA ' ' HE1' ' A' ' 49' ' ' MET . 2.9 mmt -65.77 -43.87 87.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.046 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.495 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 67.1 t80 -65.26 -45.22 85.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.03 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.6 -33.1 72.21 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.576 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.4 tp -64.28 -42.32 96.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.073 0.463 . . . . 0.0 110.313 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.32 -48.72 16.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.906 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -98.7 -4.82 32.77 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -169.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 65.9 24.34 11.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.448 0.468 . . . . 0.0 111.945 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.31 149.74 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -74.4 146.9 84.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.797 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 142.08 50.91 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.691 2.261 . . . . 0.0 112.295 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.2 p -74.73 177.51 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.795 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t -51.46 -37.17 47.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.39 -41.18 41.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.086 0.469 . . . . 0.0 111.268 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -72.62 -37.78 67.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.294 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.21 71.27 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.783 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.685 HD21 ' O ' ' A' ' 98' ' ' TYR . 7.4 mp -69.96 -40.22 75.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 111.668 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -72.55 -23.98 61.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.234 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -26.46 62.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -169.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.543 HD22 ' H ' ' A' ' 67' ' ' LEU . 1.7 pt? -104.52 -2.0 25.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.47 -38.75 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 t -156.44 130.35 8.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.66 121.99 36.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.432 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.85 137.47 58.37 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.833 2.355 . . . . 0.0 112.367 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 p -87.45 -19.59 27.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.087 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.23 137.48 57.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.369 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.04 138.19 92.36 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.495 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 10.7 Cg_exo -73.46 135.12 38.48 Favored 'Cis proline' 0 C--O 1.233 0.272 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.34 -3.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -70.88 121.62 18.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.8 124.26 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.736 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -107.46 166.3 10.76 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.372 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 47.76 40.27 11.96 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.192 0.933 . . . . 0.0 111.839 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -89.75 150.17 43.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.966 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.93 137.74 32.69 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.025 1.816 . . . . 0.0 111.3 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.59 124.24 22.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.914 0.387 . . . . 0.0 110.41 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.95 4.95 86.65 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.645 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.45 -142.55 40.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.399 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.85 -14.38 13.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.286 0.565 . . . . 0.0 109.594 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.9 tt -136.83 141.48 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.004 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -68.85 -30.97 69.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.886 -172.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -131.18 154.36 48.46 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.294 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.26 118.8 43.52 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.98 128.43 24.77 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.358 2.705 . . . . 0.0 113.206 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -126.37 140.43 52.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.672 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.2 p30 -71.0 152.5 94.92 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 -15.53 13.66 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.547 2.832 . . . . 0.0 113.683 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.412 ' CZ3' HG21 ' A' ' 36' ' ' VAL . 5.4 m-90 -80.57 -19.48 45.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.996 0.427 . . . . 0.0 110.361 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.16 19.31 8.57 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.918 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.509 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 0.9 OUTLIER -103.35 146.24 28.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 110.849 -176.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.93 126.24 36.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.354 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.685 ' O ' HD21 ' A' ' 64' ' ' LEU . 5.1 m-85 -52.9 151.62 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.84 0.713 . . . . 0.0 112.692 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.423 ' NE2' HD21 ' A' ' 114' ' ' LEU . 0.7 OUTLIER -115.68 137.49 52.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.364 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.545 HD21 ' CG2' ' A' ' 111' ' ' ILE . 3.2 tm? -123.32 122.39 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -117.1 112.55 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.787 0.327 . . . . 0.0 110.486 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.418 ' HB3' HG11 ' A' ' 109' ' ' VAL . 20.7 p -107.08 127.97 26.95 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.272 171.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 97.0 Cg_endo -85.06 139.94 29.29 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.907 -1.289 . . . . 0.0 111.648 -5.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.95 161.63 46.92 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.112 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -85.15 -20.81 29.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.965 0.412 . . . . 0.0 110.617 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -105.74 -43.98 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.5 -151.6 8.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.97 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -45.64 54.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 102' ' ' SER . 16.2 m -128.67 140.48 49.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.413 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 125.4 54.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.762 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.545 ' CG2' HD21 ' A' ' 100' ' ' LEU . 11.3 pt -108.35 125.73 65.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.147 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -151.69 163.09 39.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.057 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.5 m -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.872 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.425 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 1.8 mm? -66.88 -22.76 65.96 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -169.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.04 -169.16 43.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.831 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.29 -25.02 36.87 Favored 'Trans proline' 0 C--N 1.337 -0.058 0 C-N-CA 122.891 2.394 . . . . 0.0 112.843 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.85 -11.08 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.115 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 114' ' ' LEU . . . 76.09 9.75 85.39 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.406 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.726 ' O ' ' OD2' ' A' ' 125' ' ' ASP . 55.3 t -89.16 112.88 53.8 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.043 0.421 . . . . 0.0 111.448 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.86 156.39 39.22 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.096 2.531 . . . . 0.0 112.624 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 64.73 16.25 10.28 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.283 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 1.085 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.9 p -94.27 175.85 6.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.818 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -85.73 -23.75 27.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.43 -22.43 61.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 1.085 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 1.0 OUTLIER -55.29 132.05 46.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.346 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.97 95.75 3.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -106.6 148.96 16.52 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.301 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.438 ' HB2' HG13 ' A' ' 111' ' ' ILE . 64.6 t30 -66.91 -26.03 66.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.44 0.638 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -74.5 -28.43 60.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.921 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -74.69 -37.47 62.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.956 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.5 tp -78.39 -36.52 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.18 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.474 169.792 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.9 tp10 . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 120.77 0.319 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 36.2 mtmm -69.56 -36.74 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.598 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.74 77.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.998 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 -44.47 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.521 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.51 ' O ' HG22 ' A' ' 37' ' ' VAL . 13.4 ptm180 -67.72 -35.16 78.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.601 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 40.8 mt-30 -63.91 -36.45 83.99 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.97 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.71 -39.84 92.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 76.1 t -61.05 -43.02 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.272 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 33' ' ' ARG . 88.2 t -60.54 -39.46 81.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 41' ' ' VAL . 50.4 m -61.32 -46.95 88.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.025 0.44 . . . . 0.0 111.055 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 -34.42 73.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.277 0.56 . . . . 0.0 110.491 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 tp -65.22 -44.55 87.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.519 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 37' ' ' VAL . 32.8 m -63.53 -35.82 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.92 90.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.79 0.329 . . . . 0.0 110.47 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' O ' HD13 ' A' ' 47' ' ' LEU . 69.5 mt -62.57 -48.54 79.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.79 -37.77 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.34 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -44.81 97.22 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.769 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 67' ' ' LEU . . . -60.43 -44.13 96.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.735 0.302 . . . . 0.0 110.868 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 43' ' ' LEU . 7.3 mp -62.54 -44.11 97.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.025 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.08 -41.73 99.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.866 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -38.83 73.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.733 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -62.25 -42.67 99.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.954 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -69.98 -31.79 69.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.3 -49.1 75.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 0.0 110.51 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.02 -45.49 34.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -98.32 -1.33 41.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -172.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 m 63.14 17.34 10.1 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.86 147.58 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -66.74 140.55 96.38 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.24 149.09 69.77 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.967 2.444 . . . . 0.0 112.439 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.546 HG23 ' H ' ' A' ' 60' ' ' THR . 0.7 OUTLIER -81.71 177.46 8.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.622 176.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.546 ' H ' HG23 ' A' ' 59' ' ' THR . 8.8 t -51.42 -40.53 59.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -77.14 -42.98 35.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.302 0.572 . . . . 0.0 110.2 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -69.37 -33.59 73.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.683 -173.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.9 -49.36 42.36 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.917 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.3 tp -66.16 -41.01 90.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 111.422 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HA ' HG13 ' A' ' 68' ' ' VAL . 34.6 mt-30 -73.03 -23.11 60.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.66 61.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.56 HD21 ' H ' ' A' ' 67' ' ' LEU . 1.8 pt? -104.65 -2.0 25.63 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 65' ' ' GLN . 7.5 p -117.83 -43.62 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.818 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 65' ' ' GLN . 47.0 m -156.51 129.58 7.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -56.24 121.53 42.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 111.442 -175.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 27.9 Cg_exo -63.15 137.39 61.23 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.739 2.293 . . . . 0.0 112.604 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.5 p -86.52 -10.9 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.96 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.64 138.32 46.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.476 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 6.1 mp0 -77.03 141.79 68.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.92 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 48.2 Cg_endo -69.89 131.33 19.11 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 -1.672 . . . . 0.0 112.532 -0.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -68.96 129.38 39.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.949 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.56 125.96 28.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.67 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -119.34 163.75 16.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.538 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.32 39.28 9.61 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.369 0.604 . . . . 0.0 110.229 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -97.83 143.15 25.71 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.58 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.45 143.8 35.28 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.595 2.196 . . . . 0.0 111.628 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.08 124.63 22.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.809 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.26 10.02 86.48 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.884 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.75 -149.61 51.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.2 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.95 -5.59 15.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.388 0.613 . . . . 0.0 109.881 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 tt -142.36 137.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.694 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.18 -22.79 61.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.948 -169.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -138.3 170.16 16.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.85 128.52 70.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 172.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.43 129.11 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.346 2.031 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.16 140.47 51.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.733 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.637 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.0 p30 -72.91 153.15 91.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.23 -17.89 22.06 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.324 2.683 . . . . 0.0 113.576 -174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.562 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 7.3 m-90 -81.38 -26.68 35.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.697 0.284 . . . . 0.0 110.61 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.94 18.76 4.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.718 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.637 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 69.5 m -103.68 154.24 19.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.489 0.645 . . . . 0.0 111.281 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.36 129.88 38.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.218 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.571 ' O ' HD21 ' A' ' 64' ' ' LEU . 19.1 m-85 -60.95 146.23 47.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -127.6 140.47 52.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.155 0.502 . . . . 0.0 111.766 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' CG2' ' A' ' 111' ' ' ILE . 2.8 tm? -111.89 120.94 43.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -112.64 113.05 25.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.072 0.463 . . . . 0.0 111.176 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -106.55 131.74 21.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.171 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.75 146.14 65.72 Favored 'Cis proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.762 -1.349 . . . . 0.0 111.369 -4.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.34 161.22 34.77 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.897 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.01 -35.55 11.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.111 0.481 . . . . 0.0 109.746 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -94.99 -40.24 9.76 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.16 -157.98 9.66 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.39 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -74.49 -34.61 63.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.948 0.374 . . . . 0.0 110.839 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.47 ' HB ' HD22 ' A' ' 100' ' ' LEU . 6.5 m -135.96 124.05 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.987 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 124.58 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.482 ' CG2' HD23 ' A' ' 100' ' ' LEU . 8.7 pt -106.29 126.55 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.278 173.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 11.7 p90 -150.31 160.58 43.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.204 0.526 . . . . 0.0 111.643 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 m -108.48 126.72 53.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.6 -31.23 72.02 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 123.804 0.69 . . . . 0.0 110.748 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.562 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 78.99 -154.09 38.84 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.0 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.36 -27.41 34.13 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.233 2.622 . . . . 0.0 113.629 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.543 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.2 p-10 -87.34 -13.46 43.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.642 -173.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.36 13.27 73.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.238 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.797 ' O ' ' OG ' ' A' ' 122' ' ' SER . 77.9 t -119.03 121.23 30.56 Favored Pre-proline 0 C--O 1.247 0.93 0 CA-C-O 120.712 0.292 . . . . 0.0 111.084 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.611 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 71.9 Cg_endo -76.06 146.97 29.55 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.508 2.805 . . . . 0.0 112.983 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 121' ' ' GLU . 5.5 tp10 65.19 25.15 12.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.074 0.94 . . . . 0.0 110.338 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.797 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -93.22 172.42 8.31 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.451 172.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -76.14 -0.41 21.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.811 0.338 . . . . 0.0 111.671 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -103.56 -13.84 16.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.185 0.517 . . . . 0.0 109.964 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.647 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -65.76 134.76 53.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.582 -174.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.17 108.44 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.908 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -110.7 176.49 18.8 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.542 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.48 ' HB2' HG13 ' A' ' 111' ' ' ILE . 63.3 t30 -65.14 -28.87 69.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.364 0.602 . . . . 0.0 110.473 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -77.11 -19.44 56.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.803 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 -40.34 62.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.63 -34.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.018 0.437 . . . . 0.0 110.244 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.894 171.016 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.67 0.271 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.73 -48.01 82.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 110.397 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.08 -36.63 72.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.377 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -63.2 -47.1 83.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.109 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.55 ' O ' HG22 ' A' ' 37' ' ' VAL . 35.8 ptt180 -67.67 -34.79 77.63 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.662 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.15 -34.15 75.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.69 -40.37 92.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 92.6 t -60.78 -44.88 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.415 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 33' ' ' ARG . 60.7 t -58.76 -38.41 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.513 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -61.9 -45.93 91.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.09 -34.84 73.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 0.0 110.649 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.41 -45.1 92.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.141 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.92 -34.86 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.709 0.29 . . . . 0.0 110.315 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.92 89.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.539 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.82 -43.08 98.68 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.984 0.421 . . . . 0.0 110.047 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -56.7 -36.78 70.05 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.82 -44.75 94.14 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.948 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB3' HD11 ' A' ' 67' ' ' LEU . . . -62.48 -43.67 98.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.798 0.332 . . . . 0.0 110.711 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.91 -43.14 93.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.5 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.01 -41.15 82.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.894 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 86.7 mmm -67.87 -44.05 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.176 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -62.57 -40.31 96.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.05 -32.16 70.14 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.71 0.291 . . . . 0.0 110.262 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.6 -49.07 79.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.752 0.311 . . . . 0.0 110.422 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -77.2 -47.03 21.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -100.4 -3.49 30.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -169.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.9 m 61.38 28.93 18.27 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 2.0 ppt_? -156.58 154.87 30.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.668 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.496 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 76.0 m-85 -77.4 131.86 70.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 147.08 45.01 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.521 2.147 . . . . 0.0 112.729 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 176.8 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.518 175.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.5 t -50.15 -44.44 52.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -77.44 -43.77 31.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.059 0.457 . . . . 0.0 110.785 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.22 -36.78 84.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.106 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.45 -45.05 25.24 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.547 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -69.37 -44.65 71.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.4 ' NE2' HD12 ' A' ' 89' ' ' LEU . 33.0 mm-40 -71.59 -26.03 62.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.18 -21.86 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 85' ' ' TYR . 4.8 tp -83.24 -13.02 56.19 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.994 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.44 -29.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.565 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 t -157.34 162.88 39.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.2 122.26 87.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.94 136.69 71.36 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.643 2.229 . . . . 0.0 112.042 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -81.99 -29.66 31.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 127.4 31.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 34.0 tt0 -67.22 139.16 94.82 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 18.2 Cg_exo -67.56 131.62 16.69 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.738 -0.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -80.89 129.95 34.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.698 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.48 122.84 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.924 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -111.81 158.42 19.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.017 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 60.89 32.0 20.02 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 110.608 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -72.03 146.61 90.29 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.414 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.78 138.28 31.4 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.981 1.787 . . . . 0.0 111.272 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.81 124.63 22.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.457 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.58 4.94 75.74 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.505 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.34 -150.85 47.67 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.406 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.506 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 62.1 m-85 -101.45 -37.44 8.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.364 0.602 . . . . 0.0 109.901 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.92 137.53 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -67.05 -21.87 65.89 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -130.52 154.92 47.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.4 HD12 ' NE2' ' A' ' 65' ' ' GLN . 4.4 mm? -54.43 125.83 53.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.03 137.09 79.05 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.636 2.224 . . . . 0.0 112.142 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -138.4 138.03 37.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.295 0.569 . . . . 0.0 111.327 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.473 ' CG ' ' HG ' ' A' ' 113' ' ' SER . 11.9 m-20 -62.85 153.86 78.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.948 173.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -19.02 29.14 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.198 2.599 . . . . 0.0 112.704 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -81.96 -12.75 58.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.09 30.72 7.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.198 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.3 m -103.52 149.46 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.962 0.41 . . . . 0.0 111.021 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.81 143.5 29.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.844 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.591 ' O ' HD23 ' A' ' 64' ' ' LEU . 83.7 m-85 -83.67 148.53 27.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.48 ' NE2' HD21 ' A' ' 114' ' ' LEU . 27.0 mp0 -118.22 152.96 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 110.932 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.4 tp -131.94 140.16 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.077 171.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -135.38 115.93 13.74 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.815 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 t -106.8 132.56 20.81 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.88 139.77 63.1 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 124.251 -1.145 . . . . 0.0 111.907 -1.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.83 150.91 51.03 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.741 -172.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.69 -26.53 68.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 0.0 110.286 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -131.04 44.88 2.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.246 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 147.08 -165.62 28.54 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 13.2 mm100 -75.5 -29.55 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.77 0.785 . . . . 0.0 110.607 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 m -134.35 127.36 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.138 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -119.52 118.19 30.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.451 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.8 pt -106.6 132.21 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.087 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.68 161.02 43.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.158 0.504 . . . . 0.0 111.428 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.473 ' HG ' ' CG ' ' A' ' 92' ' ' ASP . 18.3 t -116.42 149.29 39.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.179 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -69.57 -27.42 65.11 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 123.52 0.513 . . . . 0.0 109.924 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.09 -162.09 33.51 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.155 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.42 -28.38 32.7 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.951 2.434 . . . . 0.0 113.397 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.557 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.6 p-10 -85.06 -11.56 55.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.6 12.0 80.43 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.853 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.851 ' O ' ' OG ' ' A' ' 122' ' ' SER . 72.0 t -116.94 121.47 32.62 Favored Pre-proline 0 C--O 1.249 1.042 0 CA-C-O 120.637 0.256 . . . . 0.0 111.271 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.697 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 60.3 Cg_endo -75.4 158.33 40.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 113.606 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 62.31 23.97 14.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.219 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 1.128 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -96.93 177.73 5.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.731 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.95 -28.97 43.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.202 0.525 . . . . 0.0 110.496 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 122' ' ' SER . 7.3 p-10 -77.05 -15.2 59.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 1.128 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -65.47 146.06 55.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.358 -177.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.0 mt -113.76 117.87 56.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.884 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.38 161.66 13.49 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.128 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -59.96 -37.4 79.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.504 0.668 . . . . 0.0 109.867 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -76.67 -28.51 55.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.205 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.2 p -80.91 -29.09 35.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.685 0.278 . . . . 0.0 111.21 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.6 tp -85.96 -31.39 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.217 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.126 178.193 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.798 0.332 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 99.5 mttt -67.26 -48.06 68.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.331 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.709 -174.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.24 -40.45 74.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.463 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 30.8 ptt180 -68.38 -34.15 75.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.388 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 14.8 mm100 -59.32 -31.51 69.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.479 0.18 . . . . 0.0 111.254 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.11 -44.27 97.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 24.7 t -60.71 -45.15 98.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 33' ' ' ARG . 58.3 t -59.9 -38.63 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.4 ' O ' HG21 ' A' ' 41' ' ' VAL . 39.1 t -60.44 -46.8 88.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.866 0.365 . . . . 0.0 110.677 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.521 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.9 m-20 -69.52 -35.4 75.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 109.869 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.465 HD21 ' C ' ' A' ' 127' ' ' GLY . 19.0 tp -60.89 -46.57 90.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.347 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 38' ' ' SER . 28.9 m -65.81 -36.17 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.362 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.17 98.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.397 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.568 ' O ' HD11 ' A' ' 47' ' ' LEU . 98.2 mt -61.32 -49.69 75.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.375 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.3 -39.32 90.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.216 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.526 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -63.44 -47.77 84.44 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.215 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.75 84.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.758 0.313 . . . . 0.0 111.343 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.568 HD11 ' O ' ' A' ' 43' ' ' LEU . 5.2 mp -57.59 -43.74 84.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.946 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.55 -37.35 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.844 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.526 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 20.7 mmt -59.48 -45.23 92.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.567 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 65.6 t80 -67.18 -37.7 84.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.564 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.92 -35.33 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.308 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.0 tp -68.12 -36.44 79.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.253 0.549 . . . . 0.0 110.385 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.506 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 14.0 t70 -76.0 -47.89 23.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.595 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.55 22.91 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m 71.97 -13.99 0.55 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -137.15 157.55 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.889 -0.507 . . . . 0.0 111.242 -175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -71.34 148.35 93.51 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 148.3 52.19 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.925 2.417 . . . . 0.0 112.402 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.3 p -79.84 177.99 8.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.999 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.2 t -50.98 -37.29 43.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.827 0.346 . . . . 0.0 111.888 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.06 -45.72 26.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.702 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.04 -27.9 62.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.366 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.19 -51.96 54.92 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.129 -170.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 mp -72.11 -32.9 67.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.412 0.606 . . . . 0.0 111.34 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -72.54 -24.13 61.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.82 -24.9 64.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -103.79 -2.06 26.95 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.65 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.28 -63.04 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.455 0.645 . . . . 0.0 110.742 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 138.19 17.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.35 120.38 25.76 Favored Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.366 0.416 . . . . 0.0 111.153 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.97 141.96 96.39 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 112.602 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -86.64 -9.22 56.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.846 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.3 140.55 52.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.077 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.2 137.67 68.49 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.166 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.567 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 5.2 Cg_exo -79.88 149.84 81.65 Favored 'Cis proline' 0 C--O 1.236 0.378 0 C-N-CA 123.738 -1.359 . . . . 0.0 112.558 -4.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -65.42 128.85 37.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.521 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.0 38.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.377 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.506 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 33.3 mmt180 -111.53 165.14 12.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.94 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 61.79 34.88 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.706 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -94.74 136.65 22.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.853 0.359 . . . . 0.0 110.542 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.72 143.55 56.52 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.637 2.225 . . . . 0.0 111.758 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.07 124.36 20.94 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.21 84.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.824 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.46 -157.93 53.44 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.126 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -92.29 -23.43 19.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.9 128.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.662 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -68.36 -24.46 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.044 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -130.84 171.68 12.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.09 129.91 86.41 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.023 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.09 126.87 15.06 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.063 1.842 . . . . 0.0 110.283 172.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -132.82 145.44 50.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.608 0.242 . . . . 0.0 110.902 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 0.7 OUTLIER -56.3 143.67 64.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.115 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.69 -25.84 53.0 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.254 2.636 . . . . 0.0 113.111 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.488 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 18.3 m-90 -81.91 -5.08 57.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.648 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.11 15.09 22.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.918 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 43.2 m -95.5 164.37 12.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.723 0.297 . . . . 0.0 110.584 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -111.71 129.32 56.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.118 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.461 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 64.2 m-85 -67.09 161.47 24.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.582 ' NE2' HD12 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -129.41 142.76 50.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.499 . . . . 0.0 110.861 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.51 HD23 ' CG2' ' A' ' 111' ' ' ILE . 3.3 tm? -112.41 122.77 48.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -110.24 113.63 26.47 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.66 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 13.7 p -107.16 123.05 39.5 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.555 172.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 108' ' ' GLN . 1.9 Cg_endo -84.31 140.15 33.17 Favored 'Cis proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.736 -0.943 . . . . 0.0 111.256 -4.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.73 159.62 53.84 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.62 -173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -79.63 -12.05 59.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.128 0.49 . . . . 0.0 109.951 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -121.48 30.51 6.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.02 -157.32 26.83 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 21.5 tp60 -61.2 -45.39 94.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 0.0 110.077 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 100' ' ' LEU . 15.1 m -136.12 151.09 28.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.32 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -134.61 131.28 37.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.652 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.51 ' CG2' HD23 ' A' ' 100' ' ' LEU . 4.4 pt -111.32 130.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.781 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -149.08 161.12 42.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.3 p -114.57 139.87 49.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.738 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.582 HD12 ' NE2' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -67.9 -34.43 76.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.746 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.45 -159.68 53.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.45 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 10.8 Cg_exo -70.34 -34.88 11.9 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 123.824 3.016 . . . . 0.0 111.98 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.83 -13.57 50.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.089 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.512 ' C ' ' HG ' ' A' ' 114' ' ' LEU . . . 71.75 11.96 73.86 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.5 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.941 ' O ' ' OG ' ' A' ' 122' ' ' SER . 43.6 t -96.68 113.78 63.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 116.957 0.379 . . . . 0.0 111.233 -176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 145.83 29.45 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.615 2.21 . . . . 0.0 112.462 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 66.98 22.51 10.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.337 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.941 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.3 OUTLIER -91.48 177.46 6.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.654 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.82 -16.78 61.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.23 -15.6 37.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.17 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.806 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -63.49 105.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.201 -173.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.4 mm -81.4 107.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.857 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.465 ' C ' HD21 ' A' ' 40' ' ' LEU . . . -114.15 171.26 13.68 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.666 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -66.49 -38.39 87.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.989 0.423 . . . . 0.0 110.177 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -68.32 -30.53 69.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -72.04 -39.4 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.449 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.98 -40.72 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.752 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.358 0 C-N-CA 119.398 -1.382 . . . . 0.0 114.309 179.024 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.648 0.261 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 55.4 mtmt -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.411 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.55 -39.85 94.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.807 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -69.17 -39.42 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.807 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.523 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 12.5 ptm85 -66.66 -33.48 75.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.74 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 76.0 mm-40 -59.22 -34.37 72.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.711 0.291 . . . . 0.0 110.882 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -63.3 -39.6 95.03 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.62 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 41.1 t -60.64 -47.65 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.363 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 33' ' ' ARG . 38.6 t -58.82 -37.69 68.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 41' ' ' VAL . 22.6 t -62.53 -47.0 85.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.47 . . . . 0.0 111.044 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.486 ' HB2' ' OH ' ' A' ' 98' ' ' TYR . 63.4 m-20 -70.91 -35.15 72.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.731 -0.606 . . . . 0.0 110.04 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.419 HD21 ' N ' ' A' ' 128' ' ' ASN . 17.6 tp -61.0 -44.93 96.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.076 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 38' ' ' SER . 32.8 m -63.31 -34.54 67.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.507 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 39' ' ' ASP . . . -60.21 -40.07 88.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.589 0.233 . . . . 0.0 110.63 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 47' ' ' LEU . 8.9 mp -60.27 -48.45 81.67 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.262 0.553 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.56 -37.33 85.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.823 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -62.53 -37.06 94.08 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.91 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.16 0.505 . . . . 0.0 110.044 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 43' ' ' LEU . 6.2 mp -61.1 -40.82 95.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.4 -45.52 94.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 25.7 mmt -63.44 -38.52 91.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 77' ' ' ALA . 1.2 t80 -64.2 -44.23 92.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.399 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -70.5 -33.31 71.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.93 -46.3 85.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.01 0.433 . . . . 0.0 110.141 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.99 -46.15 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.215 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -103.57 1.71 32.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m 59.15 31.73 21.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.708 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.51 146.21 8.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.844 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -72.89 144.18 85.14 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 110.466 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 55.5 Cg_endo -71.04 143.26 44.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.843 2.362 . . . . 0.0 112.745 -176.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -73.94 177.45 5.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.591 175.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 100' ' ' LEU . 61.9 m -50.21 -45.82 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.37 -37.58 65.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.236 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -71.92 -43.15 65.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.874 -170.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' A' ' 100' ' ' LEU . . . -64.37 -49.46 65.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.676 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 98' ' ' TYR . 1.4 tp -61.88 -41.68 98.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.941 0.4 . . . . 0.0 111.42 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.41 -22.92 61.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.936 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.24 66.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -168.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.414 HD23 HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -93.95 -3.83 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.986 -178.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.86 -42.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.519 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 p -156.5 130.07 8.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.09 121.82 38.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 123.383 0.427 . . . . 0.0 111.324 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.34 137.56 56.44 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.9 2.4 . . . . 0.0 112.437 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -86.22 -11.45 52.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.1 57.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.474 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -77.5 140.92 64.82 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.81 134.55 36.36 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.719 -1.367 . . . . 0.0 111.931 -2.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.95 128.55 36.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.298 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.536 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . . . -63.2 131.33 48.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.526 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -119.32 164.6 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 66.46 32.06 7.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.009 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -91.68 137.18 25.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.694 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.77 139.54 22.46 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.073 1.849 . . . . 0.0 111.843 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 124.77 23.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.711 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -8.89 76.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.73 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 -173.13 55.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.291 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -84.9 -25.7 27.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.26 133.71 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.381 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -70.12 -22.77 62.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.7 mtm180 -131.94 154.59 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.289 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.6 mt -61.73 123.64 77.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.336 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.15 147.95 91.33 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.471 2.114 . . . . 0.0 111.415 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -138.37 145.46 41.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 113' ' ' SER . 53.2 m-20 -57.99 142.99 78.87 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.63 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.38 -19.32 57.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.305 2.67 . . . . 0.0 112.541 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.74 -14.08 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.009 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.0 22.39 7.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.163 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 19.3 m -104.01 162.5 13.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.535 -0.391 . . . . 0.0 110.613 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -105.64 144.65 32.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.667 0.27 . . . . 0.0 110.341 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.62 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 18.6 m-85 -70.31 146.49 50.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.358 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -126.76 142.9 51.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.616 . . . . 0.0 111.751 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 60' ' ' THR . 13.4 tp -121.68 141.99 50.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.934 172.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -134.86 113.07 11.2 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.505 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.7 t -106.9 132.19 21.1 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.374 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.78 150.27 92.35 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.824 -1.323 . . . . 0.0 111.885 -1.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.01 147.25 50.73 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.658 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -75.07 -39.39 60.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.359 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -104.88 -38.88 6.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.897 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.19 -156.79 9.78 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.788 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -73.46 -41.69 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.209 0.528 . . . . 0.0 109.989 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.14 122.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.376 175.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 116.8 33.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.25 0.547 . . . . 0.0 112.15 -173.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.9 pt -107.34 126.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.556 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -150.41 146.55 26.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.284 0.564 . . . . 0.0 111.194 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.489 ' HB3' ' OD1' ' A' ' 92' ' ' ASP . 51.2 m -97.83 151.58 20.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.197 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 4.9 mp -75.29 -19.67 59.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.588 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.54 -156.04 53.27 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 123.875 0.734 . . . . 0.0 113.355 171.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.93 -21.01 38.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.675 2.917 . . . . 0.0 112.906 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.77 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 6.6 p-10 -86.23 -14.74 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.473 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 70.7 0.65 33.66 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.178 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.903 ' O ' ' OG ' ' A' ' 122' ' ' SER . 44.6 t -122.47 134.0 24.68 Favored Pre-proline 0 C--O 1.251 1.171 0 CA-C-O 120.56 0.219 . . . . 0.0 110.739 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.4 160.91 41.16 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.81 2.34 . . . . 0.0 111.206 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 69.53 22.64 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 109.311 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.903 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 6.5 m -89.01 170.67 10.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.464 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.18 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 167.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.401 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 14.8 m-20 -96.05 69.12 2.77 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.859 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.27 100.32 7.62 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.799 170.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.98 99.92 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.827 -172.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -104.06 155.21 17.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.218 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.419 ' N ' HD21 ' A' ' 40' ' ' LEU . 22.2 t30 -68.83 -30.96 69.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.596 0.712 . . . . 0.0 109.328 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.96 -30.89 65.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.576 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.6 p -82.32 -32.29 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.002 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.0 tp -74.34 -19.98 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.627 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 119.949 -1.12 . . . . 0.0 114.057 173.237 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.841 0.353 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.512 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 48.2 mmtm -68.43 -40.32 81.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.659 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.04 85.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.942 0.401 . . . . 0.0 110.756 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' HG21 ' A' ' 36' ' ' VAL . 7.0 m-20 -65.42 -46.72 78.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.394 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.525 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.7 ptm180 -63.85 -35.66 81.37 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.117 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 56.1 mt-30 -59.1 -39.58 82.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.862 0.363 . . . . 0.0 110.256 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -68.32 -38.66 81.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.245 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 32' ' ' ASP . 71.7 t -61.01 -47.9 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.469 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 33' ' ' ARG . 65.6 t -60.09 -37.55 73.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.831 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.457 ' O ' HG22 ' A' ' 41' ' ' VAL . 14.4 t -61.36 -47.47 85.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.99 0.424 . . . . 0.0 111.04 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.6 -33.96 71.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 15.9 tp -62.5 -44.31 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.211 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 38' ' ' SER . 32.2 m -65.7 -35.29 74.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 O-C-N 122.356 -0.215 . . . . 0.0 110.631 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.44 81.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 78.0 mt -62.04 -47.75 83.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.647 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.403 ' HG2' HD11 ' A' ' 111' ' ' ILE . 36.6 mm-40 -57.35 -36.69 71.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.28 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.51 99.69 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.689 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.519 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . . . -62.95 -37.83 88.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.223 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 36.3 mt -61.92 -44.99 95.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.449 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -61.34 -45.37 94.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.733 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.78 -38.04 79.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.27 -46.2 74.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.02 -33.26 75.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.686 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -44.57 93.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.436 0.636 . . . . 0.0 110.04 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.64 -41.61 53.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.252 -174.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 77' ' ' ALA . 48.4 m-80 -118.06 16.04 14.16 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m 72.17 -42.21 0.53 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 176.45 5.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.439 ' CD2' ' HG2' ' A' ' 108' ' ' GLN . 36.8 m-85 -88.78 144.85 33.78 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.418 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.71 152.79 42.77 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.403 2.736 . . . . 0.0 113.697 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.497 HG21 ' H ' ' A' ' 60' ' ' THR . 0.3 OUTLIER -79.46 177.06 9.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.627 173.24 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.497 ' H ' HG21 ' A' ' 59' ' ' THR . 4.1 t -51.05 -46.02 61.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.1 -39.58 65.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.38 0.609 . . . . 0.0 110.192 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -71.86 -35.43 69.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.812 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.68 70.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.109 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.79 -34.19 71.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.713 0.292 . . . . 0.0 111.657 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.561 ' OE1' ' HA ' ' A' ' 71' ' ' PRO . 28.3 mt-30 -70.28 -23.84 62.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.35 -18.2 36.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 46' ' ' ALA . 8.5 mt -94.09 -25.07 17.32 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 6.2 p -105.65 -47.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -157.27 143.38 17.8 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.434 ' HB3' ' CG ' ' A' ' 80' ' ' TYR . . . -56.06 121.0 38.33 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.24 0.338 . . . . 0.0 110.283 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.561 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 80.6 Cg_exo -52.87 136.35 59.57 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 123.108 2.539 . . . . 0.0 112.586 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -92.22 41.33 1.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.016 0.912 . . . . 0.0 109.943 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.87 133.87 36.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.636 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.8 140.11 86.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 O-C-N 123.219 0.324 . . . . 0.0 111.175 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 73.4 Cg_endo -77.45 132.39 26.97 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.922 -1.699 . . . . 0.0 112.957 0.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -66.81 128.02 34.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.704 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.8 126.75 28.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.085 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -108.94 164.46 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 60.14 36.45 21.1 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.513 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.434 ' CG ' ' HB3' ' A' ' 70' ' ' ALA . 36.1 p90 -94.85 142.01 24.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.94 138.23 28.12 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.224 1.949 . . . . 0.0 111.621 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.39 124.82 23.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.48 -10.14 73.29 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.249 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.17 -164.94 53.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.923 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -91.0 -23.35 20.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.386 0.613 . . . . 0.0 109.385 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.452 HG23 ' HB3' ' A' ' 67' ' ' LEU . 12.1 tt -142.6 138.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -68.98 -26.72 65.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -130.6 166.49 20.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.67 0.271 . . . . 0.0 110.449 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.3 127.63 90.0 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.745 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.6 136.08 64.73 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.556 2.171 . . . . 0.0 112.058 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -128.3 146.9 50.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.268 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.677 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.8 p30 -73.24 153.39 90.39 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.16 -16.93 13.73 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.587 2.858 . . . . 0.0 114.049 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.436 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.7 m-90 -80.63 -25.82 38.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.821 0.344 . . . . 0.0 110.405 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.72 13.91 6.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.041 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.677 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 9.0 m -101.17 143.74 30.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.87 0.367 . . . . 0.0 110.462 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.84 132.65 34.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.332 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -60.34 143.57 52.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.904 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 81.9 mm-40 -118.49 137.86 52.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.907 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.485 HD21 ' CG2' ' A' ' 111' ' ' ILE . 3.1 tm? -113.34 123.19 49.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -118.6 113.55 21.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.043 0.449 . . . . 0.0 110.338 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t -106.04 130.8 22.42 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.74 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.48 153.26 94.45 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 124.241 -1.149 . . . . 0.0 111.591 -3.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.59 145.54 49.75 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.247 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -78.26 -24.22 46.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.12 0.486 . . . . 0.0 110.278 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -119.16 -16.2 9.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.59 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.28 -148.84 4.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.439 ' HG2' ' CD2' ' A' ' 57' ' ' TYR . 25.1 tp60 -73.73 -45.68 50.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.956 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.464 ' HB ' HD23 ' A' ' 100' ' ' LEU . 4.3 m -142.81 127.65 15.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.721 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.0 122.07 43.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -174.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' GLN . 10.0 pt -106.54 126.59 62.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -142.07 153.59 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.27 0.557 . . . . 0.0 112.031 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.0 t -99.92 138.29 37.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.241 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.67 -20.19 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.307 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.436 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 64.68 -163.87 35.68 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.221 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.41 -25.93 29.73 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.344 2.696 . . . . 0.0 111.858 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.461 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 7.8 p-10 -80.9 -14.63 57.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.186 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.17 12.27 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.381 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 1.089 ' O ' ' OG ' ' A' ' 122' ' ' SER . 41.9 t -109.54 131.19 22.03 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-N 116.734 0.267 . . . . 0.0 111.146 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.534 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 66.2 Cg_endo -76.0 149.47 32.8 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.974 2.449 . . . . 0.0 111.89 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 43.1 mt-10 70.87 15.54 6.78 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.378 0.671 . . . . 0.0 110.793 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 1.089 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -87.39 177.16 7.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.536 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -41.38 98.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.501 0.667 . . . . 0.0 109.638 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.461 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 10.7 m-20 -88.88 65.55 7.63 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.67 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -130.54 91.82 3.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.582 174.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.86 104.62 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.701 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -117.25 174.52 15.26 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.736 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.13 -35.42 73.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -78.98 -31.26 44.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -64.0 -45.23 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.972 0.415 . . . . 0.0 110.767 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 tp -82.65 -26.68 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.811 0.815 . . . . 0.0 109.731 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-N 114.771 -1.104 . . . . 0.0 114.083 170.004 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.162 0.506 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 96.3 mttt -59.07 -46.04 89.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.18 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.43 97.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.282 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.77 -47.8 79.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.313 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -69.45 -35.22 75.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.307 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 52.4 mt-30 -59.07 -37.57 77.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 110.701 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.01 -37.95 85.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.0 t -61.16 -47.13 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.669 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -60.35 -37.9 75.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -62.0 -43.53 98.65 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.887 0.375 . . . . 0.0 111.378 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.79 -35.03 74.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.257 0.551 . . . . 0.0 110.088 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.25 -46.26 89.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.344 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -64.6 -34.9 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.36 96.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.681 0.277 . . . . 0.0 110.433 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' O ' HD11 ' A' ' 47' ' ' LEU . 94.3 mt -61.85 -49.51 75.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.069 0.461 . . . . 0.0 110.631 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -62.41 -40.46 96.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.721 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -62.68 -43.81 98.43 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.916 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -62.69 -38.52 90.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 110.918 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 43' ' ' LEU . 3.2 mp -61.66 -45.82 92.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.416 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.15 -40.39 97.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.1 mtt -65.98 -41.95 90.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.676 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.411 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 50.6 t80 -63.73 -40.99 98.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.268 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HD2' ' CE2' ' A' ' 57' ' ' TYR . 83.6 tttt -66.95 -34.68 78.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.854 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.06 -41.89 99.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.177 0.513 . . . . 0.0 110.263 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -76.76 -46.76 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.209 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.1 m-80 -105.79 -1.74 23.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -169.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m 62.99 34.28 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.542 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -170.31 165.85 8.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.449 0.166 . . . . 0.0 110.599 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.542 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 74.9 m-85 -87.4 136.43 33.34 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.05 150.55 60.58 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.87 2.38 . . . . 0.0 112.864 -174.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.415 ' HA ' ' OG ' ' A' ' 102' ' ' SER . 11.4 p -77.59 175.74 9.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.956 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -53.5 -38.59 63.85 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.97 -46.39 44.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -73.49 -29.72 62.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.134 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.75 67.13 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.146 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.31 -32.46 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -73.08 -25.92 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.115 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.6 65.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -167.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.544 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.4 pt? -103.72 -2.28 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -116.15 -45.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 111.62 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -156.69 131.86 9.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.79 121.24 27.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.39 0.431 . . . . 0.0 111.137 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -57.84 137.04 79.07 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.054 2.503 . . . . 0.0 112.406 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.4 m -79.89 -23.91 41.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.975 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.61 138.75 51.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.677 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -77.85 145.67 70.77 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 11.5 Cg_exo -71.09 135.92 38.99 Favored 'Cis proline' 0 C--O 1.233 0.238 0 C-N-CA 123.32 -1.533 . . . . 0.0 112.003 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -73.48 125.19 27.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.937 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.47 123.49 17.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.57 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -112.29 165.23 12.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.765 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 61.73 42.77 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.601 . . . . 0.0 110.221 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.5 145.51 31.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.822 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.63 138.71 19.5 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.988 1.792 . . . . 0.0 111.569 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.9 124.87 23.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.49 76.12 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.182 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.08 -160.75 50.41 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.362 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -96.78 -16.28 20.91 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.82 134.92 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.567 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.6 -21.94 61.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.056 -170.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -130.54 156.31 45.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.537 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.7 mt -55.84 120.98 37.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.718 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.13 134.0 59.13 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -130.49 138.53 50.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.803 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -61.05 152.65 70.26 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.24 -21.34 22.35 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.306 2.67 . . . . 0.0 112.832 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -81.54 -18.18 45.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.84 21.86 8.36 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.992 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 p -101.65 143.55 31.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.897 0.38 . . . . 0.0 111.075 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.97 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -57.51 149.41 21.18 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 0.0 111.508 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -111.56 137.45 49.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.554 -175.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.485 HD22 ' CG2' ' A' ' 111' ' ' ILE . 3.1 tm? -131.88 122.73 26.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.25 113.95 13.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.655 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 59' ' ' THR . 60.0 p -107.01 129.92 23.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.829 173.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.56 150.72 88.02 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.716 -3.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.498 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -78.41 156.98 43.8 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.278 -172.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.59 -43.05 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -92.63 -2.56 56.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.64 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.6 -164.03 26.54 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.874 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -72.07 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 109.439 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.3 121.26 63.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.676 169.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.498 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 6.8 t0 -93.39 114.36 26.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -172.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.485 ' CG2' HD22 ' A' ' 100' ' ' LEU . 12.5 pt -113.6 123.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -151.94 162.24 41.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.2 m -119.31 140.27 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.407 HD13 ' OE1' ' A' ' 99' ' ' GLN . 1.1 mm? -62.69 -32.27 73.33 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.1 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 -170.83 41.23 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.25 -16.16 39.5 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 122.735 2.29 . . . . 0.0 111.757 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.73 -14.12 32.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.232 -173.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.403 ' CA ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.34 8.33 70.35 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.019 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.45 ' O ' ' OD2' ' A' ' 125' ' ' ASP . 41.9 t -94.68 111.26 53.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.194 0.497 . . . . 0.0 111.791 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.08 146.54 25.64 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.403 2.736 . . . . 0.0 112.539 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 62.25 35.5 15.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.405 0.621 . . . . 0.0 111.359 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.602 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.3 p -109.2 172.64 6.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.407 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -66.25 -30.41 70.84 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.96 52.62 2.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.908 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.602 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.8 OUTLIER -126.71 136.06 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 176.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mm -100.59 101.03 11.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.68 157.7 15.8 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.74 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -61.97 -38.03 87.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 110.552 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 79.8 t90 -68.49 -31.11 70.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.744 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -78.8 -34.21 45.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.3 tp -87.65 -31.51 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.464 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.259 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.405 176.001 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 44.6 tt0 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -54.73 -49.29 71.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.378 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -72.45 -44.85 61.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.036 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.94 -46.0 86.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.194 -173.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 36.9 ptt180 -69.1 -33.79 74.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.81 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -59.5 -35.96 75.15 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.21 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 82.6 mttt -62.19 -44.34 96.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.596 0.712 . . . . 0.0 109.287 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.23 -47.09 95.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.179 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 41' ' ' VAL . 57.6 t -59.47 -38.73 76.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 t -59.82 -46.53 88.96 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.952 0.406 . . . . 0.0 110.532 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 89.7 m-20 -68.46 -34.65 76.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.144 0.497 . . . . 0.0 110.197 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.34 -43.37 96.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.591 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 37' ' ' VAL . 26.2 t -62.66 -37.39 78.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.0 91.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.984 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.665 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 95.7 mt -63.9 -49.69 71.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.362 . . . . 0.0 110.561 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.06 -33.95 75.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.76 91.82 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.483 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -60.32 -43.11 96.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.826 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.665 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 45.3 mt -59.64 -42.78 93.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.616 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.42 -44.04 95.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.59 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.502 ' SD ' ' HE2' ' A' ' 85' ' ' TYR . 92.0 mtp -67.66 -42.25 82.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.443 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.537 ' CD2' ' HG3' ' A' ' 58' ' ' PRO . 77.2 t80 -63.87 -43.82 94.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.497 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -69.34 -33.17 72.71 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.067 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.57 -45.92 92.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.158 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.52 -46.97 24.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.552 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -95.21 -6.45 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m 65.54 24.18 11.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 150.0 18.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.568 0.223 . . . . 0.0 110.682 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -75.24 145.25 79.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.779 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.537 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 6.2 Cg_exo -75.05 162.37 37.11 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.759 2.306 . . . . 0.0 112.28 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -83.84 177.4 8.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.953 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.0 t -51.41 -42.72 61.64 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.59 -45.0 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.401 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.83 -31.24 70.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.05 -49.38 47.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.177 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.81 -38.52 76.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.864 0.364 . . . . 0.0 111.493 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.57 -24.0 61.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.975 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -25.7 63.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -168.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -103.3 -1.32 28.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.214 -177.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -117.64 -39.99 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.56 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.1 m -156.61 129.18 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -55.42 121.62 39.01 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.642 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 46.4 Cg_exo -57.64 136.93 78.7 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.007 2.471 . . . . 0.0 112.699 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 p -85.13 -16.21 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.597 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.16 137.79 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.44 142.63 67.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.404 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 11.4 Cg_exo -72.19 138.11 52.36 Favored 'Cis proline' 0 C--O 1.236 0.39 0 C-N-CA 123.351 -1.52 . . . . 0.0 112.051 -2.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.6 128.67 36.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.87 125.38 23.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.392 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -113.97 163.9 14.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.122 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 56.47 36.36 27.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.343 0.592 . . . . 0.0 110.998 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -98.07 146.11 30.95 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.058 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.36 138.91 28.14 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.752 1.635 . . . . 0.0 110.213 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.37 123.97 21.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.22 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.34 88.12 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.709 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.8 -115.39 7.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.261 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.502 ' HE2' ' SD ' ' A' ' 49' ' ' MET . 60.4 m-85 -134.48 -3.43 2.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.886 0.375 . . . . 0.0 110.786 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.6 136.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -75.43 -22.19 57.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -170.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -130.57 171.16 13.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.814 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.09 127.55 80.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.472 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.77 124.84 11.92 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.533 2.156 . . . . 0.0 112.431 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -130.4 148.75 52.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.761 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.578 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.3 p30 -69.4 152.84 96.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.89 -16.22 25.1 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.532 2.821 . . . . 0.0 113.0 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.475 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 5.6 m-90 -80.53 -25.71 38.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.553 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.41 9.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.376 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.578 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 19.3 m -100.18 157.99 16.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.12 0.46 . . . . 0.0 110.786 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.49 138.67 31.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.804 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -68.6 164.36 21.61 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 87.7 mm-40 -130.62 146.68 52.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.187 0.518 . . . . 0.0 111.486 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.444 HD22 HG23 ' A' ' 111' ' ' ILE . 2.4 tm? -133.01 122.85 24.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -120.83 112.49 18.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -107.49 131.46 21.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.926 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.43 146.58 68.96 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.43 -1.488 . . . . 0.0 110.998 -5.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.68 159.86 48.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.501 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -92.8 -37.35 12.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 129' ' ' TRP . 97.5 m-70 -76.4 -56.19 4.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.634 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.71 -150.18 7.78 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.791 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -73.35 -36.23 66.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.55 131.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.474 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.6 m-20 -104.27 115.0 29.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.777 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.444 HG23 HD22 ' A' ' 100' ' ' LEU . 9.0 pt -106.69 126.51 62.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -145.9 159.55 43.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.818 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 3.0 m -116.15 124.6 50.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.235 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.444 ' HB3' ' C ' ' A' ' 118' ' ' GLY . 62.6 mt -61.39 -34.93 76.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.737 -174.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.475 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 86.79 -166.84 37.82 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.15 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.24 -18.83 44.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.64 -13.53 24.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.912 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.444 ' C ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.54 8.82 72.59 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.781 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.811 ' O ' ' OD2' ' A' ' 125' ' ' ASP . 61.6 t -93.38 114.93 64.21 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -173.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.62 154.31 34.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.373 2.715 . . . . 0.0 113.101 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 62.89 16.17 8.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.549 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 1.055 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -89.51 177.03 6.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.444 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -71.69 -37.1 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -88.14 62.63 6.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 1.055 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -138.05 109.14 6.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.721 175.035 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.3 mm -77.17 103.11 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.957 0.408 . . . . 0.0 110.528 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.05 159.49 14.05 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.149 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -67.85 -39.46 83.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.085 0.469 . . . . 0.0 110.521 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.414 ' CG ' ' HB3' ' A' ' 106' ' ' HIS . 93.1 t90 -66.34 -31.04 71.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.656 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.7 p -83.89 -29.52 27.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.714 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.1 tp -82.7 -27.66 8.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.849 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.951 177.787 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.746 0.308 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.25 -42.2 98.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.987 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.23 73.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.496 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.7 m-20 -60.92 -47.56 85.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.642 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 37' ' ' VAL . 32.1 ptt180 -69.5 -35.21 75.31 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.827 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -62.33 -35.17 78.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.634 0.254 . . . . 0.0 110.828 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.14 -41.94 98.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.487 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 95.9 t -60.69 -44.46 97.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.99 176.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 33' ' ' ARG . 90.3 t -60.22 -39.37 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.327 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 41' ' ' VAL . 37.9 t -62.18 -46.77 87.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.105 0.479 . . . . 0.0 110.681 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.96 -34.1 71.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.336 0.589 . . . . 0.0 110.311 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 17.8 tp -60.65 -44.84 95.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.206 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 38' ' ' SER . 27.7 m -65.68 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.456 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.54 97.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.859 0.361 . . . . 0.0 110.195 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 47' ' ' LEU . 96.1 mt -61.43 -48.95 78.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.776 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.63 -42.53 98.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.33 -38.09 95.67 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.053 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -42.45 96.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.861 0.362 . . . . 0.0 110.277 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.6 mp -62.25 -48.1 81.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.196 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.06 -41.13 97.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.297 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.16 -37.46 72.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.32 -41.19 98.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -68.43 -32.62 72.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.36 -48.9 73.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.905 0.383 . . . . 0.0 110.214 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.66 -39.73 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.453 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.0 m-80 -106.69 11.74 30.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.5 m 73.17 -43.19 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -117.82 164.53 14.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.712 0.292 . . . . 0.0 111.552 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -71.18 148.16 93.81 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.933 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.73 149.36 48.36 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.031 2.487 . . . . 0.0 112.529 177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.8 p -85.69 179.73 7.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -50.2 -38.89 42.27 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.42 -44.72 34.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.279 0.562 . . . . 0.0 110.677 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.87 -30.29 65.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.323 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.3 -51.17 60.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.645 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 mp -71.28 -33.54 69.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.962 0.41 . . . . 0.0 111.506 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -68.49 -26.69 65.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.809 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -23.53 63.88 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD12 ' CG2' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -103.74 -2.2 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.5 p -122.93 -48.33 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.831 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 p -152.08 128.61 10.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.608 0.242 . . . . 0.0 110.484 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.9 121.81 37.35 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.085 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.57 144.45 85.01 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.077 2.518 . . . . 0.0 112.307 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.411 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 25.4 t -94.97 2.51 55.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.17 131.26 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.461 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 8.1 tp10 -77.79 138.65 62.0 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.208 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 14.3 Cg_exo -67.03 130.84 14.08 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.565 -1.431 . . . . 0.0 112.62 0.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.411 ' CE1' ' HA ' ' A' ' 72' ' ' SER . 3.8 t60 -74.0 131.16 41.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.723 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.48 127.99 34.78 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.524 0.515 . . . . 0.0 111.576 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -114.2 167.09 10.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.844 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.3 p30 52.76 31.39 10.37 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -80.32 139.17 51.99 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.775 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.21 140.5 24.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.551 2.167 . . . . 0.0 111.719 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.36 125.07 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.178 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.54 3.18 86.67 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.45 -161.89 53.45 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.362 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.56 -22.51 24.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.428 ' CG2' HD12 ' A' ' 67' ' ' LEU . 8.3 tt -139.39 134.08 39.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.769 173.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -60.98 -29.31 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.608 -169.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -133.75 160.24 38.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.51 122.34 59.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.539 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.45 149.45 80.27 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.427 2.084 . . . . 0.0 111.876 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -140.76 140.71 34.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.788 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 1.9 p30 -63.82 152.98 85.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.22 -15.68 15.19 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.816 3.011 . . . . 0.0 113.812 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -79.05 -26.06 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.03 19.6 8.02 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.603 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.589 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 0.7 OUTLIER -95.96 151.35 19.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.417 . . . . 0.0 110.553 -178.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.25 122.6 31.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.487 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 56.6 m-85 -54.66 140.8 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.024 0.44 . . . . 0.0 111.284 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -113.69 137.89 50.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.454 HD23 ' CG2' ' A' ' 111' ' ' ILE . 2.8 tm? -118.79 122.02 41.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.405 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 1.7 tm? -122.54 113.98 20.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.887 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 p -106.35 130.52 22.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.81 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.5 139.97 63.72 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.385 -1.09 . . . . 0.0 111.93 -1.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 101' ' ' LEU . . . -60.62 143.82 47.99 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.358 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.407 ' H ' ' HB2' ' A' ' 110' ' ' ASP . 23.9 tp60 -58.52 -36.24 73.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.887 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -119.45 21.79 11.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.592 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.96 -147.92 11.72 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.816 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -45.44 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.659 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.449 ' HB ' HD22 ' A' ' 100' ' ' LEU . 3.1 m -137.67 146.96 26.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.503 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER -127.48 121.5 30.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.966 -177.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.454 ' CG2' HD23 ' A' ' 100' ' ' LEU . 7.0 pt -106.59 125.41 62.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.973 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -151.53 156.57 40.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 0.0 111.609 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.416 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 54.6 p -100.04 155.08 17.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -17.77 63.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 110.97 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.24 -172.0 55.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.437 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.01 -22.2 35.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.151 2.567 . . . . 0.0 112.273 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.72 ' OD2' HG11 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -94.91 -14.99 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.333 -173.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.51 -5.54 44.31 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.72 HG11 ' OD2' ' A' ' 117' ' ' ASP . 2.8 p -97.44 128.68 33.9 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.375 1.588 . . . . 0.0 110.683 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.686 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 56.0 Cg_endo -73.13 159.71 46.93 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.749 2.3 . . . . 0.0 113.398 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 69.37 15.83 8.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.296 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 1.003 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.3 p -98.97 175.35 5.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -77.9 -22.4 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.987 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -79.88 -11.24 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 1.003 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 1.0 OUTLIER -71.56 89.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.891 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.417 ' HA ' HG21 ' A' ' 130' ' ' THR . 46.6 mm -66.58 105.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.351 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 130' ' ' THR . . . -135.35 -161.8 9.47 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.406 ' HA ' HD21 ' A' ' 40' ' ' LEU . 10.6 t-20 -62.42 -38.11 88.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.618 0.247 . . . . 0.0 111.621 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -79.66 -30.86 41.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.417 HG21 ' HA ' ' A' ' 126' ' ' ILE . 5.4 t -69.16 -33.09 72.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.591 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.45 -34.93 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.376 173.379 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 27.6 tt0 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -64.11 -35.1 79.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -176.125 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -71.2 -38.21 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.573 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.54 -49.06 79.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 2.5 ptp180 -69.92 -36.63 75.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.484 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -60.89 -35.87 77.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.02 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 67.6 mttm -68.12 -39.73 82.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.094 0.473 . . . . 0.0 109.966 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.586 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 35.4 t -61.04 -47.78 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.716 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 33' ' ' ARG . 58.9 t -62.91 -38.32 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -61.77 -46.22 90.53 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -69.94 -35.34 74.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.107 0.48 . . . . 0.0 110.266 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.93 -46.13 86.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.437 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 37' ' ' VAL . 25.1 m -66.02 -36.12 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.13 85.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.47 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.696 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 68.2 mt -60.12 -48.26 82.46 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.556 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.92 -36.28 78.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.065 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.06 -46.06 93.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.615 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -62.55 -38.72 91.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.576 0.227 . . . . 0.0 110.617 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 37.4 mt -65.15 -50.42 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.362 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.39 -44.39 97.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.399 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -70.31 -35.76 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.963 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.521 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.6 t80 -58.64 -44.75 90.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.43 -33.12 73.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.6 tp -62.82 -51.03 68.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.565 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.45 ' OD1' ' HB3' ' A' ' 78' ' ' ARG . 16.2 t70 -78.51 -46.95 18.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -93.49 -0.07 56.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.861 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m 70.01 7.25 6.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.58 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -160.53 157.14 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.58 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 m-85 -74.29 148.22 85.99 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.178 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 60.4 Cg_endo -73.27 155.85 51.24 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.843 2.362 . . . . 0.0 112.456 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -86.06 178.18 7.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.33 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -51.31 -40.33 58.79 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -173.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -76.04 -43.28 44.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.352 0.596 . . . . 0.0 110.733 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -72.6 -27.46 62.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.5 56.12 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.964 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -33.47 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.172 0.486 . . . . 0.0 111.018 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -71.74 -25.18 61.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.677 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.58 -22.88 62.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 86' ' ' ILE . 9.3 mt -87.75 -19.1 28.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.25 -48.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 t -144.09 129.95 19.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.44 121.21 41.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.032 -175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.33 136.91 75.7 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.127 2.551 . . . . 0.0 112.594 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 m -80.07 -16.59 54.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.281 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.89 146.92 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.699 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.05 136.31 69.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.17 131.99 24.43 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.776 -1.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.32 120.94 11.39 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.425 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . . . -55.89 121.22 8.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.931 0.396 . . . . 0.0 110.158 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 22.0 tpt180 -110.38 154.81 23.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.347 -176.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 64.87 43.02 4.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.421 0.629 . . . . 0.0 110.213 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -100.47 140.23 21.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.296 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.7 144.0 58.29 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.744 2.296 . . . . 0.0 111.914 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.31 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.14 4.28 78.15 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.44 -159.58 51.84 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.326 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -88.03 -30.51 19.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 67' ' ' LEU . 7.6 tt -135.44 124.46 40.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.148 172.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -65.7 -20.25 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.538 ' HD2' ' O ' ' A' ' 89' ' ' LEU . 8.1 tmm_? -129.64 146.53 51.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -174.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.538 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 4.3 mm? -54.28 122.45 37.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 123.292 0.37 . . . . 0.0 111.159 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.38 124.44 15.55 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.945 1.764 . . . . 0.0 110.403 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 89' ' ' LEU . 90.9 mt-30 -134.79 144.38 47.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.989 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.593 ' OD2' ' HB2' ' A' ' 113' ' ' SER . 0.5 OUTLIER -56.34 145.17 59.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.76 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.93 -19.85 41.79 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.97 2.447 . . . . 0.0 112.437 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -80.78 -13.93 58.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.344 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.14 20.16 9.47 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.941 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -99.2 160.69 14.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.569 0.223 . . . . 0.0 110.568 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.66 122.97 48.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.375 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.586 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 52.8 m-85 -53.97 148.04 11.32 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.507 0.67 . . . . 0.0 112.599 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.46 ' HG2' HD21 ' A' ' 114' ' ' LEU . 62.1 mm-40 -112.01 138.6 48.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.036 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 2.2 tm? -129.39 122.64 29.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.72 113.45 17.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.883 0.373 . . . . 0.0 110.414 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -106.93 128.53 25.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.091 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.71 137.38 32.35 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.403 -1.082 . . . . 0.0 111.428 -3.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.426 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -67.35 169.35 36.75 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.768 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 6.1 tp60 -95.84 -28.08 14.9 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 0.0 109.862 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -93.25 -5.76 49.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.781 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.61 10.57 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.08 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -72.74 -45.32 59.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.971 0.415 . . . . 0.0 110.348 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.405 ' HB ' HD21 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -127.97 124.56 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 177.335 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -100.01 112.68 24.96 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.874 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.494 HG21 HD22 ' A' ' 100' ' ' LEU . 7.5 pt -112.43 125.5 69.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -151.47 155.08 37.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.593 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 15.9 p -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.358 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.664 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 3.4 mm? -100.98 -12.66 18.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 110.822 -174.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 62.87 -154.9 42.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.275 173.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.05 -33.39 19.39 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.383 2.722 . . . . 0.0 113.135 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.571 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 2.8 p30 -83.7 -14.08 52.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.738 -0.385 . . . . 0.0 112.028 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.97 -3.96 18.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.755 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 1.045 ' O ' ' OG ' ' A' ' 122' ' ' SER . 24.3 m -107.83 139.47 20.66 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-N 117.329 0.565 . . . . 0.0 112.159 -173.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.7 155.31 39.73 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.505 2.803 . . . . 0.0 112.834 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 61.1 25.53 15.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.772 0.796 . . . . 0.0 110.74 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 1.045 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -93.49 174.61 7.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.116 -179.475 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.38 -41.87 98.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.696 0.76 . . . . 0.0 109.19 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.571 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 4.6 m-20 -99.3 75.24 1.98 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.54 1.162 . . . . 0.0 109.248 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.952 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 55.9 m-20 -143.39 112.67 6.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.259 169.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.544 ' HB ' ' HG ' ' A' ' 113' ' ' SER . 44.6 mm -87.34 104.9 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 109.999 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -95.23 157.19 21.93 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.673 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.435 ' HB2' HG13 ' A' ' 111' ' ' ILE . 62.6 t30 -65.89 -28.55 69.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.291 0.567 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -78.36 -23.63 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -81.03 -29.44 35.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 tp -78.37 -21.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.799 0.333 . . . . 0.0 110.938 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.096 -1.05 . . . . 0.0 113.405 176.172 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 4.8 tp10 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.71 0.291 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 53.3 mtmt -58.77 -40.68 84.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.61 -44.96 88.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.345 . . . . 0.0 110.811 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.42 -40.53 77.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.981 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.597 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 13.1 ptm180 -65.9 -33.67 76.36 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.996 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm100 -62.99 -31.59 72.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 87.7 mttt -64.69 -39.22 93.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.597 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 31.2 t -60.7 -46.46 95.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.632 175.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.6 t -58.63 -38.78 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.061 0.458 . . . . 0.0 110.558 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 m -63.4 -43.87 96.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.891 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.9 -35.17 74.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.304 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.39 -45.25 95.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.187 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 38' ' ' SER . 23.7 m -64.64 -35.72 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.26 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.74 85.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.614 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.71 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 87.5 mt -60.55 -48.4 81.92 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.135 0.493 . . . . 0.0 110.101 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.65 -35.96 82.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.586 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.99 -42.92 99.77 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.556 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . . . -60.53 -43.96 96.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.362 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 48.7 mt -59.42 -49.07 79.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.662 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.65 -41.59 97.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.994 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.57 -38.64 74.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.976 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.98 -33.25 73.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.44 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.88 -49.75 76.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.709 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.94 -47.01 17.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.9 10.12 41.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m 70.99 -7.2 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -139.0 148.7 43.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.829 -0.545 . . . . 0.0 111.455 -175.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -69.25 142.73 92.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.0 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.69 155.99 49.15 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 123.051 2.501 . . . . 0.0 112.694 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 p -81.89 177.11 9.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.398 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -51.65 -41.39 61.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.4 -45.39 39.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.066 0.46 . . . . 0.0 110.573 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.407 ' HG2' ' HB3' ' A' ' 71' ' ' PRO . 50.4 mt-30 -68.39 -31.61 71.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.189 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' HD23 ' A' ' 100' ' ' LEU . . . -62.57 -48.85 78.67 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.086 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.44 -32.41 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -72.12 -29.17 63.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.986 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.83 60.72 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 46' ' ' ALA . 7.6 mt -89.95 -9.79 47.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.33 -53.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 p -144.74 139.14 27.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.08 122.24 46.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HB3' ' HG2' ' A' ' 62' ' ' GLN . 52.1 Cg_exo -56.24 137.38 79.6 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.875 2.383 . . . . 0.0 111.776 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -84.64 -16.04 43.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.622 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 135.86 48.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.229 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -77.57 140.56 64.2 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.146 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 57.7 Cg_endo -72.09 132.11 24.22 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.232 -0.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -66.96 129.79 41.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.692 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.6 17.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.687 0.28 . . . . 0.0 110.416 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.492 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 29.0 tpt180 -109.26 162.95 13.81 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -177.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.492 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 9.5 p30 47.83 39.75 11.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.902 0.881 . . . . 0.0 111.795 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -85.14 147.29 47.29 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.025 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.19 138.81 48.35 Favored 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.283 1.988 . . . . 0.0 111.446 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.54 124.08 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.24 10.47 86.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.371 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.71 -121.05 21.62 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.764 0.332 . . . . 0.0 112.639 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.482 ' HB2' ' CD2' ' A' ' 67' ' ' LEU . 51.1 m-85 -114.03 -17.8 11.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.449 0.642 . . . . 0.0 109.553 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 88' ' ' ARG . 6.1 tt -143.15 129.12 16.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.818 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -60.77 -23.12 64.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -167.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.449 ' O ' HG12 ' A' ' 86' ' ' ILE . 59.6 mtp180 -130.42 167.12 19.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.61 ' C ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -60.74 133.2 91.78 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.69 137.32 63.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.787 2.324 . . . . 0.0 112.46 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -133.48 150.7 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.149 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.426 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 7.7 m-20 -55.88 150.85 26.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.88 -17.96 39.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.181 . . . . 0.0 111.623 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.486 ' CZ3' ' HA2' ' A' ' 115' ' ' GLY . 6.3 m-90 -81.96 -12.3 58.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.315 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.2 10.79 31.1 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.699 -0.762 . . . . 0.0 114.001 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -102.31 143.41 32.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.352 0.576 . . . . 0.0 111.022 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.1 130.7 38.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -61.28 163.13 6.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.772 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -127.93 139.43 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.641 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.492 HD12 ' HB ' ' A' ' 109' ' ' VAL . 13.3 tp -122.89 142.51 50.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.361 173.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.65 112.83 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.481 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -107.55 129.67 23.9 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.144 172.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.09 135.66 26.72 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.465 -1.056 . . . . 0.0 110.956 -5.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.415 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -68.85 174.45 32.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.359 -173.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -94.73 -27.67 15.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.172 0.511 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -99.81 21.83 11.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 151.26 -155.26 26.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.493 HE22 ' HA ' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -73.52 -36.83 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.015 0.407 . . . . 0.0 111.21 177.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.492 ' HB ' HD12 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -132.78 129.05 57.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 -178.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.415 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 0.4 OUTLIER -107.53 114.19 28.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.475 -179.058 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 128' ' ' ASN . 5.5 pt -106.88 126.87 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.45 . . . . 0.0 110.025 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -145.02 148.35 33.62 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.5 m -106.82 137.18 45.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.513 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.46 -35.26 79.85 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.82 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.486 ' HA2' ' CZ3' ' A' ' 94' ' ' TRP . . . 86.69 -177.31 48.28 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.606 -176.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.85 -15.36 40.39 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.012 2.474 . . . . 0.0 112.926 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.604 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 15.9 p-10 -92.37 -12.5 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.723 -174.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.86 67.33 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.679 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.785 ' O ' ' OG ' ' A' ' 122' ' ' SER . 58.9 t -110.76 121.13 41.87 Favored Pre-proline 0 C--O 1.244 0.815 0 CA-C-O 120.744 0.307 . . . . 0.0 111.141 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.603 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 72.0 Cg_endo -76.13 156.5 38.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.411 2.74 . . . . 0.0 113.448 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 62.65 25.94 15.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.75 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.871 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -101.03 172.86 6.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.951 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.48 -32.48 73.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.81 -19.01 60.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.142 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.871 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -62.0 138.71 58.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.986 -174.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -104.87 104.97 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.737 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.71 169.74 13.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.203 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.404 ' HB2' HG13 ' A' ' 111' ' ' ILE . 62.8 t30 -62.38 -33.98 75.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 110.568 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -77.9 -20.24 53.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.271 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -73.48 -46.5 47.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.109 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.95 -22.3 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 110.147 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.048 168.49 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.6 tp10 . . . . . 0 C--O 1.233 0.196 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 87.7 tttt -60.27 -41.85 94.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.01 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.89 -40.32 75.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.677 0.275 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 36' ' ' VAL . 49.4 m-20 -62.49 -47.56 83.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 13.9 ptm180 -68.19 -36.73 80.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.554 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.452 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 12.5 mm-40 -63.95 -35.15 79.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -66.44 -37.73 85.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.703 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 32' ' ' ASP . 85.9 t -60.68 -44.01 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.011 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 33' ' ' ARG . 96.7 t -59.94 -40.09 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.972 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.59 -45.65 93.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.449 ' HB2' ' HH ' ' A' ' 98' ' ' TYR . 15.2 m-20 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.116 0.484 . . . . 0.0 110.018 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.5 tp -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.318 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.21 -36.64 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.31 94.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.538 ' O ' HD11 ' A' ' 47' ' ' LEU . 7.5 mp -60.67 -49.03 79.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -63.35 -36.92 85.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.953 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.39 96.89 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.217 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.513 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -60.52 -41.69 94.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.696 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.538 HD11 ' O ' ' A' ' 43' ' ' LEU . 5.8 mp -59.75 -39.94 86.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.873 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.14 -36.21 79.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -42.94 77.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -65.7 -38.69 89.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -70.21 -32.79 70.85 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.774 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.4 tp -68.29 -40.98 81.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.032 0.444 . . . . 0.0 110.221 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.14 -44.96 28.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.422 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.568 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.6 m-80 -112.16 5.35 18.45 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -171.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.2 m 66.95 9.24 6.71 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -147.37 167.59 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.966 -0.459 . . . . 0.0 111.016 -177.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.404 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 21.9 m-85 -91.2 142.83 27.56 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.382 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.83 162.18 39.94 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.378 2.719 . . . . 0.0 113.632 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.2 p -88.07 178.87 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.182 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.0 m -50.13 -46.48 53.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.832 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.43 -44.9 61.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.501 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -64.98 -42.43 94.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.444 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.34 -44.49 98.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.702 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.437 HD22 ' O ' ' A' ' 98' ' ' TYR . 2.7 mp -69.66 -41.27 75.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.727 0.298 . . . . 0.0 111.39 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -72.52 -24.54 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.36 69.88 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.576 HD21 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -96.47 -0.28 49.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.932 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.6 -24.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 111.081 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.1 p -157.66 164.23 37.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.549 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.446 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -75.84 121.81 85.79 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.62 136.89 77.02 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.493 2.128 . . . . 0.0 112.136 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.4 m -82.49 -30.47 29.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.475 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.62 122.07 16.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.517 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.501 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -69.85 148.12 96.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.222 -175.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.568 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 14.5 Cg_exo -68.63 136.19 34.97 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.506 1.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -75.97 128.15 34.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.36 126.29 26.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.506 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -106.03 158.16 17.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.477 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.03 43.94 13.87 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.795 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.446 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 34.0 p90 -88.58 139.36 29.73 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.2 140.4 53.51 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.514 2.143 . . . . 0.0 111.38 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -64.31 123.88 20.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.16 86.4 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.927 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.41 -115.05 7.35 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.051 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.3 -21.73 4.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.287 0.565 . . . . 0.0 109.55 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 88' ' ' ARG . 14.0 tt -133.55 138.32 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.43 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 87' ' ' ARG . 38.4 mtp-105 -72.57 -20.8 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.447 ' H ' HG12 ' A' ' 86' ' ' ILE . 74.7 mtp180 -129.38 158.26 39.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.336 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.7 128.39 79.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.69 123.86 14.19 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.56 2.173 . . . . 0.0 112.822 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -127.84 140.39 52.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.636 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 4.8 p30 -68.85 155.58 93.03 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.932 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.53 -31.83 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.836 2.358 . . . . 0.0 113.666 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.435 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 6.5 m-90 -78.03 -19.01 55.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.855 0.359 . . . . 0.0 111.223 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.81 20.97 6.97 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.555 172.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.636 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 4.4 m -103.3 133.23 48.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.106 0.453 . . . . 0.0 110.552 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.79 128.73 37.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.488 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 76.6 m-85 -60.57 168.17 2.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 111.075 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -130.58 137.64 49.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.203 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.543 HD22 ' CG2' ' A' ' 111' ' ' ILE . 3.3 tm? -118.09 122.75 43.91 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.11 114.26 20.1 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.126 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.3 t -106.48 135.45 19.5 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.38 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.36 137.83 52.06 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.525 -1.448 . . . . 0.0 111.804 -3.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.83 141.88 47.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.652 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.96 -21.15 65.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.089 0.471 . . . . 0.0 110.262 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -126.89 31.54 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.29 -150.05 21.71 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.852 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -73.27 -40.21 64.77 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.494 ' HB ' HD21 ' A' ' 100' ' ' LEU . 4.5 m -132.84 151.27 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.886 175.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -131.15 123.03 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.604 0.24 . . . . 0.0 110.446 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.543 ' CG2' HD22 ' A' ' 100' ' ' LEU . 13.0 pt -106.87 129.68 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.541 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -151.13 161.05 43.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.287 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.468 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 44.0 p -112.32 150.92 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.471 175.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.35 -22.2 44.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.85 -171.97 54.11 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.553 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 13.4 Cg_exo -68.39 -23.79 37.61 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.045 2.497 . . . . 0.0 112.191 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.41 -12.43 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 111.291 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.21 11.8 79.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.983 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.8 ' O ' ' OG ' ' A' ' 122' ' ' SER . 98.9 t -97.28 116.8 66.02 Favored Pre-proline 0 C--O 1.239 0.526 0 CA-C-N 117.934 0.867 . . . . 0.0 111.747 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.5 151.77 33.31 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.557 2.838 . . . . 0.0 113.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.06 27.23 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.406 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 1.223 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -100.26 177.33 5.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.008 -176.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.28 -41.89 80.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.474 0.654 . . . . 0.0 109.31 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -88.56 65.39 7.81 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.398 1.094 . . . . 0.0 108.319 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 1.223 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.4 OUTLIER -136.46 90.55 2.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.41 -1.723 . . . . 0.0 108.823 174.46 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.54 109.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.571 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.66 -162.98 10.47 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.754 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -63.27 -37.59 87.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.268 -0.466 . . . . 0.0 111.866 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 -78.63 -27.06 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.674 0.273 . . . . 0.0 110.388 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 m -56.83 -49.31 75.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.905 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.7 tt -92.13 -25.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.501 . . . . 0.0 110.632 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.78 176.581 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.751 0.31 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.25 178.95 33.72 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.279 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -85.73 -32.26 21.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 110.68 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 4.8 ttpp -52.65 -51.93 57.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.051 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -58.28 -41.48 84.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.198 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -61.72 -45.82 92.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.55 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.98 95.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.406 ' OD1' ' HG2' ' A' ' 28' ' ' LYS . 12.0 m-20 -66.52 -47.38 73.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 37' ' ' VAL . 12.8 ptm85 -69.77 -34.77 74.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.465 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -61.07 -38.52 86.49 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.826 0.346 . . . . 0.0 110.688 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -62.4 -39.3 92.78 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 21.6 t -60.94 -47.52 93.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.801 175.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 33' ' ' ARG . 99.9 t -60.31 -38.84 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.996 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 m -59.02 -47.1 86.41 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 5.4 m-20 -70.41 -34.8 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.699 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.52 -44.95 93.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.423 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 37' ' ' VAL . 91.4 t -62.41 -41.34 91.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.288 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.04 90.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.085 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.487 ' O ' HD11 ' A' ' 47' ' ' LEU . 88.3 mt -60.25 -48.65 80.85 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.61 -36.05 81.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.166 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -61.73 -39.65 97.73 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.0 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.498 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -63.02 -39.81 95.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.232 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 43' ' ' LEU . 7.3 mp -60.76 -48.27 82.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.763 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.43 -36.83 85.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 24.6 mmt -68.02 -40.17 83.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.372 . . . . 0.0 110.628 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -63.63 -38.73 92.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.84 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.83 -32.72 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.96 -48.61 78.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 110.443 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.96 -46.56 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.43 HD21 ' HA ' ' A' ' 77' ' ' ALA . 38.5 m-80 -101.22 -0.67 35.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m 62.3 29.05 17.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.519 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -164.15 158.6 19.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -82.93 140.94 43.38 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.398 . . . . 0.0 110.952 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.43 157.91 44.75 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.105 2.537 . . . . 0.0 113.771 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.6 p -84.85 179.04 7.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.791 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.2 t -49.04 -44.78 41.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -171.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.17 -45.16 23.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.503 . . . . 0.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.434 HE21 ' NH2' ' A' ' 56' ' ' ARG . 48.2 mt-30 -64.12 -34.69 78.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.83 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' HD23 ' A' ' 100' ' ' LEU . . . -65.73 -48.84 63.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.922 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.54 -38.33 77.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.903 0.382 . . . . 0.0 111.036 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -72.08 -23.49 61.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.242 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.498 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 11.0 mt -79.4 -18.33 52.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.24 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.93 -59.14 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.125 0.488 . . . . 0.0 111.905 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -152.2 148.39 27.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.94 122.07 50.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.848 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.48 139.83 65.12 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.149 2.566 . . . . 0.0 112.529 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 p -81.18 -18.28 46.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.91 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.25 142.61 54.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.444 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.05 141.6 63.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.246 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 73.4 Cg_endo -76.99 143.72 76.42 Favored 'Cis proline' 0 C--N 1.344 0.294 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.588 -4.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -69.88 121.28 17.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.034 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -58.42 130.9 48.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.807 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -112.66 164.72 13.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.863 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 63.03 32.35 15.47 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.397 0.618 . . . . 0.0 110.658 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -88.86 144.05 32.46 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.896 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.33 139.99 43.13 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.37 2.047 . . . . 0.0 111.992 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.79 125.1 23.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.09 -9.41 60.67 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.789 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.09 -171.41 54.35 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.341 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -83.14 -32.68 26.53 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.409 HG22 ' HB3' ' A' ' 67' ' ' LEU . 9.5 tt -139.07 126.94 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.678 174.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -67.4 -20.59 65.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -128.82 157.82 40.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.65 123.69 72.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.737 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.38 142.95 97.35 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.444 2.096 . . . . 0.0 111.27 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -138.18 144.7 40.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.818 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.49 142.08 52.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.8 -18.72 13.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.349 2.699 . . . . 0.0 113.457 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.414 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 23.1 m-90 -81.65 -14.28 56.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.399 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.14 25.65 5.51 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.29 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 139.6 38.76 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.641 -0.329 . . . . 0.0 110.328 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.494 ' O ' HD23 ' A' ' 114' ' ' LEU . 6.9 m-20 -87.73 119.22 27.84 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.31 -0.244 . . . . 0.0 110.345 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.431 ' HH ' ' HB2' ' A' ' 39' ' ' ASP . 50.1 m-85 -50.95 145.71 6.97 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.748 0.655 . . . . 0.0 111.839 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -121.33 143.97 48.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.287 0.565 . . . . 0.0 111.625 -175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.496 HD13 ' HB ' ' A' ' 109' ' ' VAL . 13.1 tp -122.48 142.27 50.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.741 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -128.08 112.57 14.74 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.555 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -107.4 131.22 21.88 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.438 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.44 143.64 64.9 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.055 -1.227 . . . . 0.0 111.431 -2.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.24 156.14 34.51 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.985 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -73.4 -27.09 61.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.074 0.464 . . . . 0.0 110.559 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -110.53 -27.01 9.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -147.51 -144.96 4.09 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.704 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -73.63 -43.17 60.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -140.64 128.38 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.301 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.82 127.37 54.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.0 111.23 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 pt -106.69 134.73 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.675 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.32 148.16 37.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 111.402 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 4.7 m -103.4 146.68 28.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.058 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 97' ' ' ASP . 1.8 mm? -88.3 -20.5 25.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.704 0.288 . . . . 0.0 111.197 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.26 -160.32 54.01 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.492 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.414 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 12.9 Cg_exo -69.95 -23.81 29.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.481 2.787 . . . . 0.0 112.38 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.487 ' OD2' HG23 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -91.9 -14.24 29.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.077 -173.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.01 5.84 62.77 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.357 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.487 HG23 ' OD2' ' A' ' 117' ' ' ASP . 22.8 m -93.58 118.79 67.56 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 117.548 0.674 . . . . 0.0 111.974 -175.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.49 148.06 29.28 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.38 2.72 . . . . 0.0 113.451 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 63.96 24.78 13.73 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.583 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 1.3 p -93.55 176.97 6.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.97 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -63.65 -41.88 98.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 0.0 110.405 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.51 -22.11 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.447 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.61 ' HA ' ' O ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -56.94 104.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.689 0.618 . . . . 0.0 112.034 -171.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.18 103.66 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.437 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.12 178.6 19.2 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.89 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -68.21 -25.16 65.08 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.618 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -74.94 -31.3 61.47 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.6 m -66.99 -48.03 69.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.582 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 tp -75.75 -37.65 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.295 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.44 29.8 2.2 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -100.77 -12.62 18.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.849 0.357 . . . . 0.0 110.766 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -86.89 76.32 9.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.293 0.568 . . . . 0.0 110.628 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -131.15 -172.42 2.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.874 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 40.2 m80 59.65 34.85 22.3 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.364 0.415 . . . . 0.0 111.196 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -148.03 67.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.287 0.565 . . . . 0.0 110.003 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -135.06 115.67 13.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.891 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -71.42 -16.16 62.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.587 175.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.78 0.324 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -132.26 172.04 21.26 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.992 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -76.0 101.32 5.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.874 0.369 . . . . 0.0 110.742 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -148.84 20.25 1.01 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.003 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.0 -37.0 78.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.715 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -63.2 -37.94 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.285 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.93 70.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.871 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.88 -47.04 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.461 ' O ' HG22 ' A' ' 37' ' ' VAL . 16.8 ptm180 -62.66 -34.8 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.802 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.61 -39.12 83.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.718 0.295 . . . . 0.0 111.003 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.8 -36.2 77.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 110.035 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 68.2 t -60.36 -46.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.184 177.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 33' ' ' ARG . 89.2 t -60.04 -38.82 78.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.016 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -61.09 -46.72 89.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.81 -34.93 72.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.921 0.391 . . . . 0.0 110.629 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.62 -45.81 91.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 37' ' ' VAL . 29.3 m -65.32 -34.93 73.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.572 0.225 . . . . 0.0 110.539 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.81 94.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' O ' HD13 ' A' ' 47' ' ' LEU . 95.2 mt -61.0 -47.68 85.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.13 -43.02 73.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.952 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -65.21 -50.34 57.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.94 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.42 86.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.939 0.399 . . . . 0.0 110.851 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.4 mp -61.77 -50.26 73.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.417 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.9 -31.66 68.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.56 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.474 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.9 mtt -66.95 -42.45 85.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.727 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.42 -38.59 87.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 60.2 tttm -65.19 -32.88 74.79 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.0 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -65.71 -41.05 92.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.949 0.404 . . . . 0.0 109.952 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -76.61 -46.48 25.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.329 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.449 HD21 ' HA ' ' A' ' 77' ' ' ALA . 45.0 m-80 -111.43 13.56 21.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 28.8 p 49.81 35.46 9.25 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -167.08 156.34 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.491 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 38.0 m-85 -83.53 142.08 42.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 110.874 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.74 145.06 61.85 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.016 2.477 . . . . 0.0 112.891 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -75.87 177.81 6.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.622 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -50.55 -40.4 51.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.0 -45.58 26.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.512 . . . . 0.0 110.543 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -72.18 -28.11 63.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.273 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.43 -50.3 60.29 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.825 -0.703 . . . . 0.0 113.261 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -31.02 67.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.175 0.512 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -72.29 -23.44 61.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.776 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.44 68.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 HD12 ' CG2' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -97.86 -3.35 38.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.294 -0.563 . . . . 0.0 112.45 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 86.7 t -103.2 -62.83 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -139.58 141.86 37.16 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -57.38 121.16 45.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 135.76 71.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.532 2.155 . . . . 0.0 112.231 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.7 m -90.45 -9.24 48.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.866 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 128.8 33.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.931 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.82 139.43 76.99 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.097 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 15.3 Cg_exo -69.14 140.96 61.73 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 124.299 -1.125 . . . . 0.0 113.376 1.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -86.35 136.94 32.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.658 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.449 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -74.9 122.86 24.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.963 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -104.91 156.02 18.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.334 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 59.45 49.85 8.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.507 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.562 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 38.6 p90 -92.17 144.57 29.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.03 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.62 138.96 39.53 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.297 1.998 . . . . 0.0 111.663 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -64.93 125.27 24.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.191 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.45 2.19 90.4 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.997 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.72 -152.75 51.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.362 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.95 -26.94 13.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 9.1 tt -133.32 133.87 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.52 -25.82 57.55 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -130.45 172.48 11.84 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.607 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -55.58 124.01 53.85 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.68 141.08 58.67 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -140.04 139.19 35.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 43.2 m-20 -58.67 154.43 35.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.862 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.58 -25.01 24.3 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.735 2.29 . . . . 0.0 112.839 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -80.71 -12.8 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.403 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.11 33.05 5.6 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.628 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.501 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 38.8 m -102.48 133.97 46.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.862 0.363 . . . . 0.0 111.572 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.12 124.9 28.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.08 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -65.68 138.76 58.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.24 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -112.69 142.35 45.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.503 HD22 ' CG2' ' A' ' 111' ' ' ILE . 3.4 tm? -126.21 123.28 37.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.09 113.52 27.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.701 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -106.56 119.71 50.79 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.484 171.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -84.82 159.69 66.5 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 124.042 -1.233 . . . . 0.0 111.795 -3.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.51 163.89 39.28 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -96.1 -35.64 11.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.631 0.729 . . . . 0.0 109.522 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -95.69 14.07 24.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.39 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.8 -156.01 27.31 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -72.4 -34.92 68.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.423 0.611 . . . . 0.0 110.867 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.414 ' HB ' HD21 ' A' ' 100' ' ' LEU . 31.6 m -138.02 151.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -117.99 121.5 40.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.535 -176.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.503 ' CG2' HD22 ' A' ' 100' ' ' LEU . 7.6 pt -106.75 126.63 62.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.457 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 42.6 p90 -148.25 144.44 27.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.297 0.57 . . . . 0.0 111.647 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.3 m -92.16 138.26 31.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.409 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 73.8 mt -66.27 -16.36 63.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.179 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.6 -165.53 49.94 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.683 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.71 -34.54 24.52 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 123.528 2.819 . . . . 0.0 113.053 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -90.12 -10.93 42.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.646 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.94 87.48 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.908 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.4 t -86.72 116.1 64.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.737 0.268 . . . . 0.0 110.991 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.466 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 47.0 Cg_endo -71.47 153.81 60.61 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 11.9 pt-20 55.66 25.05 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.911 1.284 . . . . 0.0 111.869 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.6 OUTLIER -94.61 177.9 5.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.759 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.69 -27.4 62.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.991 0.424 . . . . 0.0 110.787 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.16 -17.22 58.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.622 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -62.74 121.9 14.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.098 -177.111 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 70.5 mt -91.76 105.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -112.0 179.63 19.61 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.078 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -58.47 -38.78 78.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.786 0.327 . . . . 0.0 111.181 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.784 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.6 m -64.04 -43.57 95.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -87.0 -38.69 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.959 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 128.72 30.08 0.72 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.176 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -94.51 140.29 30.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.02 0.438 . . . . 0.0 110.332 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -163.16 119.65 1.82 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.179 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -72.45 81.54 1.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.309 0.576 . . . . 0.0 109.946 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -72.76 118.14 15.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.544 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -124.75 37.77 4.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.372 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -105.47 154.98 19.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.876 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -128.13 141.14 51.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.577 0.227 . . . . 0.0 110.445 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.961 177.022 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.69 0.281 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.21 -59.08 4.97 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.09 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -129.48 149.81 51.1 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -108.6 22.08 16.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.458 0.647 . . . . 0.0 109.655 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 8.1 tp10 -56.22 -43.26 78.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.934 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.77 -41.02 94.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.881 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.04 81.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.528 ' O ' HG23 ' A' ' 36' ' ' VAL . 67.7 m-20 -68.9 -48.11 64.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.197 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 12.3 ptm85 -66.9 -35.21 79.5 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.867 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -60.77 -37.81 83.13 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.094 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HD3' ' HG3' ' A' ' 93' ' ' PRO . 30.7 tttp -64.35 -41.94 96.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.669 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 60.9 t -61.1 -44.05 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.479 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 41' ' ' VAL . 77.4 t -62.91 -38.96 83.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 175.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -62.27 -46.01 90.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.438 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 64.4 m-20 -66.67 -36.31 82.24 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.306 0.574 . . . . 0.0 109.741 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.37 -42.76 99.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.98 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 37' ' ' VAL . 85.1 t -62.62 -38.11 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.441 . . . . 0.0 110.247 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.83 98.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.618 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 96.6 mt -64.47 -47.89 77.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.492 ' HG2' HD11 ' A' ' 111' ' ' ILE . 4.2 mm-40 -58.4 -44.95 89.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.281 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.25 -40.94 99.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.924 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -61.21 -42.38 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.791 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.27 -45.44 88.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.09 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.56 -43.68 98.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.02 -43.67 82.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.203 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -63.52 -41.15 98.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.446 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.65 -33.24 74.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.815 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.5 tp -67.55 -50.42 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.71 -44.75 32.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.888 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.417 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 36.6 m-80 -95.28 2.93 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.548 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m 68.67 3.78 4.05 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 171.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -159.58 165.52 32.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.727 0.298 . . . . 0.0 111.11 -178.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -74.12 142.02 78.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.572 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.49 143.28 42.4 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.189 2.592 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.538 HG21 ' H ' ' A' ' 60' ' ' THR . 1.4 m -72.35 176.82 4.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 175.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.538 ' H ' HG21 ' A' ' 59' ' ' THR . 8.8 t -51.34 -43.65 61.82 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.09 -38.97 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 110.348 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.82 -31.81 68.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.567 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -49.03 73.21 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.523 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.1 mp -69.58 -35.49 75.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.404 . . . . 0.0 111.093 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -72.54 -24.4 61.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.053 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.1 -29.38 67.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD22 ' H ' ' A' ' 67' ' ' LEU . 1.2 pt? -103.61 -1.92 27.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.672 0.272 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.682 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 74.9 t -109.49 -59.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.257 0.551 . . . . 0.0 111.074 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.0 p -156.68 136.03 12.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.05 121.57 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.459 0.474 . . . . 0.0 111.34 -172.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.98 137.07 80.32 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.007 2.472 . . . . 0.0 112.598 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.0 m -89.76 3.84 51.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.23 148.88 22.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.046 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -77.37 137.06 64.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.19 131.77 24.56 Favored 'Cis proline' 0 C--O 1.235 0.34 0 C-N-CA 122.957 -1.684 . . . . 0.0 112.247 -0.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.6 126.27 26.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.159 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.76 132.32 53.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.685 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -118.07 149.94 40.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.228 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 59.49 44.23 15.13 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.687 0.617 . . . . 0.0 110.542 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -94.84 153.39 40.01 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.274 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.55 140.37 21.29 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.307 2.005 . . . . 0.0 111.222 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.77 125.03 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.06 10.32 86.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.615 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.39 -119.89 20.2 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -126.27 -37.44 2.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 13.8 tt -124.94 127.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.874 172.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -69.29 -21.67 63.86 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -129.39 165.03 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.5 mt -60.23 126.55 84.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' ' 98' ' ' TYR . 37.9 Cg_endo -67.07 138.86 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.463 2.108 . . . . 0.0 111.511 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -133.4 138.51 46.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.762 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 4.4 p30 -67.28 152.95 95.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HG3' ' HD3' ' A' ' 35' ' ' LYS . 27.0 Cg_exo -59.27 -17.82 41.65 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.263 2.642 . . . . 0.0 113.169 -170.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.544 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.5 m-90 -81.27 -26.47 35.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.02 10.87 3.68 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.94 172.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.575 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 14.7 m -103.63 148.38 26.09 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.548 0.674 . . . . 0.0 111.038 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.19 133.71 34.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.104 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 78.4 m-85 -60.61 148.65 37.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.231 0.332 . . . . 0.0 110.312 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -130.4 143.21 50.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.15 0.5 . . . . 0.0 111.361 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.506 HD23 ' CG2' ' A' ' 111' ' ' ILE . 3.3 tm? -111.26 121.51 45.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -106.89 112.28 25.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.9 p -106.85 130.99 22.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.743 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.33 159.77 78.09 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.678 -1.384 . . . . 0.0 111.125 -4.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.96 159.24 53.86 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.136 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -96.2 -36.04 11.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -101.97 1.27 36.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.976 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.99 -155.88 13.26 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 11.9 mm100 -74.69 -29.32 61.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.271 0.535 . . . . 0.0 110.83 176.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.434 ' HB ' HD22 ' A' ' 100' ' ' LEU . 13.5 m -144.78 151.16 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.618 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.39 133.02 51.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.01 0.433 . . . . 0.0 111.614 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.506 ' CG2' HD23 ' A' ' 100' ' ' LEU . 6.7 pt -112.3 127.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.87 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -150.84 160.87 43.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.217 0.532 . . . . 0.0 111.884 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 6.2 p -106.85 146.68 30.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.651 175.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 7.3 mp -86.61 -20.31 28.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.544 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 76.53 -159.64 50.09 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.57 170.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.28 -23.79 32.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.64 2.893 . . . . 0.0 112.298 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -13.97 35.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.5 13.79 74.44 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.068 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.3 123.64 34.6 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-N 117.515 0.657 . . . . 0.0 112.194 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -78.13 157.01 30.15 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.503 2.802 . . . . 0.0 112.128 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 63.73 42.41 6.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.085 0.945 . . . . 0.0 109.497 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.6 p -120.86 177.26 5.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.881 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -73.73 -31.73 63.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.55 -28.42 67.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.753 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' A' ' 113' ' ' SER . 3.5 m-20 -47.07 112.0 0.47 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 124.282 0.989 . . . . 0.0 112.131 -172.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.424 ' HB ' HG11 ' A' ' 36' ' ' VAL . 4.8 mp -84.62 105.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 130' ' ' THR . . . -130.4 -172.24 13.09 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -63.89 -37.62 88.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.898 0.38 . . . . 0.0 111.727 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -77.3 -19.82 55.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 127' ' ' GLY . 3.4 t -88.68 -22.33 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.951 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.78 -42.98 13.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.701 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 146.07 -18.43 1.75 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.096 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -69.98 99.78 1.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 111.353 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -101.95 147.18 26.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.867 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -74.38 111.78 9.89 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -67.94 111.92 4.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.044 -172.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -89.24 88.88 7.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.055 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -84.76 23.55 1.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.021 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -113.74 -2.23 13.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.81 0.338 . . . . 0.0 110.729 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.169 -178.243 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.53 20.01 69.93 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.012 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -83.84 91.36 7.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 0.0 110.278 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -57.23 -34.29 68.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.501 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -58.79 -43.05 90.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.022 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -59.92 -38.52 82.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.48 60.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.46 ' O ' HG22 ' A' ' 36' ' ' VAL . 62.5 m-20 -69.29 -42.53 75.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.459 ' O ' HG22 ' A' ' 37' ' ' VAL . 14.2 ptm180 -62.17 -34.48 76.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.093 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -58.78 -37.05 75.42 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.8 0.334 . . . . 0.0 111.082 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -68.58 -39.59 80.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 32' ' ' ASP . 46.7 t -61.37 -41.76 91.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.651 ' O ' HG21 ' A' ' 41' ' ' VAL . 96.2 t -60.52 -41.23 86.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.589 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.8 t -59.26 -48.23 82.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.003 0.43 . . . . 0.0 110.887 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -69.86 -34.26 73.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.13 -39.9 91.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.657 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.651 HG21 ' O ' ' A' ' 37' ' ' VAL . 52.2 t -63.5 -37.73 80.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.205 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.06 -35.63 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.596 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.455 ' O ' HD11 ' A' ' 47' ' ' LEU . 9.0 mp -64.08 -47.68 79.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.465 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -56.29 -37.4 69.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.999 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.49 -45.46 85.17 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.969 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -61.32 -44.62 96.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.793 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 43' ' ' LEU . 7.9 mp -62.93 -41.88 99.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.653 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.11 -44.77 94.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.447 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.438 ' HA ' ' HE1' ' A' ' 49' ' ' MET . 2.9 mmt -65.77 -43.87 87.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.046 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.495 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 67.1 t80 -65.26 -45.22 85.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.03 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.6 -33.1 72.21 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.576 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.4 tp -64.28 -42.32 96.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.073 0.463 . . . . 0.0 110.313 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.32 -48.72 16.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.906 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -98.7 -4.82 32.77 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -169.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 65.9 24.34 11.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.448 0.468 . . . . 0.0 111.945 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.31 149.74 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -74.4 146.9 84.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.797 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 142.08 50.91 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.691 2.261 . . . . 0.0 112.295 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.2 p -74.73 177.51 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.795 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t -51.46 -37.17 47.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.39 -41.18 41.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.086 0.469 . . . . 0.0 111.268 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -72.62 -37.78 67.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.294 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.21 71.27 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.783 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.685 HD21 ' O ' ' A' ' 98' ' ' TYR . 7.4 mp -69.96 -40.22 75.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 111.668 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -72.55 -23.98 61.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.234 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -26.46 62.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -169.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.543 HD22 ' H ' ' A' ' 67' ' ' LEU . 1.7 pt? -104.52 -2.0 25.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.47 -38.75 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 t -156.44 130.35 8.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.66 121.99 36.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.432 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.85 137.47 58.37 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.833 2.355 . . . . 0.0 112.367 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 p -87.45 -19.59 27.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.087 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.23 137.48 57.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.369 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.04 138.19 92.36 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.495 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 10.7 Cg_exo -73.46 135.12 38.48 Favored 'Cis proline' 0 C--O 1.233 0.272 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.34 -3.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -70.88 121.62 18.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.8 124.26 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.736 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -107.46 166.3 10.76 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.372 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 47.76 40.27 11.96 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.192 0.933 . . . . 0.0 111.839 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -89.75 150.17 43.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.966 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.93 137.74 32.69 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.025 1.816 . . . . 0.0 111.3 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.59 124.24 22.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.914 0.387 . . . . 0.0 110.41 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.95 4.95 86.65 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.645 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.45 -142.55 40.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.399 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.85 -14.38 13.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.286 0.565 . . . . 0.0 109.594 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.9 tt -136.83 141.48 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.004 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -68.85 -30.97 69.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.886 -172.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -131.18 154.36 48.46 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.294 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.26 118.8 43.52 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.98 128.43 24.77 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.358 2.705 . . . . 0.0 113.206 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -126.37 140.43 52.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.672 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.2 p30 -71.0 152.5 94.92 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 -15.53 13.66 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.547 2.832 . . . . 0.0 113.683 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.412 ' CZ3' HG21 ' A' ' 36' ' ' VAL . 5.4 m-90 -80.57 -19.48 45.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.996 0.427 . . . . 0.0 110.361 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.16 19.31 8.57 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.918 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.509 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 0.9 OUTLIER -103.35 146.24 28.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 110.849 -176.317 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.93 126.24 36.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.354 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.685 ' O ' HD21 ' A' ' 64' ' ' LEU . 5.1 m-85 -52.9 151.62 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.84 0.713 . . . . 0.0 112.692 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.423 ' NE2' HD21 ' A' ' 114' ' ' LEU . 0.7 OUTLIER -115.68 137.49 52.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.364 -179.354 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.545 HD21 ' CG2' ' A' ' 111' ' ' ILE . 3.2 tm? -123.32 122.39 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -117.1 112.55 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.787 0.327 . . . . 0.0 110.486 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.418 ' HB3' HG11 ' A' ' 109' ' ' VAL . 20.7 p -107.08 127.97 26.95 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.272 171.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 97.0 Cg_endo -85.06 139.94 29.29 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.907 -1.289 . . . . 0.0 111.648 -5.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.95 161.63 46.92 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.112 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -85.15 -20.81 29.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.965 0.412 . . . . 0.0 110.617 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -105.74 -43.98 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.5 -151.6 8.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.97 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -45.64 54.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 102' ' ' SER . 16.2 m -128.67 140.48 49.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.413 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 125.4 54.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.762 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.545 ' CG2' HD21 ' A' ' 100' ' ' LEU . 11.3 pt -108.35 125.73 65.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.147 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -151.69 163.09 39.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.057 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.5 m -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.872 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 1.8 mm? -66.88 -22.76 65.96 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -169.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.04 -169.16 43.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.831 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.29 -25.02 36.87 Favored 'Trans proline' 0 C--N 1.337 -0.058 0 C-N-CA 122.891 2.394 . . . . 0.0 112.843 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.85 -11.08 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.115 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 114' ' ' LEU . . . 76.09 9.75 85.39 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.406 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.16 112.88 53.8 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.043 0.421 . . . . 0.0 111.448 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -75.86 156.39 39.22 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.096 2.531 . . . . 0.0 112.624 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 64.73 16.25 10.28 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.283 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 1.9 p -94.27 175.85 6.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.818 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -85.73 -23.75 27.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.43 -22.43 61.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.432 ' HB2' ' O ' ' A' ' 122' ' ' SER . 1.0 OUTLIER -55.29 132.05 46.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.346 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.97 95.75 3.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -106.6 148.96 16.52 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.301 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.666 ' OD1' ' HB2' ' A' ' 133' ' ' PHE . 64.6 t30 -66.91 -26.03 66.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.44 0.638 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -74.5 -28.43 60.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.921 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -74.69 -37.47 62.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.956 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.5 tp -78.39 -36.52 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.18 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.27 12.14 14.24 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.474 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.666 ' HB2' ' OD1' ' A' ' 128' ' ' ASN . 51.7 m-85 -69.53 -70.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.26 1.03 . . . . 0.0 110.861 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.489 ' HB2' ' ND2' ' A' ' 128' ' ' ASN . 3.0 t60 -86.02 66.57 9.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.038 0.447 . . . . 0.0 110.008 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -94.43 149.67 21.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.399 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -99.85 138.16 37.32 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -91.83 82.04 5.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.889 0.376 . . . . 0.0 111.089 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -149.43 -10.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.735 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -91.03 -29.3 17.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.975 0.417 . . . . 0.0 110.454 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.259 -179.28 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.041 0.448 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.57 19.68 3.35 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.99 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -89.59 73.67 7.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.662 0.744 . . . . 0.0 110.307 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -114.24 34.75 4.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.94 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.9 tp10 -56.04 -43.88 78.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.301 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 36.2 mtmm -69.56 -36.74 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.598 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.74 77.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.998 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 -44.47 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.521 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.51 ' O ' HG22 ' A' ' 37' ' ' VAL . 13.4 ptm180 -67.72 -35.16 78.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.601 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 40.8 mt-30 -63.91 -36.45 83.99 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.97 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.71 -39.84 92.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.507 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 76.1 t -61.05 -43.02 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.272 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 33' ' ' ARG . 88.2 t -60.54 -39.46 81.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.404 ' O ' HG21 ' A' ' 41' ' ' VAL . 50.4 m -61.32 -46.95 88.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.025 0.44 . . . . 0.0 111.055 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 -34.42 73.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.277 0.56 . . . . 0.0 110.491 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.8 tp -65.22 -44.55 87.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.519 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 37' ' ' VAL . 32.8 m -63.53 -35.82 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.92 90.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.79 0.329 . . . . 0.0 110.47 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' O ' HD13 ' A' ' 47' ' ' LEU . 69.5 mt -62.57 -48.54 79.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.79 -37.77 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.34 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -44.81 97.22 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.769 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 67' ' ' LEU . . . -60.43 -44.13 96.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.735 0.302 . . . . 0.0 110.868 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 43' ' ' LEU . 7.3 mp -62.54 -44.11 97.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.025 177.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.08 -41.73 99.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.866 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -38.83 73.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.733 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -62.25 -42.67 99.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.954 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -69.98 -31.79 69.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.3 -49.1 75.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 0.0 110.51 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.02 -45.49 34.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -98.32 -1.33 41.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -172.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 m 63.14 17.34 10.1 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.86 147.58 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -66.74 140.55 96.38 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.24 149.09 69.77 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.967 2.444 . . . . 0.0 112.439 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.546 HG23 ' H ' ' A' ' 60' ' ' THR . 0.7 OUTLIER -81.71 177.46 8.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.622 176.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.546 ' H ' HG23 ' A' ' 59' ' ' THR . 8.8 t -51.42 -40.53 59.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -77.14 -42.98 35.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.302 0.572 . . . . 0.0 110.2 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -69.37 -33.59 73.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.683 -173.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.9 -49.36 42.36 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.917 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.3 tp -66.16 -41.01 90.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 111.422 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.422 ' HA ' HG13 ' A' ' 68' ' ' VAL . 34.6 mt-30 -73.03 -23.11 60.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.66 61.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.56 HD21 ' H ' ' A' ' 67' ' ' LEU . 1.8 pt? -104.65 -2.0 25.63 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.422 HG13 ' HA ' ' A' ' 65' ' ' GLN . 7.5 p -117.83 -43.62 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.818 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 65' ' ' GLN . 47.0 m -156.51 129.58 7.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -56.24 121.53 42.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 111.442 -175.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 27.9 Cg_exo -63.15 137.39 61.23 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.739 2.293 . . . . 0.0 112.604 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.5 p -86.52 -10.9 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.96 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.64 138.32 46.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.476 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 6.1 mp0 -77.03 141.79 68.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.92 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 48.2 Cg_endo -69.89 131.33 19.11 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 -1.672 . . . . 0.0 112.532 -0.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -68.96 129.38 39.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.949 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.56 125.96 28.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.67 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -119.34 163.75 16.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.538 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.32 39.28 9.61 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.369 0.604 . . . . 0.0 110.229 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -97.83 143.15 25.71 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.58 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.45 143.8 35.28 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.595 2.196 . . . . 0.0 111.628 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.08 124.63 22.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.809 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.26 10.02 86.48 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.884 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.75 -149.61 51.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.2 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.95 -5.59 15.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.388 0.613 . . . . 0.0 109.881 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 tt -142.36 137.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.694 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.18 -22.79 61.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.948 -169.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -138.3 170.16 16.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.85 128.52 70.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 172.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.43 129.11 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.346 2.031 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.16 140.47 51.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.733 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.637 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.0 p30 -72.91 153.15 91.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.23 -17.89 22.06 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.324 2.683 . . . . 0.0 113.576 -174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.562 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 7.3 m-90 -81.38 -26.68 35.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.697 0.284 . . . . 0.0 110.61 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.94 18.76 4.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.718 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.637 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 69.5 m -103.68 154.24 19.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.489 0.645 . . . . 0.0 111.281 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.36 129.88 38.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.218 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.571 ' O ' HD21 ' A' ' 64' ' ' LEU . 19.1 m-85 -60.95 146.23 47.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -127.6 140.47 52.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.155 0.502 . . . . 0.0 111.766 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.482 HD23 ' CG2' ' A' ' 111' ' ' ILE . 2.8 tm? -111.89 120.94 43.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -112.64 113.05 25.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.072 0.463 . . . . 0.0 111.176 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.8 m -106.55 131.74 21.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.171 171.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.75 146.14 65.72 Favored 'Cis proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.762 -1.349 . . . . 0.0 111.369 -4.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.34 161.22 34.77 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.897 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.01 -35.55 11.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.111 0.481 . . . . 0.0 109.746 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -94.99 -40.24 9.76 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.16 -157.98 9.66 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.39 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -74.49 -34.61 63.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.948 0.374 . . . . 0.0 110.839 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.47 ' HB ' HD22 ' A' ' 100' ' ' LEU . 6.5 m -135.96 124.05 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.987 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 124.58 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.482 ' CG2' HD23 ' A' ' 100' ' ' LEU . 8.7 pt -106.29 126.55 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.278 173.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 11.7 p90 -150.31 160.58 43.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.204 0.526 . . . . 0.0 111.643 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 m -108.48 126.72 53.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.6 -31.23 72.02 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 123.804 0.69 . . . . 0.0 110.748 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.562 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 78.99 -154.09 38.84 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.0 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.36 -27.41 34.13 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.233 2.622 . . . . 0.0 113.629 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.543 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.2 p-10 -87.34 -13.46 43.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.642 -173.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.36 13.27 73.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.238 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.543 ' HB ' ' OD2' ' A' ' 117' ' ' ASP . 77.9 t -119.03 121.23 30.56 Favored Pre-proline 0 C--O 1.247 0.93 0 CA-C-O 120.712 0.292 . . . . 0.0 111.084 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.611 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 71.9 Cg_endo -76.06 146.97 29.55 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.508 2.805 . . . . 0.0 112.983 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 121' ' ' GLU . 5.5 tp10 65.19 25.15 12.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.074 0.94 . . . . 0.0 110.338 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.22 172.42 8.31 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.451 172.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -76.14 -0.41 21.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.811 0.338 . . . . 0.0 111.671 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -103.56 -13.84 16.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.185 0.517 . . . . 0.0 109.964 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.611 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -65.76 134.76 53.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.582 -174.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.17 108.44 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.908 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -110.7 176.49 18.8 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.542 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.48 ' HB2' HG13 ' A' ' 111' ' ' ILE . 63.3 t30 -65.14 -28.87 69.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.364 0.602 . . . . 0.0 110.473 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -77.11 -19.44 56.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.803 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 -40.34 62.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.63 -34.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.018 0.437 . . . . 0.0 110.244 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.76 36.84 3.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.894 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.457 ' HB2' ' OD1' ' A' ' 128' ' ' ASN . 39.3 m-85 -87.49 78.43 8.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.505 0.669 . . . . 0.0 110.509 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -101.95 103.4 14.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.874 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -97.94 113.36 25.17 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.27 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -148.12 87.14 1.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.226 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -71.22 133.96 46.52 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.136 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -141.77 136.05 30.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.653 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -137.71 21.7 2.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.415 0.626 . . . . 0.0 110.029 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.919 178.287 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.509 ' H2 ' ' CG ' ' A' ' 32' ' ' ASP . 22.9 ptp . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.575 0.226 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.33 -47.76 1.58 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.517 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -70.37 -25.4 63.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.738 0.304 . . . . 0.0 111.412 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -116.87 75.24 0.95 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 110.114 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -58.81 -42.78 89.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.687 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.73 -48.01 82.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 110.397 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.08 -36.63 72.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.377 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.509 ' CG ' ' H2 ' ' A' ' 25' ' ' MET . 70.9 m-20 -63.2 -47.1 83.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.109 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.55 ' O ' HG22 ' A' ' 37' ' ' VAL . 35.8 ptt180 -67.67 -34.79 77.63 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.662 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.15 -34.15 75.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.69 -40.37 92.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 92.6 t -60.78 -44.88 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.415 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 33' ' ' ARG . 60.7 t -58.76 -38.41 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.513 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -61.9 -45.93 91.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.09 -34.84 73.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 0.0 110.649 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.7 tp -63.41 -45.1 92.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.141 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.92 -34.86 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.709 0.29 . . . . 0.0 110.315 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.92 89.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.539 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.82 -43.08 98.68 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.984 0.421 . . . . 0.0 110.047 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -56.7 -36.78 70.05 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.82 -44.75 94.14 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.948 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.446 ' HB3' HD11 ' A' ' 67' ' ' LEU . . . -62.48 -43.67 98.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.798 0.332 . . . . 0.0 110.711 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.91 -43.14 93.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.5 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.01 -41.15 82.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.894 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 86.7 mmm -67.87 -44.05 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.176 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -62.57 -40.31 96.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.05 -32.16 70.14 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.71 0.291 . . . . 0.0 110.262 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.6 -49.07 79.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.752 0.311 . . . . 0.0 110.422 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -77.2 -47.03 21.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -100.4 -3.49 30.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -169.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.9 m 61.38 28.93 18.27 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 2.0 ppt_? -156.58 154.87 30.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.668 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.496 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 76.0 m-85 -77.4 131.86 70.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 147.08 45.01 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.521 2.147 . . . . 0.0 112.729 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 176.8 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.518 175.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.5 t -50.15 -44.44 52.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -77.44 -43.77 31.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.059 0.457 . . . . 0.0 110.785 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.22 -36.78 84.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.106 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.45 -45.05 25.24 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.547 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -69.37 -44.65 71.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.4 ' NE2' HD12 ' A' ' 89' ' ' LEU . 33.0 mm-40 -71.59 -26.03 62.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.18 -21.86 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 85' ' ' TYR . 4.8 tp -83.24 -13.02 56.19 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.994 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.44 -29.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.565 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 t -157.34 162.88 39.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.2 122.26 87.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.94 136.69 71.36 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.643 2.229 . . . . 0.0 112.042 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -81.99 -29.66 31.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 127.4 31.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 34.0 tt0 -67.22 139.16 94.82 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 18.2 Cg_exo -67.56 131.62 16.69 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.738 -0.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -80.89 129.95 34.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.698 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.48 122.84 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.924 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -111.81 158.42 19.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.017 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 60.89 32.0 20.02 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 110.608 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -72.03 146.61 90.29 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.414 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.78 138.28 31.4 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.981 1.787 . . . . 0.0 111.272 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.81 124.63 22.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.457 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.58 4.94 75.74 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.505 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.34 -150.85 47.67 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.406 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.506 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 62.1 m-85 -101.45 -37.44 8.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.364 0.602 . . . . 0.0 109.901 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.0 tt -131.92 137.53 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -67.05 -21.87 65.89 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -130.52 154.92 47.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.4 HD12 ' NE2' ' A' ' 65' ' ' GLN . 4.4 mm? -54.43 125.83 53.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.03 137.09 79.05 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.636 2.224 . . . . 0.0 112.142 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -138.4 138.03 37.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.295 0.569 . . . . 0.0 111.327 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.473 ' CG ' ' HG ' ' A' ' 113' ' ' SER . 11.9 m-20 -62.85 153.86 78.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.948 173.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -19.02 29.14 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.198 2.599 . . . . 0.0 112.704 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -81.96 -12.75 58.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.09 30.72 7.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.198 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.3 m -103.52 149.46 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.962 0.41 . . . . 0.0 111.021 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.81 143.5 29.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.844 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.591 ' O ' HD23 ' A' ' 64' ' ' LEU . 83.7 m-85 -83.67 148.53 27.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.48 ' NE2' HD21 ' A' ' 114' ' ' LEU . 27.0 mp0 -118.22 152.96 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 110.932 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.4 tp -131.94 140.16 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.077 171.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -135.38 115.93 13.74 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.815 175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 t -106.8 132.56 20.81 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.88 139.77 63.1 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 124.251 -1.145 . . . . 0.0 111.907 -1.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.83 150.91 51.03 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.741 -172.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.69 -26.53 68.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 0.0 110.286 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 20.4 m80 -131.04 44.88 2.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.246 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 147.08 -165.62 28.54 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 13.2 mm100 -75.5 -29.55 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.77 0.785 . . . . 0.0 110.607 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 m -134.35 127.36 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.138 176.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -119.52 118.19 30.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.451 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 13.8 pt -106.6 132.21 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.087 178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.68 161.02 43.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.158 0.504 . . . . 0.0 111.428 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.473 ' HG ' ' CG ' ' A' ' 92' ' ' ASP . 18.3 t -116.42 149.29 39.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.179 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.48 HD21 ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -69.57 -27.42 65.11 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 123.52 0.513 . . . . 0.0 109.924 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.09 -162.09 33.51 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.155 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.42 -28.38 32.7 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.951 2.434 . . . . 0.0 113.397 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.557 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.6 p-10 -85.06 -11.56 55.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.6 12.0 80.43 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.853 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.557 ' HB ' ' OD2' ' A' ' 117' ' ' ASP . 72.0 t -116.94 121.47 32.62 Favored Pre-proline 0 C--O 1.249 1.042 0 CA-C-O 120.637 0.256 . . . . 0.0 111.271 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.697 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 60.3 Cg_endo -75.4 158.33 40.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 113.606 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 62.31 23.97 14.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.219 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -96.93 177.73 5.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.731 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.95 -28.97 43.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.202 0.525 . . . . 0.0 110.496 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 122' ' ' SER . 7.3 p-10 -77.05 -15.2 59.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.697 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -65.47 146.06 55.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.358 -177.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.0 mt -113.76 117.87 56.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.884 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.38 161.66 13.49 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.128 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -59.96 -37.4 79.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.504 0.668 . . . . 0.0 109.867 175.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -76.67 -28.51 55.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.205 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.2 p -80.91 -29.09 35.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.685 0.278 . . . . 0.0 111.21 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.6 tp -85.96 -31.39 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 134.73 -15.12 4.38 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.126 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -86.48 56.87 4.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.342 0.591 . . . . 0.0 110.296 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -74.77 156.06 36.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.99 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 106' ' ' HIS . 76.7 m80 -104.1 77.87 1.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.478 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -79.39 -18.58 52.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.797 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -87.45 86.49 7.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -132.3 129.45 39.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.775 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -103.03 95.36 6.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.235 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 tttm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.963 178.402 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.76 0.314 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.41 85.16 1.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.396 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -90.32 70.2 7.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.176 0.513 . . . . 0.0 109.97 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -82.84 100.24 10.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.267 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -55.95 -43.43 77.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.712 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 99.5 mttt -67.26 -48.06 68.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.331 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.709 -174.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.24 -40.45 74.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.463 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 30.8 ptt180 -68.38 -34.15 75.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.388 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 14.8 mm100 -59.32 -31.51 69.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.479 0.18 . . . . 0.0 111.254 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.11 -44.27 97.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 24.7 t -60.71 -45.15 98.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 33' ' ' ARG . 58.3 t -59.9 -38.63 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.4 ' O ' HG21 ' A' ' 41' ' ' VAL . 39.1 t -60.44 -46.8 88.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.866 0.365 . . . . 0.0 110.677 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.521 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.9 m-20 -69.52 -35.4 75.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 109.869 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 HD21 ' C ' ' A' ' 127' ' ' GLY . 19.0 tp -60.89 -46.57 90.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.347 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 38' ' ' SER . 28.9 m -65.81 -36.17 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.362 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.17 98.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.397 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.568 ' O ' HD11 ' A' ' 47' ' ' LEU . 98.2 mt -61.32 -49.69 75.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.375 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.3 -39.32 90.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.216 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.526 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -63.44 -47.77 84.44 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.215 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.75 84.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.758 0.313 . . . . 0.0 111.343 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.568 HD11 ' O ' ' A' ' 43' ' ' LEU . 5.2 mp -57.59 -43.74 84.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.946 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.628 ' OD2' ' HA ' ' A' ' 139' ' ' HIS . 17.5 t70 -68.55 -37.35 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.844 176.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.526 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 20.7 mmt -59.48 -45.23 92.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.567 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 65.6 t80 -67.18 -37.7 84.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.564 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.92 -35.33 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.308 177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.0 tp -68.12 -36.44 79.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.253 0.549 . . . . 0.0 110.385 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.506 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 14.0 t70 -76.0 -47.89 23.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.595 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.55 22.91 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m 71.97 -13.99 0.55 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -137.15 157.55 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.889 -0.507 . . . . 0.0 111.242 -175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -71.34 148.35 93.51 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 148.3 52.19 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.925 2.417 . . . . 0.0 112.402 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.3 p -79.84 177.99 8.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.999 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.2 t -50.98 -37.29 43.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.827 0.346 . . . . 0.0 111.888 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.06 -45.72 26.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.702 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.04 -27.9 62.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.366 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.19 -51.96 54.92 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.129 -170.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 mp -72.11 -32.9 67.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.412 0.606 . . . . 0.0 111.34 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -72.54 -24.13 61.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.82 -24.9 64.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -103.79 -2.06 26.95 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.65 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.28 -63.04 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.455 0.645 . . . . 0.0 110.742 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 138.19 17.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.35 120.38 25.76 Favored Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.366 0.416 . . . . 0.0 111.153 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.97 141.96 96.39 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 112.602 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -86.64 -9.22 56.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.846 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.3 140.55 52.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.077 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.2 137.67 68.49 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.166 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.567 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 5.2 Cg_exo -79.88 149.84 81.65 Favored 'Cis proline' 0 C--O 1.236 0.378 0 C-N-CA 123.738 -1.359 . . . . 0.0 112.558 -4.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -65.42 128.85 37.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.521 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.0 38.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.377 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.506 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 33.3 mmt180 -111.53 165.14 12.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.94 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 61.79 34.88 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.706 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -94.74 136.65 22.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.853 0.359 . . . . 0.0 110.542 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.72 143.55 56.52 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.637 2.225 . . . . 0.0 111.758 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.07 124.36 20.94 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.21 84.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.824 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.46 -157.93 53.44 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.126 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -92.29 -23.43 19.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.9 128.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.662 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -68.36 -24.46 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.044 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -130.84 171.68 12.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.09 129.91 86.41 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.023 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.09 126.87 15.06 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.063 1.842 . . . . 0.0 110.283 172.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -132.82 145.44 50.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.608 0.242 . . . . 0.0 110.902 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 0.7 OUTLIER -56.3 143.67 64.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.115 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.69 -25.84 53.0 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.254 2.636 . . . . 0.0 113.111 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.488 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 18.3 m-90 -81.91 -5.08 57.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.648 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.11 15.09 22.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.918 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 43.2 m -95.5 164.37 12.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.723 0.297 . . . . 0.0 110.584 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -111.71 129.32 56.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.118 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.461 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 64.2 m-85 -67.09 161.47 24.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.582 ' NE2' HD12 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -129.41 142.76 50.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.499 . . . . 0.0 110.861 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.51 HD23 ' CG2' ' A' ' 111' ' ' ILE . 3.3 tm? -112.41 122.77 48.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -110.24 113.63 26.47 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.66 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 13.7 p -107.16 123.05 39.5 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.555 172.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 108' ' ' GLN . 1.9 Cg_endo -84.31 140.15 33.17 Favored 'Cis proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.736 -0.943 . . . . 0.0 111.256 -4.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.73 159.62 53.84 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.62 -173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -79.63 -12.05 59.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.128 0.49 . . . . 0.0 109.951 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -121.48 30.51 6.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.02 -157.32 26.83 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 21.5 tp60 -61.2 -45.39 94.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 0.0 110.077 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 100' ' ' LEU . 15.1 m -136.12 151.09 28.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.32 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -134.61 131.28 37.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.652 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.51 ' CG2' HD23 ' A' ' 100' ' ' LEU . 4.4 pt -111.32 130.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.781 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -149.08 161.12 42.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.3 p -114.57 139.87 49.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.738 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.582 HD12 ' NE2' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -67.9 -34.43 76.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.746 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.45 -159.68 53.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.45 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 10.8 Cg_exo -70.34 -34.88 11.9 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 123.824 3.016 . . . . 0.0 111.98 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.83 -13.57 50.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.089 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.512 ' C ' ' HG ' ' A' ' 114' ' ' LEU . . . 71.75 11.96 73.86 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.5 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.6 t -96.68 113.78 63.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 116.957 0.379 . . . . 0.0 111.233 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 145.83 29.45 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.615 2.21 . . . . 0.0 112.462 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 66.98 22.51 10.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.337 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.48 177.46 6.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.654 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.82 -16.78 61.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.23 -15.6 37.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.17 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.49 105.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.201 -173.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 42.4 mm -81.4 107.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.857 177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.465 ' C ' HD21 ' A' ' 40' ' ' LEU . . . -114.15 171.26 13.68 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.666 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -66.49 -38.39 87.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.989 0.423 . . . . 0.0 110.177 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.466 ' CE2' ' HD2' ' A' ' 134' ' ' HIS . 56.9 t90 -68.32 -30.53 69.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -72.04 -39.4 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.449 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.98 -40.72 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.752 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 161.08 10.89 0.04 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 119.398 -1.382 . . . . 0.0 114.309 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -95.16 72.09 3.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.705 0.753 . . . . 0.0 109.864 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.466 ' HD2' ' CE2' ' A' ' 129' ' ' TRP . 69.6 m80 -90.2 -12.44 38.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.792 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -96.1 156.25 16.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.707 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -127.29 61.5 1.37 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.388 0.613 . . . . 0.0 109.878 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -128.13 25.39 5.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.361 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -75.36 135.12 40.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.628 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 4.3 t-80 179.8 22.82 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.871 0.732 . . . . 0.0 109.457 176.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 140' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.113 -175.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.229 0.538 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.28 24.42 76.4 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.351 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -79.52 -44.0 22.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 0.0 110.55 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -85.2 -16.29 40.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.478 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -58.26 -32.48 68.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.36 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 55.4 mtmt -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.411 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.55 -39.85 94.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.807 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -69.17 -39.42 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.807 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.523 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 12.5 ptm85 -66.66 -33.48 75.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.74 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.598 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 76.0 mm-40 -59.22 -34.37 72.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.711 0.291 . . . . 0.0 110.882 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -63.3 -39.6 95.03 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.62 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 41.1 t -60.64 -47.65 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.363 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 33' ' ' ARG . 38.6 t -58.82 -37.69 68.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 41' ' ' VAL . 22.6 t -62.53 -47.0 85.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.47 . . . . 0.0 111.044 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.486 ' HB2' ' OH ' ' A' ' 98' ' ' TYR . 63.4 m-20 -70.91 -35.15 72.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.731 -0.606 . . . . 0.0 110.04 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.419 HD21 ' N ' ' A' ' 128' ' ' ASN . 17.6 tp -61.0 -44.93 96.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.076 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 38' ' ' SER . 32.8 m -63.31 -34.54 67.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.507 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 39' ' ' ASP . . . -60.21 -40.07 88.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.589 0.233 . . . . 0.0 110.63 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 47' ' ' LEU . 8.9 mp -60.27 -48.45 81.67 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.262 0.553 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.56 -37.33 85.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.823 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -62.53 -37.06 94.08 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.91 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.16 0.505 . . . . 0.0 110.044 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 43' ' ' LEU . 6.2 mp -61.1 -40.82 95.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.4 -45.52 94.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 25.7 mmt -63.44 -38.52 91.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.536 ' CE1' ' HB2' ' A' ' 77' ' ' ALA . 1.2 t80 -64.2 -44.23 92.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.399 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -70.5 -33.31 71.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.93 -46.3 85.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.01 0.433 . . . . 0.0 110.141 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.99 -46.15 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.215 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -103.57 1.71 32.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m 59.15 31.73 21.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.708 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -164.51 146.21 8.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.844 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -72.89 144.18 85.14 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 110.466 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 55.5 Cg_endo -71.04 143.26 44.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.843 2.362 . . . . 0.0 112.745 -176.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -73.94 177.45 5.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.591 175.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 100' ' ' LEU . 61.9 m -50.21 -45.82 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.37 -37.58 65.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.236 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -71.92 -43.15 65.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.874 -170.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' A' ' 100' ' ' LEU . . . -64.37 -49.46 65.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.676 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.422 HD22 ' O ' ' A' ' 98' ' ' TYR . 1.4 tp -61.88 -41.68 98.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.941 0.4 . . . . 0.0 111.42 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.41 -22.92 61.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.936 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.24 66.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -168.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.414 HD23 HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -93.95 -3.83 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.986 -178.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.86 -42.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.519 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 p -156.5 130.07 8.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.09 121.82 38.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 123.383 0.427 . . . . 0.0 111.324 -177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.34 137.56 56.44 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.9 2.4 . . . . 0.0 112.437 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -86.22 -11.45 52.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.1 57.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.474 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -77.5 140.92 64.82 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.81 134.55 36.36 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.719 -1.367 . . . . 0.0 111.931 -2.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.95 128.55 36.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.298 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.536 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . . . -63.2 131.33 48.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.526 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -119.32 164.6 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 66.46 32.06 7.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.009 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -91.68 137.18 25.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.694 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.77 139.54 22.46 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.073 1.849 . . . . 0.0 111.843 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 124.77 23.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.711 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -8.89 76.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.73 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 -173.13 55.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.291 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -84.9 -25.7 27.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.26 133.71 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.381 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -70.12 -22.77 62.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.7 mtm180 -131.94 154.59 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.289 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.6 mt -61.73 123.64 77.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.336 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.15 147.95 91.33 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.471 2.114 . . . . 0.0 111.415 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -138.37 145.46 41.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.489 ' OD1' ' HB3' ' A' ' 113' ' ' SER . 53.2 m-20 -57.99 142.99 78.87 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.63 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.38 -19.32 57.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.305 2.67 . . . . 0.0 112.541 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.74 -14.08 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.009 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.0 22.39 7.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.163 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 19.3 m -104.01 162.5 13.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.535 -0.391 . . . . 0.0 110.613 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -105.64 144.65 32.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.667 0.27 . . . . 0.0 110.341 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.62 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 18.6 m-85 -70.31 146.49 50.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.358 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -126.76 142.9 51.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.616 . . . . 0.0 111.751 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 60' ' ' THR . 13.4 tp -121.68 141.99 50.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.934 172.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -134.86 113.07 11.2 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.505 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.7 t -106.9 132.19 21.1 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.374 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.78 150.27 92.35 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.824 -1.323 . . . . 0.0 111.885 -1.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.01 147.25 50.73 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.658 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -75.07 -39.39 60.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.359 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -104.88 -38.88 6.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.897 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.19 -156.79 9.78 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.788 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -73.46 -41.69 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.209 0.528 . . . . 0.0 109.989 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.14 122.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.376 175.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 116.8 33.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.25 0.547 . . . . 0.0 112.15 -173.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.9 pt -107.34 126.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.556 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -150.41 146.55 26.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.284 0.564 . . . . 0.0 111.194 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.489 ' HB3' ' OD1' ' A' ' 92' ' ' ASP . 51.2 m -97.83 151.58 20.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.197 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 4.9 mp -75.29 -19.67 59.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.588 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.54 -156.04 53.27 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 123.875 0.734 . . . . 0.0 113.355 171.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.93 -21.01 38.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.675 2.917 . . . . 0.0 112.906 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 6.6 p-10 -86.23 -14.74 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.473 ' O ' HD22 ' A' ' 114' ' ' LEU . . . 70.7 0.65 33.66 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.178 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.6 t -122.47 134.0 24.68 Favored Pre-proline 0 C--O 1.251 1.171 0 CA-C-O 120.56 0.219 . . . . 0.0 110.739 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.4 160.91 41.16 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.81 2.34 . . . . 0.0 111.206 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 69.53 22.64 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 109.311 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 m -89.01 170.67 10.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.464 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.18 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 167.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.401 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 14.8 m-20 -96.05 69.12 2.77 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.859 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.27 100.32 7.62 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.799 170.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 64.4 mt -79.98 99.92 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.827 -172.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -104.06 155.21 17.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.218 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.419 ' N ' HD21 ' A' ' 40' ' ' LEU . 22.2 t30 -68.83 -30.96 69.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.596 0.712 . . . . 0.0 109.328 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.96 -30.89 65.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.576 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.6 p -82.32 -32.29 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.002 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.0 tp -74.34 -19.98 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.627 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.09 -23.59 1.92 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.949 -1.12 . . . . 0.0 114.057 173.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -74.48 77.56 1.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.239 0.52 . . . . 0.0 111.011 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -73.95 -29.93 62.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.487 0.66 . . . . 0.0 109.252 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -155.36 98.53 1.98 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.86 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -61.47 149.09 39.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.385 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -160.64 157.06 26.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.989 -172.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -121.85 26.55 8.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.247 0.546 . . . . 0.0 109.902 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -128.51 144.22 51.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.091 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.765 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.02 -74.47 0.29 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 54.77 60.22 3.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -61.02 -29.38 69.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 172.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -52.51 -42.81 64.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.995 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.512 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 48.2 mmtm -68.43 -40.32 81.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.659 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.04 85.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.942 0.401 . . . . 0.0 110.756 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' O ' HG21 ' A' ' 36' ' ' VAL . 7.0 m-20 -65.42 -46.72 78.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.394 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.525 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.7 ptm180 -63.85 -35.66 81.37 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.117 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 56.1 mt-30 -59.1 -39.58 82.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.862 0.363 . . . . 0.0 110.256 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -68.32 -38.66 81.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.245 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 32' ' ' ASP . 71.7 t -61.01 -47.9 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.469 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 33' ' ' ARG . 65.6 t -60.09 -37.55 73.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.831 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.457 ' O ' HG22 ' A' ' 41' ' ' VAL . 14.4 t -61.36 -47.47 85.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.99 0.424 . . . . 0.0 111.04 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.6 -33.96 71.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 15.9 tp -62.5 -44.31 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.211 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 38' ' ' SER . 32.2 m -65.7 -35.29 74.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 O-C-N 122.356 -0.215 . . . . 0.0 110.631 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.44 81.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 78.0 mt -62.04 -47.75 83.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.647 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.403 ' HG2' HD11 ' A' ' 111' ' ' ILE . 36.6 mm-40 -57.35 -36.69 71.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.28 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.51 99.69 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.689 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.519 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . . . -62.95 -37.83 88.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.223 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 36.3 mt -61.92 -44.99 95.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.449 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -61.34 -45.37 94.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.733 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.78 -38.04 79.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.27 -46.2 74.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.02 -33.26 75.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.686 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -44.57 93.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.436 0.636 . . . . 0.0 110.04 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.64 -41.61 53.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.252 -174.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 77' ' ' ALA . 48.4 m-80 -118.06 16.04 14.16 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m 72.17 -42.21 0.53 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 176.45 5.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.439 ' CD2' ' HG2' ' A' ' 108' ' ' GLN . 36.8 m-85 -88.78 144.85 33.78 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.418 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.71 152.79 42.77 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.403 2.736 . . . . 0.0 113.697 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.497 HG21 ' H ' ' A' ' 60' ' ' THR . 0.3 OUTLIER -79.46 177.06 9.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.627 173.24 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.497 ' H ' HG21 ' A' ' 59' ' ' THR . 4.1 t -51.05 -46.02 61.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.1 -39.58 65.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.38 0.609 . . . . 0.0 110.192 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -71.86 -35.43 69.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.812 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.68 70.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.109 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.79 -34.19 71.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.713 0.292 . . . . 0.0 111.657 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.561 ' OE1' ' HA ' ' A' ' 71' ' ' PRO . 28.3 mt-30 -70.28 -23.84 62.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.35 -18.2 36.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.519 ' HG ' ' HB3' ' A' ' 46' ' ' ALA . 8.5 mt -94.09 -25.07 17.32 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 6.2 p -105.65 -47.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -157.27 143.38 17.8 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.434 ' HB3' ' CG ' ' A' ' 80' ' ' TYR . . . -56.06 121.0 38.33 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.24 0.338 . . . . 0.0 110.283 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.561 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 80.6 Cg_exo -52.87 136.35 59.57 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 123.108 2.539 . . . . 0.0 112.586 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -92.22 41.33 1.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.016 0.912 . . . . 0.0 109.943 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.87 133.87 36.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.636 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.8 140.11 86.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 O-C-N 123.219 0.324 . . . . 0.0 111.175 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 73.4 Cg_endo -77.45 132.39 26.97 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.922 -1.699 . . . . 0.0 112.957 0.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -66.81 128.02 34.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.704 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.8 126.75 28.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.085 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -108.94 164.46 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 60.14 36.45 21.1 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.513 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.434 ' CG ' ' HB3' ' A' ' 70' ' ' ALA . 36.1 p90 -94.85 142.01 24.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.94 138.23 28.12 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.224 1.949 . . . . 0.0 111.621 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.39 124.82 23.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.48 -10.14 73.29 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.249 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.17 -164.94 53.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.923 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -91.0 -23.35 20.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.386 0.613 . . . . 0.0 109.385 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.452 HG23 ' HB3' ' A' ' 67' ' ' LEU . 12.1 tt -142.6 138.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -68.98 -26.72 65.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -130.6 166.49 20.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.67 0.271 . . . . 0.0 110.449 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.3 127.63 90.0 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.745 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.6 136.08 64.73 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.556 2.171 . . . . 0.0 112.058 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -128.3 146.9 50.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.268 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.677 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.8 p30 -73.24 153.39 90.39 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.16 -16.93 13.73 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.587 2.858 . . . . 0.0 114.049 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.436 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.7 m-90 -80.63 -25.82 38.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.821 0.344 . . . . 0.0 110.405 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.72 13.91 6.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.041 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.677 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 9.0 m -101.17 143.74 30.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.87 0.367 . . . . 0.0 110.462 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.84 132.65 34.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.332 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -60.34 143.57 52.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.904 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 81.9 mm-40 -118.49 137.86 52.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.907 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.485 HD21 ' CG2' ' A' ' 111' ' ' ILE . 3.1 tm? -113.34 123.19 49.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -118.6 113.55 21.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.043 0.449 . . . . 0.0 110.338 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t -106.04 130.8 22.42 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.74 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.48 153.26 94.45 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 124.241 -1.149 . . . . 0.0 111.591 -3.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.59 145.54 49.75 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.247 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -78.26 -24.22 46.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.12 0.486 . . . . 0.0 110.278 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -119.16 -16.2 9.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.59 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.28 -148.84 4.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.439 ' HG2' ' CD2' ' A' ' 57' ' ' TYR . 25.1 tp60 -73.73 -45.68 50.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.956 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.464 ' HB ' HD23 ' A' ' 100' ' ' LEU . 4.3 m -142.81 127.65 15.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.721 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.0 122.07 43.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -174.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 99' ' ' GLN . 10.0 pt -106.54 126.59 62.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -142.07 153.59 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.27 0.557 . . . . 0.0 112.031 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.0 t -99.92 138.29 37.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.241 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.67 -20.19 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.307 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.436 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 64.68 -163.87 35.68 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.221 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.41 -25.93 29.73 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.344 2.696 . . . . 0.0 111.858 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.461 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 7.8 p-10 -80.9 -14.63 57.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.186 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.17 12.27 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.381 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.412 HG21 ' O ' ' A' ' 117' ' ' ASP . 41.9 t -109.54 131.19 22.03 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-N 116.734 0.267 . . . . 0.0 111.146 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.534 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 66.2 Cg_endo -76.0 149.47 32.8 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.974 2.449 . . . . 0.0 111.89 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 43.1 mt-10 70.87 15.54 6.78 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.378 0.671 . . . . 0.0 110.793 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.457 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.0 OUTLIER -87.39 177.16 7.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.536 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -41.38 98.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.501 0.667 . . . . 0.0 109.638 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.461 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 10.7 m-20 -88.88 65.55 7.63 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.534 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -130.54 91.82 3.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.582 174.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.86 104.62 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.701 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -117.25 174.52 15.26 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.736 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.13 -35.42 73.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -78.98 -31.26 44.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -64.0 -45.23 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.972 0.415 . . . . 0.0 110.767 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 tp -82.65 -26.68 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.811 0.815 . . . . 0.0 109.731 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.09 38.82 88.65 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 114.771 -1.104 . . . . 0.0 114.083 170.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.63 6.41 7.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.485 0.643 . . . . 0.0 111.896 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -78.1 -30.31 49.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.091 0.472 . . . . 0.0 109.892 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -102.56 135.98 43.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -113.58 156.51 23.52 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.935 0.397 . . . . 0.0 110.727 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -126.36 173.98 8.93 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.541 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 35.4 m80 63.06 80.2 0.24 Allowed 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.64 0.588 . . . . 0.0 110.869 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -75.57 93.8 3.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.273 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.306 -179.874 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.018 0.437 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.37 133.08 4.57 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.885 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.7 -32.64 72.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.954 0.406 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -67.39 -33.89 76.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.387 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -58.48 -38.65 78.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.263 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 96.3 mttt -59.07 -46.04 89.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.18 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.43 97.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.282 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.77 -47.8 79.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.313 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -69.45 -35.22 75.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.307 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 52.4 mt-30 -59.07 -37.57 77.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 110.701 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.01 -37.95 85.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.0 t -61.16 -47.13 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.669 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -60.35 -37.9 75.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -62.0 -43.53 98.65 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.887 0.375 . . . . 0.0 111.378 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.79 -35.03 74.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.257 0.551 . . . . 0.0 110.088 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.25 -46.26 89.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.344 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -64.6 -34.9 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.36 96.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.681 0.277 . . . . 0.0 110.433 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' O ' HD11 ' A' ' 47' ' ' LEU . 94.3 mt -61.85 -49.51 75.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.069 0.461 . . . . 0.0 110.631 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -62.41 -40.46 96.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.721 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -62.68 -43.81 98.43 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.916 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -62.69 -38.52 90.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 110.918 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.509 HD11 ' O ' ' A' ' 43' ' ' LEU . 3.2 mp -61.66 -45.82 92.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.416 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.15 -40.39 97.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.514 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.1 mtt -65.98 -41.95 90.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.676 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.411 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 50.6 t80 -63.73 -40.99 98.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.268 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HD2' ' CE2' ' A' ' 57' ' ' TYR . 83.6 tttt -66.95 -34.68 78.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.854 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.06 -41.89 99.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.177 0.513 . . . . 0.0 110.263 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -76.76 -46.76 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.209 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.1 m-80 -105.79 -1.74 23.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -169.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m 62.99 34.28 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.542 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -170.31 165.85 8.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.449 0.166 . . . . 0.0 110.599 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.542 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 74.9 m-85 -87.4 136.43 33.34 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.05 150.55 60.58 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.87 2.38 . . . . 0.0 112.864 -174.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.415 ' HA ' ' OG ' ' A' ' 102' ' ' SER . 11.4 p -77.59 175.74 9.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.956 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.5 t -53.5 -38.59 63.85 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.97 -46.39 44.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -73.49 -29.72 62.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.134 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.75 67.13 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.146 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.31 -32.46 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -73.08 -25.92 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.115 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.6 65.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -167.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.544 ' H ' HD23 ' A' ' 67' ' ' LEU . 2.4 pt? -103.72 -2.28 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -116.15 -45.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 111.62 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -156.69 131.86 9.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -53.79 121.24 27.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.39 0.431 . . . . 0.0 111.137 -176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -57.84 137.04 79.07 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.054 2.503 . . . . 0.0 112.406 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.4 m -79.89 -23.91 41.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.975 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.61 138.75 51.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.677 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.407 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -77.85 145.67 70.77 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 11.5 Cg_exo -71.09 135.92 38.99 Favored 'Cis proline' 0 C--O 1.233 0.238 0 C-N-CA 123.32 -1.533 . . . . 0.0 112.003 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -73.48 125.19 27.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.937 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.47 123.49 17.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.57 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -112.29 165.23 12.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.765 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 61.73 42.77 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.601 . . . . 0.0 110.221 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.5 145.51 31.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.822 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.63 138.71 19.5 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.988 1.792 . . . . 0.0 111.569 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.9 124.87 23.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.49 76.12 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.182 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.08 -160.75 50.41 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.362 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -96.78 -16.28 20.91 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.82 134.92 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.567 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.6 -21.94 61.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.056 -170.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -130.54 156.31 45.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.537 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.7 mt -55.84 120.98 37.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.718 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.13 134.0 59.13 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -130.49 138.53 50.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.803 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -61.05 152.65 70.26 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.24 -21.34 22.35 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.306 2.67 . . . . 0.0 112.832 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -81.54 -18.18 45.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.84 21.86 8.36 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.992 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 p -101.65 143.55 31.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.897 0.38 . . . . 0.0 111.075 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.97 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -57.51 149.41 21.18 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 0.0 111.508 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -111.56 137.45 49.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.554 -175.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.485 HD22 ' CG2' ' A' ' 111' ' ' ILE . 3.1 tm? -131.88 122.73 26.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.25 113.95 13.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.655 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 59' ' ' THR . 60.0 p -107.01 129.92 23.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.829 173.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.56 150.72 88.02 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.716 -3.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.498 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -78.41 156.98 43.8 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.278 -172.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.59 -43.05 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -92.63 -2.56 56.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.64 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.6 -164.03 26.54 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.874 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -72.07 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 109.439 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.3 121.26 63.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.676 169.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.498 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 6.8 t0 -93.39 114.36 26.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -172.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.485 ' CG2' HD22 ' A' ' 100' ' ' LEU . 12.5 pt -113.6 123.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -151.94 162.24 41.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.2 m -119.31 140.27 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.407 HD13 ' OE1' ' A' ' 99' ' ' GLN . 1.1 mm? -62.69 -32.27 73.33 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.1 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 -170.83 41.23 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.25 -16.16 39.5 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 122.735 2.29 . . . . 0.0 111.757 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.73 -14.12 32.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.232 -173.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.403 ' CA ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.34 8.33 70.35 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.019 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.68 111.26 53.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.194 0.497 . . . . 0.0 111.791 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.08 146.54 25.64 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.403 2.736 . . . . 0.0 112.539 177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 62.25 35.5 15.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.405 0.621 . . . . 0.0 111.359 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 1.3 p -109.2 172.64 6.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.407 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -66.25 -30.41 70.84 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.669 ' OD2' 'CA ' ' A' ' 201' ' ' ' CA' . 1.6 p30 -85.96 52.62 2.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.908 176.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 122' ' ' SER . 0.8 OUTLIER -126.71 136.06 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 176.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mm -100.59 101.03 11.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.68 157.7 15.8 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.74 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -61.97 -38.03 87.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 110.552 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 79.8 t90 -68.49 -31.11 70.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.744 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -78.8 -34.21 45.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.3 tp -87.65 -31.51 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.464 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.35 39.76 0.46 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.405 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -131.14 48.27 2.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.329 0.585 . . . . 0.0 110.377 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -103.99 -25.55 12.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.925 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -93.4 54.19 2.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.659 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -137.3 113.71 10.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.372 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -175.37 114.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.08 0.467 . . . . 0.0 110.532 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -117.59 139.08 51.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.208 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -86.07 -23.18 26.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.691 172.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . 0.669 'CA ' ' OD2' ' A' ' 124' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.69 0.281 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.19 -147.21 7.07 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.693 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 53.05 47.08 25.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.212 0.529 . . . . 0.0 110.706 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -85.28 70.05 10.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.702 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 44.6 tt0 -57.86 -32.59 67.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.437 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -54.73 -49.29 71.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.378 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -72.45 -44.85 61.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.036 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.94 -46.0 86.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.194 -173.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 36.9 ptt180 -69.1 -33.79 74.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.81 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -59.5 -35.96 75.15 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.21 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 82.6 mttt -62.19 -44.34 96.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.596 0.712 . . . . 0.0 109.287 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.23 -47.09 95.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.179 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 41' ' ' VAL . 57.6 t -59.47 -38.73 76.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 t -59.82 -46.53 88.96 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.952 0.406 . . . . 0.0 110.532 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 89.7 m-20 -68.46 -34.65 76.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.144 0.497 . . . . 0.0 110.197 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.34 -43.37 96.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.591 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 37' ' ' VAL . 26.2 t -62.66 -37.39 78.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.0 91.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.984 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.665 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 95.7 mt -63.9 -49.69 71.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.362 . . . . 0.0 110.561 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.06 -33.95 75.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.76 91.82 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.483 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -60.32 -43.11 96.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.826 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.665 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 45.3 mt -59.64 -42.78 93.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.616 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.42 -44.04 95.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.59 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.502 ' SD ' ' HE2' ' A' ' 85' ' ' TYR . 92.0 mtp -67.66 -42.25 82.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.443 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.537 ' CD2' ' HG3' ' A' ' 58' ' ' PRO . 77.2 t80 -63.87 -43.82 94.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.497 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -69.34 -33.17 72.71 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.067 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.57 -45.92 92.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.158 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.52 -46.97 24.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.552 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -95.21 -6.45 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m 65.54 24.18 11.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 150.0 18.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.568 0.223 . . . . 0.0 110.682 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -75.24 145.25 79.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.779 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.537 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 6.2 Cg_exo -75.05 162.37 37.11 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.759 2.306 . . . . 0.0 112.28 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -83.84 177.4 8.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.953 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.0 t -51.41 -42.72 61.64 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -175.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.59 -45.0 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.401 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.83 -31.24 70.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.05 -49.38 47.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.177 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.81 -38.52 76.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.864 0.364 . . . . 0.0 111.493 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.57 -24.0 61.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.975 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -25.7 63.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -168.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.55 HD22 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -103.3 -1.32 28.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.214 -177.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -117.64 -39.99 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.56 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.1 m -156.61 129.18 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -55.42 121.62 39.01 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.642 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 46.4 Cg_exo -57.64 136.93 78.7 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.007 2.471 . . . . 0.0 112.699 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 p -85.13 -16.21 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.597 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.16 137.79 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.44 142.63 67.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.404 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 11.4 Cg_exo -72.19 138.11 52.36 Favored 'Cis proline' 0 C--O 1.236 0.39 0 C-N-CA 123.351 -1.52 . . . . 0.0 112.051 -2.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.6 128.67 36.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.87 125.38 23.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.392 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -113.97 163.9 14.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.122 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 56.47 36.36 27.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.343 0.592 . . . . 0.0 110.998 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -98.07 146.11 30.95 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.058 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.36 138.91 28.14 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.752 1.635 . . . . 0.0 110.213 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.37 123.97 21.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.22 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.34 88.12 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.709 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.8 -115.39 7.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.261 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' HE2' ' SD ' ' A' ' 49' ' ' MET . 60.4 m-85 -134.48 -3.43 2.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.886 0.375 . . . . 0.0 110.786 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.6 136.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -75.43 -22.19 57.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -170.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -130.57 171.16 13.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.814 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.09 127.55 80.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.472 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.77 124.84 11.92 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.533 2.156 . . . . 0.0 112.431 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -130.4 148.75 52.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.761 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.578 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.3 p30 -69.4 152.84 96.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.89 -16.22 25.1 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.532 2.821 . . . . 0.0 113.0 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.475 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 5.6 m-90 -80.53 -25.71 38.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.553 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.41 9.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.376 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.578 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 19.3 m -100.18 157.99 16.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.12 0.46 . . . . 0.0 110.786 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.49 138.67 31.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.804 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -68.6 164.36 21.61 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 87.7 mm-40 -130.62 146.68 52.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.187 0.518 . . . . 0.0 111.486 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.444 HD22 HG23 ' A' ' 111' ' ' ILE . 2.4 tm? -133.01 122.85 24.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -120.83 112.49 18.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -107.49 131.46 21.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.926 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.43 146.58 68.96 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.43 -1.488 . . . . 0.0 110.998 -5.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.68 159.86 48.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.501 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -92.8 -37.35 12.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.414 ' HB3' ' CG ' ' A' ' 129' ' ' TRP . 97.5 m-70 -76.4 -56.19 4.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.634 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.71 -150.18 7.78 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.791 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -73.35 -36.23 66.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.8 m -137.55 131.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.474 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.6 m-20 -104.27 115.0 29.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.777 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.444 HG23 HD22 ' A' ' 100' ' ' LEU . 9.0 pt -106.69 126.51 62.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -145.9 159.55 43.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.818 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 3.0 m -116.15 124.6 50.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.235 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.444 ' HB3' ' C ' ' A' ' 118' ' ' GLY . 62.6 mt -61.39 -34.93 76.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.737 -174.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.475 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 86.79 -166.84 37.82 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.15 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.24 -18.83 44.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.64 -13.53 24.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.912 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.444 ' C ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.54 8.82 72.59 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.781 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.38 114.93 64.21 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -173.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -76.62 154.31 34.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.373 2.715 . . . . 0.0 113.101 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 62.89 16.17 8.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.549 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -89.51 177.03 6.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.444 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -71.69 -37.1 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -88.14 62.63 6.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -138.05 109.14 6.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.721 175.035 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.3 mm -77.17 103.11 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.957 0.408 . . . . 0.0 110.528 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.05 159.49 14.05 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.149 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -67.85 -39.46 83.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.085 0.469 . . . . 0.0 110.521 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.414 ' CG ' ' HB3' ' A' ' 106' ' ' HIS . 93.1 t90 -66.34 -31.04 71.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.656 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.7 p -83.89 -29.52 27.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.714 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.1 tp -82.7 -27.66 8.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.849 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 149.79 -40.06 0.87 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.951 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -71.52 99.5 2.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.82 0.343 . . . . 0.0 111.57 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -134.97 111.67 10.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.233 0.54 . . . . 0.0 111.006 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -78.78 78.84 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.69 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -100.87 -14.44 17.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.087 0.47 . . . . 0.0 110.265 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -90.63 31.5 1.04 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.147 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -76.68 95.66 4.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.591 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -141.92 147.0 36.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.376 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.739 -0.648 . . . . 0.0 109.818 -179.595 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.45 139.48 5.91 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.883 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -138.67 16.19 2.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.072 0.463 . . . . 0.0 110.656 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -120.88 112.25 18.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.228 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -57.58 -30.97 65.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.925 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.25 -42.2 98.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.987 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.23 73.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.496 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.7 m-20 -60.92 -47.56 85.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.642 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 37' ' ' VAL . 32.1 ptt180 -69.5 -35.21 75.31 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.827 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -62.33 -35.17 78.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.634 0.254 . . . . 0.0 110.828 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.14 -41.94 98.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.487 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 95.9 t -60.69 -44.46 97.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.99 176.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 33' ' ' ARG . 90.3 t -60.22 -39.37 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.327 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 41' ' ' VAL . 37.9 t -62.18 -46.77 87.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.105 0.479 . . . . 0.0 110.681 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.96 -34.1 71.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.336 0.589 . . . . 0.0 110.311 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 17.8 tp -60.65 -44.84 95.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.206 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 38' ' ' SER . 27.7 m -65.68 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.456 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.54 97.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.859 0.361 . . . . 0.0 110.195 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.513 ' O ' HD13 ' A' ' 47' ' ' LEU . 96.1 mt -61.43 -48.95 78.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.776 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.63 -42.53 98.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.33 -38.09 95.67 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.053 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -42.45 96.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.861 0.362 . . . . 0.0 110.277 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.513 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.6 mp -62.25 -48.1 81.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.196 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.06 -41.13 97.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.297 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.16 -37.46 72.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.32 -41.19 98.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -68.43 -32.62 72.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.36 -48.9 73.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.905 0.383 . . . . 0.0 110.214 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.66 -39.73 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.453 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.0 m-80 -106.69 11.74 30.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.5 m 73.17 -43.19 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -117.82 164.53 14.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.712 0.292 . . . . 0.0 111.552 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -71.18 148.16 93.81 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.933 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.73 149.36 48.36 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.031 2.487 . . . . 0.0 112.529 177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.8 p -85.69 179.73 7.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -50.2 -38.89 42.27 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.42 -44.72 34.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.279 0.562 . . . . 0.0 110.677 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.87 -30.29 65.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.323 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.3 -51.17 60.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.645 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 mp -71.28 -33.54 69.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.962 0.41 . . . . 0.0 111.506 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -68.49 -26.69 65.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.809 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -23.53 63.88 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD12 ' CG2' ' A' ' 86' ' ' ILE . 0.6 OUTLIER -103.74 -2.2 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.5 p -122.93 -48.33 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.831 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 p -152.08 128.61 10.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.608 0.242 . . . . 0.0 110.484 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.9 121.81 37.35 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.085 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.57 144.45 85.01 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.077 2.518 . . . . 0.0 112.307 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.411 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 25.4 t -94.97 2.51 55.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.17 131.26 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.461 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 8.1 tp10 -77.79 138.65 62.0 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.208 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.461 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 14.3 Cg_exo -67.03 130.84 14.08 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.565 -1.431 . . . . 0.0 112.62 0.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.411 ' CE1' ' HA ' ' A' ' 72' ' ' SER . 3.8 t60 -74.0 131.16 41.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.723 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.48 127.99 34.78 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.524 0.515 . . . . 0.0 111.576 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -114.2 167.09 10.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.844 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.3 p30 52.76 31.39 10.37 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -80.32 139.17 51.99 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.775 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.21 140.5 24.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.551 2.167 . . . . 0.0 111.719 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.36 125.07 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.178 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.54 3.18 86.67 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.45 -161.89 53.45 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.362 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.56 -22.51 24.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.428 ' CG2' HD12 ' A' ' 67' ' ' LEU . 8.3 tt -139.39 134.08 39.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.769 173.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -60.98 -29.31 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.608 -169.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -133.75 160.24 38.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.51 122.34 59.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.539 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.45 149.45 80.27 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.427 2.084 . . . . 0.0 111.876 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -140.76 140.71 34.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.788 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 1.9 p30 -63.82 152.98 85.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.22 -15.68 15.19 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.816 3.011 . . . . 0.0 113.812 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -79.05 -26.06 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.03 19.6 8.02 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.603 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.589 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 0.7 OUTLIER -95.96 151.35 19.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.417 . . . . 0.0 110.553 -178.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.25 122.6 31.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.487 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 56.6 m-85 -54.66 140.8 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.024 0.44 . . . . 0.0 111.284 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -113.69 137.89 50.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.454 HD23 ' CG2' ' A' ' 111' ' ' ILE . 2.8 tm? -118.79 122.02 41.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.405 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 1.7 tm? -122.54 113.98 20.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.887 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 p -106.35 130.52 22.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.81 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.5 139.97 63.72 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.385 -1.09 . . . . 0.0 111.93 -1.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 101' ' ' LEU . . . -60.62 143.82 47.99 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.358 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.407 ' H ' ' HB2' ' A' ' 110' ' ' ASP . 23.9 tp60 -58.52 -36.24 73.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.887 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -119.45 21.79 11.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.592 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.96 -147.92 11.72 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.816 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -45.44 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.659 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.449 ' HB ' HD22 ' A' ' 100' ' ' LEU . 3.1 m -137.67 146.96 26.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.503 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER -127.48 121.5 30.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.966 -177.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.454 ' CG2' HD23 ' A' ' 100' ' ' LEU . 7.0 pt -106.59 125.41 62.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.973 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -151.53 156.57 40.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 0.0 111.609 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.416 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 54.6 p -100.04 155.08 17.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -17.77 63.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 110.97 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.24 -172.0 55.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.437 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.01 -22.2 35.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.151 2.567 . . . . 0.0 112.273 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.72 ' OD2' HG11 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -94.91 -14.99 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.333 -173.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.51 -5.54 44.31 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.72 HG11 ' OD2' ' A' ' 117' ' ' ASP . 2.8 p -97.44 128.68 33.9 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.375 1.588 . . . . 0.0 110.683 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.686 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 56.0 Cg_endo -73.13 159.71 46.93 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.749 2.3 . . . . 0.0 113.398 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 69.37 15.83 8.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.296 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 1.3 p -98.97 175.35 5.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -77.9 -22.4 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.987 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -79.88 -11.24 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.686 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 1.0 OUTLIER -71.56 89.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.891 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.417 ' HA ' HG21 ' A' ' 130' ' ' THR . 46.6 mm -66.58 105.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.351 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 130' ' ' THR . . . -135.35 -161.8 9.47 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.406 ' HA ' HD21 ' A' ' 40' ' ' LEU . 10.6 t-20 -62.42 -38.11 88.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.618 0.247 . . . . 0.0 111.621 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -79.66 -30.86 41.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.417 HG21 ' HA ' ' A' ' 126' ' ' ILE . 5.4 t -69.16 -33.09 72.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.591 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.45 -34.93 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.95 83.74 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.376 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -73.64 -22.89 59.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -130.85 91.48 3.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.382 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -72.43 96.46 1.91 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.824 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -74.92 102.3 4.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -81.07 135.42 35.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.143 0.497 . . . . 0.0 111.561 -173.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -138.17 91.01 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.63 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -99.76 138.19 37.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.541 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.948 179.191 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.958 0.409 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.59 167.68 40.12 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.908 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 66.52 98.44 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.493 0.663 . . . . 0.0 110.732 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -98.25 47.93 1.0 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.809 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 27.6 tt0 -53.68 -39.17 64.89 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.421 -175.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -64.11 -35.1 79.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -176.125 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -71.2 -38.21 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.573 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.54 -49.06 79.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.488 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 2.5 ptp180 -69.92 -36.63 75.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.484 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -60.89 -35.87 77.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.02 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 67.6 mttm -68.12 -39.73 82.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.094 0.473 . . . . 0.0 109.966 175.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.586 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 35.4 t -61.04 -47.78 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.716 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 33' ' ' ARG . 58.9 t -62.91 -38.32 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -61.77 -46.22 90.53 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -69.94 -35.34 74.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.107 0.48 . . . . 0.0 110.266 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.93 -46.13 86.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.437 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 37' ' ' VAL . 25.1 m -66.02 -36.12 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.13 85.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.47 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.696 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 68.2 mt -60.12 -48.26 82.46 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.556 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.92 -36.28 78.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.065 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.06 -46.06 93.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.615 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -62.55 -38.72 91.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.576 0.227 . . . . 0.0 110.617 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 37.4 mt -65.15 -50.42 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.362 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.39 -44.39 97.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.399 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -70.31 -35.76 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.963 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.521 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.6 t80 -58.64 -44.75 90.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.43 -33.12 73.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.6 tp -62.82 -51.03 68.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.565 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.45 ' OD1' ' HB3' ' A' ' 78' ' ' ARG . 16.2 t70 -78.51 -46.95 18.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -93.49 -0.07 56.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.861 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m 70.01 7.25 6.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.58 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -160.53 157.14 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.58 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 m-85 -74.29 148.22 85.99 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.178 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 60.4 Cg_endo -73.27 155.85 51.24 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.843 2.362 . . . . 0.0 112.456 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -86.06 178.18 7.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.33 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -51.31 -40.33 58.79 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -173.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -76.04 -43.28 44.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.352 0.596 . . . . 0.0 110.733 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -72.6 -27.46 62.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.5 56.12 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.964 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -33.47 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.172 0.486 . . . . 0.0 111.018 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -71.74 -25.18 61.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.677 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.58 -22.88 62.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 86' ' ' ILE . 9.3 mt -87.75 -19.1 28.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.25 -48.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 t -144.09 129.95 19.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.44 121.21 41.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.032 -175.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.33 136.91 75.7 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.127 2.551 . . . . 0.0 112.594 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 m -80.07 -16.59 54.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.281 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.89 146.92 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.699 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.05 136.31 69.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.17 131.99 24.43 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.776 -1.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.32 120.94 11.39 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . . . -55.89 121.22 8.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.931 0.396 . . . . 0.0 110.158 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 22.0 tpt180 -110.38 154.81 23.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.347 -176.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 64.87 43.02 4.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.421 0.629 . . . . 0.0 110.213 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -100.47 140.23 21.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.296 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.7 144.0 58.29 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.744 2.296 . . . . 0.0 111.914 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.31 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.14 4.28 78.15 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.44 -159.58 51.84 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.326 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -88.03 -30.51 19.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 67' ' ' LEU . 7.6 tt -135.44 124.46 40.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.148 172.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -65.7 -20.25 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.538 ' HD2' ' O ' ' A' ' 89' ' ' LEU . 8.1 tmm_? -129.64 146.53 51.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -174.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.538 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 4.3 mm? -54.28 122.45 37.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 123.292 0.37 . . . . 0.0 111.159 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.38 124.44 15.55 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.945 1.764 . . . . 0.0 110.403 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 89' ' ' LEU . 90.9 mt-30 -134.79 144.38 47.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.989 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.593 ' OD2' ' HB2' ' A' ' 113' ' ' SER . 0.5 OUTLIER -56.34 145.17 59.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.76 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.93 -19.85 41.79 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.97 2.447 . . . . 0.0 112.437 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -80.78 -13.93 58.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.344 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.14 20.16 9.47 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.941 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -99.2 160.69 14.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.569 0.223 . . . . 0.0 110.568 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.66 122.97 48.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.375 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.586 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 52.8 m-85 -53.97 148.04 11.32 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.507 0.67 . . . . 0.0 112.599 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.46 ' HG2' HD21 ' A' ' 114' ' ' LEU . 62.1 mm-40 -112.01 138.6 48.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.036 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 110' ' ' ASP . 2.2 tm? -129.39 122.64 29.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.72 113.45 17.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.883 0.373 . . . . 0.0 110.414 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -106.93 128.53 25.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.091 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.71 137.38 32.35 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.403 -1.082 . . . . 0.0 111.428 -3.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.426 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -67.35 169.35 36.75 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.768 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 6.1 tp60 -95.84 -28.08 14.9 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 0.0 109.862 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -93.25 -5.76 49.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.781 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.61 10.57 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.08 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -72.74 -45.32 59.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.971 0.415 . . . . 0.0 110.348 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.405 ' HB ' HD21 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -127.97 124.56 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 177.335 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -100.01 112.68 24.96 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.874 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.494 HG21 HD22 ' A' ' 100' ' ' LEU . 7.5 pt -112.43 125.5 69.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -151.47 155.08 37.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.593 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 15.9 p -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.358 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.664 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 3.4 mm? -100.98 -12.66 18.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 110.822 -174.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 62.87 -154.9 42.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.275 173.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.05 -33.39 19.39 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.383 2.722 . . . . 0.0 113.135 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.571 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 2.8 p30 -83.7 -14.08 52.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.738 -0.385 . . . . 0.0 112.028 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.97 -3.96 18.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.755 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.3 m -107.83 139.47 20.66 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-N 117.329 0.565 . . . . 0.0 112.159 -173.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.7 155.31 39.73 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.505 2.803 . . . . 0.0 112.834 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 61.1 25.53 15.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.772 0.796 . . . . 0.0 110.74 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.49 174.61 7.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.116 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.38 -41.87 98.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.696 0.76 . . . . 0.0 109.19 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.571 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 4.6 m-20 -99.3 75.24 1.98 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.54 1.162 . . . . 0.0 109.248 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.664 ' OD1' ' HA ' ' A' ' 114' ' ' LEU . 55.9 m-20 -143.39 112.67 6.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.259 169.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.544 ' HB ' ' HG ' ' A' ' 113' ' ' SER . 44.6 mm -87.34 104.9 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 109.999 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -95.23 157.19 21.93 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.673 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.435 ' HB2' HG13 ' A' ' 111' ' ' ILE . 62.6 t30 -65.89 -28.55 69.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.291 0.567 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -78.36 -23.63 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -81.03 -29.44 35.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 tp -78.37 -21.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.799 0.333 . . . . 0.0 110.938 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 130.17 -6.14 6.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.096 -1.05 . . . . 0.0 113.405 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -86.31 165.53 16.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.935 0.368 . . . . 0.0 110.638 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 58.34 32.22 21.82 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.795 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -91.06 56.36 3.15 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 28.2 t60 62.09 71.53 0.53 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.494 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -116.44 143.7 45.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.738 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -152.51 129.75 11.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.889 0.376 . . . . 0.0 111.235 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -83.25 -13.34 55.47 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.851 174.079 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.726 0.298 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 30' ' ' LYS . . . -156.76 79.54 0.18 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.112 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -59.17 -41.29 88.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.956 0.407 . . . . 0.0 110.603 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -78.73 -34.69 45.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.701 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 4.8 tp10 -61.4 -38.19 86.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.394 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 53.3 mtmt -58.77 -40.68 84.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.61 -44.96 88.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.345 . . . . 0.0 110.811 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.42 -40.53 77.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.981 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.597 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 13.1 ptm180 -65.9 -33.67 76.36 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.996 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm100 -62.99 -31.59 72.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 87.7 mttt -64.69 -39.22 93.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.597 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 31.2 t -60.7 -46.46 95.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.632 175.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.6 t -58.63 -38.78 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.061 0.458 . . . . 0.0 110.558 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 41' ' ' VAL . 38.9 m -63.4 -43.87 96.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.891 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.9 -35.17 74.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.304 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.39 -45.25 95.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.187 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 38' ' ' SER . 23.7 m -64.64 -35.72 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.26 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.74 85.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.614 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.71 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 87.5 mt -60.55 -48.4 81.92 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.135 0.493 . . . . 0.0 110.101 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.65 -35.96 82.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.586 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.99 -42.92 99.77 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.556 ' HB3' ' HG ' ' A' ' 67' ' ' LEU . . . -60.53 -43.96 96.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.362 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 48.7 mt -59.42 -49.07 79.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.662 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.65 -41.59 97.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.994 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.57 -38.64 74.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.976 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.98 -33.25 73.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.44 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.88 -49.75 76.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.709 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.94 -47.01 17.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.9 10.12 41.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m 70.99 -7.2 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -139.0 148.7 43.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.829 -0.545 . . . . 0.0 111.455 -175.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -69.25 142.73 92.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.0 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.69 155.99 49.15 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 123.051 2.501 . . . . 0.0 112.694 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 p -81.89 177.11 9.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.398 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -51.65 -41.39 61.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.4 -45.39 39.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.066 0.46 . . . . 0.0 110.573 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.407 ' HG2' ' HB3' ' A' ' 71' ' ' PRO . 50.4 mt-30 -68.39 -31.61 71.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.189 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.45 ' HA3' HD23 ' A' ' 100' ' ' LEU . . . -62.57 -48.85 78.67 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.086 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.44 -32.41 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -72.12 -29.17 63.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.986 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.83 60.72 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -173.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.556 ' HG ' ' HB3' ' A' ' 46' ' ' ALA . 7.6 mt -89.95 -9.79 47.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.33 -53.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 p -144.74 139.14 27.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.08 122.24 46.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HB3' ' HG2' ' A' ' 62' ' ' GLN . 52.1 Cg_exo -56.24 137.38 79.6 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.875 2.383 . . . . 0.0 111.776 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -84.64 -16.04 43.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.622 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 135.86 48.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.229 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -77.57 140.56 64.2 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.146 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 57.7 Cg_endo -72.09 132.11 24.22 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.232 -0.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -66.96 129.79 41.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.692 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.6 17.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.687 0.28 . . . . 0.0 110.416 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.492 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 29.0 tpt180 -109.26 162.95 13.81 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -177.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.492 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 9.5 p30 47.83 39.75 11.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.902 0.881 . . . . 0.0 111.795 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -85.14 147.29 47.29 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.025 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.19 138.81 48.35 Favored 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.283 1.988 . . . . 0.0 111.446 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.54 124.08 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.24 10.47 86.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.371 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.71 -121.05 21.62 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.764 0.332 . . . . 0.0 112.639 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.482 ' HB2' ' CD2' ' A' ' 67' ' ' LEU . 51.1 m-85 -114.03 -17.8 11.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.449 0.642 . . . . 0.0 109.553 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 88' ' ' ARG . 6.1 tt -143.15 129.12 16.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.818 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -60.77 -23.12 64.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -167.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.449 ' O ' HG12 ' A' ' 86' ' ' ILE . 59.6 mtp180 -130.42 167.12 19.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.61 ' C ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -60.74 133.2 91.78 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.69 137.32 63.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.787 2.324 . . . . 0.0 112.46 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -133.48 150.7 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.149 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.426 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 7.7 m-20 -55.88 150.85 26.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.88 -17.96 39.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.181 . . . . 0.0 111.623 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.486 ' CZ3' ' HA2' ' A' ' 115' ' ' GLY . 6.3 m-90 -81.96 -12.3 58.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.315 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.2 10.79 31.1 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.699 -0.762 . . . . 0.0 114.001 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -102.31 143.41 32.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.352 0.576 . . . . 0.0 111.022 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.1 130.7 38.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -61.28 163.13 6.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.772 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -127.93 139.43 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.641 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.492 HD12 ' HB ' ' A' ' 109' ' ' VAL . 13.3 tp -122.89 142.51 50.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.361 173.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.65 112.83 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.481 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.0 m -107.55 129.67 23.9 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.144 172.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -83.09 135.66 26.72 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.465 -1.056 . . . . 0.0 110.956 -5.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -68.85 174.45 32.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.359 -173.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -94.73 -27.67 15.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.172 0.511 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -99.81 21.83 11.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 151.26 -155.26 26.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.493 HE22 ' HA ' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -73.52 -36.83 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.015 0.407 . . . . 0.0 111.21 177.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.492 ' HB ' HD12 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -132.78 129.05 57.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 -178.807 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.415 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 0.4 OUTLIER -107.53 114.19 28.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.475 -179.058 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 128' ' ' ASN . 5.5 pt -106.88 126.87 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.45 . . . . 0.0 110.025 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -145.02 148.35 33.62 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.5 m -106.82 137.18 45.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.513 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.46 -35.26 79.85 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.82 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.486 ' HA2' ' CZ3' ' A' ' 94' ' ' TRP . . . 86.69 -177.31 48.28 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.606 -176.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.85 -15.36 40.39 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.012 2.474 . . . . 0.0 112.926 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.604 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 15.9 p-10 -92.37 -12.5 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.723 -174.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.86 67.33 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.679 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.604 ' HB ' ' OD2' ' A' ' 117' ' ' ASP . 58.9 t -110.76 121.13 41.87 Favored Pre-proline 0 C--O 1.244 0.815 0 CA-C-O 120.744 0.307 . . . . 0.0 111.141 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.603 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 72.0 Cg_endo -76.13 156.5 38.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.411 2.74 . . . . 0.0 113.448 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 62.65 25.94 15.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.75 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -101.03 172.86 6.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.951 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.48 -32.48 73.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.81 -19.01 60.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.142 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.603 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -62.0 138.71 58.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.986 -174.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -104.87 104.97 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.737 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.71 169.74 13.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.203 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.568 ' OD1' ' HB2' ' A' ' 133' ' ' PHE . 62.8 t30 -62.38 -33.98 75.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 110.568 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -77.9 -20.24 53.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.271 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -73.48 -46.5 47.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.109 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.95 -22.3 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 110.147 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.54 42.91 7.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.048 168.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.568 ' HB2' ' OD1' ' A' ' 128' ' ' ASN . 28.6 m-85 -83.85 62.09 6.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.537 0.684 . . . . 0.0 110.373 174.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -142.87 92.29 2.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.454 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -79.05 142.78 36.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.197 0.522 . . . . 0.0 111.303 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -142.6 75.25 1.48 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.463 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -74.17 -32.53 63.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.806 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -76.76 84.01 3.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.236 0.541 . . . . 0.0 110.172 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -94.56 46.03 1.14 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.973 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.993 179.652 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.22 -28.18 6.14 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.294 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -93.78 82.76 4.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.101 0.477 . . . . 0.0 110.056 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -113.25 75.09 0.9 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.423 0.63 . . . . 0.0 109.391 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.6 tp10 -53.4 -40.14 64.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.789 -175.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 87.7 tttt -60.27 -41.85 94.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.01 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.89 -40.32 75.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.677 0.275 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 36' ' ' VAL . 49.4 m-20 -62.49 -47.56 83.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 13.9 ptm180 -68.19 -36.73 80.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.554 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.452 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 12.5 mm-40 -63.95 -35.15 79.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -66.44 -37.73 85.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.703 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 32' ' ' ASP . 85.9 t -60.68 -44.01 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.011 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 33' ' ' ARG . 96.7 t -59.94 -40.09 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.972 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.59 -45.65 93.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.449 ' HB2' ' HH ' ' A' ' 98' ' ' TYR . 15.2 m-20 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.116 0.484 . . . . 0.0 110.018 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.5 tp -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.318 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.21 -36.64 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.31 94.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.538 ' O ' HD11 ' A' ' 47' ' ' LEU . 7.5 mp -60.67 -49.03 79.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -63.35 -36.92 85.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.953 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.39 96.89 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.217 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.513 ' HB3' ' HB3' ' A' ' 67' ' ' LEU . . . -60.52 -41.69 94.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.696 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.538 HD11 ' O ' ' A' ' 43' ' ' LEU . 5.8 mp -59.75 -39.94 86.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.873 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.14 -36.21 79.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -42.94 77.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -65.7 -38.69 89.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -70.21 -32.79 70.85 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.774 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.4 tp -68.29 -40.98 81.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.032 0.444 . . . . 0.0 110.221 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.14 -44.96 28.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.422 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.568 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.6 m-80 -112.16 5.35 18.45 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -171.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.2 m 66.95 9.24 6.71 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -147.37 167.59 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.966 -0.459 . . . . 0.0 111.016 -177.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.404 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 21.9 m-85 -91.2 142.83 27.56 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.382 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.83 162.18 39.94 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.378 2.719 . . . . 0.0 113.632 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.2 p -88.07 178.87 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.182 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.0 m -50.13 -46.48 53.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.832 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.43 -44.9 61.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.501 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -64.98 -42.43 94.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.444 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.34 -44.49 98.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.702 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.437 HD22 ' O ' ' A' ' 98' ' ' TYR . 2.7 mp -69.66 -41.27 75.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.727 0.298 . . . . 0.0 111.39 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -72.52 -24.54 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.36 69.88 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.576 HD21 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -96.47 -0.28 49.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.932 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.6 -24.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 111.081 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.1 p -157.66 164.23 37.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.549 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.446 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -75.84 121.81 85.79 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.62 136.89 77.02 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.493 2.128 . . . . 0.0 112.136 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.4 m -82.49 -30.47 29.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.475 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.62 122.07 16.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.517 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.501 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -69.85 148.12 96.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.222 -175.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.568 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 14.5 Cg_exo -68.63 136.19 34.97 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.506 1.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -75.97 128.15 34.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.36 126.29 26.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.506 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -106.03 158.16 17.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.477 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.03 43.94 13.87 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.795 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.446 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 34.0 p90 -88.58 139.36 29.73 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.2 140.4 53.51 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.514 2.143 . . . . 0.0 111.38 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -64.31 123.88 20.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.16 86.4 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.927 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.41 -115.05 7.35 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.051 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.3 -21.73 4.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.287 0.565 . . . . 0.0 109.55 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 88' ' ' ARG . 14.0 tt -133.55 138.32 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.43 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 87' ' ' ARG . 38.4 mtp-105 -72.57 -20.8 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.447 ' H ' HG12 ' A' ' 86' ' ' ILE . 74.7 mtp180 -129.38 158.26 39.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.336 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.7 128.39 79.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.69 123.86 14.19 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.56 2.173 . . . . 0.0 112.822 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -127.84 140.39 52.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.636 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 4.8 p30 -68.85 155.58 93.03 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.932 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.53 -31.83 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.836 2.358 . . . . 0.0 113.666 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.435 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 6.5 m-90 -78.03 -19.01 55.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.855 0.359 . . . . 0.0 111.223 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.81 20.97 6.97 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.555 172.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.636 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 4.4 m -103.3 133.23 48.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.106 0.453 . . . . 0.0 110.552 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.79 128.73 37.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.488 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 76.6 m-85 -60.57 168.17 2.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 111.075 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -130.58 137.64 49.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.203 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.543 HD22 ' CG2' ' A' ' 111' ' ' ILE . 3.3 tm? -118.09 122.75 43.91 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.11 114.26 20.1 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.126 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.3 t -106.48 135.45 19.5 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.38 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.36 137.83 52.06 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.525 -1.448 . . . . 0.0 111.804 -3.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.83 141.88 47.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.652 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.96 -21.15 65.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.089 0.471 . . . . 0.0 110.262 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -126.89 31.54 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.29 -150.05 21.71 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.852 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -73.27 -40.21 64.77 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.494 ' HB ' HD21 ' A' ' 100' ' ' LEU . 4.5 m -132.84 151.27 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.886 175.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -131.15 123.03 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.604 0.24 . . . . 0.0 110.446 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.543 ' CG2' HD22 ' A' ' 100' ' ' LEU . 13.0 pt -106.87 129.68 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.541 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -151.13 161.05 43.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.287 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.468 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 44.0 p -112.32 150.92 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.471 175.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.35 -22.2 44.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.85 -171.97 54.11 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.553 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.435 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 13.4 Cg_exo -68.39 -23.79 37.61 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.045 2.497 . . . . 0.0 112.191 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.41 -12.43 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 111.291 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.21 11.8 79.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.983 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.28 116.8 66.02 Favored Pre-proline 0 C--O 1.239 0.526 0 CA-C-N 117.934 0.867 . . . . 0.0 111.747 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.5 151.77 33.31 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.557 2.838 . . . . 0.0 113.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.06 27.23 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.406 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -100.26 177.33 5.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.008 -176.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.28 -41.89 80.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.474 0.654 . . . . 0.0 109.31 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -88.56 65.39 7.81 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.398 1.094 . . . . 0.0 108.319 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 122' ' ' SER . 0.4 OUTLIER -136.46 90.55 2.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.41 -1.723 . . . . 0.0 108.823 174.46 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.54 109.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.571 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.66 -162.98 10.47 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.754 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -63.27 -37.59 87.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.268 -0.466 . . . . 0.0 111.866 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 -78.63 -27.06 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.674 0.273 . . . . 0.0 110.388 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 m -56.83 -49.31 75.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.905 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.7 tt -92.13 -25.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.501 . . . . 0.0 110.632 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.23 35.45 52.91 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.78 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -84.39 129.33 34.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.893 0.378 . . . . 0.0 110.167 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -171.75 135.83 0.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.574 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 60.91 26.97 16.84 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.469 0.652 . . . . 0.0 109.806 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -102.15 70.7 1.21 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.576 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -131.7 42.94 3.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.575 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 47.1 m170 -83.39 114.05 21.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.525 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -143.48 33.17 1.3 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.234 0.54 . . . . 0.0 110.935 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.826 176.818 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.56 0.219 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -61.72 -45.82 92.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.55 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.98 95.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.52 -47.38 73.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 37' ' ' VAL . 12.8 ptm85 -69.77 -34.77 74.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.465 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -61.07 -38.52 86.49 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.826 0.346 . . . . 0.0 110.688 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -62.4 -39.3 92.78 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 21.6 t -60.94 -47.52 93.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.801 175.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 33' ' ' ARG . 99.9 t -60.31 -38.84 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.996 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 m -59.02 -47.1 86.41 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 5.4 m-20 -70.41 -34.8 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.699 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.52 -44.95 93.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.423 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 37' ' ' VAL . 91.4 t -62.41 -41.34 91.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.288 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.04 90.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.085 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 47' ' ' LEU . 88.3 mt -60.25 -48.65 80.85 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.61 -36.05 81.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.166 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -61.73 -39.65 97.73 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.0 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.521 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -63.02 -39.81 95.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.232 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 43' ' ' LEU . 7.3 mp -60.76 -48.27 82.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.763 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.43 -36.83 85.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 24.6 mmt -68.02 -40.17 83.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.372 . . . . 0.0 110.628 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -63.63 -38.73 92.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.84 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.83 -32.72 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.96 -48.61 78.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 110.443 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.96 -46.56 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' A' ' 77' ' ' ALA . 38.5 m-80 -101.22 -0.67 35.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m 62.3 29.05 17.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.544 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -164.15 158.6 19.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -82.93 140.94 43.38 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.398 . . . . 0.0 110.952 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.43 157.91 44.75 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.105 2.537 . . . . 0.0 113.771 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.6 p -84.85 179.04 7.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.791 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.425 ' HA ' HD23 ' A' ' 100' ' ' LEU . 5.2 t -49.04 -44.78 41.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -171.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.17 -45.16 23.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.503 . . . . 0.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.462 HE22 ' NH2' ' A' ' 56' ' ' ARG . 48.2 mt-30 -64.12 -34.69 78.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.83 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -65.73 -48.84 63.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.922 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.54 -38.33 77.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.903 0.382 . . . . 0.0 111.036 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -72.08 -23.49 61.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.242 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.521 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 11.0 mt -79.4 -18.33 52.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.24 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.93 -59.14 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.125 0.488 . . . . 0.0 111.905 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -152.2 148.39 27.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.94 122.07 50.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.848 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HB3' ' HG2' ' A' ' 62' ' ' GLN . 78.2 Cg_exo -53.48 139.83 65.12 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.149 2.566 . . . . 0.0 112.529 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 p -81.18 -18.28 46.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.91 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.25 142.61 54.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.444 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.05 141.6 63.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.246 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.544 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 73.4 Cg_endo -76.99 143.72 76.42 Favored 'Cis proline' 0 C--N 1.344 0.294 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.588 -4.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -69.88 121.28 17.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.034 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -58.42 130.9 48.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.807 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -112.66 164.72 13.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.863 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 63.03 32.35 15.47 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.397 0.618 . . . . 0.0 110.658 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -88.86 144.05 32.46 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.896 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.33 139.99 43.13 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.37 2.047 . . . . 0.0 111.992 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.79 125.1 23.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.09 -9.41 60.67 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.789 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.09 -171.41 54.35 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.341 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.403 ' HB2' HD22 ' A' ' 67' ' ' LEU . 83.8 m-85 -83.14 -32.68 26.53 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.436 HG22 ' HB3' ' A' ' 67' ' ' LEU . 9.5 tt -139.07 126.94 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.678 174.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -67.4 -20.59 65.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -128.82 157.82 40.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.65 123.69 72.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.737 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.38 142.95 97.35 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.444 2.096 . . . . 0.0 111.27 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -138.18 144.7 40.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.818 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.49 142.08 52.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.8 -18.72 13.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.349 2.699 . . . . 0.0 113.457 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 23.1 m-90 -81.65 -14.28 56.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.399 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.14 25.65 5.51 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.29 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 139.6 38.76 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.641 -0.329 . . . . 0.0 110.328 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -87.73 119.22 27.84 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.31 -0.244 . . . . 0.0 110.345 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -50.95 145.71 6.97 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.748 0.655 . . . . 0.0 111.839 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.417 ' HG2' HD21 ' A' ' 114' ' ' LEU . 88.3 mm-40 -121.33 143.97 48.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.287 0.565 . . . . 0.0 111.625 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 109' ' ' VAL . 13.1 tp -122.48 142.27 50.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.741 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -128.08 112.57 14.74 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.555 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -107.4 131.22 21.88 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.438 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.44 143.64 64.9 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.055 -1.227 . . . . 0.0 111.431 -2.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.24 156.14 34.51 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.985 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -73.4 -27.09 61.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.074 0.464 . . . . 0.0 110.559 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -110.53 -27.01 9.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -147.51 -144.96 4.09 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.704 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -73.63 -43.17 60.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -140.64 128.38 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.301 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.82 127.37 54.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.0 111.23 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 pt -106.69 134.73 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.675 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.32 148.16 37.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 111.402 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.621 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 4.7 m -103.4 146.68 28.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.058 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 114' ' ' LEU . 1.8 mm? -88.3 -20.5 25.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.704 0.288 . . . . 0.0 111.197 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.26 -160.32 54.01 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.492 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 12.9 Cg_exo -69.95 -23.81 29.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.481 2.787 . . . . 0.0 112.38 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.5 ' OD2' HG22 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -91.9 -14.24 29.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.077 -173.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.01 5.84 62.77 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.357 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.7 ' O ' ' OG ' ' A' ' 122' ' ' SER . 22.8 m -93.58 118.79 67.56 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 117.548 0.674 . . . . 0.0 111.974 -175.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.49 148.06 29.28 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.38 2.72 . . . . 0.0 113.451 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 63.96 24.78 13.73 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.583 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.924 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.3 p -93.55 176.97 6.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.97 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -63.65 -41.88 98.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 0.0 110.405 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.51 -22.11 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.447 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.924 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.6 OUTLIER -56.94 104.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.689 0.618 . . . . 0.0 112.034 -171.046 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.18 103.66 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.437 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.12 178.6 19.2 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.89 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -68.21 -25.16 65.08 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.618 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -74.94 -31.3 61.47 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.6 m -66.99 -48.03 69.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.582 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 tp -75.75 -37.65 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.295 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 177.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.731 0.3 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -63.2 -37.94 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.285 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.93 70.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.871 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.88 -47.04 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 37' ' ' VAL . 16.8 ptm180 -62.66 -34.8 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.802 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.61 -39.12 83.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.718 0.295 . . . . 0.0 111.003 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.8 -36.2 77.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 110.035 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 68.2 t -60.36 -46.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.184 177.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 33' ' ' ARG . 89.2 t -60.04 -38.82 78.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.016 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -61.09 -46.72 89.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.81 -34.93 72.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.921 0.391 . . . . 0.0 110.629 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.62 -45.81 91.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 37' ' ' VAL . 29.3 m -65.32 -34.93 73.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.572 0.225 . . . . 0.0 110.539 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.81 94.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 47' ' ' LEU . 95.2 mt -61.0 -47.68 85.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.13 -43.02 73.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.952 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -65.21 -50.34 57.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.94 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.42 86.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.939 0.399 . . . . 0.0 110.851 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.4 mp -61.77 -50.26 73.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.417 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.9 -31.66 68.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.56 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.9 mtt -66.95 -42.45 85.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.727 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.42 -38.59 87.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 60.2 tttm -65.19 -32.88 74.79 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.0 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -65.71 -41.05 92.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.949 0.404 . . . . 0.0 109.952 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -76.61 -46.48 25.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.329 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -111.43 13.56 21.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 28.8 p 49.81 35.46 9.25 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -167.08 156.34 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.503 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 38.0 m-85 -83.53 142.08 42.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 110.874 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.74 145.06 61.85 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.016 2.477 . . . . 0.0 112.891 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -75.87 177.81 6.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.622 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.418 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.9 t -50.55 -40.4 51.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.0 -45.58 26.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.512 . . . . 0.0 110.543 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -72.18 -28.11 63.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.273 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.43 -50.3 60.29 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.825 -0.703 . . . . 0.0 113.261 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -31.02 67.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.175 0.512 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -72.29 -23.44 61.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.776 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.44 68.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.414 HD13 ' CG2' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -97.86 -3.35 38.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.294 -0.563 . . . . 0.0 112.45 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 86.7 t -103.2 -62.83 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -139.58 141.86 37.16 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -57.38 121.16 45.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 135.76 71.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.532 2.155 . . . . 0.0 112.231 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.7 m -90.45 -9.24 48.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.866 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 128.8 33.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.931 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 38.9 tt0 -73.82 139.43 76.99 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.097 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.487 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 15.3 Cg_exo -69.14 140.96 61.73 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 124.299 -1.125 . . . . 0.0 113.376 1.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -86.35 136.94 32.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.658 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.9 122.86 24.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.963 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -104.91 156.02 18.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.334 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 59.45 49.85 8.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.507 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.571 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 38.6 p90 -92.17 144.57 29.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.03 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.62 138.96 39.53 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.297 1.998 . . . . 0.0 111.663 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -64.93 125.27 24.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.191 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.45 2.19 90.4 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.997 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.72 -152.75 51.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.362 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.95 -26.94 13.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 9.1 tt -133.32 133.87 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.52 -25.82 57.55 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -130.45 172.48 11.84 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.607 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -55.58 124.01 53.85 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.68 141.08 58.67 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -140.04 139.19 35.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 43.2 m-20 -58.67 154.43 35.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.862 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.58 -25.01 24.3 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.735 2.29 . . . . 0.0 112.839 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -80.71 -12.8 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.403 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.11 33.05 5.6 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.628 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.523 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 38.8 m -102.48 133.97 46.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.862 0.363 . . . . 0.0 111.572 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.12 124.9 28.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.08 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -65.68 138.76 58.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.24 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -112.69 142.35 45.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.675 HD23 HG23 ' A' ' 111' ' ' ILE . 3.4 tm? -126.21 123.28 37.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.09 113.52 27.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.701 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 26.7 p -106.56 119.71 50.79 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.484 171.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 91.6 Cg_endo -84.82 159.69 66.5 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 124.042 -1.233 . . . . 0.0 111.795 -3.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.51 163.89 39.28 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -96.1 -35.64 11.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.631 0.729 . . . . 0.0 109.522 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -95.69 14.07 24.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.39 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.8 -156.01 27.31 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -72.4 -34.92 68.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.423 0.611 . . . . 0.0 110.867 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.663 ' HB ' HD21 ' A' ' 100' ' ' LEU . 31.6 m -138.02 151.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -117.99 121.5 40.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.535 -176.304 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.675 HG23 HD23 ' A' ' 100' ' ' LEU . 7.6 pt -106.75 126.63 62.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 42.6 p90 -148.25 144.44 27.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.297 0.57 . . . . 0.0 111.647 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.3 m -92.16 138.26 31.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.409 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 73.8 mt -66.27 -16.36 63.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.179 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.6 -165.53 49.94 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.683 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.71 -34.54 24.52 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 123.528 2.819 . . . . 0.0 113.053 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -90.12 -10.93 42.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.646 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.94 87.48 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.908 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.729 ' O ' ' OG ' ' A' ' 122' ' ' SER . 89.4 t -86.72 116.1 64.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.737 0.268 . . . . 0.0 110.991 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.486 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 47.0 Cg_endo -71.47 153.81 60.61 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 11.9 pt-20 55.66 25.05 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.911 1.284 . . . . 0.0 111.869 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.788 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.6 OUTLIER -94.61 177.9 5.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.759 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.69 -27.4 62.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.991 0.424 . . . . 0.0 110.787 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.16 -17.22 58.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.622 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.788 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -62.74 121.9 14.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.098 -177.111 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 70.5 mt -91.76 105.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -112.0 179.63 19.61 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.078 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -58.47 -38.78 78.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.786 0.327 . . . . 0.0 111.181 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.784 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.6 m -64.04 -43.57 95.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -87.0 -38.69 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.959 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.176 177.542 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 8.1 tp10 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.713 0.292 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.77 -41.02 94.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.881 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.04 81.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 36' ' ' VAL . 67.7 m-20 -68.9 -48.11 64.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.197 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 12.3 ptm85 -66.9 -35.21 79.5 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.867 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -60.77 -37.81 83.13 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.094 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HD3' ' HG3' ' A' ' 93' ' ' PRO . 30.7 tttp -64.35 -41.94 96.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.679 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 60.9 t -61.1 -44.05 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.479 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 41' ' ' VAL . 77.4 t -62.91 -38.96 83.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 175.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -62.27 -46.01 90.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.45 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 64.4 m-20 -66.67 -36.31 82.24 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.306 0.574 . . . . 0.0 109.741 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.37 -42.76 99.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.98 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 37' ' ' VAL . 85.1 t -62.62 -38.11 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.441 . . . . 0.0 110.247 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.83 98.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.618 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 96.6 mt -64.47 -47.89 77.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.514 ' HG2' HD11 ' A' ' 111' ' ' ILE . 4.2 mm-40 -58.4 -44.95 89.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.281 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.25 -40.94 99.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.924 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -61.21 -42.38 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.791 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.27 -45.44 88.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.09 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.56 -43.68 98.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.02 -43.67 82.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.203 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -63.52 -41.15 98.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.446 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.65 -33.24 74.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.815 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.5 tp -67.55 -50.42 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.71 -44.75 32.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.888 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 36.6 m-80 -95.28 2.93 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.548 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m 68.67 3.78 4.05 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 171.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -159.58 165.52 32.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.727 0.298 . . . . 0.0 111.11 -178.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -74.12 142.02 78.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.572 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.49 143.28 42.4 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.189 2.592 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 60' ' ' THR . 1.4 m -72.35 176.82 4.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 175.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.617 ' H ' HG22 ' A' ' 59' ' ' THR . 8.8 t -51.34 -43.65 61.82 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.09 -38.97 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 110.348 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.82 -31.81 68.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.567 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -49.03 73.21 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.523 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.1 mp -69.58 -35.49 75.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.404 . . . . 0.0 111.093 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -72.54 -24.4 61.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.053 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.1 -29.38 67.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.2 pt? -103.61 -1.92 27.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.672 0.272 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 74.9 t -109.49 -59.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.257 0.551 . . . . 0.0 111.074 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.0 p -156.68 136.03 12.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -53.05 121.57 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.459 0.474 . . . . 0.0 111.34 -172.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 51.1 Cg_exo -56.98 137.07 80.32 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.007 2.472 . . . . 0.0 112.598 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.0 m -89.76 3.84 51.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.23 148.88 22.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.046 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -77.37 137.06 64.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.19 131.77 24.56 Favored 'Cis proline' 0 C--O 1.235 0.34 0 C-N-CA 122.957 -1.684 . . . . 0.0 112.247 -0.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.6 126.27 26.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.159 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.76 132.32 53.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.685 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -118.07 149.94 40.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.228 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 59.49 44.23 15.13 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.687 0.617 . . . . 0.0 110.542 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -94.84 153.39 40.01 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.274 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.55 140.37 21.29 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.307 2.005 . . . . 0.0 111.222 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.77 125.03 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.06 10.32 86.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.615 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.39 -119.89 20.2 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -126.27 -37.44 2.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.689 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 13.8 tt -124.94 127.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.874 172.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -69.29 -21.67 63.86 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -129.39 165.03 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.405 HD22 HD23 ' A' ' 64' ' ' LEU . 69.5 mt -60.23 126.55 84.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.464 ' O ' ' HD2' ' A' ' 98' ' ' TYR . 37.9 Cg_endo -67.07 138.86 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.463 2.108 . . . . 0.0 111.511 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -133.4 138.51 46.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.762 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 4.4 p30 -67.28 152.95 95.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HG3' ' HD3' ' A' ' 35' ' ' LYS . 27.0 Cg_exo -59.27 -17.82 41.65 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.263 2.642 . . . . 0.0 113.169 -170.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.556 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.5 m-90 -81.27 -26.47 35.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.02 10.87 3.68 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.94 172.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.584 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 14.7 m -103.63 148.38 26.09 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.548 0.674 . . . . 0.0 111.038 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.19 133.71 34.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.104 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 78.4 m-85 -60.61 148.65 37.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.231 0.332 . . . . 0.0 110.312 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -130.4 143.21 50.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.15 0.5 . . . . 0.0 111.361 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -111.26 121.51 45.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -106.89 112.28 25.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.9 p -106.85 130.99 22.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.743 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.33 159.77 78.09 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.678 -1.384 . . . . 0.0 111.125 -4.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.96 159.24 53.86 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.136 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -96.2 -36.04 11.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -101.97 1.27 36.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.976 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.99 -155.88 13.26 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -74.69 -29.32 61.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.271 0.535 . . . . 0.0 110.83 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.635 ' HB ' HD21 ' A' ' 100' ' ' LEU . 13.5 m -144.78 151.16 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.618 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.39 133.02 51.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.01 0.433 . . . . 0.0 111.614 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.623 HG23 HD23 ' A' ' 100' ' ' LEU . 6.7 pt -112.3 127.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.87 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -150.84 160.87 43.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.217 0.532 . . . . 0.0 111.884 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 6.2 p -106.85 146.68 30.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.651 175.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 7.3 mp -86.61 -20.31 28.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.556 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 76.53 -159.64 50.09 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.57 170.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.28 -23.79 32.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.64 2.893 . . . . 0.0 112.298 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -13.97 35.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.5 13.79 74.44 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.068 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 122' ' ' SER . 30.8 m -111.3 123.64 34.6 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-N 117.515 0.657 . . . . 0.0 112.194 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -78.13 157.01 30.15 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.503 2.802 . . . . 0.0 112.128 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 63.73 42.41 6.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.085 0.945 . . . . 0.0 109.497 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.667 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.6 p -120.86 177.26 5.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.881 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -73.73 -31.73 63.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.55 -28.42 67.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.753 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.667 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 3.5 m-20 -47.07 112.0 0.47 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 124.282 0.989 . . . . 0.0 112.131 -172.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.587 ' HB ' HG11 ' A' ' 36' ' ' VAL . 4.8 mp -84.62 105.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.505 ' O ' HG22 ' A' ' 130' ' ' THR . . . -130.4 -172.24 13.09 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -63.89 -37.62 88.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.898 0.38 . . . . 0.0 111.727 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -77.3 -19.82 55.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.4 t -88.68 -22.33 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.951 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.78 -42.98 13.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.701 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.096 -178.553 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.661 0.267 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -59.92 -38.52 82.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.48 60.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.5 m-20 -69.29 -42.53 75.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 37' ' ' VAL . 14.2 ptm180 -62.17 -34.48 76.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.093 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -58.78 -37.05 75.42 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.8 0.334 . . . . 0.0 111.082 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -68.58 -39.59 80.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 32' ' ' ASP . 46.7 t -61.37 -41.76 91.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.662 ' O ' HG23 ' A' ' 41' ' ' VAL . 96.2 t -60.52 -41.23 86.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.589 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.8 t -59.26 -48.23 82.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.003 0.43 . . . . 0.0 110.887 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.403 ' HB2' ' OH ' ' A' ' 98' ' ' TYR . 31.1 m-20 -69.86 -34.26 73.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.13 -39.9 91.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.657 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 37' ' ' VAL . 52.2 t -63.5 -37.73 80.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.205 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.06 -35.63 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.596 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 47' ' ' LEU . 9.0 mp -64.08 -47.68 79.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.465 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -56.29 -37.4 69.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.999 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.49 -45.46 85.17 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.969 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -61.32 -44.62 96.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.793 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 43' ' ' LEU . 7.9 mp -62.93 -41.88 99.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.653 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.11 -44.77 94.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.447 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mmt -65.77 -43.87 87.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.046 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.495 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 67.1 t80 -65.26 -45.22 85.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.03 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.6 -33.1 72.21 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.576 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.4 tp -64.28 -42.32 96.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.073 0.463 . . . . 0.0 110.313 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.32 -48.72 16.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.906 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -98.7 -4.82 32.77 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -169.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 65.9 24.34 11.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.448 0.468 . . . . 0.0 111.945 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.31 149.74 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.403 ' HB2' ' OE1' ' A' ' 108' ' ' GLN . 31.2 m-85 -74.4 146.9 84.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.797 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 142.08 50.91 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.691 2.261 . . . . 0.0 112.295 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.2 p -74.73 177.51 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.795 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.511 ' HA ' HD12 ' A' ' 100' ' ' LEU . 13.3 t -51.46 -37.17 47.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.39 -41.18 41.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.086 0.469 . . . . 0.0 111.268 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -72.62 -37.78 67.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.294 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.21 71.27 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.783 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.697 HD21 ' O ' ' A' ' 98' ' ' TYR . 7.4 mp -69.96 -40.22 75.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 111.668 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -72.55 -23.98 61.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.234 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -26.46 62.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -169.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.7 pt? -104.52 -2.0 25.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.47 -38.75 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 t -156.44 130.35 8.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.66 121.99 36.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.432 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.85 137.47 58.37 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.833 2.355 . . . . 0.0 112.367 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 p -87.45 -19.59 27.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.087 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.23 137.48 57.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.369 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.04 138.19 92.36 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.495 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 10.7 Cg_exo -73.46 135.12 38.48 Favored 'Cis proline' 0 C--O 1.233 0.272 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.34 -3.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -70.88 121.62 18.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.8 124.26 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.736 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -107.46 166.3 10.76 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.372 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 47.76 40.27 11.96 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.192 0.933 . . . . 0.0 111.839 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -89.75 150.17 43.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.966 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.93 137.74 32.69 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.025 1.816 . . . . 0.0 111.3 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.59 124.24 22.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.914 0.387 . . . . 0.0 110.41 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.95 4.95 86.65 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.645 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.45 -142.55 40.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.399 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.85 -14.38 13.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.286 0.565 . . . . 0.0 109.594 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.9 tt -136.83 141.48 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.004 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -68.85 -30.97 69.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.886 -172.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -131.18 154.36 48.46 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.294 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.26 118.8 43.52 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.98 128.43 24.77 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.358 2.705 . . . . 0.0 113.206 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -126.37 140.43 52.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.672 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.2 p30 -71.0 152.5 94.92 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 -15.53 13.66 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.547 2.832 . . . . 0.0 113.683 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.422 ' CZ3' HG21 ' A' ' 36' ' ' VAL . 5.4 m-90 -80.57 -19.48 45.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.996 0.427 . . . . 0.0 110.361 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.16 19.31 8.57 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.918 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.496 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 0.9 OUTLIER -103.35 146.24 28.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 110.849 -176.317 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.93 126.24 36.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.354 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.697 ' O ' HD21 ' A' ' 64' ' ' LEU . 5.1 m-85 -52.9 151.62 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.84 0.713 . . . . 0.0 112.692 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.68 137.49 52.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.364 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.2 tm? -123.32 122.39 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -117.1 112.55 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.787 0.327 . . . . 0.0 110.486 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.484 ' HB3' HG12 ' A' ' 109' ' ' VAL . 20.7 p -107.08 127.97 26.95 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.272 171.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 97.0 Cg_endo -85.06 139.94 29.29 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.907 -1.289 . . . . 0.0 111.648 -5.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.95 161.63 46.92 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.112 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -85.15 -20.81 29.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.965 0.412 . . . . 0.0 110.617 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -105.74 -43.98 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.5 -151.6 8.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.97 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -73.33 -45.64 54.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.65 ' HB ' HD21 ' A' ' 100' ' ' LEU . 16.2 m -128.67 140.48 49.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.413 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 125.4 54.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.762 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.612 HG23 HD23 ' A' ' 100' ' ' LEU . 11.3 pt -108.35 125.73 65.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.147 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -151.69 163.09 39.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.057 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.5 m -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.872 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.446 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 1.8 mm? -66.88 -22.76 65.96 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -169.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.04 -169.16 43.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.831 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.29 -25.02 36.87 Favored 'Trans proline' 0 C--N 1.337 -0.058 0 C-N-CA 122.891 2.394 . . . . 0.0 112.843 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.85 -11.08 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.115 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 114' ' ' LEU . . . 76.09 9.75 85.39 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.406 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.726 ' O ' ' OD2' ' A' ' 125' ' ' ASP . 55.3 t -89.16 112.88 53.8 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.043 0.421 . . . . 0.0 111.448 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.419 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 3.3 Cg_exo -75.86 156.39 39.22 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.096 2.531 . . . . 0.0 112.624 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 64.73 16.25 10.28 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.283 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 1.085 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.9 p -94.27 175.85 6.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.818 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -85.73 -23.75 27.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.43 -22.43 61.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 1.085 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 1.0 OUTLIER -55.29 132.05 46.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.346 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.97 95.75 3.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -106.6 148.96 16.52 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.301 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.468 ' HB2' HG13 ' A' ' 111' ' ' ILE . 64.6 t30 -66.91 -26.03 66.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.44 0.638 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -74.5 -28.43 60.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.921 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -74.69 -37.47 62.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.956 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.5 tp -78.39 -36.52 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.18 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.474 169.792 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.9 tp10 . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 120.77 0.319 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 36.2 mtmm -69.56 -36.74 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.598 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.74 77.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.998 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 -44.47 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.521 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 37' ' ' VAL . 13.4 ptm180 -67.72 -35.16 78.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.601 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 40.8 mt-30 -63.91 -36.45 83.99 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.97 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.71 -39.84 92.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 76.1 t -61.05 -43.02 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.272 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 33' ' ' ARG . 88.2 t -60.54 -39.46 81.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.411 ' O ' HG22 ' A' ' 41' ' ' VAL . 50.4 m -61.32 -46.95 88.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.025 0.44 . . . . 0.0 111.055 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 -34.42 73.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.277 0.56 . . . . 0.0 110.491 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 128' ' ' ASN . 25.8 tp -65.22 -44.55 87.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.519 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 37' ' ' VAL . 32.8 m -63.53 -35.82 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.92 90.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.79 0.329 . . . . 0.0 110.47 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.57 -48.54 79.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.79 -37.77 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.34 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -44.81 97.22 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.769 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.43 -44.13 96.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.735 0.302 . . . . 0.0 110.868 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.54 -44.11 97.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.025 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.08 -41.73 99.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.866 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -38.83 73.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.733 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 77' ' ' ALA . 4.9 t80 -62.25 -42.67 99.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.954 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -69.98 -31.79 69.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.3 -49.1 75.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 0.0 110.51 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.02 -45.49 34.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -98.32 -1.33 41.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -172.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 m 63.14 17.34 10.1 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.86 147.58 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -66.74 140.55 96.38 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.24 149.09 69.77 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.967 2.444 . . . . 0.0 112.439 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 60' ' ' THR . 0.7 OUTLIER -81.71 177.46 8.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.622 176.518 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.574 ' H ' HG22 ' A' ' 59' ' ' THR . 8.8 t -51.42 -40.53 59.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -77.14 -42.98 35.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.302 0.572 . . . . 0.0 110.2 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -69.37 -33.59 73.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.683 -173.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.9 -49.36 42.36 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.917 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.592 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.3 tp -66.16 -41.01 90.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 111.422 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HA ' HG12 ' A' ' 68' ' ' VAL . 34.6 mt-30 -73.03 -23.11 60.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.66 61.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.8 pt? -104.65 -2.0 25.63 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 65' ' ' GLN . 7.5 p -117.83 -43.62 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.818 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 65' ' ' GLN . 47.0 m -156.51 129.58 7.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -56.24 121.53 42.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 111.442 -175.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 27.9 Cg_exo -63.15 137.39 61.23 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.739 2.293 . . . . 0.0 112.604 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.5 p -86.52 -10.9 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.96 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.64 138.32 46.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 6.1 mp0 -77.03 141.79 68.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.92 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 48.2 Cg_endo -69.89 131.33 19.11 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 -1.672 . . . . 0.0 112.532 -0.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -68.96 129.38 39.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.949 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . . . -70.56 125.96 28.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.67 -177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -119.34 163.75 16.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.538 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.32 39.28 9.61 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.369 0.604 . . . . 0.0 110.229 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -97.83 143.15 25.71 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.58 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.45 143.8 35.28 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.595 2.196 . . . . 0.0 111.628 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.08 124.63 22.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.809 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.26 10.02 86.48 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.884 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.75 -149.61 51.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.2 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.95 -5.59 15.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.388 0.613 . . . . 0.0 109.881 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 tt -142.36 137.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.694 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.18 -22.79 61.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.948 -169.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -138.3 170.16 16.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.85 128.52 70.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 172.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.43 129.11 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.346 2.031 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.16 140.47 51.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.733 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.0 p30 -72.91 153.15 91.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 92' ' ' ASP . 13.8 Cg_endo -56.23 -17.89 22.06 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.324 2.683 . . . . 0.0 113.576 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.575 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 7.3 m-90 -81.38 -26.68 35.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.697 0.284 . . . . 0.0 110.61 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.94 18.76 4.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.718 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.65 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 69.5 m -103.68 154.24 19.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.489 0.645 . . . . 0.0 111.281 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.36 129.88 38.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.218 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.592 ' O ' HD21 ' A' ' 64' ' ' LEU . 19.1 m-85 -60.95 146.23 47.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -127.6 140.47 52.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.155 0.502 . . . . 0.0 111.766 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.693 HD21 ' HB ' ' A' ' 109' ' ' VAL . 2.8 tm? -111.89 120.94 43.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -112.64 113.05 25.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.072 0.463 . . . . 0.0 111.176 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 19.8 m -106.55 131.74 21.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.171 171.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 94.1 Cg_endo -81.75 146.14 65.72 Favored 'Cis proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.762 -1.349 . . . . 0.0 111.369 -4.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.34 161.22 34.77 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.897 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.01 -35.55 11.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.111 0.481 . . . . 0.0 109.746 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -94.99 -40.24 9.76 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.16 -157.98 9.66 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.39 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -74.49 -34.61 63.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.948 0.374 . . . . 0.0 110.839 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.693 ' HB ' HD21 ' A' ' 100' ' ' LEU . 6.5 m -135.96 124.05 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.987 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 124.58 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.658 HG23 HD23 ' A' ' 100' ' ' LEU . 8.7 pt -106.29 126.55 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.278 173.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 11.7 p90 -150.31 160.58 43.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.204 0.526 . . . . 0.0 111.643 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 m -108.48 126.72 53.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.6 -31.23 72.02 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 123.804 0.69 . . . . 0.0 110.748 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.575 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 78.99 -154.09 38.84 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.0 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.36 -27.41 34.13 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.233 2.622 . . . . 0.0 113.629 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.551 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.2 p-10 -87.34 -13.46 43.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.642 -173.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.36 13.27 73.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.238 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.797 ' O ' ' OG ' ' A' ' 122' ' ' SER . 77.9 t -119.03 121.23 30.56 Favored Pre-proline 0 C--O 1.247 0.93 0 CA-C-O 120.712 0.292 . . . . 0.0 111.084 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.659 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 71.9 Cg_endo -76.06 146.97 29.55 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.508 2.805 . . . . 0.0 112.983 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 121' ' ' GLU . 5.5 tp10 65.19 25.15 12.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.074 0.94 . . . . 0.0 110.338 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.797 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -93.22 172.42 8.31 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.451 172.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -76.14 -0.41 21.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.811 0.338 . . . . 0.0 111.671 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -103.56 -13.84 16.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.185 0.517 . . . . 0.0 109.964 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.659 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -65.76 134.76 53.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.582 -174.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.17 108.44 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.908 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -110.7 176.49 18.8 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.542 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.509 ' HB2' HG13 ' A' ' 111' ' ' ILE . 63.3 t30 -65.14 -28.87 69.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.364 0.602 . . . . 0.0 110.473 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -77.11 -19.44 56.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.803 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 -40.34 62.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.63 -34.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.018 0.437 . . . . 0.0 110.244 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.894 171.016 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.67 0.271 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.73 -48.01 82.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 110.397 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.08 -36.63 72.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.377 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -63.2 -47.1 83.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.109 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 37' ' ' VAL . 35.8 ptt180 -67.67 -34.79 77.63 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.662 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.15 -34.15 75.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.69 -40.37 92.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 92.6 t -60.78 -44.88 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.415 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 33' ' ' ARG . 60.7 t -58.76 -38.41 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.513 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -61.9 -45.93 91.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.09 -34.84 73.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 0.0 110.649 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.411 HD21 ' HA ' ' A' ' 128' ' ' ASN . 17.7 tp -63.41 -45.1 92.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.92 -34.86 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.709 0.29 . . . . 0.0 110.315 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.92 89.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.539 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.82 -43.08 98.68 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.984 0.421 . . . . 0.0 110.047 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.41 ' HG2' HD11 ' A' ' 111' ' ' ILE . 5.5 mm-40 -56.7 -36.78 70.05 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 172.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.82 -44.75 94.14 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.948 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -62.48 -43.67 98.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.798 0.332 . . . . 0.0 110.711 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.91 -43.14 93.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.5 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.01 -41.15 82.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.894 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 86.7 mmm -67.87 -44.05 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.176 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.4 ' HE2' ' NE ' ' A' ' 56' ' ' ARG . 81.7 t80 -62.57 -40.31 96.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.05 -32.16 70.14 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.71 0.291 . . . . 0.0 110.262 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.6 -49.07 79.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.752 0.311 . . . . 0.0 110.422 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -77.2 -47.03 21.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -100.4 -3.49 30.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -169.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.9 m 61.38 28.93 18.27 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 2.0 ppt_? -156.58 154.87 30.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.668 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.511 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 76.0 m-85 -77.4 131.86 70.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 147.08 45.01 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.521 2.147 . . . . 0.0 112.729 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 176.8 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.518 175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.437 ' HA ' HD23 ' A' ' 100' ' ' LEU . 6.5 t -50.15 -44.44 52.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -77.44 -43.77 31.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.059 0.457 . . . . 0.0 110.785 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.22 -36.78 84.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.106 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.45 -45.05 25.24 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.547 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.568 HD21 ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -69.37 -44.65 71.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.024 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -71.59 -26.03 62.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.18 -21.86 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 46' ' ' ALA . 4.8 tp -83.24 -13.02 56.19 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.994 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.44 -29.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.565 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 t -157.34 162.88 39.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.2 122.26 87.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.94 136.69 71.36 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.643 2.229 . . . . 0.0 112.042 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -81.99 -29.66 31.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 127.4 31.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 34.0 tt0 -67.22 139.16 94.82 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 18.2 Cg_exo -67.56 131.62 16.69 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.738 -0.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -80.89 129.95 34.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.698 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.48 122.84 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.924 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -111.81 158.42 19.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.017 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 60.89 32.0 20.02 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 110.608 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -72.03 146.61 90.29 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.414 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.78 138.28 31.4 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.981 1.787 . . . . 0.0 111.272 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.81 124.63 22.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.457 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.58 4.94 75.74 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.505 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.34 -150.85 47.67 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.406 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.55 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 62.1 m-85 -101.45 -37.44 8.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.364 0.602 . . . . 0.0 109.901 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 88' ' ' ARG . 13.0 tt -131.92 137.53 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -67.05 -21.87 65.89 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.428 ' H ' HG12 ' A' ' 86' ' ' ILE . 46.9 mtm180 -130.52 154.92 47.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.43 125.83 53.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.03 137.09 79.05 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.636 2.224 . . . . 0.0 112.142 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -138.4 138.03 37.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.295 0.569 . . . . 0.0 111.327 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.85 153.86 78.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.948 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -19.02 29.14 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.198 2.599 . . . . 0.0 112.704 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -81.96 -12.75 58.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.09 30.72 7.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.198 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.3 m -103.52 149.46 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.962 0.41 . . . . 0.0 111.021 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.81 143.5 29.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.844 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.568 ' O ' HD21 ' A' ' 64' ' ' LEU . 83.7 m-85 -83.67 148.53 27.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.476 ' NE2' HD21 ' A' ' 114' ' ' LEU . 27.0 mp0 -118.22 152.96 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 110.932 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 60' ' ' THR . 13.4 tp -131.94 140.16 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.077 171.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.405 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 2.8 tm? -135.38 115.93 13.74 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.815 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 t -106.8 132.56 20.81 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.88 139.77 63.1 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 124.251 -1.145 . . . . 0.0 111.907 -1.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 101' ' ' LEU . . . -68.83 150.91 51.03 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.741 -172.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.69 -26.53 68.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 0.0 110.286 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -131.04 44.88 2.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.246 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 147.08 -165.62 28.54 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -75.5 -29.55 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.77 0.785 . . . . 0.0 110.607 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 100' ' ' LEU . 2.1 m -134.35 127.36 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.138 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -119.52 118.19 30.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.451 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.41 HD11 ' HG2' ' A' ' 44' ' ' GLU . 13.8 pt -106.6 132.21 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.087 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.68 161.02 43.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.158 0.504 . . . . 0.0 111.428 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.422 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . 18.3 t -116.42 149.29 39.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.179 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.476 HD21 ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -69.57 -27.42 65.11 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 123.52 0.513 . . . . 0.0 109.924 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.09 -162.09 33.51 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.155 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.42 -28.38 32.7 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.951 2.434 . . . . 0.0 113.397 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.566 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.6 p-10 -85.06 -11.56 55.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.6 12.0 80.43 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.853 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.851 ' O ' ' OG ' ' A' ' 122' ' ' SER . 72.0 t -116.94 121.47 32.62 Favored Pre-proline 0 C--O 1.249 1.042 0 CA-C-O 120.637 0.256 . . . . 0.0 111.271 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.743 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 60.3 Cg_endo -75.4 158.33 40.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 113.606 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 62.31 23.97 14.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.219 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . 1.127 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -96.93 177.73 5.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.731 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.95 -28.97 43.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.202 0.525 . . . . 0.0 110.496 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 122' ' ' SER . 7.3 p-10 -77.05 -15.2 59.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 1.127 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -65.47 146.06 55.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.358 -177.295 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.0 mt -113.76 117.87 56.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.884 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.38 161.66 13.49 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.128 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 40' ' ' LEU . 7.9 p30 -59.96 -37.4 79.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.504 0.668 . . . . 0.0 109.867 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -76.67 -28.51 55.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.205 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.2 p -80.91 -29.09 35.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.685 0.278 . . . . 0.0 111.21 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.6 tp -85.96 -31.39 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.217 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.126 178.193 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.798 0.332 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 99.5 mttt -67.26 -48.06 68.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.331 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.709 -174.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.24 -40.45 74.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.477 ' O ' HG23 ' A' ' 37' ' ' VAL . 30.8 ptt180 -68.38 -34.15 75.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.388 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 14.8 mm100 -59.32 -31.51 69.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.479 0.18 . . . . 0.0 111.254 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.11 -44.27 97.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.575 HG11 ' HB ' ' A' ' 126' ' ' ILE . 24.7 t -60.71 -45.15 98.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 33' ' ' ARG . 58.3 t -59.9 -38.63 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.403 ' O ' HG22 ' A' ' 41' ' ' VAL . 39.1 t -60.44 -46.8 88.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.866 0.365 . . . . 0.0 110.677 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.532 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.9 m-20 -69.52 -35.4 75.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 109.869 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD21 ' C ' ' A' ' 127' ' ' GLY . 19.0 tp -60.89 -46.57 90.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.347 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 38' ' ' SER . 28.9 m -65.81 -36.17 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.362 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.17 98.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.397 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.56 ' O ' HD13 ' A' ' 47' ' ' LEU . 98.2 mt -61.32 -49.69 75.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.375 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.3 -39.32 90.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.216 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -63.44 -47.77 84.44 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.215 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.75 84.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.758 0.313 . . . . 0.0 111.343 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.2 mp -57.59 -43.74 84.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.946 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.55 -37.35 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.844 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 20.7 mmt -59.48 -45.23 92.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.567 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 65.6 t80 -67.18 -37.7 84.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.564 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 88.0 tttt -64.92 -35.33 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.308 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.0 tp -68.12 -36.44 79.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.253 0.549 . . . . 0.0 110.385 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.514 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 14.0 t70 -76.0 -47.89 23.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.595 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.55 22.91 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m 71.97 -13.99 0.55 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.446 HH21 ' HD3' ' A' ' 75' ' ' PRO . 7.3 ppt_? -137.15 157.55 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.889 -0.507 . . . . 0.0 111.242 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.4 ' CE1' ' HD2' ' A' ' 51' ' ' LYS . 47.0 m-85 -71.34 148.35 93.51 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 148.3 52.19 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.925 2.417 . . . . 0.0 112.402 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.3 p -79.84 177.99 8.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.999 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.2 t -50.98 -37.29 43.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.827 0.346 . . . . 0.0 111.888 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.06 -45.72 26.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.702 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.04 -27.9 62.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.366 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.19 -51.96 54.92 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.129 -170.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 mp -72.11 -32.9 67.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.412 0.606 . . . . 0.0 111.34 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -72.54 -24.13 61.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.82 -24.9 64.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -103.79 -2.06 26.95 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.65 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.28 -63.04 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.455 0.645 . . . . 0.0 110.742 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 138.19 17.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.35 120.38 25.76 Favored Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.366 0.416 . . . . 0.0 111.153 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.97 141.96 96.39 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 112.602 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -86.64 -9.22 56.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.846 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.3 140.55 52.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.077 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.2 137.67 68.49 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.166 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.567 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 5.2 Cg_exo -79.88 149.84 81.65 Favored 'Cis proline' 0 C--O 1.236 0.378 0 C-N-CA 123.738 -1.359 . . . . 0.0 112.558 -4.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -65.42 128.85 37.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.521 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.0 38.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.377 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.514 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 33.3 mmt180 -111.53 165.14 12.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.94 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 61.79 34.88 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.706 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -94.74 136.65 22.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.853 0.359 . . . . 0.0 110.542 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.72 143.55 56.52 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.637 2.225 . . . . 0.0 111.758 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.07 124.36 20.94 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.21 84.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.824 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.46 -157.93 53.44 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.126 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -92.29 -23.43 19.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.9 128.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.662 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -68.36 -24.46 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.044 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -130.84 171.68 12.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.09 129.91 86.41 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.023 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.09 126.87 15.06 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.063 1.842 . . . . 0.0 110.283 172.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -132.82 145.44 50.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.608 0.242 . . . . 0.0 110.902 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 0.7 OUTLIER -56.3 143.67 64.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.115 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 48.4 Cg_exo -55.69 -25.84 53.0 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.254 2.636 . . . . 0.0 113.111 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.486 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 18.3 m-90 -81.91 -5.08 57.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.648 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.11 15.09 22.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.918 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 43.2 m -95.5 164.37 12.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.723 0.297 . . . . 0.0 110.584 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -111.71 129.32 56.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.118 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.47 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 64.2 m-85 -67.09 161.47 24.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.589 ' NE2' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -129.41 142.76 50.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.499 . . . . 0.0 110.861 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.68 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -112.41 122.77 48.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 101' ' ' LEU . 1.2 tm? -110.24 113.63 26.47 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.66 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 13.7 p -107.16 123.05 39.5 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.555 172.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 1.9 Cg_endo -84.31 140.15 33.17 Favored 'Cis proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.736 -0.943 . . . . 0.0 111.256 -4.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.73 159.62 53.84 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.62 -173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -79.63 -12.05 59.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.128 0.49 . . . . 0.0 109.951 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -121.48 30.51 6.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.02 -157.32 26.83 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 21.5 tp60 -61.2 -45.39 94.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 0.0 110.077 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.68 ' HB ' HD21 ' A' ' 100' ' ' LEU . 15.1 m -136.12 151.09 28.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.32 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -134.61 131.28 37.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.652 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.668 HG23 HD23 ' A' ' 100' ' ' LEU . 4.4 pt -111.32 130.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.781 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -149.08 161.12 42.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.3 p -114.57 139.87 49.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.738 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.589 HD13 ' NE2' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -67.9 -34.43 76.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.746 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.45 -159.68 53.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.45 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 10.8 Cg_exo -70.34 -34.88 11.9 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 123.824 3.016 . . . . 0.0 111.98 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.83 -13.57 50.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.089 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.532 ' C ' ' HG ' ' A' ' 114' ' ' LEU . . . 71.75 11.96 73.86 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.5 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.941 ' O ' ' OG ' ' A' ' 122' ' ' SER . 43.6 t -96.68 113.78 63.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 116.957 0.379 . . . . 0.0 111.233 -176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 145.83 29.45 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.615 2.21 . . . . 0.0 112.462 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 66.98 22.51 10.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.337 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.941 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.3 OUTLIER -91.48 177.46 6.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.654 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.82 -16.78 61.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.23 -15.6 37.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.17 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.806 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -63.49 105.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.201 -173.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.575 ' HB ' HG11 ' A' ' 36' ' ' VAL . 42.4 mm -81.4 107.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.857 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.462 ' C ' HD21 ' A' ' 40' ' ' LEU . . . -114.15 171.26 13.68 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.666 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 40' ' ' LEU . 26.5 p-10 -66.49 -38.39 87.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.989 0.423 . . . . 0.0 110.177 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -68.32 -30.53 69.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -72.04 -39.4 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.449 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.98 -40.72 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.752 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.358 0 C-N-CA 119.398 -1.382 . . . . 0.0 114.309 179.024 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.648 0.261 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 55.4 mtmt -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.411 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.55 -39.85 94.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.807 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -69.17 -39.42 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.807 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.533 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 12.5 ptm85 -66.66 -33.48 75.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.74 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 76.0 mm-40 -59.22 -34.37 72.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.711 0.291 . . . . 0.0 110.882 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -63.3 -39.6 95.03 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.629 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 41.1 t -60.64 -47.65 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.363 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 33' ' ' ARG . 38.6 t -58.82 -37.69 68.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 41' ' ' VAL . 22.6 t -62.53 -47.0 85.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.47 . . . . 0.0 111.044 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.49 ' HB2' ' OH ' ' A' ' 98' ' ' TYR . 63.4 m-20 -70.91 -35.15 72.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.731 -0.606 . . . . 0.0 110.04 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.428 HD21 ' N ' ' A' ' 128' ' ' ASN . 17.6 tp -61.0 -44.93 96.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.076 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 38' ' ' SER . 32.8 m -63.31 -34.54 67.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.507 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 39' ' ' ASP . . . -60.21 -40.07 88.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.589 0.233 . . . . 0.0 110.63 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 47' ' ' LEU . 8.9 mp -60.27 -48.45 81.67 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.262 0.553 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.56 -37.33 85.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.823 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -62.53 -37.06 94.08 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.91 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.16 0.505 . . . . 0.0 110.044 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 43' ' ' LEU . 6.2 mp -61.1 -40.82 95.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.4 -45.52 94.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 25.7 mmt -63.44 -38.52 91.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 77' ' ' ALA . 1.2 t80 -64.2 -44.23 92.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.399 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -70.5 -33.31 71.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.93 -46.3 85.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.01 0.433 . . . . 0.0 110.141 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.99 -46.15 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.215 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -103.57 1.71 32.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m 59.15 31.73 21.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.708 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -164.51 146.21 8.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.844 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.4 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 21.0 m-85 -72.89 144.18 85.14 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 110.466 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 55.5 Cg_endo -71.04 143.26 44.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.843 2.362 . . . . 0.0 112.745 -176.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.567 HG22 ' H ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -73.94 177.45 5.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.591 175.608 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 100' ' ' LEU . 61.9 m -50.21 -45.82 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.37 -37.58 65.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.236 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -71.92 -43.15 65.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.874 -170.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.443 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -64.37 -49.46 65.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.676 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.4 tp -61.88 -41.68 98.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.941 0.4 . . . . 0.0 111.42 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.41 -22.92 61.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.936 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.24 66.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -168.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.526 HD21 HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -93.95 -3.83 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.986 -178.63 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.86 -42.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.519 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 p -156.5 130.07 8.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -55.09 121.82 38.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 123.383 0.427 . . . . 0.0 111.324 -177.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 27.1 Cg_exo -64.34 137.56 56.44 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.9 2.4 . . . . 0.0 112.437 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -86.22 -11.45 52.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.1 57.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.474 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -77.5 140.92 64.82 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.81 134.55 36.36 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.719 -1.367 . . . . 0.0 111.931 -2.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -66.95 128.55 36.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.298 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . . . -63.2 131.33 48.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.526 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -119.32 164.6 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 66.46 32.06 7.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.009 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -91.68 137.18 25.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.694 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.77 139.54 22.46 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.073 1.849 . . . . 0.0 111.843 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 124.77 23.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.711 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -8.89 76.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.73 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 -173.13 55.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.291 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -84.9 -25.7 27.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.26 133.71 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.381 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -70.12 -22.77 62.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.7 mtm180 -131.94 154.59 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.289 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.6 mt -61.73 123.64 77.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.336 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.15 147.95 91.33 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.471 2.114 . . . . 0.0 111.415 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -138.37 145.46 41.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 113' ' ' SER . 53.2 m-20 -57.99 142.99 78.87 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.63 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.38 -19.32 57.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.305 2.67 . . . . 0.0 112.541 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.74 -14.08 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.009 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.0 22.39 7.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.163 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.578 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 19.3 m -104.01 162.5 13.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.535 -0.391 . . . . 0.0 110.613 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -105.64 144.65 32.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.667 0.27 . . . . 0.0 110.341 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 18.6 m-85 -70.31 146.49 50.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.358 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -126.76 142.9 51.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.616 . . . . 0.0 111.751 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 60' ' ' THR . 13.4 tp -121.68 141.99 50.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.934 172.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -134.86 113.07 11.2 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.505 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.7 t -106.9 132.19 21.1 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.374 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.78 150.27 92.35 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.824 -1.323 . . . . 0.0 111.885 -1.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.01 147.25 50.73 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.658 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -75.07 -39.39 60.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.359 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -104.88 -38.88 6.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.897 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.19 -156.79 9.78 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.788 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -73.46 -41.69 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.209 0.528 . . . . 0.0 109.989 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.14 122.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.376 175.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 116.8 33.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.25 0.547 . . . . 0.0 112.15 -173.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.9 pt -107.34 126.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.556 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 30.8 p90 -150.41 146.55 26.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.284 0.564 . . . . 0.0 111.194 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.493 ' HB3' ' OD1' ' A' ' 92' ' ' ASP . 51.2 m -97.83 151.58 20.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.197 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 4.9 mp -75.29 -19.67 59.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.588 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.54 -156.04 53.27 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 123.875 0.734 . . . . 0.0 113.355 171.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.93 -21.01 38.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.675 2.917 . . . . 0.0 112.906 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.77 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 6.6 p-10 -86.23 -14.74 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.484 ' O ' HD23 ' A' ' 114' ' ' LEU . . . 70.7 0.65 33.66 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.178 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.903 ' O ' ' OG ' ' A' ' 122' ' ' SER . 44.6 t -122.47 134.0 24.68 Favored Pre-proline 0 C--O 1.251 1.171 0 CA-C-O 120.56 0.219 . . . . 0.0 110.739 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.4 160.91 41.16 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.81 2.34 . . . . 0.0 111.206 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 69.53 22.64 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 109.311 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.903 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 6.5 m -89.01 170.67 10.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.464 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.18 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 167.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.421 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 14.8 m-20 -96.05 69.12 2.77 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.859 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.27 100.32 7.62 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.799 170.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 64.4 mt -79.98 99.92 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.827 -172.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -104.06 155.21 17.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.218 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 40' ' ' LEU . 22.2 t30 -68.83 -30.96 69.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.596 0.712 . . . . 0.0 109.328 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.96 -30.89 65.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.576 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.6 p -82.32 -32.29 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.002 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.0 tp -74.34 -19.98 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.627 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 119.949 -1.12 . . . . 0.0 114.057 173.237 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.841 0.353 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 48.2 mmtm -68.43 -40.32 81.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.659 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.04 85.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.942 0.401 . . . . 0.0 110.756 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.0 m-20 -65.42 -46.72 78.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.394 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.7 ptm180 -63.85 -35.66 81.37 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.117 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 56.1 mt-30 -59.1 -39.58 82.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.862 0.363 . . . . 0.0 110.256 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -68.32 -38.66 81.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.245 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 32' ' ' ASP . 71.7 t -61.01 -47.9 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.469 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 33' ' ' ARG . 65.6 t -60.09 -37.55 73.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.831 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 41' ' ' VAL . 14.4 t -61.36 -47.47 85.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.99 0.424 . . . . 0.0 111.04 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.6 -33.96 71.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 176.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 15.9 tp -62.5 -44.31 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.211 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 38' ' ' SER . 32.2 m -65.7 -35.29 74.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 O-C-N 122.356 -0.215 . . . . 0.0 110.631 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.44 81.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 78.0 mt -62.04 -47.75 83.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.647 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HG2' HD11 ' A' ' 111' ' ' ILE . 36.6 mm-40 -57.35 -36.69 71.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.28 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.51 99.69 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.689 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.568 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -62.95 -37.83 88.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.223 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 36.3 mt -61.92 -44.99 95.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.449 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -61.34 -45.37 94.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.733 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.78 -38.04 79.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.27 -46.2 74.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.02 -33.26 75.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.686 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -44.57 93.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.436 0.636 . . . . 0.0 110.04 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.64 -41.61 53.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.252 -174.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.503 HD21 ' HA ' ' A' ' 77' ' ' ALA . 48.4 m-80 -118.06 16.04 14.16 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m 72.17 -42.21 0.53 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 176.45 5.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 108' ' ' GLN . 36.8 m-85 -88.78 144.85 33.78 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.418 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.71 152.79 42.77 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.403 2.736 . . . . 0.0 113.697 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 60' ' ' THR . 0.3 OUTLIER -79.46 177.06 9.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.627 173.24 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 59' ' ' THR . 4.1 t -51.05 -46.02 61.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.1 -39.58 65.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.38 0.609 . . . . 0.0 110.192 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -71.86 -35.43 69.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.812 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.68 70.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.109 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 89' ' ' LEU . 1.2 mm? -70.79 -34.19 71.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.713 0.292 . . . . 0.0 111.657 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.533 ' OE1' ' HA ' ' A' ' 71' ' ' PRO . 28.3 mt-30 -70.28 -23.84 62.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.35 -18.2 36.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.628 ' HB3' HG22 ' A' ' 86' ' ' ILE . 8.5 mt -94.09 -25.07 17.32 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 6.2 p -105.65 -47.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -157.27 143.38 17.8 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.439 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -56.06 121.0 38.33 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.24 0.338 . . . . 0.0 110.283 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.533 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 80.6 Cg_exo -52.87 136.35 59.57 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 123.108 2.539 . . . . 0.0 112.586 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -92.22 41.33 1.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.016 0.912 . . . . 0.0 109.943 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.87 133.87 36.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.636 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.8 140.11 86.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 O-C-N 123.219 0.324 . . . . 0.0 111.175 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.41 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 73.4 Cg_endo -77.45 132.39 26.97 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.922 -1.699 . . . . 0.0 112.957 0.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -66.81 128.02 34.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.704 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.8 126.75 28.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.085 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -108.94 164.46 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 60.14 36.45 21.1 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.513 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 36.1 p90 -94.85 142.01 24.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.94 138.23 28.12 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.224 1.949 . . . . 0.0 111.621 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.39 124.82 23.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.48 -10.14 73.29 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.249 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.17 -164.94 53.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.923 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -91.0 -23.35 20.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.386 0.613 . . . . 0.0 109.385 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.628 HG22 ' HB3' ' A' ' 67' ' ' LEU . 12.1 tt -142.6 138.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -68.98 -26.72 65.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -130.6 166.49 20.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.67 0.271 . . . . 0.0 110.449 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 64' ' ' LEU . 4.1 mm? -62.3 127.63 90.0 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.745 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.6 136.08 64.73 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.556 2.171 . . . . 0.0 112.058 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -128.3 146.9 50.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.268 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.679 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.8 p30 -73.24 153.39 90.39 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.16 -16.93 13.73 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.587 2.858 . . . . 0.0 114.049 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.444 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.7 m-90 -80.63 -25.82 38.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.821 0.344 . . . . 0.0 110.405 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.72 13.91 6.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.041 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.679 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 9.0 m -101.17 143.74 30.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.87 0.367 . . . . 0.0 110.462 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.84 132.65 34.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.332 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -60.34 143.57 52.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.904 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 81.9 mm-40 -118.49 137.86 52.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.907 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 111' ' ' ILE . 3.1 tm? -113.34 123.19 49.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -118.6 113.55 21.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.043 0.449 . . . . 0.0 110.338 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t -106.04 130.8 22.42 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.74 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.48 153.26 94.45 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 124.241 -1.149 . . . . 0.0 111.591 -3.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.59 145.54 49.75 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.247 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -78.26 -24.22 46.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.12 0.486 . . . . 0.0 110.278 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -119.16 -16.2 9.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.59 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.28 -148.84 4.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.461 ' HG2' ' CD2' ' A' ' 57' ' ' TYR . 25.1 tp60 -73.73 -45.68 50.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.956 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.742 ' HB ' HD21 ' A' ' 100' ' ' LEU . 4.3 m -142.81 127.65 15.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.721 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.0 122.07 43.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -174.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 100' ' ' LEU . 10.0 pt -106.54 126.59 62.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -142.07 153.59 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.27 0.557 . . . . 0.0 112.031 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.0 t -99.92 138.29 37.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.241 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.67 -20.19 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.307 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.444 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 64.68 -163.87 35.68 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.221 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.41 -25.93 29.73 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.344 2.696 . . . . 0.0 111.858 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 7.8 p-10 -80.9 -14.63 57.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.186 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.17 12.27 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.381 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 1.089 ' O ' ' OG ' ' A' ' 122' ' ' SER . 41.9 t -109.54 131.19 22.03 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-N 116.734 0.267 . . . . 0.0 111.146 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.574 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 66.2 Cg_endo -76.0 149.47 32.8 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.974 2.449 . . . . 0.0 111.89 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 43.1 mt-10 70.87 15.54 6.78 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.378 0.671 . . . . 0.0 110.793 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . 1.089 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -87.39 177.16 7.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.536 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -41.38 98.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.501 0.667 . . . . 0.0 109.638 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.482 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 10.7 m-20 -88.88 65.55 7.63 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.67 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -130.54 91.82 3.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.582 174.069 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.86 104.62 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.701 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -117.25 174.52 15.26 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.736 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.13 -35.42 73.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -78.98 -31.26 44.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -64.0 -45.23 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.972 0.415 . . . . 0.0 110.767 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 tp -82.65 -26.68 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.811 0.815 . . . . 0.0 109.731 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-N 114.771 -1.104 . . . . 0.0 114.083 170.004 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.162 0.506 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 96.3 mttt -59.07 -46.04 89.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.18 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.43 97.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.282 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.3 m-20 -63.77 -47.8 79.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.313 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.4 ' NH2' ' HG2' ' A' ' 30' ' ' LYS . 19.6 ptt180 -69.45 -35.22 75.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.307 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 52.4 mt-30 -59.07 -37.57 77.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 110.701 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.01 -37.95 85.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 32' ' ' ASP . 72.0 t -61.16 -47.13 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.669 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -60.35 -37.9 75.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -62.0 -43.53 98.65 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.887 0.375 . . . . 0.0 111.378 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.79 -35.03 74.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.257 0.551 . . . . 0.0 110.088 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.25 -46.26 89.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.344 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -64.6 -34.9 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.36 96.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.681 0.277 . . . . 0.0 110.433 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.512 ' O ' HD13 ' A' ' 47' ' ' LEU . 94.3 mt -61.85 -49.51 75.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.069 0.461 . . . . 0.0 110.631 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -62.41 -40.46 96.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.721 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -62.68 -43.81 98.43 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.916 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -62.69 -38.52 90.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 110.918 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.512 HD13 ' O ' ' A' ' 43' ' ' LEU . 3.2 mp -61.66 -45.82 92.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.416 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.15 -40.39 97.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.1 mtt -65.98 -41.95 90.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.676 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.407 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 50.6 t80 -63.73 -40.99 98.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.268 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 57' ' ' TYR . 83.6 tttt -66.95 -34.68 78.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.854 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.06 -41.89 99.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.177 0.513 . . . . 0.0 110.263 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -76.76 -46.76 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.209 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.1 m-80 -105.79 -1.74 23.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -169.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m 62.99 34.28 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.55 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -170.31 165.85 8.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.449 0.166 . . . . 0.0 110.599 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.55 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 74.9 m-85 -87.4 136.43 33.34 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.05 150.55 60.58 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.87 2.38 . . . . 0.0 112.864 -174.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.422 ' HA ' ' OG ' ' A' ' 102' ' ' SER . 11.4 p -77.59 175.74 9.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.956 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.459 ' HA ' HD12 ' A' ' 100' ' ' LEU . 11.5 t -53.5 -38.59 63.85 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -174.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.97 -46.39 44.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -73.49 -29.72 62.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.134 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.75 67.13 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.146 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.31 -32.46 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -73.08 -25.92 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.115 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.6 65.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -167.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.4 pt? -103.72 -2.28 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -116.15 -45.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 111.62 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -156.69 131.86 9.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -53.79 121.24 27.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.39 0.431 . . . . 0.0 111.137 -176.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 45.2 Cg_exo -57.84 137.04 79.07 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.054 2.503 . . . . 0.0 112.406 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.4 m -79.89 -23.91 41.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.975 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.61 138.75 51.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.677 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -77.85 145.67 70.77 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 11.5 Cg_exo -71.09 135.92 38.99 Favored 'Cis proline' 0 C--O 1.233 0.238 0 C-N-CA 123.32 -1.533 . . . . 0.0 112.003 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -73.48 125.19 27.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.937 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -60.47 123.49 17.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.57 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -112.29 165.23 12.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.765 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 61.73 42.77 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.601 . . . . 0.0 110.221 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.5 145.51 31.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.822 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.63 138.71 19.5 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.988 1.792 . . . . 0.0 111.569 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.9 124.87 23.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.49 76.12 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.182 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.08 -160.75 50.41 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.362 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -96.78 -16.28 20.91 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.82 134.92 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.567 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.6 -21.94 61.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.056 -170.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -130.54 156.31 45.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.537 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.7 mt -55.84 120.98 37.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.718 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.13 134.0 59.13 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -130.49 138.53 50.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.803 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -61.05 152.65 70.26 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.24 -21.34 22.35 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.306 2.67 . . . . 0.0 112.832 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -81.54 -18.18 45.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.84 21.86 8.36 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.992 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 p -101.65 143.55 31.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.897 0.38 . . . . 0.0 111.075 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.97 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -57.51 149.41 21.18 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 0.0 111.508 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -111.56 137.45 49.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.554 -175.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.568 HD23 HG23 ' A' ' 111' ' ' ILE . 3.1 tm? -131.88 122.73 26.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.25 113.95 13.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.655 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 59' ' ' THR . 60.0 p -107.01 129.92 23.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.829 173.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.56 150.72 88.02 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.716 -3.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.51 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -78.41 156.98 43.8 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.278 -172.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.59 -43.05 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 129' ' ' TRP . 91.0 m-70 -92.63 -2.56 56.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.64 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.6 -164.03 26.54 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.874 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -72.07 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 109.439 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -122.3 121.26 63.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.676 169.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.51 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 6.8 t0 -93.39 114.36 26.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -172.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.568 HG23 HD23 ' A' ' 100' ' ' LEU . 12.5 pt -113.6 123.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -151.94 162.24 41.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.2 m -119.31 140.27 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HB3' ' CA ' ' A' ' 118' ' ' GLY . 1.1 mm? -62.69 -32.27 73.33 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.1 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 -170.83 41.23 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.25 -16.16 39.5 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 122.735 2.29 . . . . 0.0 111.757 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.73 -14.12 32.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.232 -173.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.418 ' CA ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.34 8.33 70.35 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.019 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.45 ' O ' ' OD2' ' A' ' 125' ' ' ASP . 41.9 t -94.68 111.26 53.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.194 0.497 . . . . 0.0 111.791 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 119' ' ' VAL . 6.3 Cg_exo -77.08 146.54 25.64 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.403 2.736 . . . . 0.0 112.539 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 62.25 35.5 15.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.405 0.621 . . . . 0.0 111.359 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.602 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.3 p -109.2 172.64 6.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.407 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -66.25 -30.41 70.84 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.96 52.62 2.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.908 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.602 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.8 OUTLIER -126.71 136.06 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 176.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mm -100.59 101.03 11.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.68 157.7 15.8 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.74 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -61.97 -38.03 87.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 110.552 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 106' ' ' HIS . 79.8 t90 -68.49 -31.11 70.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.744 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -78.8 -34.21 45.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.3 tp -87.65 -31.51 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.464 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.259 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.405 176.001 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 44.6 tt0 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -54.73 -49.29 71.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.378 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -72.45 -44.85 61.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.036 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.94 -46.0 86.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.194 -173.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 36.9 ptt180 -69.1 -33.79 74.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.81 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -59.5 -35.96 75.15 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.21 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 82.6 mttt -62.19 -44.34 96.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.596 0.712 . . . . 0.0 109.287 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.23 -47.09 95.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.179 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.6 t -59.47 -38.73 76.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 t -59.82 -46.53 88.96 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.952 0.406 . . . . 0.0 110.532 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.48 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 89.7 m-20 -68.46 -34.65 76.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.144 0.497 . . . . 0.0 110.197 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.34 -43.37 96.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.591 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 37' ' ' VAL . 26.2 t -62.66 -37.39 78.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.0 91.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.984 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.676 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 95.7 mt -63.9 -49.69 71.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.362 . . . . 0.0 110.561 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.06 -33.95 75.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.76 91.82 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.483 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.32 -43.11 96.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.826 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 45.3 mt -59.64 -42.78 93.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.616 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.42 -44.04 95.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.59 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.503 ' SD ' ' HE2' ' A' ' 85' ' ' TYR . 92.0 mtp -67.66 -42.25 82.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.443 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.521 ' CD2' ' HG3' ' A' ' 58' ' ' PRO . 77.2 t80 -63.87 -43.82 94.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.497 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -69.34 -33.17 72.71 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.067 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.57 -45.92 92.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.158 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.52 -46.97 24.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.552 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -95.21 -6.45 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m 65.54 24.18 11.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 150.0 18.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.568 0.223 . . . . 0.0 110.682 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -75.24 145.25 79.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.779 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 6.2 Cg_exo -75.05 162.37 37.11 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.759 2.306 . . . . 0.0 112.28 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -83.84 177.4 8.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.953 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.408 ' HA ' HD12 ' A' ' 100' ' ' LEU . 9.0 t -51.41 -42.72 61.64 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -175.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.59 -45.0 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.401 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.83 -31.24 70.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.05 -49.38 47.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.177 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.81 -38.52 76.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.864 0.364 . . . . 0.0 111.493 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.57 -24.0 61.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.975 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -25.7 63.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -168.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -103.3 -1.32 28.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.214 -177.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -117.64 -39.99 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.56 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.1 m -156.61 129.18 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -55.42 121.62 39.01 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.642 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 46.4 Cg_exo -57.64 136.93 78.7 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.007 2.471 . . . . 0.0 112.699 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 p -85.13 -16.21 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.597 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.16 137.79 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -77.44 142.63 67.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 -178.157 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.19 138.11 52.36 Favored 'Cis proline' 0 C--O 1.236 0.39 0 C-N-CA 123.351 -1.52 . . . . 0.0 112.051 -2.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.6 128.67 36.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.87 125.38 23.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.392 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -113.97 163.9 14.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.122 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 56.47 36.36 27.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.343 0.592 . . . . 0.0 110.998 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -98.07 146.11 30.95 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.058 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.36 138.91 28.14 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.752 1.635 . . . . 0.0 110.213 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.37 123.97 21.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.22 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.34 88.12 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.709 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.8 -115.39 7.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.261 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' HE2' ' SD ' ' A' ' 49' ' ' MET . 60.4 m-85 -134.48 -3.43 2.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.886 0.375 . . . . 0.0 110.786 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.6 136.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -75.43 -22.19 57.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -170.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -130.57 171.16 13.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.814 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.09 127.55 80.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.472 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.77 124.84 11.92 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.533 2.156 . . . . 0.0 112.431 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -130.4 148.75 52.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.761 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.3 p30 -69.4 152.84 96.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.89 -16.22 25.1 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.532 2.821 . . . . 0.0 113.0 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.483 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 5.6 m-90 -80.53 -25.71 38.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.553 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.41 9.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.376 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.585 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 19.3 m -100.18 157.99 16.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.12 0.46 . . . . 0.0 110.786 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.49 138.67 31.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.804 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -68.6 164.36 21.61 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -130.62 146.68 52.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.187 0.518 . . . . 0.0 111.486 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.698 HD23 HG23 ' A' ' 111' ' ' ILE . 2.4 tm? -133.01 122.85 24.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -120.83 112.49 18.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -107.49 131.46 21.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.926 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.43 146.58 68.96 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.43 -1.488 . . . . 0.0 110.998 -5.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.68 159.86 48.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.501 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -92.8 -37.35 12.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 129' ' ' TRP . 97.5 m-70 -76.4 -56.19 4.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.634 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.71 -150.18 7.78 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.791 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -73.35 -36.23 66.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.508 ' HB ' HD21 ' A' ' 100' ' ' LEU . 2.8 m -137.55 131.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.474 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.6 m-20 -104.27 115.0 29.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.777 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.698 HG23 HD23 ' A' ' 100' ' ' LEU . 9.0 pt -106.69 126.51 62.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -145.9 159.55 43.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.818 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 3.0 m -116.15 124.6 50.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.235 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.456 ' HB3' ' C ' ' A' ' 118' ' ' GLY . 62.6 mt -61.39 -34.93 76.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.737 -174.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.483 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 86.79 -166.84 37.82 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.15 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.24 -18.83 44.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.64 -13.53 24.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.912 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.456 ' C ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.54 8.82 72.59 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.781 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.811 ' O ' ' OD2' ' A' ' 125' ' ' ASP . 61.6 t -93.38 114.93 64.21 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -173.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.4 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 82.0 Cg_endo -76.62 154.31 34.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.373 2.715 . . . . 0.0 113.101 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 62.89 16.17 8.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.549 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . 1.055 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -89.51 177.03 6.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.444 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -71.69 -37.1 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -88.14 62.63 6.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 1.055 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -138.05 109.14 6.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.721 175.035 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.3 mm -77.17 103.11 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.957 0.408 . . . . 0.0 110.528 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.05 159.49 14.05 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.149 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.421 ' HA ' HG22 ' A' ' 131' ' ' ILE . 25.3 p-10 -67.85 -39.46 83.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.085 0.469 . . . . 0.0 110.521 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.42 ' CG ' ' HB3' ' A' ' 106' ' ' HIS . 93.1 t90 -66.34 -31.04 71.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.656 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.7 p -83.89 -29.52 27.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.714 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 128' ' ' ASN . 11.1 tp -82.7 -27.66 8.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.849 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.951 177.787 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.746 0.308 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.25 -42.2 98.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.987 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.23 73.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.496 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.7 m-20 -60.92 -47.56 85.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.642 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' HG23 ' A' ' 37' ' ' VAL . 32.1 ptt180 -69.5 -35.21 75.31 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.827 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -62.33 -35.17 78.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.634 0.254 . . . . 0.0 110.828 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.14 -41.94 98.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 95.9 t -60.69 -44.46 97.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.99 176.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 33' ' ' ARG . 90.3 t -60.22 -39.37 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.327 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 41' ' ' VAL . 37.9 t -62.18 -46.77 87.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.105 0.479 . . . . 0.0 110.681 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.96 -34.1 71.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.336 0.589 . . . . 0.0 110.311 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 128' ' ' ASN . 17.8 tp -60.65 -44.84 95.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.206 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 38' ' ' SER . 27.7 m -65.68 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.456 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.54 97.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.859 0.361 . . . . 0.0 110.195 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 47' ' ' LEU . 96.1 mt -61.43 -48.95 78.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.776 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.63 -42.53 98.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.33 -38.09 95.67 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.053 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -42.45 96.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.861 0.362 . . . . 0.0 110.277 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.6 mp -62.25 -48.1 81.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.196 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.06 -41.13 97.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.297 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.16 -37.46 72.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.32 -41.19 98.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -68.43 -32.62 72.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.36 -48.9 73.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.905 0.383 . . . . 0.0 110.214 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.66 -39.73 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.0 m-80 -106.69 11.74 30.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.5 m 73.17 -43.19 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.401 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 6.6 ppt_? -117.82 164.53 14.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.712 0.292 . . . . 0.0 111.552 -175.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -71.18 148.16 93.81 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.933 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.73 149.36 48.36 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.031 2.487 . . . . 0.0 112.529 177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.8 p -85.69 179.73 7.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -50.2 -38.89 42.27 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.42 -44.72 34.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.279 0.562 . . . . 0.0 110.677 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.87 -30.29 65.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.323 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.3 -51.17 60.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.645 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 mp -71.28 -33.54 69.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.962 0.41 . . . . 0.0 111.506 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -68.49 -26.69 65.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.809 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -23.53 63.88 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 HD23 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -103.74 -2.2 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.5 p -122.93 -48.33 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.831 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 p -152.08 128.61 10.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.608 0.242 . . . . 0.0 110.484 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.9 121.81 37.35 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.085 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.57 144.45 85.01 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.077 2.518 . . . . 0.0 112.307 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.4 t -94.97 2.51 55.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.17 131.26 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.484 ' OE2' ' HA ' ' A' ' 75' ' ' PRO . 8.1 tp10 -77.79 138.65 62.0 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.208 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 14.3 Cg_exo -67.03 130.84 14.08 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.565 -1.431 . . . . 0.0 112.62 0.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -74.0 131.16 41.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.723 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.403 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -57.48 127.99 34.78 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.524 0.515 . . . . 0.0 111.576 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -114.2 167.09 10.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.844 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 52.76 31.39 10.37 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -80.32 139.17 51.99 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.775 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.21 140.5 24.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.551 2.167 . . . . 0.0 111.719 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.36 125.07 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.178 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.54 3.18 86.67 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.45 -161.89 53.45 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.362 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.56 -22.51 24.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' A' ' 67' ' ' LEU . 8.3 tt -139.39 134.08 39.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.769 173.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -60.98 -29.31 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.608 -169.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -133.75 160.24 38.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.51 122.34 59.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.539 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.45 149.45 80.27 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.427 2.084 . . . . 0.0 111.876 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -140.76 140.71 34.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.788 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 1.9 p30 -63.82 152.98 85.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.22 -15.68 15.19 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.816 3.011 . . . . 0.0 113.812 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -79.05 -26.06 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.03 19.6 8.02 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.603 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.584 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 0.7 OUTLIER -95.96 151.35 19.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.417 . . . . 0.0 110.553 -178.263 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.25 122.6 31.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.494 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 56.6 m-85 -54.66 140.8 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.024 0.44 . . . . 0.0 111.284 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -113.69 137.89 50.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.651 HD23 HG23 ' A' ' 111' ' ' ILE . 2.8 tm? -118.79 122.02 41.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.411 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 1.7 tm? -122.54 113.98 20.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.887 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 p -106.35 130.52 22.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.81 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.5 139.97 63.72 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.385 -1.09 . . . . 0.0 111.93 -1.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 101' ' ' LEU . . . -60.62 143.82 47.99 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.358 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -58.52 -36.24 73.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.887 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -119.45 21.79 11.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.592 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.96 -147.92 11.72 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.816 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -70.41 -45.44 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.659 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.612 ' HB ' HD21 ' A' ' 100' ' ' LEU . 3.1 m -137.67 146.96 26.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.503 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.48 121.5 30.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.966 -177.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.651 HG23 HD23 ' A' ' 100' ' ' LEU . 7.0 pt -106.59 125.41 62.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.973 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -151.53 156.57 40.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 0.0 111.609 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.436 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 54.6 p -100.04 155.08 17.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -17.77 63.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 110.97 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.24 -172.0 55.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.437 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.01 -22.2 35.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.151 2.567 . . . . 0.0 112.273 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.733 ' OD2' HG12 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -94.91 -14.99 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.333 -173.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.51 -5.54 44.31 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.733 HG12 ' OD2' ' A' ' 117' ' ' ASP . 2.8 p -97.44 128.68 33.9 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.375 1.588 . . . . 0.0 110.683 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.718 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 56.0 Cg_endo -73.13 159.71 46.93 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.749 2.3 . . . . 0.0 113.398 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 69.37 15.83 8.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.296 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 1.003 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.3 p -98.97 175.35 5.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -77.9 -22.4 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.987 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -79.88 -11.24 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 1.003 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 1.0 OUTLIER -71.56 89.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.891 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.5 ' HA ' HG21 ' A' ' 130' ' ' THR . 46.6 mm -66.58 105.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.351 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 130' ' ' THR . . . -135.35 -161.8 9.47 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.467 ' HA ' HD21 ' A' ' 40' ' ' LEU . 10.6 t-20 -62.42 -38.11 88.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.618 0.247 . . . . 0.0 111.621 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -79.66 -30.86 41.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 126' ' ' ILE . 5.4 t -69.16 -33.09 72.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.591 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.45 -34.93 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.376 173.379 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 27.6 tt0 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -64.11 -35.1 79.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -176.125 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.2 -38.21 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.573 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.54 -49.06 79.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 2.5 ptp180 -69.92 -36.63 75.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.484 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -60.89 -35.87 77.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.02 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -68.12 -39.73 82.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.094 0.473 . . . . 0.0 109.966 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 35.4 t -61.04 -47.78 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.716 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 33' ' ' ARG . 58.9 t -62.91 -38.32 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -61.77 -46.22 90.53 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -69.94 -35.34 74.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.107 0.48 . . . . 0.0 110.266 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 ' HA ' ' A' ' 128' ' ' ASN . 45.0 tp -63.93 -46.13 86.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.437 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.1 m -66.02 -36.12 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.13 85.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.47 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 68.2 mt -60.12 -48.26 82.46 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.556 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.92 -36.28 78.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.065 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.06 -46.06 93.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.615 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -62.55 -38.72 91.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.576 0.227 . . . . 0.0 110.617 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 37.4 mt -65.15 -50.42 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.362 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.39 -44.39 97.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.399 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -70.31 -35.76 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.963 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.6 t80 -58.64 -44.75 90.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.43 -33.12 73.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.6 tp -62.82 -51.03 68.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.565 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 78' ' ' ARG . 16.2 t70 -78.51 -46.95 18.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -93.49 -0.07 56.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.861 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m 70.01 7.25 6.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -160.53 157.14 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.591 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 m-85 -74.29 148.22 85.99 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.178 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 60.4 Cg_endo -73.27 155.85 51.24 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.843 2.362 . . . . 0.0 112.456 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -86.06 178.18 7.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.33 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -51.31 -40.33 58.79 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -173.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -76.04 -43.28 44.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.352 0.596 . . . . 0.0 110.733 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -72.6 -27.46 62.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.5 56.12 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.964 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -33.47 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.172 0.486 . . . . 0.0 111.018 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -71.74 -25.18 61.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.677 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.58 -22.88 62.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.498 ' HB3' HG22 ' A' ' 86' ' ' ILE . 9.3 mt -87.75 -19.1 28.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 89' ' ' LEU . 4.2 p -122.25 -48.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 t -144.09 129.95 19.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.44 121.21 41.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.032 -175.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.33 136.91 75.7 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.127 2.551 . . . . 0.0 112.594 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 m -80.07 -16.59 54.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.281 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.89 146.92 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.699 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.05 136.31 69.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.17 131.99 24.43 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.776 -1.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.32 120.94 11.39 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . . . -55.89 121.22 8.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.931 0.396 . . . . 0.0 110.158 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.457 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 22.0 tpt180 -110.38 154.81 23.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.347 -176.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 64.87 43.02 4.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.421 0.629 . . . . 0.0 110.213 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -100.47 140.23 21.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.296 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.7 144.0 58.29 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.744 2.296 . . . . 0.0 111.914 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.31 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.14 4.28 78.15 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.44 -159.58 51.84 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.326 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -88.03 -30.51 19.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.498 HG22 ' HB3' ' A' ' 67' ' ' LEU . 7.6 tt -135.44 124.46 40.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.148 172.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -65.7 -20.25 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.558 ' HD2' ' O ' ' A' ' 89' ' ' LEU . 8.1 tmm_? -129.64 146.53 51.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -174.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.558 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 4.3 mm? -54.28 122.45 37.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 123.292 0.37 . . . . 0.0 111.159 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.38 124.44 15.55 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.945 1.764 . . . . 0.0 110.403 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 89' ' ' LEU . 90.9 mt-30 -134.79 144.38 47.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.989 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.607 ' OD2' ' HB2' ' A' ' 113' ' ' SER . 0.5 OUTLIER -56.34 145.17 59.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.76 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.93 -19.85 41.79 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.97 2.447 . . . . 0.0 112.437 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -80.78 -13.93 58.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.344 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.14 20.16 9.47 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.941 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -99.2 160.69 14.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.569 0.223 . . . . 0.0 110.568 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.66 122.97 48.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.375 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.593 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 52.8 m-85 -53.97 148.04 11.32 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.507 0.67 . . . . 0.0 112.599 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.545 ' HG2' HD21 ' A' ' 114' ' ' LEU . 62.1 mm-40 -112.01 138.6 48.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.036 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.765 HD23 HG23 ' A' ' 111' ' ' ILE . 2.2 tm? -129.39 122.64 29.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.72 113.45 17.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.883 0.373 . . . . 0.0 110.414 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 5.3 m -106.93 128.53 25.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.091 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 1.0 OUTLIER -82.71 137.38 32.35 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.403 -1.082 . . . . 0.0 111.428 -3.205 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -67.35 169.35 36.75 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.768 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.494 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 6.1 tp60 -95.84 -28.08 14.9 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 0.0 109.862 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -93.25 -5.76 49.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.781 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.61 10.57 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.08 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -72.74 -45.32 59.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.971 0.415 . . . . 0.0 110.348 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -127.97 124.56 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 177.335 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -100.01 112.68 24.96 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.874 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.765 HG23 HD23 ' A' ' 100' ' ' LEU . 7.5 pt -112.43 125.5 69.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -151.47 155.08 37.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.607 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 15.9 p -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.358 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.672 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 3.4 mm? -100.98 -12.66 18.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 110.822 -174.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 62.87 -154.9 42.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.275 173.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 124' ' ' ASP . 14.4 Cg_exo -69.05 -33.39 19.39 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.383 2.722 . . . . 0.0 113.135 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.577 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 2.8 p30 -83.7 -14.08 52.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.738 -0.385 . . . . 0.0 112.028 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.97 -3.96 18.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.755 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 1.045 ' O ' ' OG ' ' A' ' 122' ' ' SER . 24.3 m -107.83 139.47 20.66 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-N 117.329 0.565 . . . . 0.0 112.159 -173.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.7 155.31 39.73 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.505 2.803 . . . . 0.0 112.834 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 61.1 25.53 15.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.772 0.796 . . . . 0.0 110.74 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 1.045 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -93.49 174.61 7.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.116 -179.475 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.38 -41.87 98.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.696 0.76 . . . . 0.0 109.19 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.577 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 4.6 m-20 -99.3 75.24 1.98 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.54 1.162 . . . . 0.0 109.248 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.952 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 55.9 m-20 -143.39 112.67 6.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.259 169.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.544 ' HB ' ' OG ' ' A' ' 113' ' ' SER . 44.6 mm -87.34 104.9 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 109.999 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -95.23 157.19 21.93 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.673 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.459 ' HB2' HG13 ' A' ' 111' ' ' ILE . 62.6 t30 -65.89 -28.55 69.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.291 0.567 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -78.36 -23.63 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -81.03 -29.44 35.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 tp -78.37 -21.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.799 0.333 . . . . 0.0 110.938 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.096 -1.05 . . . . 0.0 113.405 176.172 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 4.8 tp10 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.71 0.291 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 53.3 mtmt -58.77 -40.68 84.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.61 -44.96 88.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.345 . . . . 0.0 110.811 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.42 -40.53 77.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.981 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.61 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 13.1 ptm180 -65.9 -33.67 76.36 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.996 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm100 -62.99 -31.59 72.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 87.7 mttt -64.69 -39.22 93.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 31.2 t -60.7 -46.46 95.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.632 175.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 33' ' ' ARG . 82.6 t -58.63 -38.78 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.061 0.458 . . . . 0.0 110.558 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 41' ' ' VAL . 38.9 m -63.4 -43.87 96.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.891 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.9 -35.17 74.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.304 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.39 -45.25 95.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.187 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 38' ' ' SER . 23.7 m -64.64 -35.72 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.26 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.74 85.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.614 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.722 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 87.5 mt -60.55 -48.4 81.92 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.135 0.493 . . . . 0.0 110.101 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.65 -35.96 82.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.586 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.99 -42.92 99.77 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.819 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -60.53 -43.96 96.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.362 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 48.7 mt -59.42 -49.07 79.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.662 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.65 -41.59 97.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.994 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.57 -38.64 74.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.976 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.98 -33.25 73.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.44 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.88 -49.75 76.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.709 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.94 -47.01 17.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.9 10.12 41.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m 70.99 -7.2 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -139.0 148.7 43.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.829 -0.545 . . . . 0.0 111.455 -175.071 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.406 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 10.2 m-85 -69.25 142.73 92.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.0 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.69 155.99 49.15 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 123.051 2.501 . . . . 0.0 112.694 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 p -81.89 177.11 9.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.398 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -51.65 -41.39 61.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.4 -45.39 39.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.066 0.46 . . . . 0.0 110.573 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.449 ' HG2' ' HB3' ' A' ' 71' ' ' PRO . 50.4 mt-30 -68.39 -31.61 71.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.189 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -62.57 -48.85 78.67 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.086 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.44 -32.41 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -72.12 -29.17 63.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.986 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . . . -60.29 -20.83 60.72 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.819 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 7.6 mt -89.95 -9.79 47.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.33 -53.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 p -144.74 139.14 27.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.08 122.24 46.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HB3' ' HG2' ' A' ' 62' ' ' GLN . 52.1 Cg_exo -56.24 137.38 79.6 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.875 2.383 . . . . 0.0 111.776 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -84.64 -16.04 43.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.622 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 135.86 48.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.229 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.413 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 7.9 pt-20 -77.57 140.56 64.2 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.146 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.488 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 57.7 Cg_endo -72.09 132.11 24.22 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.232 -0.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -66.96 129.79 41.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.692 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.6 17.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.687 0.28 . . . . 0.0 110.416 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 29.0 tpt180 -109.26 162.95 13.81 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -177.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.458 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 9.5 p30 47.83 39.75 11.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.902 0.881 . . . . 0.0 111.795 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -85.14 147.29 47.29 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.025 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.19 138.81 48.35 Favored 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.283 1.988 . . . . 0.0 111.446 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.54 124.08 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.24 10.47 86.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.371 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.71 -121.05 21.62 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.764 0.332 . . . . 0.0 112.639 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.526 ' HB2' HD23 ' A' ' 67' ' ' LEU . 51.1 m-85 -114.03 -17.8 11.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.449 0.642 . . . . 0.0 109.553 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 88' ' ' ARG . 6.1 tt -143.15 129.12 16.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.818 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -60.77 -23.12 64.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -167.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.439 ' O ' HG12 ' A' ' 86' ' ' ILE . 59.6 mtp180 -130.42 167.12 19.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -60.74 133.2 91.78 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.601 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.69 137.32 63.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.787 2.324 . . . . 0.0 112.46 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -133.48 150.7 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.149 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.437 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 7.7 m-20 -55.88 150.85 26.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.88 -17.96 39.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.181 . . . . 0.0 111.623 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.484 ' CZ3' ' HA2' ' A' ' 115' ' ' GLY . 6.3 m-90 -81.96 -12.3 58.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.315 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.2 10.79 31.1 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.699 -0.762 . . . . 0.0 114.001 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -102.31 143.41 32.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.352 0.576 . . . . 0.0 111.022 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.1 130.7 38.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -61.28 163.13 6.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.772 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -127.93 139.43 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.641 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.517 HD11 ' HB ' ' A' ' 109' ' ' VAL . 13.3 tp -122.89 142.51 50.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.361 173.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.65 112.83 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.481 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 6.0 m -107.55 129.67 23.9 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.144 172.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 108' ' ' GLN . 2.0 Cg_endo -83.09 135.66 26.72 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.465 -1.056 . . . . 0.0 110.956 -5.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -68.85 174.45 32.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.359 -173.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -94.73 -27.67 15.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.172 0.511 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -99.81 21.83 11.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 151.26 -155.26 26.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 16.2 mm-40 -73.52 -36.83 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.015 0.407 . . . . 0.0 111.21 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -132.78 129.05 57.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 -178.807 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.42 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 0.4 OUTLIER -107.53 114.19 28.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.475 -179.058 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.434 HG13 ' HB2' ' A' ' 128' ' ' ASN . 5.5 pt -106.88 126.87 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.45 . . . . 0.0 110.025 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -145.02 148.35 33.62 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.417 ' HB3' ' OD1' ' A' ' 92' ' ' ASP . 2.5 m -106.82 137.18 45.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.513 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.46 -35.26 79.85 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.82 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.484 ' HA2' ' CZ3' ' A' ' 94' ' ' TRP . . . 86.69 -177.31 48.28 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.606 -176.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.85 -15.36 40.39 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.012 2.474 . . . . 0.0 112.926 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.61 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 15.9 p-10 -92.37 -12.5 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.723 -174.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.86 67.33 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.679 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.785 ' O ' ' OG ' ' A' ' 122' ' ' SER . 58.9 t -110.76 121.13 41.87 Favored Pre-proline 0 C--O 1.244 0.815 0 CA-C-O 120.744 0.307 . . . . 0.0 111.141 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.658 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 72.0 Cg_endo -76.13 156.5 38.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.411 2.74 . . . . 0.0 113.448 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 62.65 25.94 15.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.75 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.871 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -101.03 172.86 6.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.951 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.48 -32.48 73.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.81 -19.01 60.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.142 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.871 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -62.0 138.71 58.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.986 -174.195 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -104.87 104.97 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.737 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.71 169.74 13.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.203 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.434 ' HB2' HG13 ' A' ' 111' ' ' ILE . 62.8 t30 -62.38 -33.98 75.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 110.568 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -77.9 -20.24 53.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.271 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -73.48 -46.5 47.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.109 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.95 -22.3 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 110.147 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.048 168.49 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.6 tp10 . . . . . 0 C--O 1.233 0.196 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 87.7 tttt -60.27 -41.85 94.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.01 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.89 -40.32 75.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.677 0.275 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 36' ' ' VAL . 49.4 m-20 -62.49 -47.56 83.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 13.9 ptm180 -68.19 -36.73 80.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.554 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 12.5 mm-40 -63.95 -35.15 79.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -66.44 -37.73 85.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.703 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 32' ' ' ASP . 85.9 t -60.68 -44.01 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.011 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 33' ' ' ARG . 96.7 t -59.94 -40.09 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.972 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.59 -45.65 93.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.4 ' O ' HD13 ' A' ' 43' ' ' LEU . 15.2 m-20 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.116 0.484 . . . . 0.0 110.018 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.5 tp -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.318 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.21 -36.64 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.31 94.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 47' ' ' LEU . 7.5 mp -60.67 -49.03 79.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -63.35 -36.92 85.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.953 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.39 96.89 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.217 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.52 -41.69 94.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.696 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.8 mp -59.75 -39.94 86.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.873 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.14 -36.21 79.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -42.94 77.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -65.7 -38.69 89.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -70.21 -32.79 70.85 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.774 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.4 tp -68.29 -40.98 81.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.032 0.444 . . . . 0.0 110.221 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.14 -44.96 28.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.422 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.58 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.6 m-80 -112.16 5.35 18.45 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -171.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.2 m 66.95 9.24 6.71 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -147.37 167.59 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.966 -0.459 . . . . 0.0 111.016 -177.282 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.422 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 21.9 m-85 -91.2 142.83 27.56 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.382 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.83 162.18 39.94 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.378 2.719 . . . . 0.0 113.632 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.2 p -88.07 178.87 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.182 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.0 m -50.13 -46.48 53.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.832 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.43 -44.9 61.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.501 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -64.98 -42.43 94.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.444 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.34 -44.49 98.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.702 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD21 ' O ' ' A' ' 98' ' ' TYR . 2.7 mp -69.66 -41.27 75.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.727 0.298 . . . . 0.0 111.39 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -72.52 -24.54 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.36 69.88 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.702 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -96.47 -0.28 49.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.932 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.6 -24.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 111.081 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.1 p -157.66 164.23 37.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.549 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.459 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -75.84 121.81 85.79 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.62 136.89 77.02 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.493 2.128 . . . . 0.0 112.136 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.4 m -82.49 -30.47 29.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.475 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.62 122.07 16.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.517 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -69.85 148.12 96.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.222 -175.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.58 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 14.5 Cg_exo -68.63 136.19 34.97 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.506 1.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -75.97 128.15 34.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.36 126.29 26.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.506 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -106.03 158.16 17.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.477 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.03 43.94 13.87 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.795 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.459 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 34.0 p90 -88.58 139.36 29.73 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.2 140.4 53.51 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.514 2.143 . . . . 0.0 111.38 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -64.31 123.88 20.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.16 86.4 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.927 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.41 -115.05 7.35 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.051 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.3 -21.73 4.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.287 0.565 . . . . 0.0 109.55 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.526 HG12 ' H ' ' A' ' 88' ' ' ARG . 14.0 tt -133.55 138.32 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.43 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 87' ' ' ARG . 38.4 mtp-105 -72.57 -20.8 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' H ' HG12 ' A' ' 86' ' ' ILE . 74.7 mtp180 -129.38 158.26 39.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.336 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.7 128.39 79.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.69 123.86 14.19 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.56 2.173 . . . . 0.0 112.822 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -127.84 140.39 52.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.635 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 4.8 p30 -68.85 155.58 93.03 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.932 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.53 -31.83 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.836 2.358 . . . . 0.0 113.666 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.445 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 6.5 m-90 -78.03 -19.01 55.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.855 0.359 . . . . 0.0 111.223 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.81 20.97 6.97 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.555 172.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.635 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 4.4 m -103.3 133.23 48.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.106 0.453 . . . . 0.0 110.552 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.79 128.73 37.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.495 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 76.6 m-85 -60.57 168.17 2.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 111.075 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -130.58 137.64 49.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.203 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.616 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -118.09 122.75 43.91 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.11 114.26 20.1 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.126 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.3 t -106.48 135.45 19.5 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.38 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.36 137.83 52.06 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.525 -1.448 . . . . 0.0 111.804 -3.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.83 141.88 47.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.652 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.96 -21.15 65.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.089 0.471 . . . . 0.0 110.262 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -126.89 31.54 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.29 -150.05 21.71 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.852 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -73.27 -40.21 64.77 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.616 ' HB ' HD21 ' A' ' 100' ' ' LEU . 4.5 m -132.84 151.27 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.886 175.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -131.15 123.03 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.604 0.24 . . . . 0.0 110.446 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.538 ' CG2' HD23 ' A' ' 100' ' ' LEU . 13.0 pt -106.87 129.68 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.541 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -151.13 161.05 43.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.287 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.485 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 44.0 p -112.32 150.92 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.471 175.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.35 -22.2 44.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.85 -171.97 54.11 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.553 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 13.4 Cg_exo -68.39 -23.79 37.61 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.045 2.497 . . . . 0.0 112.191 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.41 -12.43 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 111.291 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.21 11.8 79.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.983 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.8 ' O ' ' OG ' ' A' ' 122' ' ' SER . 98.9 t -97.28 116.8 66.02 Favored Pre-proline 0 C--O 1.239 0.526 0 CA-C-N 117.934 0.867 . . . . 0.0 111.747 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.5 151.77 33.31 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.557 2.838 . . . . 0.0 113.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.06 27.23 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.406 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 1.223 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -100.26 177.33 5.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.008 -176.157 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.28 -41.89 80.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.474 0.654 . . . . 0.0 109.31 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -88.56 65.39 7.81 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.398 1.094 . . . . 0.0 108.319 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 1.223 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.4 OUTLIER -136.46 90.55 2.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.41 -1.723 . . . . 0.0 108.823 174.46 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.54 109.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.571 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.66 -162.98 10.47 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.754 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -63.27 -37.59 87.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.268 -0.466 . . . . 0.0 111.866 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 -78.63 -27.06 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.674 0.273 . . . . 0.0 110.388 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 m -56.83 -49.31 75.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.905 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.7 tt -92.13 -25.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.501 . . . . 0.0 110.632 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.78 176.581 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.751 0.31 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.25 178.95 33.72 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.279 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -85.73 -32.26 21.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 110.68 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 4.8 ttpp -52.65 -51.93 57.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.051 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -58.28 -41.48 84.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.198 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -61.72 -45.82 92.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.55 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.98 95.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.417 ' OD1' ' HG2' ' A' ' 28' ' ' LYS . 12.0 m-20 -66.52 -47.38 73.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 37' ' ' VAL . 12.8 ptm85 -69.77 -34.77 74.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.465 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -61.07 -38.52 86.49 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.826 0.346 . . . . 0.0 110.688 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -62.4 -39.3 92.78 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 21.6 t -60.94 -47.52 93.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.801 175.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 33' ' ' ARG . 99.9 t -60.31 -38.84 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.996 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 m -59.02 -47.1 86.41 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 5.4 m-20 -70.41 -34.8 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.699 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.52 -44.95 93.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.423 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 37' ' ' VAL . 91.4 t -62.41 -41.34 91.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.288 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.04 90.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.085 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 47' ' ' LEU . 88.3 mt -60.25 -48.65 80.85 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.61 -36.05 81.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.166 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -61.73 -39.65 97.73 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.0 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.521 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -63.02 -39.81 95.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.232 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 43' ' ' LEU . 7.3 mp -60.76 -48.27 82.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.763 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.43 -36.83 85.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 24.6 mmt -68.02 -40.17 83.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.372 . . . . 0.0 110.628 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -63.63 -38.73 92.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.84 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.83 -32.72 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.96 -48.61 78.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 110.443 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.96 -46.56 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' A' ' 77' ' ' ALA . 38.5 m-80 -101.22 -0.67 35.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m 62.3 29.05 17.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.544 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -164.15 158.6 19.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -82.93 140.94 43.38 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.398 . . . . 0.0 110.952 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.43 157.91 44.75 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.105 2.537 . . . . 0.0 113.771 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.6 p -84.85 179.04 7.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.791 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.425 ' HA ' HD23 ' A' ' 100' ' ' LEU . 5.2 t -49.04 -44.78 41.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -171.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.17 -45.16 23.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.503 . . . . 0.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.462 HE22 ' NH2' ' A' ' 56' ' ' ARG . 48.2 mt-30 -64.12 -34.69 78.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.83 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -65.73 -48.84 63.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.922 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.54 -38.33 77.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.903 0.382 . . . . 0.0 111.036 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -72.08 -23.49 61.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.242 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.521 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 11.0 mt -79.4 -18.33 52.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.24 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.93 -59.14 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.125 0.488 . . . . 0.0 111.905 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -152.2 148.39 27.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.94 122.07 50.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.848 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HB3' ' HG2' ' A' ' 62' ' ' GLN . 78.2 Cg_exo -53.48 139.83 65.12 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.149 2.566 . . . . 0.0 112.529 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 p -81.18 -18.28 46.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.91 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.25 142.61 54.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.444 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.05 141.6 63.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.246 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.544 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 73.4 Cg_endo -76.99 143.72 76.42 Favored 'Cis proline' 0 C--N 1.344 0.294 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.588 -4.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -69.88 121.28 17.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.034 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -58.42 130.9 48.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.807 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -112.66 164.72 13.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.863 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 63.03 32.35 15.47 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.397 0.618 . . . . 0.0 110.658 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -88.86 144.05 32.46 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.896 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.33 139.99 43.13 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.37 2.047 . . . . 0.0 111.992 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.79 125.1 23.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.09 -9.41 60.67 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.789 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.09 -171.41 54.35 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.341 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.403 ' HB2' HD22 ' A' ' 67' ' ' LEU . 83.8 m-85 -83.14 -32.68 26.53 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.436 HG22 ' HB3' ' A' ' 67' ' ' LEU . 9.5 tt -139.07 126.94 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.678 174.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -67.4 -20.59 65.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -128.82 157.82 40.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -59.65 123.69 72.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.737 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.38 142.95 97.35 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.444 2.096 . . . . 0.0 111.27 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -138.18 144.7 40.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.818 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.49 142.08 52.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.8 -18.72 13.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.349 2.699 . . . . 0.0 113.457 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 23.1 m-90 -81.65 -14.28 56.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.399 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.14 25.65 5.51 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.29 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 139.6 38.76 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.641 -0.329 . . . . 0.0 110.328 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -87.73 119.22 27.84 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.31 -0.244 . . . . 0.0 110.345 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -50.95 145.71 6.97 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.748 0.655 . . . . 0.0 111.839 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.417 ' HG2' HD21 ' A' ' 114' ' ' LEU . 88.3 mm-40 -121.33 143.97 48.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.287 0.565 . . . . 0.0 111.625 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 109' ' ' VAL . 13.1 tp -122.48 142.27 50.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.741 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -128.08 112.57 14.74 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.555 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -107.4 131.22 21.88 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.438 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.44 143.64 64.9 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.055 -1.227 . . . . 0.0 111.431 -2.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.24 156.14 34.51 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.985 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -73.4 -27.09 61.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.074 0.464 . . . . 0.0 110.559 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -110.53 -27.01 9.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -147.51 -144.96 4.09 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.704 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -73.63 -43.17 60.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -140.64 128.38 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.301 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.82 127.37 54.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.0 111.23 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 pt -106.69 134.73 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.675 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.32 148.16 37.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 111.402 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.621 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 4.7 m -103.4 146.68 28.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.058 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 114' ' ' LEU . 1.8 mm? -88.3 -20.5 25.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.704 0.288 . . . . 0.0 111.197 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.26 -160.32 54.01 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.492 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 12.9 Cg_exo -69.95 -23.81 29.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.481 2.787 . . . . 0.0 112.38 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.5 ' OD2' HG22 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -91.9 -14.24 29.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.077 -173.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.01 5.84 62.77 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.357 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.5 HG22 ' OD2' ' A' ' 117' ' ' ASP . 22.8 m -93.58 118.79 67.56 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 117.548 0.674 . . . . 0.0 111.974 -175.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.49 148.06 29.28 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.38 2.72 . . . . 0.0 113.451 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 63.96 24.78 13.73 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.583 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.444 ' OG ' HG23 ' A' ' 119' ' ' VAL . 1.3 p -93.55 176.97 6.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.97 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -63.65 -41.88 98.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 0.0 110.405 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.51 -22.11 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.447 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.621 ' HA ' ' O ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -56.94 104.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.689 0.618 . . . . 0.0 112.034 -171.046 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.18 103.66 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.437 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.12 178.6 19.2 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.89 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -68.21 -25.16 65.08 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.618 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -74.94 -31.3 61.47 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.6 m -66.99 -48.03 69.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.582 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 tp -75.75 -37.65 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.295 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.44 29.8 2.2 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -100.77 -12.62 18.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.849 0.357 . . . . 0.0 110.766 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -86.89 76.32 9.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.293 0.568 . . . . 0.0 110.628 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -131.15 -172.42 2.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.874 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 40.2 m80 59.65 34.85 22.3 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.364 0.415 . . . . 0.0 111.196 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -148.03 67.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.287 0.565 . . . . 0.0 110.003 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -135.06 115.67 13.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.891 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -71.42 -16.16 62.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.587 175.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.78 0.324 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -132.26 172.04 21.26 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.992 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -76.0 101.32 5.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.874 0.369 . . . . 0.0 110.742 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -148.84 20.25 1.01 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.003 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.0 -37.0 78.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.715 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -63.2 -37.94 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.285 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.93 70.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.871 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.88 -47.04 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 37' ' ' VAL . 16.8 ptm180 -62.66 -34.8 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.802 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.61 -39.12 83.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.718 0.295 . . . . 0.0 111.003 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.8 -36.2 77.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 110.035 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 68.2 t -60.36 -46.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.184 177.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 33' ' ' ARG . 89.2 t -60.04 -38.82 78.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.016 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -61.09 -46.72 89.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.81 -34.93 72.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.921 0.391 . . . . 0.0 110.629 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.62 -45.81 91.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 37' ' ' VAL . 29.3 m -65.32 -34.93 73.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.572 0.225 . . . . 0.0 110.539 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.81 94.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 47' ' ' LEU . 95.2 mt -61.0 -47.68 85.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.13 -43.02 73.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.952 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -65.21 -50.34 57.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.94 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.42 86.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.939 0.399 . . . . 0.0 110.851 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.4 mp -61.77 -50.26 73.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.417 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.9 -31.66 68.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.56 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.9 mtt -66.95 -42.45 85.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.727 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.42 -38.59 87.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 60.2 tttm -65.19 -32.88 74.79 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.0 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -65.71 -41.05 92.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.949 0.404 . . . . 0.0 109.952 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -76.61 -46.48 25.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.329 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -111.43 13.56 21.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 28.8 p 49.81 35.46 9.25 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -167.08 156.34 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.503 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 38.0 m-85 -83.53 142.08 42.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 110.874 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.74 145.06 61.85 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.016 2.477 . . . . 0.0 112.891 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -75.87 177.81 6.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.622 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.418 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.9 t -50.55 -40.4 51.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.0 -45.58 26.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.512 . . . . 0.0 110.543 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -72.18 -28.11 63.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.273 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.43 -50.3 60.29 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.825 -0.703 . . . . 0.0 113.261 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -31.02 67.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.175 0.512 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -72.29 -23.44 61.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.776 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.44 68.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.414 HD13 ' CG2' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -97.86 -3.35 38.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.294 -0.563 . . . . 0.0 112.45 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 86.7 t -103.2 -62.83 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -139.58 141.86 37.16 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -57.38 121.16 45.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 135.76 71.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.532 2.155 . . . . 0.0 112.231 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.7 m -90.45 -9.24 48.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.866 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 128.8 33.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.931 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 38.9 tt0 -73.82 139.43 76.99 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.097 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.487 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 15.3 Cg_exo -69.14 140.96 61.73 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 124.299 -1.125 . . . . 0.0 113.376 1.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -86.35 136.94 32.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.658 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.9 122.86 24.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.963 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -104.91 156.02 18.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.334 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 59.45 49.85 8.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.507 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.571 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 38.6 p90 -92.17 144.57 29.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.03 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.62 138.96 39.53 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.297 1.998 . . . . 0.0 111.663 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -64.93 125.27 24.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.191 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.45 2.19 90.4 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.997 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.72 -152.75 51.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.362 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.95 -26.94 13.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 9.1 tt -133.32 133.87 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.52 -25.82 57.55 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -130.45 172.48 11.84 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.607 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -55.58 124.01 53.85 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.68 141.08 58.67 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -140.04 139.19 35.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 43.2 m-20 -58.67 154.43 35.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.862 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.58 -25.01 24.3 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.735 2.29 . . . . 0.0 112.839 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -80.71 -12.8 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.403 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.11 33.05 5.6 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.628 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.523 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 38.8 m -102.48 133.97 46.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.862 0.363 . . . . 0.0 111.572 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.12 124.9 28.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.08 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -65.68 138.76 58.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.24 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -112.69 142.35 45.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.675 HD23 HG23 ' A' ' 111' ' ' ILE . 3.4 tm? -126.21 123.28 37.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.09 113.52 27.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.701 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 26.7 p -106.56 119.71 50.79 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.484 171.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 91.6 Cg_endo -84.82 159.69 66.5 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 124.042 -1.233 . . . . 0.0 111.795 -3.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.51 163.89 39.28 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -96.1 -35.64 11.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.631 0.729 . . . . 0.0 109.522 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -95.69 14.07 24.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.39 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.8 -156.01 27.31 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -72.4 -34.92 68.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.423 0.611 . . . . 0.0 110.867 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.663 ' HB ' HD21 ' A' ' 100' ' ' LEU . 31.6 m -138.02 151.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -117.99 121.5 40.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.535 -176.304 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.675 HG23 HD23 ' A' ' 100' ' ' LEU . 7.6 pt -106.75 126.63 62.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 42.6 p90 -148.25 144.44 27.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.297 0.57 . . . . 0.0 111.647 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.3 m -92.16 138.26 31.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.409 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 73.8 mt -66.27 -16.36 63.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.179 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.6 -165.53 49.94 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.683 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.71 -34.54 24.52 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 123.528 2.819 . . . . 0.0 113.053 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -90.12 -10.93 42.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.646 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.94 87.48 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.908 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.4 t -86.72 116.1 64.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.737 0.268 . . . . 0.0 110.991 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.486 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 47.0 Cg_endo -71.47 153.81 60.61 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 11.9 pt-20 55.66 25.05 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.911 1.284 . . . . 0.0 111.869 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.6 OUTLIER -94.61 177.9 5.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.759 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.69 -27.4 62.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.991 0.424 . . . . 0.0 110.787 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.16 -17.22 58.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.622 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.445 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -62.74 121.9 14.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.098 -177.111 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 70.5 mt -91.76 105.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -112.0 179.63 19.61 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.078 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -58.47 -38.78 78.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.786 0.327 . . . . 0.0 111.181 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.784 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.6 m -64.04 -43.57 95.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -87.0 -38.69 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.959 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 128.72 30.08 0.72 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.176 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -94.51 140.29 30.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.02 0.438 . . . . 0.0 110.332 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -163.16 119.65 1.82 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.179 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -72.45 81.54 1.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.309 0.576 . . . . 0.0 109.946 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -72.76 118.14 15.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.544 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -124.75 37.77 4.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.372 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -105.47 154.98 19.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.876 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -128.13 141.14 51.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.577 0.227 . . . . 0.0 110.445 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.961 177.022 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.69 0.281 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.21 -59.08 4.97 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.09 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -129.48 149.81 51.1 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -108.6 22.08 16.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.458 0.647 . . . . 0.0 109.655 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 8.1 tp10 -56.22 -43.26 78.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.934 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.77 -41.02 94.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.881 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.04 81.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 36' ' ' VAL . 67.7 m-20 -68.9 -48.11 64.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.197 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 12.3 ptm85 -66.9 -35.21 79.5 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.867 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -60.77 -37.81 83.13 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.094 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HD3' ' HG3' ' A' ' 93' ' ' PRO . 30.7 tttp -64.35 -41.94 96.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.679 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 60.9 t -61.1 -44.05 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.479 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 41' ' ' VAL . 77.4 t -62.91 -38.96 83.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 175.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -62.27 -46.01 90.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.45 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 64.4 m-20 -66.67 -36.31 82.24 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.306 0.574 . . . . 0.0 109.741 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.37 -42.76 99.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.98 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 37' ' ' VAL . 85.1 t -62.62 -38.11 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.441 . . . . 0.0 110.247 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.83 98.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.618 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 96.6 mt -64.47 -47.89 77.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.514 ' HG2' HD11 ' A' ' 111' ' ' ILE . 4.2 mm-40 -58.4 -44.95 89.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.281 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.25 -40.94 99.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.924 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -61.21 -42.38 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.791 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.27 -45.44 88.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.09 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.56 -43.68 98.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.02 -43.67 82.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.203 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -63.52 -41.15 98.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.446 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.65 -33.24 74.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.815 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.5 tp -67.55 -50.42 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.71 -44.75 32.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.888 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 36.6 m-80 -95.28 2.93 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.548 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m 68.67 3.78 4.05 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 171.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -159.58 165.52 32.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.727 0.298 . . . . 0.0 111.11 -178.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -74.12 142.02 78.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.572 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.49 143.28 42.4 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.189 2.592 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 60' ' ' THR . 1.4 m -72.35 176.82 4.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 175.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.617 ' H ' HG22 ' A' ' 59' ' ' THR . 8.8 t -51.34 -43.65 61.82 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.09 -38.97 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 110.348 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.82 -31.81 68.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.567 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -49.03 73.21 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.523 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.1 mp -69.58 -35.49 75.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.404 . . . . 0.0 111.093 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -72.54 -24.4 61.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.053 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.1 -29.38 67.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.2 pt? -103.61 -1.92 27.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.672 0.272 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 74.9 t -109.49 -59.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.257 0.551 . . . . 0.0 111.074 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.0 p -156.68 136.03 12.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -53.05 121.57 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.459 0.474 . . . . 0.0 111.34 -172.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 51.1 Cg_exo -56.98 137.07 80.32 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.007 2.472 . . . . 0.0 112.598 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.0 m -89.76 3.84 51.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.23 148.88 22.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.046 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -77.37 137.06 64.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.19 131.77 24.56 Favored 'Cis proline' 0 C--O 1.235 0.34 0 C-N-CA 122.957 -1.684 . . . . 0.0 112.247 -0.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.6 126.27 26.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.159 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.76 132.32 53.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.685 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -118.07 149.94 40.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.228 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 59.49 44.23 15.13 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.687 0.617 . . . . 0.0 110.542 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -94.84 153.39 40.01 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.274 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.55 140.37 21.29 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.307 2.005 . . . . 0.0 111.222 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.77 125.03 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.06 10.32 86.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.615 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.39 -119.89 20.2 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -126.27 -37.44 2.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.689 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 13.8 tt -124.94 127.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.874 172.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -69.29 -21.67 63.86 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -129.39 165.03 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.405 HD22 HD23 ' A' ' 64' ' ' LEU . 69.5 mt -60.23 126.55 84.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.464 ' O ' ' HD2' ' A' ' 98' ' ' TYR . 37.9 Cg_endo -67.07 138.86 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.463 2.108 . . . . 0.0 111.511 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -133.4 138.51 46.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.762 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 4.4 p30 -67.28 152.95 95.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HG3' ' HD3' ' A' ' 35' ' ' LYS . 27.0 Cg_exo -59.27 -17.82 41.65 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.263 2.642 . . . . 0.0 113.169 -170.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.556 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.5 m-90 -81.27 -26.47 35.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.02 10.87 3.68 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.94 172.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.584 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 14.7 m -103.63 148.38 26.09 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.548 0.674 . . . . 0.0 111.038 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.19 133.71 34.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.104 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 78.4 m-85 -60.61 148.65 37.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.231 0.332 . . . . 0.0 110.312 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -130.4 143.21 50.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.15 0.5 . . . . 0.0 111.361 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -111.26 121.51 45.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -106.89 112.28 25.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.9 p -106.85 130.99 22.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.743 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.33 159.77 78.09 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.678 -1.384 . . . . 0.0 111.125 -4.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.96 159.24 53.86 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.136 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -96.2 -36.04 11.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -101.97 1.27 36.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.976 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.99 -155.88 13.26 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -74.69 -29.32 61.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.271 0.535 . . . . 0.0 110.83 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.635 ' HB ' HD21 ' A' ' 100' ' ' LEU . 13.5 m -144.78 151.16 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.618 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.39 133.02 51.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.01 0.433 . . . . 0.0 111.614 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.623 HG23 HD23 ' A' ' 100' ' ' LEU . 6.7 pt -112.3 127.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.87 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -150.84 160.87 43.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.217 0.532 . . . . 0.0 111.884 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 6.2 p -106.85 146.68 30.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.651 175.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 7.3 mp -86.61 -20.31 28.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.556 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 76.53 -159.64 50.09 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.57 170.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.28 -23.79 32.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.64 2.893 . . . . 0.0 112.298 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -13.97 35.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.5 13.79 74.44 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.068 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.3 123.64 34.6 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-N 117.515 0.657 . . . . 0.0 112.194 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -78.13 157.01 30.15 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.503 2.802 . . . . 0.0 112.128 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 63.73 42.41 6.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.085 0.945 . . . . 0.0 109.497 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.6 p -120.86 177.26 5.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.881 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -73.73 -31.73 63.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.55 -28.42 67.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.753 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 113' ' ' SER . 3.5 m-20 -47.07 112.0 0.47 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 124.282 0.989 . . . . 0.0 112.131 -172.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.587 ' HB ' HG11 ' A' ' 36' ' ' VAL . 4.8 mp -84.62 105.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.505 ' O ' HG22 ' A' ' 130' ' ' THR . . . -130.4 -172.24 13.09 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -63.89 -37.62 88.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.898 0.38 . . . . 0.0 111.727 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -77.3 -19.82 55.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.4 t -88.68 -22.33 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.951 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.78 -42.98 13.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.701 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 146.07 -18.43 1.75 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.096 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -69.98 99.78 1.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 111.353 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -101.95 147.18 26.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.867 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -74.38 111.78 9.89 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -67.94 111.92 4.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.044 -172.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -89.24 88.88 7.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.055 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -84.76 23.55 1.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.021 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -113.74 -2.23 13.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.81 0.338 . . . . 0.0 110.729 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.169 -178.243 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.53 20.01 69.93 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.012 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -83.84 91.36 7.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 0.0 110.278 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -57.23 -34.29 68.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.501 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -58.79 -43.05 90.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.022 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -59.92 -38.52 82.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.48 60.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.5 m-20 -69.29 -42.53 75.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 37' ' ' VAL . 14.2 ptm180 -62.17 -34.48 76.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.093 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -58.78 -37.05 75.42 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.8 0.334 . . . . 0.0 111.082 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -68.58 -39.59 80.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 32' ' ' ASP . 46.7 t -61.37 -41.76 91.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.662 ' O ' HG23 ' A' ' 41' ' ' VAL . 96.2 t -60.52 -41.23 86.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.589 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.8 t -59.26 -48.23 82.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.003 0.43 . . . . 0.0 110.887 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.403 ' HB2' ' OH ' ' A' ' 98' ' ' TYR . 31.1 m-20 -69.86 -34.26 73.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.13 -39.9 91.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.657 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 37' ' ' VAL . 52.2 t -63.5 -37.73 80.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.205 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.06 -35.63 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.596 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 47' ' ' LEU . 9.0 mp -64.08 -47.68 79.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.465 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -56.29 -37.4 69.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.999 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.49 -45.46 85.17 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.969 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -61.32 -44.62 96.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.793 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 43' ' ' LEU . 7.9 mp -62.93 -41.88 99.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.653 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.11 -44.77 94.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.447 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mmt -65.77 -43.87 87.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.046 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.495 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 67.1 t80 -65.26 -45.22 85.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.03 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.6 -33.1 72.21 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.576 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.4 tp -64.28 -42.32 96.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.073 0.463 . . . . 0.0 110.313 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.32 -48.72 16.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.906 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -98.7 -4.82 32.77 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -169.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 65.9 24.34 11.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.448 0.468 . . . . 0.0 111.945 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.31 149.74 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.403 ' HB2' ' OE1' ' A' ' 108' ' ' GLN . 31.2 m-85 -74.4 146.9 84.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.797 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 142.08 50.91 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.691 2.261 . . . . 0.0 112.295 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.2 p -74.73 177.51 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.795 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.511 ' HA ' HD12 ' A' ' 100' ' ' LEU . 13.3 t -51.46 -37.17 47.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.39 -41.18 41.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.086 0.469 . . . . 0.0 111.268 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -72.62 -37.78 67.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.294 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.21 71.27 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.783 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.697 HD21 ' O ' ' A' ' 98' ' ' TYR . 7.4 mp -69.96 -40.22 75.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 111.668 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -72.55 -23.98 61.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.234 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -26.46 62.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -169.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.7 pt? -104.52 -2.0 25.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.47 -38.75 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 t -156.44 130.35 8.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.66 121.99 36.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.432 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.85 137.47 58.37 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.833 2.355 . . . . 0.0 112.367 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 p -87.45 -19.59 27.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.087 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.23 137.48 57.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.369 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.04 138.19 92.36 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.495 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 10.7 Cg_exo -73.46 135.12 38.48 Favored 'Cis proline' 0 C--O 1.233 0.272 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.34 -3.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -70.88 121.62 18.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.8 124.26 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.736 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -107.46 166.3 10.76 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.372 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 47.76 40.27 11.96 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.192 0.933 . . . . 0.0 111.839 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -89.75 150.17 43.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.966 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.93 137.74 32.69 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.025 1.816 . . . . 0.0 111.3 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.59 124.24 22.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.914 0.387 . . . . 0.0 110.41 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.95 4.95 86.65 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.645 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.45 -142.55 40.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.399 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.85 -14.38 13.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.286 0.565 . . . . 0.0 109.594 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.9 tt -136.83 141.48 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.004 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -68.85 -30.97 69.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.886 -172.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -131.18 154.36 48.46 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.294 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.26 118.8 43.52 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.98 128.43 24.77 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.358 2.705 . . . . 0.0 113.206 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -126.37 140.43 52.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.672 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.2 p30 -71.0 152.5 94.92 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 -15.53 13.66 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.547 2.832 . . . . 0.0 113.683 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.422 ' CZ3' HG21 ' A' ' 36' ' ' VAL . 5.4 m-90 -80.57 -19.48 45.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.996 0.427 . . . . 0.0 110.361 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.16 19.31 8.57 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.918 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.496 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 0.9 OUTLIER -103.35 146.24 28.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 110.849 -176.317 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.93 126.24 36.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.354 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.697 ' O ' HD21 ' A' ' 64' ' ' LEU . 5.1 m-85 -52.9 151.62 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.84 0.713 . . . . 0.0 112.692 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.68 137.49 52.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.364 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.2 tm? -123.32 122.39 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -117.1 112.55 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.787 0.327 . . . . 0.0 110.486 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.484 ' HB3' HG12 ' A' ' 109' ' ' VAL . 20.7 p -107.08 127.97 26.95 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.272 171.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 97.0 Cg_endo -85.06 139.94 29.29 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.907 -1.289 . . . . 0.0 111.648 -5.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.95 161.63 46.92 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.112 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -85.15 -20.81 29.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.965 0.412 . . . . 0.0 110.617 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -105.74 -43.98 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.5 -151.6 8.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.97 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -73.33 -45.64 54.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.65 ' HB ' HD21 ' A' ' 100' ' ' LEU . 16.2 m -128.67 140.48 49.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.413 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 125.4 54.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.762 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.612 HG23 HD23 ' A' ' 100' ' ' LEU . 11.3 pt -108.35 125.73 65.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.147 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -151.69 163.09 39.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.057 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.5 m -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.872 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.446 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 1.8 mm? -66.88 -22.76 65.96 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -169.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.04 -169.16 43.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.831 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.29 -25.02 36.87 Favored 'Trans proline' 0 C--N 1.337 -0.058 0 C-N-CA 122.891 2.394 . . . . 0.0 112.843 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.85 -11.08 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.115 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 114' ' ' LEU . . . 76.09 9.75 85.39 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.406 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.16 112.88 53.8 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.043 0.421 . . . . 0.0 111.448 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.419 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 3.3 Cg_exo -75.86 156.39 39.22 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.096 2.531 . . . . 0.0 112.624 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 64.73 16.25 10.28 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.283 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 1.9 p -94.27 175.85 6.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.818 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -85.73 -23.75 27.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.43 -22.43 61.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 122' ' ' SER . 1.0 OUTLIER -55.29 132.05 46.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.346 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.97 95.75 3.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -106.6 148.96 16.52 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.301 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.676 ' OD1' ' HB2' ' A' ' 133' ' ' PHE . 64.6 t30 -66.91 -26.03 66.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.44 0.638 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -74.5 -28.43 60.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.921 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -74.69 -37.47 62.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.956 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.5 tp -78.39 -36.52 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.18 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.27 12.14 14.24 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.474 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.676 ' HB2' ' OD1' ' A' ' 128' ' ' ASN . 51.7 m-85 -69.53 -70.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.26 1.03 . . . . 0.0 110.861 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.516 ' HB2' ' ND2' ' A' ' 128' ' ' ASN . 3.0 t60 -86.02 66.57 9.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.038 0.447 . . . . 0.0 110.008 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -94.43 149.67 21.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.399 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -99.85 138.16 37.32 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -91.83 82.04 5.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.889 0.376 . . . . 0.0 111.089 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -149.43 -10.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.735 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -91.03 -29.3 17.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.975 0.417 . . . . 0.0 110.454 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.259 -179.28 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.041 0.448 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.57 19.68 3.35 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.99 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -89.59 73.67 7.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.662 0.744 . . . . 0.0 110.307 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -114.24 34.75 4.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.94 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.9 tp10 -56.04 -43.88 78.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.301 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 36.2 mtmm -69.56 -36.74 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.598 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.74 77.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.998 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 -44.47 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.521 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 37' ' ' VAL . 13.4 ptm180 -67.72 -35.16 78.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.601 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 40.8 mt-30 -63.91 -36.45 83.99 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.97 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.71 -39.84 92.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 76.1 t -61.05 -43.02 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.272 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 33' ' ' ARG . 88.2 t -60.54 -39.46 81.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.411 ' O ' HG22 ' A' ' 41' ' ' VAL . 50.4 m -61.32 -46.95 88.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.025 0.44 . . . . 0.0 111.055 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 -34.42 73.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.277 0.56 . . . . 0.0 110.491 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 128' ' ' ASN . 25.8 tp -65.22 -44.55 87.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.519 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 37' ' ' VAL . 32.8 m -63.53 -35.82 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.92 90.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.79 0.329 . . . . 0.0 110.47 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.57 -48.54 79.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.79 -37.77 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.34 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -44.81 97.22 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.769 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.43 -44.13 96.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.735 0.302 . . . . 0.0 110.868 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.54 -44.11 97.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.025 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.08 -41.73 99.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.866 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -38.83 73.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.733 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 77' ' ' ALA . 4.9 t80 -62.25 -42.67 99.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.954 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -69.98 -31.79 69.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.3 -49.1 75.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 0.0 110.51 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.02 -45.49 34.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -98.32 -1.33 41.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -172.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 m 63.14 17.34 10.1 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.86 147.58 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -66.74 140.55 96.38 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.24 149.09 69.77 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.967 2.444 . . . . 0.0 112.439 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 60' ' ' THR . 0.7 OUTLIER -81.71 177.46 8.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.622 176.518 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.574 ' H ' HG22 ' A' ' 59' ' ' THR . 8.8 t -51.42 -40.53 59.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -77.14 -42.98 35.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.302 0.572 . . . . 0.0 110.2 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -69.37 -33.59 73.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.683 -173.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.9 -49.36 42.36 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.917 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.592 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.3 tp -66.16 -41.01 90.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 111.422 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HA ' HG12 ' A' ' 68' ' ' VAL . 34.6 mt-30 -73.03 -23.11 60.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.66 61.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.8 pt? -104.65 -2.0 25.63 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 65' ' ' GLN . 7.5 p -117.83 -43.62 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.818 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 65' ' ' GLN . 47.0 m -156.51 129.58 7.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -56.24 121.53 42.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 111.442 -175.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 27.9 Cg_exo -63.15 137.39 61.23 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.739 2.293 . . . . 0.0 112.604 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.5 p -86.52 -10.9 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.96 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.64 138.32 46.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 6.1 mp0 -77.03 141.79 68.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.92 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 48.2 Cg_endo -69.89 131.33 19.11 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 -1.672 . . . . 0.0 112.532 -0.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -68.96 129.38 39.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.949 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . . . -70.56 125.96 28.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.67 -177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -119.34 163.75 16.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.538 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.32 39.28 9.61 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.369 0.604 . . . . 0.0 110.229 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -97.83 143.15 25.71 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.58 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.45 143.8 35.28 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.595 2.196 . . . . 0.0 111.628 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.08 124.63 22.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.809 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.26 10.02 86.48 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.884 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.75 -149.61 51.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.2 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.95 -5.59 15.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.388 0.613 . . . . 0.0 109.881 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 tt -142.36 137.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.694 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.18 -22.79 61.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.948 -169.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -138.3 170.16 16.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.85 128.52 70.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 172.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.43 129.11 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.346 2.031 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.16 140.47 51.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.733 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.0 p30 -72.91 153.15 91.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 92' ' ' ASP . 13.8 Cg_endo -56.23 -17.89 22.06 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.324 2.683 . . . . 0.0 113.576 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.575 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 7.3 m-90 -81.38 -26.68 35.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.697 0.284 . . . . 0.0 110.61 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.94 18.76 4.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.718 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.65 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 69.5 m -103.68 154.24 19.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.489 0.645 . . . . 0.0 111.281 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.36 129.88 38.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.218 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.592 ' O ' HD21 ' A' ' 64' ' ' LEU . 19.1 m-85 -60.95 146.23 47.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -127.6 140.47 52.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.155 0.502 . . . . 0.0 111.766 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.693 HD21 ' HB ' ' A' ' 109' ' ' VAL . 2.8 tm? -111.89 120.94 43.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -112.64 113.05 25.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.072 0.463 . . . . 0.0 111.176 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 19.8 m -106.55 131.74 21.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.171 171.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 94.1 Cg_endo -81.75 146.14 65.72 Favored 'Cis proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.762 -1.349 . . . . 0.0 111.369 -4.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.34 161.22 34.77 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.897 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.01 -35.55 11.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.111 0.481 . . . . 0.0 109.746 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -94.99 -40.24 9.76 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.16 -157.98 9.66 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.39 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -74.49 -34.61 63.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.948 0.374 . . . . 0.0 110.839 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.693 ' HB ' HD21 ' A' ' 100' ' ' LEU . 6.5 m -135.96 124.05 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.987 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 124.58 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.658 HG23 HD23 ' A' ' 100' ' ' LEU . 8.7 pt -106.29 126.55 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.278 173.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 11.7 p90 -150.31 160.58 43.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.204 0.526 . . . . 0.0 111.643 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 m -108.48 126.72 53.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.6 -31.23 72.02 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 123.804 0.69 . . . . 0.0 110.748 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.575 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 78.99 -154.09 38.84 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.0 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.36 -27.41 34.13 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.233 2.622 . . . . 0.0 113.629 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.551 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.2 p-10 -87.34 -13.46 43.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.642 -173.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.36 13.27 73.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.238 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.551 ' HB ' ' OD2' ' A' ' 117' ' ' ASP . 77.9 t -119.03 121.23 30.56 Favored Pre-proline 0 C--O 1.247 0.93 0 CA-C-O 120.712 0.292 . . . . 0.0 111.084 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.659 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 71.9 Cg_endo -76.06 146.97 29.55 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.508 2.805 . . . . 0.0 112.983 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 121' ' ' GLU . 5.5 tp10 65.19 25.15 12.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.074 0.94 . . . . 0.0 110.338 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.22 172.42 8.31 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.451 172.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -76.14 -0.41 21.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.811 0.338 . . . . 0.0 111.671 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -103.56 -13.84 16.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.185 0.517 . . . . 0.0 109.964 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.659 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -65.76 134.76 53.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.582 -174.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.17 108.44 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.908 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -110.7 176.49 18.8 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.542 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.509 ' HB2' HG13 ' A' ' 111' ' ' ILE . 63.3 t30 -65.14 -28.87 69.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.364 0.602 . . . . 0.0 110.473 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -77.11 -19.44 56.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.803 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 -40.34 62.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.63 -34.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.018 0.437 . . . . 0.0 110.244 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.76 36.84 3.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.894 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.465 ' HB2' ' OD1' ' A' ' 128' ' ' ASN . 39.3 m-85 -87.49 78.43 8.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.505 0.669 . . . . 0.0 110.509 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -101.95 103.4 14.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.874 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -97.94 113.36 25.17 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.27 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -148.12 87.14 1.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.226 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -71.22 133.96 46.52 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.136 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -141.77 136.05 30.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.653 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -137.71 21.7 2.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.415 0.626 . . . . 0.0 110.029 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.919 178.287 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.575 0.226 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.33 -47.76 1.58 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.517 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -70.37 -25.4 63.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.738 0.304 . . . . 0.0 111.412 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -116.87 75.24 0.95 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 110.114 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -58.81 -42.78 89.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.687 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.73 -48.01 82.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 110.397 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.08 -36.63 72.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.377 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -63.2 -47.1 83.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.109 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 37' ' ' VAL . 35.8 ptt180 -67.67 -34.79 77.63 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.662 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.15 -34.15 75.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.69 -40.37 92.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 92.6 t -60.78 -44.88 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.415 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 33' ' ' ARG . 60.7 t -58.76 -38.41 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.513 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -61.9 -45.93 91.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.09 -34.84 73.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 0.0 110.649 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.411 HD21 ' HA ' ' A' ' 128' ' ' ASN . 17.7 tp -63.41 -45.1 92.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.92 -34.86 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.709 0.29 . . . . 0.0 110.315 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.92 89.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.539 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.82 -43.08 98.68 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.984 0.421 . . . . 0.0 110.047 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.41 ' HG2' HD11 ' A' ' 111' ' ' ILE . 5.5 mm-40 -56.7 -36.78 70.05 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 172.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.82 -44.75 94.14 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.948 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -62.48 -43.67 98.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.798 0.332 . . . . 0.0 110.711 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.91 -43.14 93.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.5 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.01 -41.15 82.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.894 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 86.7 mmm -67.87 -44.05 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.176 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.4 ' HE2' ' NE ' ' A' ' 56' ' ' ARG . 81.7 t80 -62.57 -40.31 96.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.05 -32.16 70.14 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.71 0.291 . . . . 0.0 110.262 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.6 -49.07 79.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.752 0.311 . . . . 0.0 110.422 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -77.2 -47.03 21.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -100.4 -3.49 30.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -169.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.9 m 61.38 28.93 18.27 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 2.0 ppt_? -156.58 154.87 30.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.668 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.511 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 76.0 m-85 -77.4 131.86 70.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 147.08 45.01 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.521 2.147 . . . . 0.0 112.729 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 176.8 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.518 175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.437 ' HA ' HD23 ' A' ' 100' ' ' LEU . 6.5 t -50.15 -44.44 52.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -77.44 -43.77 31.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.059 0.457 . . . . 0.0 110.785 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.22 -36.78 84.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.106 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.45 -45.05 25.24 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.547 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.568 HD21 ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -69.37 -44.65 71.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.024 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -71.59 -26.03 62.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.18 -21.86 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 46' ' ' ALA . 4.8 tp -83.24 -13.02 56.19 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.994 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.44 -29.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.565 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 t -157.34 162.88 39.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.2 122.26 87.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.94 136.69 71.36 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.643 2.229 . . . . 0.0 112.042 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -81.99 -29.66 31.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 127.4 31.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.462 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 34.0 tt0 -67.22 139.16 94.82 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 18.2 Cg_exo -67.56 131.62 16.69 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.738 -0.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -80.89 129.95 34.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.698 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.48 122.84 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.924 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -111.81 158.42 19.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.017 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 60.89 32.0 20.02 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 110.608 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -72.03 146.61 90.29 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.414 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.78 138.28 31.4 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.981 1.787 . . . . 0.0 111.272 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.81 124.63 22.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.457 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.58 4.94 75.74 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.505 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.34 -150.85 47.67 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.406 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.55 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 62.1 m-85 -101.45 -37.44 8.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.364 0.602 . . . . 0.0 109.901 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 88' ' ' ARG . 13.0 tt -131.92 137.53 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -67.05 -21.87 65.89 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.428 ' H ' HG12 ' A' ' 86' ' ' ILE . 46.9 mtm180 -130.52 154.92 47.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -54.43 125.83 53.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.03 137.09 79.05 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.636 2.224 . . . . 0.0 112.142 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -138.4 138.03 37.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.295 0.569 . . . . 0.0 111.327 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.85 153.86 78.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.948 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -19.02 29.14 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.198 2.599 . . . . 0.0 112.704 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -81.96 -12.75 58.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.09 30.72 7.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.198 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.3 m -103.52 149.46 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.962 0.41 . . . . 0.0 111.021 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.81 143.5 29.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.844 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.568 ' O ' HD21 ' A' ' 64' ' ' LEU . 83.7 m-85 -83.67 148.53 27.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.476 ' NE2' HD21 ' A' ' 114' ' ' LEU . 27.0 mp0 -118.22 152.96 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 110.932 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 60' ' ' THR . 13.4 tp -131.94 140.16 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.077 171.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.405 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 2.8 tm? -135.38 115.93 13.74 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.815 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 t -106.8 132.56 20.81 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.88 139.77 63.1 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 124.251 -1.145 . . . . 0.0 111.907 -1.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 101' ' ' LEU . . . -68.83 150.91 51.03 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.741 -172.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.69 -26.53 68.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 0.0 110.286 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 20.4 m80 -131.04 44.88 2.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.246 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 147.08 -165.62 28.54 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.434 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 13.2 mm100 -75.5 -29.55 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.77 0.785 . . . . 0.0 110.607 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 100' ' ' LEU . 2.1 m -134.35 127.36 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.138 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -119.52 118.19 30.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.451 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.41 HD11 ' HG2' ' A' ' 44' ' ' GLU . 13.8 pt -106.6 132.21 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.087 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.68 161.02 43.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.158 0.504 . . . . 0.0 111.428 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.422 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . 18.3 t -116.42 149.29 39.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.179 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.476 HD21 ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -69.57 -27.42 65.11 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 123.52 0.513 . . . . 0.0 109.924 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.09 -162.09 33.51 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.155 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.42 -28.38 32.7 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.951 2.434 . . . . 0.0 113.397 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.566 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.6 p-10 -85.06 -11.56 55.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.6 12.0 80.43 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.853 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.566 ' HB ' ' OD2' ' A' ' 117' ' ' ASP . 72.0 t -116.94 121.47 32.62 Favored Pre-proline 0 C--O 1.249 1.042 0 CA-C-O 120.637 0.256 . . . . 0.0 111.271 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.743 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 60.3 Cg_endo -75.4 158.33 40.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 113.606 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 62.31 23.97 14.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.219 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.427 ' HB2' ' OD1' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -96.93 177.73 5.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.731 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.95 -28.97 43.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.202 0.525 . . . . 0.0 110.496 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 122' ' ' SER . 7.3 p-10 -77.05 -15.2 59.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.743 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -65.47 146.06 55.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.358 -177.295 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.0 mt -113.76 117.87 56.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.884 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.38 161.66 13.49 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.128 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 40' ' ' LEU . 7.9 p30 -59.96 -37.4 79.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.504 0.668 . . . . 0.0 109.867 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -76.67 -28.51 55.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.205 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.2 p -80.91 -29.09 35.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.685 0.278 . . . . 0.0 111.21 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.6 tp -85.96 -31.39 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 134.73 -15.12 4.38 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.126 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -86.48 56.87 4.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.342 0.591 . . . . 0.0 110.296 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -74.77 156.06 36.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.99 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 106' ' ' HIS . 76.7 m80 -104.1 77.87 1.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.478 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -79.39 -18.58 52.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.797 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -87.45 86.49 7.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -132.3 129.45 39.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.775 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -103.03 95.36 6.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.235 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 tttm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.963 178.402 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.76 0.314 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.41 85.16 1.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.396 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -90.32 70.2 7.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.176 0.513 . . . . 0.0 109.97 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -82.84 100.24 10.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.267 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -55.95 -43.43 77.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.712 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 99.5 mttt -67.26 -48.06 68.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.331 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.709 -174.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.24 -40.45 74.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.477 ' O ' HG23 ' A' ' 37' ' ' VAL . 30.8 ptt180 -68.38 -34.15 75.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.388 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 14.8 mm100 -59.32 -31.51 69.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.479 0.18 . . . . 0.0 111.254 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.11 -44.27 97.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.575 HG11 ' HB ' ' A' ' 126' ' ' ILE . 24.7 t -60.71 -45.15 98.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 33' ' ' ARG . 58.3 t -59.9 -38.63 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.403 ' O ' HG22 ' A' ' 41' ' ' VAL . 39.1 t -60.44 -46.8 88.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.866 0.365 . . . . 0.0 110.677 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.532 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.9 m-20 -69.52 -35.4 75.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 109.869 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD21 ' C ' ' A' ' 127' ' ' GLY . 19.0 tp -60.89 -46.57 90.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.347 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 38' ' ' SER . 28.9 m -65.81 -36.17 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.362 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.17 98.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.397 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.56 ' O ' HD13 ' A' ' 47' ' ' LEU . 98.2 mt -61.32 -49.69 75.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.375 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.3 -39.32 90.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.216 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -63.44 -47.77 84.44 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.215 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.75 84.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.758 0.313 . . . . 0.0 111.343 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.2 mp -57.59 -43.74 84.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.946 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.636 ' OD2' ' HA ' ' A' ' 139' ' ' HIS . 17.5 t70 -68.55 -37.35 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.844 176.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 20.7 mmt -59.48 -45.23 92.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.567 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 65.6 t80 -67.18 -37.7 84.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.564 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 88.0 tttt -64.92 -35.33 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.308 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.0 tp -68.12 -36.44 79.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.253 0.549 . . . . 0.0 110.385 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.514 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 14.0 t70 -76.0 -47.89 23.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.595 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.55 22.91 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m 71.97 -13.99 0.55 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.446 HH21 ' HD3' ' A' ' 75' ' ' PRO . 7.3 ppt_? -137.15 157.55 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.889 -0.507 . . . . 0.0 111.242 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.4 ' CE1' ' HD2' ' A' ' 51' ' ' LYS . 47.0 m-85 -71.34 148.35 93.51 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 148.3 52.19 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.925 2.417 . . . . 0.0 112.402 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.3 p -79.84 177.99 8.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.999 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.2 t -50.98 -37.29 43.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.827 0.346 . . . . 0.0 111.888 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.06 -45.72 26.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.702 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.04 -27.9 62.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.366 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.19 -51.96 54.92 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.129 -170.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 mp -72.11 -32.9 67.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.412 0.606 . . . . 0.0 111.34 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -72.54 -24.13 61.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.82 -24.9 64.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -103.79 -2.06 26.95 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.65 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.28 -63.04 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.455 0.645 . . . . 0.0 110.742 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 138.19 17.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.35 120.38 25.76 Favored Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.366 0.416 . . . . 0.0 111.153 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.97 141.96 96.39 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 112.602 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -86.64 -9.22 56.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.846 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.3 140.55 52.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.077 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.2 137.67 68.49 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.166 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.567 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 5.2 Cg_exo -79.88 149.84 81.65 Favored 'Cis proline' 0 C--O 1.236 0.378 0 C-N-CA 123.738 -1.359 . . . . 0.0 112.558 -4.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -65.42 128.85 37.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.521 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.0 38.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.377 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.514 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 33.3 mmt180 -111.53 165.14 12.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.94 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 61.79 34.88 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.706 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -94.74 136.65 22.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.853 0.359 . . . . 0.0 110.542 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.72 143.55 56.52 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.637 2.225 . . . . 0.0 111.758 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.07 124.36 20.94 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.21 84.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.824 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.46 -157.93 53.44 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.126 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -92.29 -23.43 19.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.9 128.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.662 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -68.36 -24.46 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.044 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -130.84 171.68 12.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.09 129.91 86.41 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.023 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.09 126.87 15.06 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.063 1.842 . . . . 0.0 110.283 172.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -132.82 145.44 50.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.608 0.242 . . . . 0.0 110.902 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 0.7 OUTLIER -56.3 143.67 64.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.115 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 48.4 Cg_exo -55.69 -25.84 53.0 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.254 2.636 . . . . 0.0 113.111 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.486 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 18.3 m-90 -81.91 -5.08 57.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.648 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.11 15.09 22.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.918 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 43.2 m -95.5 164.37 12.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.723 0.297 . . . . 0.0 110.584 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -111.71 129.32 56.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.118 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.47 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 64.2 m-85 -67.09 161.47 24.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.589 ' NE2' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -129.41 142.76 50.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.499 . . . . 0.0 110.861 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.68 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -112.41 122.77 48.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 101' ' ' LEU . 1.2 tm? -110.24 113.63 26.47 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.66 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 13.7 p -107.16 123.05 39.5 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.555 172.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 1.9 Cg_endo -84.31 140.15 33.17 Favored 'Cis proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.736 -0.943 . . . . 0.0 111.256 -4.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.73 159.62 53.84 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.62 -173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -79.63 -12.05 59.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.128 0.49 . . . . 0.0 109.951 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -121.48 30.51 6.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.02 -157.32 26.83 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 21.5 tp60 -61.2 -45.39 94.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 0.0 110.077 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.68 ' HB ' HD21 ' A' ' 100' ' ' LEU . 15.1 m -136.12 151.09 28.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.32 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -134.61 131.28 37.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.652 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.668 HG23 HD23 ' A' ' 100' ' ' LEU . 4.4 pt -111.32 130.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.781 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -149.08 161.12 42.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.3 p -114.57 139.87 49.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.738 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.589 HD13 ' NE2' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -67.9 -34.43 76.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.746 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.45 -159.68 53.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.45 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 10.8 Cg_exo -70.34 -34.88 11.9 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 123.824 3.016 . . . . 0.0 111.98 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.83 -13.57 50.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.089 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.532 ' C ' ' HG ' ' A' ' 114' ' ' LEU . . . 71.75 11.96 73.86 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.5 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.6 t -96.68 113.78 63.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 116.957 0.379 . . . . 0.0 111.233 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 145.83 29.45 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.615 2.21 . . . . 0.0 112.462 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 66.98 22.51 10.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.337 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.48 177.46 6.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.654 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.82 -16.78 61.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.23 -15.6 37.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.17 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.49 105.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.201 -173.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.575 ' HB ' HG11 ' A' ' 36' ' ' VAL . 42.4 mm -81.4 107.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.857 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.462 ' C ' HD21 ' A' ' 40' ' ' LEU . . . -114.15 171.26 13.68 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.666 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 40' ' ' LEU . 26.5 p-10 -66.49 -38.39 87.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.989 0.423 . . . . 0.0 110.177 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -68.32 -30.53 69.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -72.04 -39.4 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.449 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.98 -40.72 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.752 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 161.08 10.89 0.04 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 119.398 -1.382 . . . . 0.0 114.309 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -95.16 72.09 3.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.705 0.753 . . . . 0.0 109.864 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -90.2 -12.44 38.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.792 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -96.1 156.25 16.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.707 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -127.29 61.5 1.37 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.388 0.613 . . . . 0.0 109.878 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -128.13 25.39 5.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.361 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -75.36 135.12 40.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.636 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 4.3 t-80 179.8 22.82 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.871 0.732 . . . . 0.0 109.457 176.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 140' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.113 -175.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.229 0.538 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.28 24.42 76.4 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.351 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -79.52 -44.0 22.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 0.0 110.55 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -85.2 -16.29 40.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.478 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -58.26 -32.48 68.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.36 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 55.4 mtmt -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.411 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.55 -39.85 94.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.807 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -69.17 -39.42 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.807 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.533 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 12.5 ptm85 -66.66 -33.48 75.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.74 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 76.0 mm-40 -59.22 -34.37 72.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.711 0.291 . . . . 0.0 110.882 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -63.3 -39.6 95.03 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.629 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 41.1 t -60.64 -47.65 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.363 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 33' ' ' ARG . 38.6 t -58.82 -37.69 68.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 41' ' ' VAL . 22.6 t -62.53 -47.0 85.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.47 . . . . 0.0 111.044 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.49 ' HB2' ' OH ' ' A' ' 98' ' ' TYR . 63.4 m-20 -70.91 -35.15 72.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.731 -0.606 . . . . 0.0 110.04 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.428 HD21 ' N ' ' A' ' 128' ' ' ASN . 17.6 tp -61.0 -44.93 96.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.076 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 38' ' ' SER . 32.8 m -63.31 -34.54 67.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.507 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 39' ' ' ASP . . . -60.21 -40.07 88.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.589 0.233 . . . . 0.0 110.63 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 47' ' ' LEU . 8.9 mp -60.27 -48.45 81.67 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.262 0.553 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.56 -37.33 85.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.823 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -62.53 -37.06 94.08 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.91 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.16 0.505 . . . . 0.0 110.044 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 43' ' ' LEU . 6.2 mp -61.1 -40.82 95.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.4 -45.52 94.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 25.7 mmt -63.44 -38.52 91.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 77' ' ' ALA . 1.2 t80 -64.2 -44.23 92.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.399 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -70.5 -33.31 71.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.93 -46.3 85.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.01 0.433 . . . . 0.0 110.141 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.99 -46.15 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.215 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -103.57 1.71 32.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m 59.15 31.73 21.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.708 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -164.51 146.21 8.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.844 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.4 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 21.0 m-85 -72.89 144.18 85.14 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 110.466 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 55.5 Cg_endo -71.04 143.26 44.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.843 2.362 . . . . 0.0 112.745 -176.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.567 HG22 ' H ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -73.94 177.45 5.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.591 175.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 100' ' ' LEU . 61.9 m -50.21 -45.82 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.37 -37.58 65.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.236 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -71.92 -43.15 65.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.874 -170.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.443 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -64.37 -49.46 65.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.676 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.4 tp -61.88 -41.68 98.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.941 0.4 . . . . 0.0 111.42 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.41 -22.92 61.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.936 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.24 66.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -168.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.526 HD21 HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -93.95 -3.83 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.986 -178.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.86 -42.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.519 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 p -156.5 130.07 8.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -55.09 121.82 38.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 123.383 0.427 . . . . 0.0 111.324 -177.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 27.1 Cg_exo -64.34 137.56 56.44 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.9 2.4 . . . . 0.0 112.437 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -86.22 -11.45 52.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.1 57.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.474 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -77.5 140.92 64.82 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.81 134.55 36.36 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.719 -1.367 . . . . 0.0 111.931 -2.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -66.95 128.55 36.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.298 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . . . -63.2 131.33 48.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.526 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -119.32 164.6 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 66.46 32.06 7.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.009 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -91.68 137.18 25.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.694 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.77 139.54 22.46 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.073 1.849 . . . . 0.0 111.843 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 124.77 23.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.711 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -8.89 76.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.73 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 -173.13 55.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.291 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -84.9 -25.7 27.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.26 133.71 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.381 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -70.12 -22.77 62.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.7 mtm180 -131.94 154.59 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.289 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.6 mt -61.73 123.64 77.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.336 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.15 147.95 91.33 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.471 2.114 . . . . 0.0 111.415 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -138.37 145.46 41.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 113' ' ' SER . 53.2 m-20 -57.99 142.99 78.87 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.63 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.38 -19.32 57.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.305 2.67 . . . . 0.0 112.541 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.74 -14.08 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.009 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.0 22.39 7.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.163 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.578 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 19.3 m -104.01 162.5 13.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.535 -0.391 . . . . 0.0 110.613 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -105.64 144.65 32.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.667 0.27 . . . . 0.0 110.341 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 18.6 m-85 -70.31 146.49 50.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.358 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -126.76 142.9 51.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.616 . . . . 0.0 111.751 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 60' ' ' THR . 13.4 tp -121.68 141.99 50.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.934 172.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -134.86 113.07 11.2 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.505 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.7 t -106.9 132.19 21.1 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.374 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.78 150.27 92.35 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.824 -1.323 . . . . 0.0 111.885 -1.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.01 147.25 50.73 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.658 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -75.07 -39.39 60.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.359 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -104.88 -38.88 6.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.897 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.19 -156.79 9.78 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.788 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -73.46 -41.69 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.209 0.528 . . . . 0.0 109.989 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.14 122.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.376 175.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 116.8 33.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.25 0.547 . . . . 0.0 112.15 -173.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.9 pt -107.34 126.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.556 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 30.8 p90 -150.41 146.55 26.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.284 0.564 . . . . 0.0 111.194 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.493 ' HB3' ' OD1' ' A' ' 92' ' ' ASP . 51.2 m -97.83 151.58 20.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.197 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 4.9 mp -75.29 -19.67 59.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.588 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.54 -156.04 53.27 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 123.875 0.734 . . . . 0.0 113.355 171.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.93 -21.01 38.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.675 2.917 . . . . 0.0 112.906 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 6.6 p-10 -86.23 -14.74 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.484 ' O ' HD23 ' A' ' 114' ' ' LEU . . . 70.7 0.65 33.66 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.178 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.6 t -122.47 134.0 24.68 Favored Pre-proline 0 C--O 1.251 1.171 0 CA-C-O 120.56 0.219 . . . . 0.0 110.739 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.4 160.91 41.16 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.81 2.34 . . . . 0.0 111.206 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 69.53 22.64 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 109.311 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 m -89.01 170.67 10.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.464 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.18 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 167.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.421 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 14.8 m-20 -96.05 69.12 2.77 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.859 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.27 100.32 7.62 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.799 170.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 64.4 mt -79.98 99.92 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.827 -172.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -104.06 155.21 17.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.218 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 40' ' ' LEU . 22.2 t30 -68.83 -30.96 69.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.596 0.712 . . . . 0.0 109.328 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.96 -30.89 65.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.576 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.6 p -82.32 -32.29 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.002 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.0 tp -74.34 -19.98 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.627 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.09 -23.59 1.92 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.949 -1.12 . . . . 0.0 114.057 173.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -74.48 77.56 1.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.239 0.52 . . . . 0.0 111.011 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -73.95 -29.93 62.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.487 0.66 . . . . 0.0 109.252 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -155.36 98.53 1.98 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.86 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -61.47 149.09 39.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.385 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -160.64 157.06 26.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.989 -172.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -121.85 26.55 8.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.247 0.546 . . . . 0.0 109.902 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -128.51 144.22 51.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.091 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.765 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.02 -74.47 0.29 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 54.77 60.22 3.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -61.02 -29.38 69.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 172.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -52.51 -42.81 64.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.995 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 48.2 mmtm -68.43 -40.32 81.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.659 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.04 85.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.942 0.401 . . . . 0.0 110.756 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.0 m-20 -65.42 -46.72 78.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.394 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.7 ptm180 -63.85 -35.66 81.37 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.117 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 56.1 mt-30 -59.1 -39.58 82.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.862 0.363 . . . . 0.0 110.256 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -68.32 -38.66 81.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.245 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 32' ' ' ASP . 71.7 t -61.01 -47.9 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.469 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 33' ' ' ARG . 65.6 t -60.09 -37.55 73.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.831 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 41' ' ' VAL . 14.4 t -61.36 -47.47 85.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.99 0.424 . . . . 0.0 111.04 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.6 -33.96 71.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 176.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 15.9 tp -62.5 -44.31 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.211 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 38' ' ' SER . 32.2 m -65.7 -35.29 74.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 O-C-N 122.356 -0.215 . . . . 0.0 110.631 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.44 81.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 78.0 mt -62.04 -47.75 83.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.647 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HG2' HD11 ' A' ' 111' ' ' ILE . 36.6 mm-40 -57.35 -36.69 71.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.28 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.51 99.69 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.689 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.568 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -62.95 -37.83 88.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.223 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 36.3 mt -61.92 -44.99 95.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.449 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -61.34 -45.37 94.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.733 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.78 -38.04 79.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.27 -46.2 74.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.02 -33.26 75.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.686 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -44.57 93.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.436 0.636 . . . . 0.0 110.04 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.64 -41.61 53.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.252 -174.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.503 HD21 ' HA ' ' A' ' 77' ' ' ALA . 48.4 m-80 -118.06 16.04 14.16 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m 72.17 -42.21 0.53 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 176.45 5.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 108' ' ' GLN . 36.8 m-85 -88.78 144.85 33.78 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.418 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.71 152.79 42.77 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.403 2.736 . . . . 0.0 113.697 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 60' ' ' THR . 0.3 OUTLIER -79.46 177.06 9.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.627 173.24 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 59' ' ' THR . 4.1 t -51.05 -46.02 61.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.1 -39.58 65.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.38 0.609 . . . . 0.0 110.192 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -71.86 -35.43 69.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.812 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.68 70.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.109 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 89' ' ' LEU . 1.2 mm? -70.79 -34.19 71.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.713 0.292 . . . . 0.0 111.657 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.533 ' OE1' ' HA ' ' A' ' 71' ' ' PRO . 28.3 mt-30 -70.28 -23.84 62.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.35 -18.2 36.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.628 ' HB3' HG22 ' A' ' 86' ' ' ILE . 8.5 mt -94.09 -25.07 17.32 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 6.2 p -105.65 -47.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -157.27 143.38 17.8 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.439 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -56.06 121.0 38.33 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.24 0.338 . . . . 0.0 110.283 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.533 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 80.6 Cg_exo -52.87 136.35 59.57 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 123.108 2.539 . . . . 0.0 112.586 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -92.22 41.33 1.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.016 0.912 . . . . 0.0 109.943 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.87 133.87 36.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.636 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.8 140.11 86.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 O-C-N 123.219 0.324 . . . . 0.0 111.175 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.41 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 73.4 Cg_endo -77.45 132.39 26.97 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.922 -1.699 . . . . 0.0 112.957 0.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -66.81 128.02 34.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.704 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.8 126.75 28.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.085 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -108.94 164.46 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 60.14 36.45 21.1 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.513 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 36.1 p90 -94.85 142.01 24.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.94 138.23 28.12 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.224 1.949 . . . . 0.0 111.621 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.39 124.82 23.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.48 -10.14 73.29 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.249 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.17 -164.94 53.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.923 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -91.0 -23.35 20.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.386 0.613 . . . . 0.0 109.385 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.628 HG22 ' HB3' ' A' ' 67' ' ' LEU . 12.1 tt -142.6 138.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -68.98 -26.72 65.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -130.6 166.49 20.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.67 0.271 . . . . 0.0 110.449 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 64' ' ' LEU . 4.1 mm? -62.3 127.63 90.0 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.745 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.6 136.08 64.73 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.556 2.171 . . . . 0.0 112.058 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -128.3 146.9 50.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.268 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.679 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.8 p30 -73.24 153.39 90.39 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.16 -16.93 13.73 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.587 2.858 . . . . 0.0 114.049 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.444 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.7 m-90 -80.63 -25.82 38.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.821 0.344 . . . . 0.0 110.405 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.72 13.91 6.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.041 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.679 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 9.0 m -101.17 143.74 30.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.87 0.367 . . . . 0.0 110.462 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.84 132.65 34.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.332 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -60.34 143.57 52.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.904 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 81.9 mm-40 -118.49 137.86 52.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.907 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 111' ' ' ILE . 3.1 tm? -113.34 123.19 49.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -118.6 113.55 21.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.043 0.449 . . . . 0.0 110.338 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t -106.04 130.8 22.42 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.74 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.48 153.26 94.45 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 124.241 -1.149 . . . . 0.0 111.591 -3.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.59 145.54 49.75 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.247 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -78.26 -24.22 46.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.12 0.486 . . . . 0.0 110.278 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -119.16 -16.2 9.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.59 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.28 -148.84 4.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.461 ' HG2' ' CD2' ' A' ' 57' ' ' TYR . 25.1 tp60 -73.73 -45.68 50.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.956 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.742 ' HB ' HD21 ' A' ' 100' ' ' LEU . 4.3 m -142.81 127.65 15.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.721 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.0 122.07 43.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -174.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 100' ' ' LEU . 10.0 pt -106.54 126.59 62.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -142.07 153.59 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.27 0.557 . . . . 0.0 112.031 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.0 t -99.92 138.29 37.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.241 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.67 -20.19 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.307 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.444 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 64.68 -163.87 35.68 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.221 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.41 -25.93 29.73 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.344 2.696 . . . . 0.0 111.858 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 7.8 p-10 -80.9 -14.63 57.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.186 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.17 12.27 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.381 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 117' ' ' ASP . 41.9 t -109.54 131.19 22.03 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-N 116.734 0.267 . . . . 0.0 111.146 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.574 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 66.2 Cg_endo -76.0 149.47 32.8 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.974 2.449 . . . . 0.0 111.89 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 43.1 mt-10 70.87 15.54 6.78 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.378 0.671 . . . . 0.0 110.793 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.0 OUTLIER -87.39 177.16 7.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.536 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -41.38 98.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.501 0.667 . . . . 0.0 109.638 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.482 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 10.7 m-20 -88.88 65.55 7.63 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.574 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -130.54 91.82 3.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.582 174.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.86 104.62 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.701 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -117.25 174.52 15.26 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.736 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.13 -35.42 73.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -78.98 -31.26 44.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -64.0 -45.23 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.972 0.415 . . . . 0.0 110.767 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 tp -82.65 -26.68 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.811 0.815 . . . . 0.0 109.731 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.09 38.82 88.65 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 114.771 -1.104 . . . . 0.0 114.083 170.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.63 6.41 7.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.485 0.643 . . . . 0.0 111.896 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -78.1 -30.31 49.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.091 0.472 . . . . 0.0 109.892 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -102.56 135.98 43.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -113.58 156.51 23.52 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.935 0.397 . . . . 0.0 110.727 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -126.36 173.98 8.93 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.541 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 35.4 m80 63.06 80.2 0.24 Allowed 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.64 0.588 . . . . 0.0 110.869 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -75.57 93.8 3.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.273 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.306 -179.874 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.018 0.437 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.37 133.08 4.57 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.885 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.7 -32.64 72.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.954 0.406 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -67.39 -33.89 76.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.387 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -58.48 -38.65 78.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.263 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 96.3 mttt -59.07 -46.04 89.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.18 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.43 97.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.282 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.3 m-20 -63.77 -47.8 79.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.313 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' NH2' ' HG2' ' A' ' 30' ' ' LYS . 19.6 ptt180 -69.45 -35.22 75.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.307 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 52.4 mt-30 -59.07 -37.57 77.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 110.701 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.01 -37.95 85.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 32' ' ' ASP . 72.0 t -61.16 -47.13 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.669 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -60.35 -37.9 75.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -62.0 -43.53 98.65 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.887 0.375 . . . . 0.0 111.378 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.79 -35.03 74.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.257 0.551 . . . . 0.0 110.088 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.25 -46.26 89.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.344 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -64.6 -34.9 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.36 96.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.681 0.277 . . . . 0.0 110.433 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.512 ' O ' HD13 ' A' ' 47' ' ' LEU . 94.3 mt -61.85 -49.51 75.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.069 0.461 . . . . 0.0 110.631 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -62.41 -40.46 96.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.721 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -62.68 -43.81 98.43 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.916 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -62.69 -38.52 90.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 110.918 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.512 HD13 ' O ' ' A' ' 43' ' ' LEU . 3.2 mp -61.66 -45.82 92.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.416 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.15 -40.39 97.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.1 mtt -65.98 -41.95 90.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.676 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.407 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 50.6 t80 -63.73 -40.99 98.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.268 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 57' ' ' TYR . 83.6 tttt -66.95 -34.68 78.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.854 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.06 -41.89 99.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.177 0.513 . . . . 0.0 110.263 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -76.76 -46.76 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.209 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.1 m-80 -105.79 -1.74 23.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -169.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m 62.99 34.28 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.55 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -170.31 165.85 8.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.449 0.166 . . . . 0.0 110.599 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.55 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 74.9 m-85 -87.4 136.43 33.34 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.05 150.55 60.58 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.87 2.38 . . . . 0.0 112.864 -174.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.422 ' HA ' ' OG ' ' A' ' 102' ' ' SER . 11.4 p -77.59 175.74 9.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.956 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.459 ' HA ' HD12 ' A' ' 100' ' ' LEU . 11.5 t -53.5 -38.59 63.85 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -174.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.97 -46.39 44.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -73.49 -29.72 62.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.134 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.75 67.13 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.146 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.31 -32.46 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -73.08 -25.92 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.115 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.6 65.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -167.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.4 pt? -103.72 -2.28 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -116.15 -45.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 111.62 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -156.69 131.86 9.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -53.79 121.24 27.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.39 0.431 . . . . 0.0 111.137 -176.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 45.2 Cg_exo -57.84 137.04 79.07 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.054 2.503 . . . . 0.0 112.406 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.4 m -79.89 -23.91 41.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.975 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.61 138.75 51.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.677 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -77.85 145.67 70.77 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 11.5 Cg_exo -71.09 135.92 38.99 Favored 'Cis proline' 0 C--O 1.233 0.238 0 C-N-CA 123.32 -1.533 . . . . 0.0 112.003 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -73.48 125.19 27.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.937 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -60.47 123.49 17.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.57 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -112.29 165.23 12.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.765 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 61.73 42.77 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.601 . . . . 0.0 110.221 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.5 145.51 31.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.822 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.63 138.71 19.5 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.988 1.792 . . . . 0.0 111.569 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.9 124.87 23.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.49 76.12 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.182 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.08 -160.75 50.41 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.362 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -96.78 -16.28 20.91 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.82 134.92 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.567 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.6 -21.94 61.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.056 -170.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -130.54 156.31 45.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.537 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.7 mt -55.84 120.98 37.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.718 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.13 134.0 59.13 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -130.49 138.53 50.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.803 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -61.05 152.65 70.26 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.24 -21.34 22.35 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.306 2.67 . . . . 0.0 112.832 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -81.54 -18.18 45.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.84 21.86 8.36 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.992 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 p -101.65 143.55 31.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.897 0.38 . . . . 0.0 111.075 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.97 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -57.51 149.41 21.18 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 0.0 111.508 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -111.56 137.45 49.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.554 -175.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.568 HD23 HG23 ' A' ' 111' ' ' ILE . 3.1 tm? -131.88 122.73 26.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.25 113.95 13.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.655 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 59' ' ' THR . 60.0 p -107.01 129.92 23.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.829 173.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.56 150.72 88.02 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.716 -3.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.51 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -78.41 156.98 43.8 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.278 -172.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.59 -43.05 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 129' ' ' TRP . 91.0 m-70 -92.63 -2.56 56.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.64 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.6 -164.03 26.54 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.874 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 56.0 mm-40 -72.07 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 109.439 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -122.3 121.26 63.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.676 169.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.51 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 6.8 t0 -93.39 114.36 26.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -172.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.568 HG23 HD23 ' A' ' 100' ' ' LEU . 12.5 pt -113.6 123.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -151.94 162.24 41.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.2 m -119.31 140.27 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HB3' ' CA ' ' A' ' 118' ' ' GLY . 1.1 mm? -62.69 -32.27 73.33 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.1 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 -170.83 41.23 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.25 -16.16 39.5 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 122.735 2.29 . . . . 0.0 111.757 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.73 -14.12 32.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.232 -173.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.418 ' CA ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.34 8.33 70.35 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.019 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 41.9 t -94.68 111.26 53.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.194 0.497 . . . . 0.0 111.791 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 119' ' ' VAL . 6.3 Cg_exo -77.08 146.54 25.64 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.403 2.736 . . . . 0.0 112.539 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 62.25 35.5 15.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.405 0.621 . . . . 0.0 111.359 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 1.3 p -109.2 172.64 6.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.407 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -66.25 -30.41 70.84 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.669 ' OD2' 'CA ' ' A' ' 201' ' ' ' CA' . 1.6 p30 -85.96 52.62 2.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.908 176.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 122' ' ' SER . 0.8 OUTLIER -126.71 136.06 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 176.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mm -100.59 101.03 11.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.68 157.7 15.8 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.74 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -61.97 -38.03 87.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 110.552 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 106' ' ' HIS . 79.8 t90 -68.49 -31.11 70.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.744 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -78.8 -34.21 45.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.3 tp -87.65 -31.51 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.464 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.35 39.76 0.46 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.405 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -131.14 48.27 2.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.329 0.585 . . . . 0.0 110.377 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -103.99 -25.55 12.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.925 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -93.4 54.19 2.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.659 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -137.3 113.71 10.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.372 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -175.37 114.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.08 0.467 . . . . 0.0 110.532 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -117.59 139.08 51.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.208 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -86.07 -23.18 26.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.691 172.991 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . 0.669 'CA ' ' OD2' ' A' ' 124' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.69 0.281 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.19 -147.21 7.07 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.693 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 53.05 47.08 25.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.212 0.529 . . . . 0.0 110.706 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -85.28 70.05 10.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.702 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 44.6 tt0 -57.86 -32.59 67.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.437 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -54.73 -49.29 71.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.378 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -72.45 -44.85 61.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.036 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.94 -46.0 86.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.194 -173.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 36.9 ptt180 -69.1 -33.79 74.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.81 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -59.5 -35.96 75.15 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.21 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 82.6 mttt -62.19 -44.34 96.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.596 0.712 . . . . 0.0 109.287 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.23 -47.09 95.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.179 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.6 t -59.47 -38.73 76.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 t -59.82 -46.53 88.96 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.952 0.406 . . . . 0.0 110.532 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.48 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 89.7 m-20 -68.46 -34.65 76.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.144 0.497 . . . . 0.0 110.197 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.34 -43.37 96.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.591 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 37' ' ' VAL . 26.2 t -62.66 -37.39 78.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.0 91.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.984 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.676 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 95.7 mt -63.9 -49.69 71.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.362 . . . . 0.0 110.561 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.06 -33.95 75.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.76 91.82 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.483 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.32 -43.11 96.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.826 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 45.3 mt -59.64 -42.78 93.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.616 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.42 -44.04 95.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.59 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.503 ' SD ' ' HE2' ' A' ' 85' ' ' TYR . 92.0 mtp -67.66 -42.25 82.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.443 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.521 ' CD2' ' HG3' ' A' ' 58' ' ' PRO . 77.2 t80 -63.87 -43.82 94.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.497 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -69.34 -33.17 72.71 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.067 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.57 -45.92 92.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.158 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.52 -46.97 24.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.552 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -95.21 -6.45 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m 65.54 24.18 11.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 150.0 18.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.568 0.223 . . . . 0.0 110.682 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -75.24 145.25 79.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.779 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 6.2 Cg_exo -75.05 162.37 37.11 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.759 2.306 . . . . 0.0 112.28 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -83.84 177.4 8.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.953 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.408 ' HA ' HD12 ' A' ' 100' ' ' LEU . 9.0 t -51.41 -42.72 61.64 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -175.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.59 -45.0 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.401 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.83 -31.24 70.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.05 -49.38 47.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.177 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.81 -38.52 76.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.864 0.364 . . . . 0.0 111.493 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.57 -24.0 61.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.975 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -25.7 63.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -168.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -103.3 -1.32 28.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.214 -177.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -117.64 -39.99 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.56 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.1 m -156.61 129.18 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -55.42 121.62 39.01 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.642 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 46.4 Cg_exo -57.64 136.93 78.7 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.007 2.471 . . . . 0.0 112.699 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 p -85.13 -16.21 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.597 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.16 137.79 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -77.44 142.63 67.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 -178.157 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.19 138.11 52.36 Favored 'Cis proline' 0 C--O 1.236 0.39 0 C-N-CA 123.351 -1.52 . . . . 0.0 112.051 -2.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.6 128.67 36.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.87 125.38 23.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.392 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -113.97 163.9 14.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.122 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 56.47 36.36 27.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.343 0.592 . . . . 0.0 110.998 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -98.07 146.11 30.95 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.058 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.36 138.91 28.14 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.752 1.635 . . . . 0.0 110.213 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.37 123.97 21.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.22 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.34 88.12 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.709 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.8 -115.39 7.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.261 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' HE2' ' SD ' ' A' ' 49' ' ' MET . 60.4 m-85 -134.48 -3.43 2.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.886 0.375 . . . . 0.0 110.786 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.6 136.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -75.43 -22.19 57.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -170.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -130.57 171.16 13.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.814 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.09 127.55 80.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.472 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.77 124.84 11.92 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.533 2.156 . . . . 0.0 112.431 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -130.4 148.75 52.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.761 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.3 p30 -69.4 152.84 96.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.89 -16.22 25.1 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.532 2.821 . . . . 0.0 113.0 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.483 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 5.6 m-90 -80.53 -25.71 38.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.553 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.41 9.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.376 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.585 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 19.3 m -100.18 157.99 16.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.12 0.46 . . . . 0.0 110.786 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.49 138.67 31.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.804 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -68.6 164.36 21.61 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -130.62 146.68 52.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.187 0.518 . . . . 0.0 111.486 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.698 HD23 HG23 ' A' ' 111' ' ' ILE . 2.4 tm? -133.01 122.85 24.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -120.83 112.49 18.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -107.49 131.46 21.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.926 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.43 146.58 68.96 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.43 -1.488 . . . . 0.0 110.998 -5.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.68 159.86 48.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.501 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -92.8 -37.35 12.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 129' ' ' TRP . 97.5 m-70 -76.4 -56.19 4.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.634 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.71 -150.18 7.78 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.791 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -73.35 -36.23 66.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.508 ' HB ' HD21 ' A' ' 100' ' ' LEU . 2.8 m -137.55 131.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.474 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.6 m-20 -104.27 115.0 29.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.777 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.698 HG23 HD23 ' A' ' 100' ' ' LEU . 9.0 pt -106.69 126.51 62.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -145.9 159.55 43.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.818 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 3.0 m -116.15 124.6 50.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.235 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.456 ' HB3' ' C ' ' A' ' 118' ' ' GLY . 62.6 mt -61.39 -34.93 76.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.737 -174.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.483 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 86.79 -166.84 37.82 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.15 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.24 -18.83 44.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.64 -13.53 24.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.912 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.456 ' C ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.54 8.82 72.59 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.781 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.38 114.93 64.21 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -173.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.4 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 82.0 Cg_endo -76.62 154.31 34.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.373 2.715 . . . . 0.0 113.101 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 62.89 16.17 8.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.549 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -89.51 177.03 6.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.444 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -71.69 -37.1 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -88.14 62.63 6.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -138.05 109.14 6.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.721 175.035 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.3 mm -77.17 103.11 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.957 0.408 . . . . 0.0 110.528 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.05 159.49 14.05 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.149 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.421 ' HA ' HG22 ' A' ' 131' ' ' ILE . 25.3 p-10 -67.85 -39.46 83.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.085 0.469 . . . . 0.0 110.521 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.42 ' CG ' ' HB3' ' A' ' 106' ' ' HIS . 93.1 t90 -66.34 -31.04 71.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.656 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.7 p -83.89 -29.52 27.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.714 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 128' ' ' ASN . 11.1 tp -82.7 -27.66 8.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.849 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 149.79 -40.06 0.87 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.951 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -71.52 99.5 2.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.82 0.343 . . . . 0.0 111.57 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -134.97 111.67 10.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.233 0.54 . . . . 0.0 111.006 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -78.78 78.84 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.69 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -100.87 -14.44 17.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.087 0.47 . . . . 0.0 110.265 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -90.63 31.5 1.04 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.147 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -76.68 95.66 4.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.591 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -141.92 147.0 36.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.376 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.739 -0.648 . . . . 0.0 109.818 -179.595 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.45 139.48 5.91 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.883 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -138.67 16.19 2.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.072 0.463 . . . . 0.0 110.656 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -120.88 112.25 18.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.228 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -57.58 -30.97 65.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.925 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.25 -42.2 98.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.987 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.23 73.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.496 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.7 m-20 -60.92 -47.56 85.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.642 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' HG23 ' A' ' 37' ' ' VAL . 32.1 ptt180 -69.5 -35.21 75.31 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.827 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -62.33 -35.17 78.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.634 0.254 . . . . 0.0 110.828 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.14 -41.94 98.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 95.9 t -60.69 -44.46 97.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.99 176.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 33' ' ' ARG . 90.3 t -60.22 -39.37 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.327 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 41' ' ' VAL . 37.9 t -62.18 -46.77 87.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.105 0.479 . . . . 0.0 110.681 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.96 -34.1 71.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.336 0.589 . . . . 0.0 110.311 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 128' ' ' ASN . 17.8 tp -60.65 -44.84 95.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.206 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 38' ' ' SER . 27.7 m -65.68 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.456 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.54 97.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.859 0.361 . . . . 0.0 110.195 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 47' ' ' LEU . 96.1 mt -61.43 -48.95 78.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.776 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.63 -42.53 98.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.33 -38.09 95.67 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.053 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -42.45 96.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.861 0.362 . . . . 0.0 110.277 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.6 mp -62.25 -48.1 81.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.196 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.06 -41.13 97.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.297 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.16 -37.46 72.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.32 -41.19 98.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -68.43 -32.62 72.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.36 -48.9 73.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.905 0.383 . . . . 0.0 110.214 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.66 -39.73 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.0 m-80 -106.69 11.74 30.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.5 m 73.17 -43.19 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.401 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 6.6 ppt_? -117.82 164.53 14.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.712 0.292 . . . . 0.0 111.552 -175.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -71.18 148.16 93.81 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.933 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.73 149.36 48.36 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.031 2.487 . . . . 0.0 112.529 177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.8 p -85.69 179.73 7.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -50.2 -38.89 42.27 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.42 -44.72 34.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.279 0.562 . . . . 0.0 110.677 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.87 -30.29 65.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.323 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.3 -51.17 60.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.645 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 mp -71.28 -33.54 69.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.962 0.41 . . . . 0.0 111.506 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -68.49 -26.69 65.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.809 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -23.53 63.88 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 HD23 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -103.74 -2.2 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.5 p -122.93 -48.33 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.831 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 p -152.08 128.61 10.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.608 0.242 . . . . 0.0 110.484 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.9 121.81 37.35 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.085 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.57 144.45 85.01 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.077 2.518 . . . . 0.0 112.307 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.4 t -94.97 2.51 55.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.17 131.26 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.484 ' OE2' ' HA ' ' A' ' 75' ' ' PRO . 8.1 tp10 -77.79 138.65 62.0 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.208 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 14.3 Cg_exo -67.03 130.84 14.08 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.565 -1.431 . . . . 0.0 112.62 0.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -74.0 131.16 41.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.723 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.403 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -57.48 127.99 34.78 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.524 0.515 . . . . 0.0 111.576 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -114.2 167.09 10.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.844 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 52.76 31.39 10.37 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -80.32 139.17 51.99 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.775 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.21 140.5 24.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.551 2.167 . . . . 0.0 111.719 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.36 125.07 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.178 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.54 3.18 86.67 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.45 -161.89 53.45 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.362 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.56 -22.51 24.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' A' ' 67' ' ' LEU . 8.3 tt -139.39 134.08 39.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.769 173.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -60.98 -29.31 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.608 -169.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -133.75 160.24 38.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.51 122.34 59.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.539 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.45 149.45 80.27 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.427 2.084 . . . . 0.0 111.876 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -140.76 140.71 34.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.788 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 1.9 p30 -63.82 152.98 85.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.22 -15.68 15.19 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.816 3.011 . . . . 0.0 113.812 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -79.05 -26.06 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.03 19.6 8.02 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.603 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.584 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 0.7 OUTLIER -95.96 151.35 19.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.417 . . . . 0.0 110.553 -178.263 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.25 122.6 31.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.494 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 56.6 m-85 -54.66 140.8 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.024 0.44 . . . . 0.0 111.284 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -113.69 137.89 50.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.651 HD23 HG23 ' A' ' 111' ' ' ILE . 2.8 tm? -118.79 122.02 41.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.411 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 1.7 tm? -122.54 113.98 20.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.887 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 p -106.35 130.52 22.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.81 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.5 139.97 63.72 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.385 -1.09 . . . . 0.0 111.93 -1.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 101' ' ' LEU . . . -60.62 143.82 47.99 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.358 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -58.52 -36.24 73.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.887 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -119.45 21.79 11.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.592 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.96 -147.92 11.72 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.816 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -70.41 -45.44 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.659 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.612 ' HB ' HD21 ' A' ' 100' ' ' LEU . 3.1 m -137.67 146.96 26.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.503 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.48 121.5 30.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.966 -177.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.651 HG23 HD23 ' A' ' 100' ' ' LEU . 7.0 pt -106.59 125.41 62.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.973 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -151.53 156.57 40.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 0.0 111.609 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.436 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 54.6 p -100.04 155.08 17.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -17.77 63.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 110.97 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.24 -172.0 55.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.437 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.01 -22.2 35.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.151 2.567 . . . . 0.0 112.273 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.733 ' OD2' HG12 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -94.91 -14.99 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.333 -173.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.51 -5.54 44.31 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.733 HG12 ' OD2' ' A' ' 117' ' ' ASP . 2.8 p -97.44 128.68 33.9 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.375 1.588 . . . . 0.0 110.683 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.718 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 56.0 Cg_endo -73.13 159.71 46.93 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.749 2.3 . . . . 0.0 113.398 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 69.37 15.83 8.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.296 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 1.3 p -98.97 175.35 5.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -77.9 -22.4 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.987 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -79.88 -11.24 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.718 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 1.0 OUTLIER -71.56 89.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.891 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.5 ' HA ' HG21 ' A' ' 130' ' ' THR . 46.6 mm -66.58 105.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.351 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 130' ' ' THR . . . -135.35 -161.8 9.47 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.467 ' HA ' HD21 ' A' ' 40' ' ' LEU . 10.6 t-20 -62.42 -38.11 88.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.618 0.247 . . . . 0.0 111.621 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -79.66 -30.86 41.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 126' ' ' ILE . 5.4 t -69.16 -33.09 72.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.591 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.45 -34.93 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.95 83.74 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.376 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -73.64 -22.89 59.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -130.85 91.48 3.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.382 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -72.43 96.46 1.91 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.824 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -74.92 102.3 4.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -81.07 135.42 35.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.143 0.497 . . . . 0.0 111.561 -173.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -138.17 91.01 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.63 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -99.76 138.19 37.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.541 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.948 179.191 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.958 0.409 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.59 167.68 40.12 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.908 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 66.52 98.44 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.493 0.663 . . . . 0.0 110.732 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -98.25 47.93 1.0 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.809 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 27.6 tt0 -53.68 -39.17 64.89 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.421 -175.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -64.11 -35.1 79.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -176.125 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.2 -38.21 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.573 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.54 -49.06 79.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 2.5 ptp180 -69.92 -36.63 75.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.484 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -60.89 -35.87 77.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.02 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -68.12 -39.73 82.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.094 0.473 . . . . 0.0 109.966 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 35.4 t -61.04 -47.78 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.716 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 33' ' ' ARG . 58.9 t -62.91 -38.32 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -61.77 -46.22 90.53 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -69.94 -35.34 74.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.107 0.48 . . . . 0.0 110.266 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 ' HA ' ' A' ' 128' ' ' ASN . 45.0 tp -63.93 -46.13 86.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.437 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.1 m -66.02 -36.12 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.13 85.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.47 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 68.2 mt -60.12 -48.26 82.46 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.556 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.92 -36.28 78.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.065 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.06 -46.06 93.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.615 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -62.55 -38.72 91.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.576 0.227 . . . . 0.0 110.617 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 37.4 mt -65.15 -50.42 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.362 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.39 -44.39 97.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.399 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -70.31 -35.76 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.963 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.6 t80 -58.64 -44.75 90.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.43 -33.12 73.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.6 tp -62.82 -51.03 68.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.565 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 78' ' ' ARG . 16.2 t70 -78.51 -46.95 18.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -93.49 -0.07 56.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.861 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m 70.01 7.25 6.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -160.53 157.14 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.591 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 m-85 -74.29 148.22 85.99 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.178 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 60.4 Cg_endo -73.27 155.85 51.24 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.843 2.362 . . . . 0.0 112.456 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -86.06 178.18 7.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.33 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -51.31 -40.33 58.79 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -173.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -76.04 -43.28 44.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.352 0.596 . . . . 0.0 110.733 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -72.6 -27.46 62.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.5 56.12 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.964 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -33.47 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.172 0.486 . . . . 0.0 111.018 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -71.74 -25.18 61.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.677 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.58 -22.88 62.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.498 ' HB3' HG22 ' A' ' 86' ' ' ILE . 9.3 mt -87.75 -19.1 28.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 89' ' ' LEU . 4.2 p -122.25 -48.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 t -144.09 129.95 19.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.44 121.21 41.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.032 -175.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.33 136.91 75.7 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.127 2.551 . . . . 0.0 112.594 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 m -80.07 -16.59 54.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.281 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.89 146.92 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.699 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.05 136.31 69.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.17 131.99 24.43 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.776 -1.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.32 120.94 11.39 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . . . -55.89 121.22 8.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.931 0.396 . . . . 0.0 110.158 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.457 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 22.0 tpt180 -110.38 154.81 23.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.347 -176.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 64.87 43.02 4.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.421 0.629 . . . . 0.0 110.213 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -100.47 140.23 21.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.296 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.7 144.0 58.29 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.744 2.296 . . . . 0.0 111.914 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.31 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.14 4.28 78.15 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.44 -159.58 51.84 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.326 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -88.03 -30.51 19.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.498 HG22 ' HB3' ' A' ' 67' ' ' LEU . 7.6 tt -135.44 124.46 40.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.148 172.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -65.7 -20.25 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.558 ' HD2' ' O ' ' A' ' 89' ' ' LEU . 8.1 tmm_? -129.64 146.53 51.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -174.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.558 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 4.3 mm? -54.28 122.45 37.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 123.292 0.37 . . . . 0.0 111.159 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.38 124.44 15.55 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.945 1.764 . . . . 0.0 110.403 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 89' ' ' LEU . 90.9 mt-30 -134.79 144.38 47.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.989 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.607 ' OD2' ' HB2' ' A' ' 113' ' ' SER . 0.5 OUTLIER -56.34 145.17 59.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.76 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.93 -19.85 41.79 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.97 2.447 . . . . 0.0 112.437 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -80.78 -13.93 58.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.344 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.14 20.16 9.47 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.941 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -99.2 160.69 14.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.569 0.223 . . . . 0.0 110.568 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.66 122.97 48.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.375 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.593 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 52.8 m-85 -53.97 148.04 11.32 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.507 0.67 . . . . 0.0 112.599 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.545 ' HG2' HD21 ' A' ' 114' ' ' LEU . 62.1 mm-40 -112.01 138.6 48.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.036 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.765 HD23 HG23 ' A' ' 111' ' ' ILE . 2.2 tm? -129.39 122.64 29.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.72 113.45 17.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.883 0.373 . . . . 0.0 110.414 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 5.3 m -106.93 128.53 25.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.091 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 1.0 OUTLIER -82.71 137.38 32.35 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.403 -1.082 . . . . 0.0 111.428 -3.205 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -67.35 169.35 36.75 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.768 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.494 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 6.1 tp60 -95.84 -28.08 14.9 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 0.0 109.862 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -93.25 -5.76 49.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.781 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.61 10.57 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.08 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -72.74 -45.32 59.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.971 0.415 . . . . 0.0 110.348 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -127.97 124.56 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 177.335 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -100.01 112.68 24.96 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.874 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.765 HG23 HD23 ' A' ' 100' ' ' LEU . 7.5 pt -112.43 125.5 69.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -151.47 155.08 37.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.607 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 15.9 p -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.358 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.672 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 3.4 mm? -100.98 -12.66 18.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 110.822 -174.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 62.87 -154.9 42.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.275 173.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 124' ' ' ASP . 14.4 Cg_exo -69.05 -33.39 19.39 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.383 2.722 . . . . 0.0 113.135 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.577 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 2.8 p30 -83.7 -14.08 52.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.738 -0.385 . . . . 0.0 112.028 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.97 -3.96 18.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.755 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 122' ' ' SER . 24.3 m -107.83 139.47 20.66 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-N 117.329 0.565 . . . . 0.0 112.159 -173.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.7 155.31 39.73 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.505 2.803 . . . . 0.0 112.834 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 61.1 25.53 15.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.772 0.796 . . . . 0.0 110.74 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.408 ' HB3' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -93.49 174.61 7.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.116 -179.475 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.38 -41.87 98.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.696 0.76 . . . . 0.0 109.19 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.577 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 4.6 m-20 -99.3 75.24 1.98 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.54 1.162 . . . . 0.0 109.248 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.672 ' OD1' ' HA ' ' A' ' 114' ' ' LEU . 55.9 m-20 -143.39 112.67 6.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.259 169.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.544 ' HB ' ' OG ' ' A' ' 113' ' ' SER . 44.6 mm -87.34 104.9 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 109.999 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -95.23 157.19 21.93 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.673 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.459 ' HB2' HG13 ' A' ' 111' ' ' ILE . 62.6 t30 -65.89 -28.55 69.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.291 0.567 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -78.36 -23.63 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -81.03 -29.44 35.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 tp -78.37 -21.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.799 0.333 . . . . 0.0 110.938 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 130.17 -6.14 6.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.096 -1.05 . . . . 0.0 113.405 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -86.31 165.53 16.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.935 0.368 . . . . 0.0 110.638 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 74.3 m80 58.34 32.22 21.82 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.795 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -91.06 56.36 3.15 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 28.2 t60 62.09 71.53 0.53 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.494 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -116.44 143.7 45.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.738 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -152.51 129.75 11.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.889 0.376 . . . . 0.0 111.235 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -83.25 -13.34 55.47 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.851 174.079 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.726 0.298 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 30' ' ' LYS . . . -156.76 79.54 0.18 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.112 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -59.17 -41.29 88.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.956 0.407 . . . . 0.0 110.603 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -78.73 -34.69 45.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.701 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 4.8 tp10 -61.4 -38.19 86.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.394 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 53.3 mtmt -58.77 -40.68 84.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.61 -44.96 88.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.345 . . . . 0.0 110.811 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.42 -40.53 77.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.981 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.61 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 13.1 ptm180 -65.9 -33.67 76.36 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.996 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm100 -62.99 -31.59 72.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 87.7 mttt -64.69 -39.22 93.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 31.2 t -60.7 -46.46 95.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.632 175.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 33' ' ' ARG . 82.6 t -58.63 -38.78 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.061 0.458 . . . . 0.0 110.558 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 41' ' ' VAL . 38.9 m -63.4 -43.87 96.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.891 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.9 -35.17 74.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.304 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.39 -45.25 95.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.187 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 38' ' ' SER . 23.7 m -64.64 -35.72 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.26 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.74 85.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.614 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.722 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 87.5 mt -60.55 -48.4 81.92 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.135 0.493 . . . . 0.0 110.101 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.65 -35.96 82.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.586 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.99 -42.92 99.77 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.819 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -60.53 -43.96 96.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.362 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 48.7 mt -59.42 -49.07 79.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.662 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.65 -41.59 97.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.994 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.57 -38.64 74.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.976 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.98 -33.25 73.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.44 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.88 -49.75 76.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.709 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.94 -47.01 17.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.9 10.12 41.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m 70.99 -7.2 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -139.0 148.7 43.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.829 -0.545 . . . . 0.0 111.455 -175.071 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.406 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 10.2 m-85 -69.25 142.73 92.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.0 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.69 155.99 49.15 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 123.051 2.501 . . . . 0.0 112.694 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 p -81.89 177.11 9.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.398 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -51.65 -41.39 61.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.4 -45.39 39.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.066 0.46 . . . . 0.0 110.573 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.449 ' HG2' ' HB3' ' A' ' 71' ' ' PRO . 50.4 mt-30 -68.39 -31.61 71.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.189 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -62.57 -48.85 78.67 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.086 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.44 -32.41 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -72.12 -29.17 63.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.986 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . . . -60.29 -20.83 60.72 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.819 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 7.6 mt -89.95 -9.79 47.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.33 -53.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 p -144.74 139.14 27.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.08 122.24 46.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HB3' ' HG2' ' A' ' 62' ' ' GLN . 52.1 Cg_exo -56.24 137.38 79.6 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.875 2.383 . . . . 0.0 111.776 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -84.64 -16.04 43.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.622 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 135.86 48.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.229 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 7.9 pt-20 -77.57 140.56 64.2 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.146 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.488 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 57.7 Cg_endo -72.09 132.11 24.22 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.232 -0.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -66.96 129.79 41.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.692 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.6 17.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.687 0.28 . . . . 0.0 110.416 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 29.0 tpt180 -109.26 162.95 13.81 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -177.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.458 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 9.5 p30 47.83 39.75 11.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.902 0.881 . . . . 0.0 111.795 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -85.14 147.29 47.29 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.025 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.19 138.81 48.35 Favored 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.283 1.988 . . . . 0.0 111.446 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.54 124.08 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.24 10.47 86.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.371 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.71 -121.05 21.62 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.764 0.332 . . . . 0.0 112.639 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' HB2' HD23 ' A' ' 67' ' ' LEU . 51.1 m-85 -114.03 -17.8 11.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.449 0.642 . . . . 0.0 109.553 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 88' ' ' ARG . 6.1 tt -143.15 129.12 16.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.818 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -60.77 -23.12 64.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -167.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.439 ' O ' HG12 ' A' ' 86' ' ' ILE . 59.6 mtp180 -130.42 167.12 19.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -60.74 133.2 91.78 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.69 137.32 63.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.787 2.324 . . . . 0.0 112.46 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -133.48 150.7 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.149 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.437 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 7.7 m-20 -55.88 150.85 26.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.88 -17.96 39.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.181 . . . . 0.0 111.623 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.484 ' CZ3' ' HA2' ' A' ' 115' ' ' GLY . 6.3 m-90 -81.96 -12.3 58.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.315 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.2 10.79 31.1 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.699 -0.762 . . . . 0.0 114.001 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -102.31 143.41 32.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.352 0.576 . . . . 0.0 111.022 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.1 130.7 38.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -61.28 163.13 6.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.772 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -127.93 139.43 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.641 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.517 HD11 ' HB ' ' A' ' 109' ' ' VAL . 13.3 tp -122.89 142.51 50.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.361 173.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.65 112.83 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.481 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 6.0 m -107.55 129.67 23.9 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.144 172.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 108' ' ' GLN . 2.0 Cg_endo -83.09 135.66 26.72 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.465 -1.056 . . . . 0.0 110.956 -5.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -68.85 174.45 32.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.359 -173.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -94.73 -27.67 15.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.172 0.511 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -99.81 21.83 11.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 151.26 -155.26 26.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 16.2 mm-40 -73.52 -36.83 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.015 0.407 . . . . 0.0 111.21 177.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -132.78 129.05 57.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 -178.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.42 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 0.4 OUTLIER -107.53 114.19 28.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.475 -179.058 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.434 HG13 ' HB2' ' A' ' 128' ' ' ASN . 5.5 pt -106.88 126.87 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.45 . . . . 0.0 110.025 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -145.02 148.35 33.62 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.417 ' HB3' ' OD1' ' A' ' 92' ' ' ASP . 2.5 m -106.82 137.18 45.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.513 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.46 -35.26 79.85 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.82 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.484 ' HA2' ' CZ3' ' A' ' 94' ' ' TRP . . . 86.69 -177.31 48.28 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.606 -176.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.85 -15.36 40.39 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.012 2.474 . . . . 0.0 112.926 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.61 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 15.9 p-10 -92.37 -12.5 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.723 -174.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.86 67.33 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.679 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.61 ' HB ' ' OD2' ' A' ' 117' ' ' ASP . 58.9 t -110.76 121.13 41.87 Favored Pre-proline 0 C--O 1.244 0.815 0 CA-C-O 120.744 0.307 . . . . 0.0 111.141 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.658 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 72.0 Cg_endo -76.13 156.5 38.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.411 2.74 . . . . 0.0 113.448 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 62.65 25.94 15.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.75 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -101.03 172.86 6.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.951 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.48 -32.48 73.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.81 -19.01 60.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.142 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.658 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -62.0 138.71 58.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.986 -174.195 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -104.87 104.97 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.737 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.71 169.74 13.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.203 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.58 ' OD1' ' HB2' ' A' ' 133' ' ' PHE . 62.8 t30 -62.38 -33.98 75.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 110.568 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -77.9 -20.24 53.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.271 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -73.48 -46.5 47.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.109 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.95 -22.3 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 110.147 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.54 42.91 7.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.048 168.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.58 ' HB2' ' OD1' ' A' ' 128' ' ' ASN . 28.6 m-85 -83.85 62.09 6.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.537 0.684 . . . . 0.0 110.373 174.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -142.87 92.29 2.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.454 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -79.05 142.78 36.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.197 0.522 . . . . 0.0 111.303 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -142.6 75.25 1.48 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.463 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -74.17 -32.53 63.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.806 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -76.76 84.01 3.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.236 0.541 . . . . 0.0 110.172 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -94.56 46.03 1.14 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.973 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.993 179.652 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.22 -28.18 6.14 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.294 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -93.78 82.76 4.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.101 0.477 . . . . 0.0 110.056 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -113.25 75.09 0.9 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.423 0.63 . . . . 0.0 109.391 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.6 tp10 -53.4 -40.14 64.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.789 -175.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 87.7 tttt -60.27 -41.85 94.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.01 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.89 -40.32 75.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.677 0.275 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 36' ' ' VAL . 49.4 m-20 -62.49 -47.56 83.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 13.9 ptm180 -68.19 -36.73 80.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.554 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 12.5 mm-40 -63.95 -35.15 79.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -66.44 -37.73 85.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.703 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 32' ' ' ASP . 85.9 t -60.68 -44.01 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.011 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 33' ' ' ARG . 96.7 t -59.94 -40.09 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.972 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.59 -45.65 93.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.4 ' O ' HD13 ' A' ' 43' ' ' LEU . 15.2 m-20 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.116 0.484 . . . . 0.0 110.018 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.5 tp -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.318 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.21 -36.64 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.31 94.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 47' ' ' LEU . 7.5 mp -60.67 -49.03 79.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -63.35 -36.92 85.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.953 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.39 96.89 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.217 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.52 -41.69 94.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.696 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.8 mp -59.75 -39.94 86.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.873 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.14 -36.21 79.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -42.94 77.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -65.7 -38.69 89.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -70.21 -32.79 70.85 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.774 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.4 tp -68.29 -40.98 81.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.032 0.444 . . . . 0.0 110.221 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.14 -44.96 28.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.422 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.58 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.6 m-80 -112.16 5.35 18.45 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -171.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.2 m 66.95 9.24 6.71 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -147.37 167.59 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.966 -0.459 . . . . 0.0 111.016 -177.282 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.422 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 21.9 m-85 -91.2 142.83 27.56 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.382 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.83 162.18 39.94 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.378 2.719 . . . . 0.0 113.632 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.2 p -88.07 178.87 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.182 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.0 m -50.13 -46.48 53.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.832 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.43 -44.9 61.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.501 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -64.98 -42.43 94.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.444 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.34 -44.49 98.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.702 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD21 ' O ' ' A' ' 98' ' ' TYR . 2.7 mp -69.66 -41.27 75.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.727 0.298 . . . . 0.0 111.39 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -72.52 -24.54 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.36 69.88 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.702 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -96.47 -0.28 49.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.932 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.6 -24.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 111.081 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.1 p -157.66 164.23 37.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.549 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.459 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -75.84 121.81 85.79 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.62 136.89 77.02 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.493 2.128 . . . . 0.0 112.136 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.4 m -82.49 -30.47 29.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.475 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.62 122.07 16.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.517 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -69.85 148.12 96.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.222 -175.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.58 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 14.5 Cg_exo -68.63 136.19 34.97 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.506 1.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -75.97 128.15 34.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.36 126.29 26.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.506 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -106.03 158.16 17.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.477 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 60.03 43.94 13.87 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.795 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.459 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 34.0 p90 -88.58 139.36 29.73 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.2 140.4 53.51 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.514 2.143 . . . . 0.0 111.38 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -64.31 123.88 20.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.16 86.4 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.927 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.41 -115.05 7.35 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.051 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.3 -21.73 4.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.287 0.565 . . . . 0.0 109.55 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.526 HG12 ' H ' ' A' ' 88' ' ' ARG . 14.0 tt -133.55 138.32 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.43 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 87' ' ' ARG . 38.4 mtp-105 -72.57 -20.8 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' H ' HG12 ' A' ' 86' ' ' ILE . 74.7 mtp180 -129.38 158.26 39.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.336 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.7 128.39 79.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.69 123.86 14.19 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.56 2.173 . . . . 0.0 112.822 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -127.84 140.39 52.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.635 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 4.8 p30 -68.85 155.58 93.03 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.932 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.53 -31.83 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.836 2.358 . . . . 0.0 113.666 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.445 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 6.5 m-90 -78.03 -19.01 55.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.855 0.359 . . . . 0.0 111.223 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.81 20.97 6.97 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.555 172.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.635 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 4.4 m -103.3 133.23 48.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.106 0.453 . . . . 0.0 110.552 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.79 128.73 37.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.495 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 76.6 m-85 -60.57 168.17 2.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 111.075 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -130.58 137.64 49.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.203 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.616 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -118.09 122.75 43.91 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.11 114.26 20.1 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.126 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.3 t -106.48 135.45 19.5 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.38 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.36 137.83 52.06 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.525 -1.448 . . . . 0.0 111.804 -3.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.83 141.88 47.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.652 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.96 -21.15 65.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.089 0.471 . . . . 0.0 110.262 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -126.89 31.54 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.29 -150.05 21.71 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.852 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -73.27 -40.21 64.77 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.616 ' HB ' HD21 ' A' ' 100' ' ' LEU . 4.5 m -132.84 151.27 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.886 175.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -131.15 123.03 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.604 0.24 . . . . 0.0 110.446 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.538 ' CG2' HD23 ' A' ' 100' ' ' LEU . 13.0 pt -106.87 129.68 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.541 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -151.13 161.05 43.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.287 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.485 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 44.0 p -112.32 150.92 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.471 175.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.35 -22.2 44.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.85 -171.97 54.11 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.553 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 13.4 Cg_exo -68.39 -23.79 37.61 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.045 2.497 . . . . 0.0 112.191 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.41 -12.43 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 111.291 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.21 11.8 79.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.983 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.28 116.8 66.02 Favored Pre-proline 0 C--O 1.239 0.526 0 CA-C-N 117.934 0.867 . . . . 0.0 111.747 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.5 151.77 33.31 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.557 2.838 . . . . 0.0 113.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.06 27.23 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.406 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -100.26 177.33 5.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.008 -176.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.28 -41.89 80.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.474 0.654 . . . . 0.0 109.31 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -88.56 65.39 7.81 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.398 1.094 . . . . 0.0 108.319 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 122' ' ' SER . 0.4 OUTLIER -136.46 90.55 2.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.41 -1.723 . . . . 0.0 108.823 174.46 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.54 109.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.571 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.66 -162.98 10.47 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.754 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -63.27 -37.59 87.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.268 -0.466 . . . . 0.0 111.866 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 -78.63 -27.06 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.674 0.273 . . . . 0.0 110.388 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 m -56.83 -49.31 75.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.905 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.7 tt -92.13 -25.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.501 . . . . 0.0 110.632 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.23 35.45 52.91 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.78 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -84.39 129.33 34.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.893 0.378 . . . . 0.0 110.167 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -171.75 135.83 0.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.574 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 60.91 26.97 16.84 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.469 0.652 . . . . 0.0 109.806 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -102.15 70.7 1.21 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.576 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -131.7 42.94 3.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.575 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 47.1 m170 -83.39 114.05 21.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.525 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -143.48 33.17 1.3 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.234 0.54 . . . . 0.0 110.935 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.826 176.818 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.56 0.219 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -61.72 -45.82 92.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.55 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.98 95.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.52 -47.38 73.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 37' ' ' VAL . 12.8 ptm85 -69.77 -34.77 74.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.465 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -61.07 -38.52 86.49 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.826 0.346 . . . . 0.0 110.688 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -62.4 -39.3 92.78 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 21.6 t -60.94 -47.52 93.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.801 175.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 33' ' ' ARG . 99.9 t -60.31 -38.84 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.996 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 m -59.02 -47.1 86.41 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 5.4 m-20 -70.41 -34.8 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.699 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.52 -44.95 93.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.423 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 37' ' ' VAL . 91.4 t -62.41 -41.34 91.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.288 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.04 90.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.085 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 47' ' ' LEU . 88.3 mt -60.25 -48.65 80.85 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.61 -36.05 81.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.166 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -61.73 -39.65 97.73 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.0 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.521 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -63.02 -39.81 95.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.232 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 43' ' ' LEU . 7.3 mp -60.76 -48.27 82.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.763 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.43 -36.83 85.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 24.6 mmt -68.02 -40.17 83.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.372 . . . . 0.0 110.628 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -63.63 -38.73 92.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.84 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.83 -32.72 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.96 -48.61 78.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 110.443 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.96 -46.56 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' A' ' 77' ' ' ALA . 38.5 m-80 -101.22 -0.67 35.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m 62.3 29.05 17.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.544 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -164.15 158.6 19.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -82.93 140.94 43.38 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.398 . . . . 0.0 110.952 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.43 157.91 44.75 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.105 2.537 . . . . 0.0 113.771 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.6 p -84.85 179.04 7.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.791 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.425 ' HA ' HD23 ' A' ' 100' ' ' LEU . 5.2 t -49.04 -44.78 41.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -171.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.17 -45.16 23.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.503 . . . . 0.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.462 HE22 ' NH2' ' A' ' 56' ' ' ARG . 48.2 mt-30 -64.12 -34.69 78.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.83 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -65.73 -48.84 63.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.922 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.54 -38.33 77.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.903 0.382 . . . . 0.0 111.036 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.435 HE22 HD21 ' A' ' 89' ' ' LEU . 70.4 mm-40 -72.08 -23.49 61.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.242 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.521 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 11.0 mt -79.4 -18.33 52.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.24 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.93 -59.14 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.125 0.488 . . . . 0.0 111.905 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -152.2 148.39 27.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.94 122.07 50.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.848 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HB3' ' HG2' ' A' ' 62' ' ' GLN . 78.2 Cg_exo -53.48 139.83 65.12 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.149 2.566 . . . . 0.0 112.529 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 p -81.18 -18.28 46.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.91 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.25 142.61 54.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.444 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.05 141.6 63.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.246 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.544 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 73.4 Cg_endo -76.99 143.72 76.42 Favored 'Cis proline' 0 C--N 1.344 0.294 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.588 -4.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -69.88 121.28 17.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.034 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -58.42 130.9 48.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.807 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -112.66 164.72 13.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.863 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 63.03 32.35 15.47 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.397 0.618 . . . . 0.0 110.658 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -88.86 144.05 32.46 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.896 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.33 139.99 43.13 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.37 2.047 . . . . 0.0 111.992 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.79 125.1 23.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.09 -9.41 60.67 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.789 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.09 -171.41 54.35 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.341 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.403 ' HB2' HD22 ' A' ' 67' ' ' LEU . 83.8 m-85 -83.14 -32.68 26.53 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.436 HG22 ' HB3' ' A' ' 67' ' ' LEU . 9.5 tt -139.07 126.94 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.678 174.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -67.4 -20.59 65.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -128.82 157.82 40.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.435 HD21 HE22 ' A' ' 65' ' ' GLN . 3.7 mm? -59.65 123.69 72.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.737 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.38 142.95 97.35 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.444 2.096 . . . . 0.0 111.27 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -138.18 144.7 40.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.818 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.49 142.08 52.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.8 -18.72 13.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.349 2.699 . . . . 0.0 113.457 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 23.1 m-90 -81.65 -14.28 56.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.399 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.14 25.65 5.51 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.29 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 139.6 38.76 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.641 -0.329 . . . . 0.0 110.328 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -87.73 119.22 27.84 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.31 -0.244 . . . . 0.0 110.345 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -50.95 145.71 6.97 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.748 0.655 . . . . 0.0 111.839 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.417 ' HG2' HD21 ' A' ' 114' ' ' LEU . 88.3 mm-40 -121.33 143.97 48.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.287 0.565 . . . . 0.0 111.625 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 109' ' ' VAL . 13.1 tp -122.48 142.27 50.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.741 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -128.08 112.57 14.74 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.555 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -107.4 131.22 21.88 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.438 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.44 143.64 64.9 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.055 -1.227 . . . . 0.0 111.431 -2.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.24 156.14 34.51 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.985 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -73.4 -27.09 61.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.074 0.464 . . . . 0.0 110.559 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -110.53 -27.01 9.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -147.51 -144.96 4.09 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.704 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -73.63 -43.17 60.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -140.64 128.38 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.301 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.82 127.37 54.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.0 111.23 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 pt -106.69 134.73 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.675 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.32 148.16 37.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 111.402 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.621 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 4.7 m -103.4 146.68 28.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.058 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 114' ' ' LEU . 1.8 mm? -88.3 -20.5 25.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.704 0.288 . . . . 0.0 111.197 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.26 -160.32 54.01 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.492 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 12.9 Cg_exo -69.95 -23.81 29.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.481 2.787 . . . . 0.0 112.38 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.5 ' OD2' HG22 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -91.9 -14.24 29.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.077 -173.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.01 5.84 62.77 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.357 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.7 ' O ' ' OG ' ' A' ' 122' ' ' SER . 22.8 m -93.58 118.79 67.56 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 117.548 0.674 . . . . 0.0 111.974 -175.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.49 148.06 29.28 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.38 2.72 . . . . 0.0 113.451 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 63.96 24.78 13.73 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.583 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.924 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.3 p -93.55 176.97 6.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.97 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -63.65 -41.88 98.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 0.0 110.405 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.51 -22.11 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.447 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.924 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.6 OUTLIER -56.94 104.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.689 0.618 . . . . 0.0 112.034 -171.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.18 103.66 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.437 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.12 178.6 19.2 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.89 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -68.21 -25.16 65.08 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.618 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -74.94 -31.3 61.47 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.6 m -66.99 -48.03 69.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.582 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 tp -75.75 -37.65 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.295 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 177.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.731 0.3 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -63.2 -37.94 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.285 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.93 70.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.871 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.88 -47.04 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 37' ' ' VAL . 16.8 ptm180 -62.66 -34.8 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.802 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.61 -39.12 83.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.718 0.295 . . . . 0.0 111.003 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.8 -36.2 77.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 110.035 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 68.2 t -60.36 -46.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.184 177.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 33' ' ' ARG . 89.2 t -60.04 -38.82 78.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.016 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -61.09 -46.72 89.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.81 -34.93 72.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.921 0.391 . . . . 0.0 110.629 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.62 -45.81 91.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 37' ' ' VAL . 29.3 m -65.32 -34.93 73.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.572 0.225 . . . . 0.0 110.539 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.81 94.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 47' ' ' LEU . 95.2 mt -61.0 -47.68 85.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.13 -43.02 73.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.952 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -65.21 -50.34 57.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.94 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.42 86.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.939 0.399 . . . . 0.0 110.851 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.4 mp -61.77 -50.26 73.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.417 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.9 -31.66 68.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.56 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.9 mtt -66.95 -42.45 85.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.727 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.42 -38.59 87.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 60.2 tttm -65.19 -32.88 74.79 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.0 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -65.71 -41.05 92.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.949 0.404 . . . . 0.0 109.952 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -76.61 -46.48 25.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.329 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.514 HD21 ' HA ' ' A' ' 77' ' ' ALA . 45.0 m-80 -111.43 13.56 21.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 28.8 p 49.81 35.46 9.25 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -167.08 156.34 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.503 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 38.0 m-85 -83.53 142.08 42.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 110.874 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.74 145.06 61.85 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.016 2.477 . . . . 0.0 112.891 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -75.87 177.81 6.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.622 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.418 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.9 t -50.55 -40.4 51.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.0 -45.58 26.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.512 . . . . 0.0 110.543 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -72.18 -28.11 63.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.273 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.43 -50.3 60.29 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.825 -0.703 . . . . 0.0 113.261 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -31.02 67.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.175 0.512 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -72.29 -23.44 61.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.776 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.44 68.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.414 HD13 ' CG2' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -97.86 -3.35 38.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.294 -0.563 . . . . 0.0 112.45 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 86.7 t -103.2 -62.83 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -139.58 141.86 37.16 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -57.38 121.16 45.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 135.76 71.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.532 2.155 . . . . 0.0 112.231 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.7 m -90.45 -9.24 48.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.866 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 128.8 33.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.931 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 38.9 tt0 -73.82 139.43 76.99 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.097 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.487 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 15.3 Cg_exo -69.14 140.96 61.73 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 124.299 -1.125 . . . . 0.0 113.376 1.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -86.35 136.94 32.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.658 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -74.9 122.86 24.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.963 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -104.91 156.02 18.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.334 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 59.45 49.85 8.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.507 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.571 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 38.6 p90 -92.17 144.57 29.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.03 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.62 138.96 39.53 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.297 1.998 . . . . 0.0 111.663 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -64.93 125.27 24.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.191 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.45 2.19 90.4 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.997 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.72 -152.75 51.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.362 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.95 -26.94 13.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 9.1 tt -133.32 133.87 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.52 -25.82 57.55 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -130.45 172.48 11.84 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.607 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -55.58 124.01 53.85 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.68 141.08 58.67 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -140.04 139.19 35.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 43.2 m-20 -58.67 154.43 35.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.862 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.58 -25.01 24.3 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.735 2.29 . . . . 0.0 112.839 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -80.71 -12.8 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.403 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.11 33.05 5.6 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.628 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.523 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 38.8 m -102.48 133.97 46.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.862 0.363 . . . . 0.0 111.572 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.12 124.9 28.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.08 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -65.68 138.76 58.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.24 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -112.69 142.35 45.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.675 HD23 HG23 ' A' ' 111' ' ' ILE . 3.4 tm? -126.21 123.28 37.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.09 113.52 27.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.701 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 26.7 p -106.56 119.71 50.79 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.484 171.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 91.6 Cg_endo -84.82 159.69 66.5 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 124.042 -1.233 . . . . 0.0 111.795 -3.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.51 163.89 39.28 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -96.1 -35.64 11.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.631 0.729 . . . . 0.0 109.522 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -95.69 14.07 24.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.39 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.8 -156.01 27.31 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -72.4 -34.92 68.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.423 0.611 . . . . 0.0 110.867 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.663 ' HB ' HD21 ' A' ' 100' ' ' LEU . 31.6 m -138.02 151.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -117.99 121.5 40.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.535 -176.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.675 HG23 HD23 ' A' ' 100' ' ' LEU . 7.6 pt -106.75 126.63 62.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 42.6 p90 -148.25 144.44 27.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.297 0.57 . . . . 0.0 111.647 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.3 m -92.16 138.26 31.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.409 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 73.8 mt -66.27 -16.36 63.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.179 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.6 -165.53 49.94 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.683 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.71 -34.54 24.52 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 123.528 2.819 . . . . 0.0 113.053 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -90.12 -10.93 42.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.646 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.94 87.48 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.908 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.729 ' O ' ' OG ' ' A' ' 122' ' ' SER . 89.4 t -86.72 116.1 64.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.737 0.268 . . . . 0.0 110.991 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.486 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 47.0 Cg_endo -71.47 153.81 60.61 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 11.9 pt-20 55.66 25.05 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.911 1.284 . . . . 0.0 111.869 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.788 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.6 OUTLIER -94.61 177.9 5.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.759 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.69 -27.4 62.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.991 0.424 . . . . 0.0 110.787 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.16 -17.22 58.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.622 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.788 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -62.74 121.9 14.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.098 -177.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 70.5 mt -91.76 105.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -112.0 179.63 19.61 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.078 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -58.47 -38.78 78.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.786 0.327 . . . . 0.0 111.181 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.784 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.6 m -64.04 -43.57 95.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -87.0 -38.69 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.959 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.45 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.176 177.542 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 8.1 tp10 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.713 0.292 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.77 -41.02 94.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.881 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.04 81.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 36' ' ' VAL . 67.7 m-20 -68.9 -48.11 64.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.197 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 12.3 ptm85 -66.9 -35.21 79.5 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.867 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -60.77 -37.81 83.13 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.094 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HD3' ' HG3' ' A' ' 93' ' ' PRO . 30.7 tttp -64.35 -41.94 96.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.679 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 60.9 t -61.1 -44.05 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.479 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 41' ' ' VAL . 77.4 t -62.91 -38.96 83.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 175.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -62.27 -46.01 90.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.45 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 64.4 m-20 -66.67 -36.31 82.24 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.306 0.574 . . . . 0.0 109.741 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.37 -42.76 99.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.98 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 37' ' ' VAL . 85.1 t -62.62 -38.11 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.441 . . . . 0.0 110.247 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.83 98.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.618 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 96.6 mt -64.47 -47.89 77.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.514 ' HG2' HD11 ' A' ' 111' ' ' ILE . 4.2 mm-40 -58.4 -44.95 89.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.281 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.25 -40.94 99.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.924 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -61.21 -42.38 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.791 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.27 -45.44 88.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.09 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.56 -43.68 98.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.02 -43.67 82.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.203 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -63.52 -41.15 98.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.446 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.65 -33.24 74.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.815 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.5 tp -67.55 -50.42 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.71 -44.75 32.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.888 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 36.6 m-80 -95.28 2.93 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.548 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m 68.67 3.78 4.05 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 171.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -159.58 165.52 32.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.727 0.298 . . . . 0.0 111.11 -178.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -74.12 142.02 78.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.572 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.49 143.28 42.4 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.189 2.592 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 60' ' ' THR . 1.4 m -72.35 176.82 4.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 175.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.617 ' H ' HG22 ' A' ' 59' ' ' THR . 8.8 t -51.34 -43.65 61.82 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.09 -38.97 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 110.348 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.82 -31.81 68.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.567 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -49.03 73.21 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.523 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.1 mp -69.58 -35.49 75.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.404 . . . . 0.0 111.093 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -72.54 -24.4 61.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.053 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.1 -29.38 67.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.2 pt? -103.61 -1.92 27.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.672 0.272 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 74.9 t -109.49 -59.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.257 0.551 . . . . 0.0 111.074 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.0 p -156.68 136.03 12.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -53.05 121.57 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.459 0.474 . . . . 0.0 111.34 -172.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 51.1 Cg_exo -56.98 137.07 80.32 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.007 2.472 . . . . 0.0 112.598 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.0 m -89.76 3.84 51.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.23 148.88 22.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.046 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -77.37 137.06 64.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.19 131.77 24.56 Favored 'Cis proline' 0 C--O 1.235 0.34 0 C-N-CA 122.957 -1.684 . . . . 0.0 112.247 -0.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.6 126.27 26.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.159 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.76 132.32 53.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.685 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -118.07 149.94 40.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.228 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 59.49 44.23 15.13 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.687 0.617 . . . . 0.0 110.542 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -94.84 153.39 40.01 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.274 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.55 140.37 21.29 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.307 2.005 . . . . 0.0 111.222 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.77 125.03 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.06 10.32 86.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.615 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.39 -119.89 20.2 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -126.27 -37.44 2.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.689 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 13.8 tt -124.94 127.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.874 172.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -69.29 -21.67 63.86 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -129.39 165.03 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.405 HD22 HD23 ' A' ' 64' ' ' LEU . 69.5 mt -60.23 126.55 84.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.464 ' O ' ' HD2' ' A' ' 98' ' ' TYR . 37.9 Cg_endo -67.07 138.86 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.463 2.108 . . . . 0.0 111.511 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -133.4 138.51 46.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.762 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 4.4 p30 -67.28 152.95 95.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HG3' ' HD3' ' A' ' 35' ' ' LYS . 27.0 Cg_exo -59.27 -17.82 41.65 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.263 2.642 . . . . 0.0 113.169 -170.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.556 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.5 m-90 -81.27 -26.47 35.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.02 10.87 3.68 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.94 172.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.584 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 14.7 m -103.63 148.38 26.09 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.548 0.674 . . . . 0.0 111.038 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.19 133.71 34.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.104 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 78.4 m-85 -60.61 148.65 37.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.231 0.332 . . . . 0.0 110.312 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -130.4 143.21 50.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.15 0.5 . . . . 0.0 111.361 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -111.26 121.51 45.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -106.89 112.28 25.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.9 p -106.85 130.99 22.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.743 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.33 159.77 78.09 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.678 -1.384 . . . . 0.0 111.125 -4.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.96 159.24 53.86 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.136 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -96.2 -36.04 11.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -101.97 1.27 36.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.976 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.99 -155.88 13.26 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.484 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 11.9 mm100 -74.69 -29.32 61.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.271 0.535 . . . . 0.0 110.83 176.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.635 ' HB ' HD21 ' A' ' 100' ' ' LEU . 13.5 m -144.78 151.16 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.618 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.39 133.02 51.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.01 0.433 . . . . 0.0 111.614 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.623 HG23 HD23 ' A' ' 100' ' ' LEU . 6.7 pt -112.3 127.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.87 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -150.84 160.87 43.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.217 0.532 . . . . 0.0 111.884 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 6.2 p -106.85 146.68 30.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.651 175.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 7.3 mp -86.61 -20.31 28.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.556 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 76.53 -159.64 50.09 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.57 170.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.28 -23.79 32.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.64 2.893 . . . . 0.0 112.298 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -13.97 35.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.5 13.79 74.44 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.068 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.447 ' O ' ' OG ' ' A' ' 122' ' ' SER . 30.8 m -111.3 123.64 34.6 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-N 117.515 0.657 . . . . 0.0 112.194 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -78.13 157.01 30.15 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.503 2.802 . . . . 0.0 112.128 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 63.73 42.41 6.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.085 0.945 . . . . 0.0 109.497 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.667 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.6 p -120.86 177.26 5.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.881 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -73.73 -31.73 63.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.55 -28.42 67.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.753 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.667 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 3.5 m-20 -47.07 112.0 0.47 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 124.282 0.989 . . . . 0.0 112.131 -172.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.587 ' HB ' HG11 ' A' ' 36' ' ' VAL . 4.8 mp -84.62 105.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.505 ' O ' HG22 ' A' ' 130' ' ' THR . . . -130.4 -172.24 13.09 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -63.89 -37.62 88.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.898 0.38 . . . . 0.0 111.727 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -77.3 -19.82 55.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.4 t -88.68 -22.33 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.951 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.78 -42.98 13.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.701 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.096 -178.553 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.661 0.267 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -59.92 -38.52 82.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.48 60.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.5 m-20 -69.29 -42.53 75.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 37' ' ' VAL . 14.2 ptm180 -62.17 -34.48 76.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.093 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -58.78 -37.05 75.42 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.8 0.334 . . . . 0.0 111.082 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -68.58 -39.59 80.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 32' ' ' ASP . 46.7 t -61.37 -41.76 91.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.662 ' O ' HG23 ' A' ' 41' ' ' VAL . 96.2 t -60.52 -41.23 86.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.589 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.8 t -59.26 -48.23 82.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.003 0.43 . . . . 0.0 110.887 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.403 ' HB2' ' OH ' ' A' ' 98' ' ' TYR . 31.1 m-20 -69.86 -34.26 73.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.13 -39.9 91.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.657 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 37' ' ' VAL . 52.2 t -63.5 -37.73 80.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.205 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.06 -35.63 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.596 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 47' ' ' LEU . 9.0 mp -64.08 -47.68 79.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.465 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -56.29 -37.4 69.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.999 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.49 -45.46 85.17 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.969 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -61.32 -44.62 96.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.793 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 43' ' ' LEU . 7.9 mp -62.93 -41.88 99.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.653 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.11 -44.77 94.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.447 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mmt -65.77 -43.87 87.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.046 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.495 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 67.1 t80 -65.26 -45.22 85.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.03 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.6 -33.1 72.21 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.576 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.4 tp -64.28 -42.32 96.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.073 0.463 . . . . 0.0 110.313 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.32 -48.72 16.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.906 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -98.7 -4.82 32.77 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -169.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 65.9 24.34 11.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.448 0.468 . . . . 0.0 111.945 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.31 149.74 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.403 ' HB2' ' OE1' ' A' ' 108' ' ' GLN . 31.2 m-85 -74.4 146.9 84.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.797 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 142.08 50.91 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.691 2.261 . . . . 0.0 112.295 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.2 p -74.73 177.51 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.795 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.511 ' HA ' HD12 ' A' ' 100' ' ' LEU . 13.3 t -51.46 -37.17 47.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.39 -41.18 41.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.086 0.469 . . . . 0.0 111.268 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -72.62 -37.78 67.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.294 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.21 71.27 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.783 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.697 HD21 ' O ' ' A' ' 98' ' ' TYR . 7.4 mp -69.96 -40.22 75.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 111.668 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -72.55 -23.98 61.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.234 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -26.46 62.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -169.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.7 pt? -104.52 -2.0 25.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.47 -38.75 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 t -156.44 130.35 8.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.66 121.99 36.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.432 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.85 137.47 58.37 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.833 2.355 . . . . 0.0 112.367 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 p -87.45 -19.59 27.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.087 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.23 137.48 57.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.369 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.04 138.19 92.36 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.495 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 10.7 Cg_exo -73.46 135.12 38.48 Favored 'Cis proline' 0 C--O 1.233 0.272 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.34 -3.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -70.88 121.62 18.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.8 124.26 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.736 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -107.46 166.3 10.76 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.372 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 47.76 40.27 11.96 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.192 0.933 . . . . 0.0 111.839 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -89.75 150.17 43.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.966 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.93 137.74 32.69 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.025 1.816 . . . . 0.0 111.3 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.59 124.24 22.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.914 0.387 . . . . 0.0 110.41 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.95 4.95 86.65 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.645 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.45 -142.55 40.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.399 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.85 -14.38 13.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.286 0.565 . . . . 0.0 109.594 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.9 tt -136.83 141.48 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.004 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -68.85 -30.97 69.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.886 -172.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -131.18 154.36 48.46 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.294 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.26 118.8 43.52 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.98 128.43 24.77 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.358 2.705 . . . . 0.0 113.206 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -126.37 140.43 52.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.672 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.2 p30 -71.0 152.5 94.92 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 -15.53 13.66 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.547 2.832 . . . . 0.0 113.683 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.422 ' CZ3' HG21 ' A' ' 36' ' ' VAL . 5.4 m-90 -80.57 -19.48 45.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.996 0.427 . . . . 0.0 110.361 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.16 19.31 8.57 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.918 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.496 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 0.9 OUTLIER -103.35 146.24 28.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 110.849 -176.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.93 126.24 36.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.354 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.697 ' O ' HD21 ' A' ' 64' ' ' LEU . 5.1 m-85 -52.9 151.62 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.84 0.713 . . . . 0.0 112.692 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.68 137.49 52.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.364 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.2 tm? -123.32 122.39 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -117.1 112.55 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.787 0.327 . . . . 0.0 110.486 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.484 ' HB3' HG12 ' A' ' 109' ' ' VAL . 20.7 p -107.08 127.97 26.95 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.272 171.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 97.0 Cg_endo -85.06 139.94 29.29 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.907 -1.289 . . . . 0.0 111.648 -5.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.95 161.63 46.92 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.112 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -85.15 -20.81 29.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.965 0.412 . . . . 0.0 110.617 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -105.74 -43.98 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.5 -151.6 8.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.97 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -73.33 -45.64 54.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.65 ' HB ' HD21 ' A' ' 100' ' ' LEU . 16.2 m -128.67 140.48 49.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.413 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 125.4 54.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.762 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.612 HG23 HD23 ' A' ' 100' ' ' LEU . 11.3 pt -108.35 125.73 65.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.147 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -151.69 163.09 39.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.057 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.5 m -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.872 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.446 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 1.8 mm? -66.88 -22.76 65.96 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -169.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.04 -169.16 43.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.831 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.29 -25.02 36.87 Favored 'Trans proline' 0 C--N 1.337 -0.058 0 C-N-CA 122.891 2.394 . . . . 0.0 112.843 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.85 -11.08 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.115 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 114' ' ' LEU . . . 76.09 9.75 85.39 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.406 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.726 ' O ' ' OD2' ' A' ' 125' ' ' ASP . 55.3 t -89.16 112.88 53.8 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.043 0.421 . . . . 0.0 111.448 -178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.419 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 3.3 Cg_exo -75.86 156.39 39.22 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.096 2.531 . . . . 0.0 112.624 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 64.73 16.25 10.28 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.283 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 1.085 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.9 p -94.27 175.85 6.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.818 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -85.73 -23.75 27.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.43 -22.43 61.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 1.085 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 1.0 OUTLIER -55.29 132.05 46.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.346 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.97 95.75 3.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -106.6 148.96 16.52 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.301 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.468 ' HB2' HG13 ' A' ' 111' ' ' ILE . 64.6 t30 -66.91 -26.03 66.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.44 0.638 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -74.5 -28.43 60.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.921 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -74.69 -37.47 62.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.956 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.5 tp -78.39 -36.52 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.18 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.56 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.474 169.792 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.9 tp10 . . . . . 0 CA--C 1.522 -0.134 0 CA-C-O 120.77 0.319 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 36.2 mtmm -69.56 -36.74 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.598 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.74 77.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.998 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 -44.47 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.521 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 37' ' ' VAL . 13.4 ptm180 -67.72 -35.16 78.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.601 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 40.8 mt-30 -63.91 -36.45 83.99 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.97 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.71 -39.84 92.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 76.1 t -61.05 -43.02 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.272 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 33' ' ' ARG . 88.2 t -60.54 -39.46 81.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.411 ' O ' HG22 ' A' ' 41' ' ' VAL . 50.4 m -61.32 -46.95 88.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.025 0.44 . . . . 0.0 111.055 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 -34.42 73.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.277 0.56 . . . . 0.0 110.491 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 128' ' ' ASN . 25.8 tp -65.22 -44.55 87.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.519 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 37' ' ' VAL . 32.8 m -63.53 -35.82 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.92 90.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.79 0.329 . . . . 0.0 110.47 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.57 -48.54 79.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.79 -37.77 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.34 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -44.81 97.22 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.769 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.43 -44.13 96.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.735 0.302 . . . . 0.0 110.868 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.54 -44.11 97.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.025 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.08 -41.73 99.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.866 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -38.83 73.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.733 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 77' ' ' ALA . 4.9 t80 -62.25 -42.67 99.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.954 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -69.98 -31.79 69.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.3 -49.1 75.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 0.0 110.51 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.02 -45.49 34.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -98.32 -1.33 41.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -172.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 m 63.14 17.34 10.1 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.86 147.58 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -66.74 140.55 96.38 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.24 149.09 69.77 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.967 2.444 . . . . 0.0 112.439 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 60' ' ' THR . 0.7 OUTLIER -81.71 177.46 8.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.622 176.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.574 ' H ' HG22 ' A' ' 59' ' ' THR . 8.8 t -51.42 -40.53 59.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -77.14 -42.98 35.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.302 0.572 . . . . 0.0 110.2 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -69.37 -33.59 73.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.683 -173.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.9 -49.36 42.36 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.917 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.592 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.3 tp -66.16 -41.01 90.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 111.422 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HA ' HG12 ' A' ' 68' ' ' VAL . 34.6 mt-30 -73.03 -23.11 60.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.66 61.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.8 pt? -104.65 -2.0 25.63 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 65' ' ' GLN . 7.5 p -117.83 -43.62 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.818 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 65' ' ' GLN . 47.0 m -156.51 129.58 7.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -56.24 121.53 42.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 111.442 -175.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 27.9 Cg_exo -63.15 137.39 61.23 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.739 2.293 . . . . 0.0 112.604 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.5 p -86.52 -10.9 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.96 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.64 138.32 46.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 6.1 mp0 -77.03 141.79 68.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.92 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 48.2 Cg_endo -69.89 131.33 19.11 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 -1.672 . . . . 0.0 112.532 -0.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -68.96 129.38 39.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.949 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . . . -70.56 125.96 28.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.67 -177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -119.34 163.75 16.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.538 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.32 39.28 9.61 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.369 0.604 . . . . 0.0 110.229 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -97.83 143.15 25.71 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.58 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.45 143.8 35.28 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.595 2.196 . . . . 0.0 111.628 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.08 124.63 22.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.809 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.26 10.02 86.48 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.884 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.75 -149.61 51.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.2 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.95 -5.59 15.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.388 0.613 . . . . 0.0 109.881 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 tt -142.36 137.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.694 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.18 -22.79 61.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.948 -169.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -138.3 170.16 16.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.85 128.52 70.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 172.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.43 129.11 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.346 2.031 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.16 140.47 51.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.733 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.0 p30 -72.91 153.15 91.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 92' ' ' ASP . 13.8 Cg_endo -56.23 -17.89 22.06 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.324 2.683 . . . . 0.0 113.576 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.575 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 7.3 m-90 -81.38 -26.68 35.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.697 0.284 . . . . 0.0 110.61 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.94 18.76 4.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.718 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.65 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 69.5 m -103.68 154.24 19.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.489 0.645 . . . . 0.0 111.281 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.36 129.88 38.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.218 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.592 ' O ' HD21 ' A' ' 64' ' ' LEU . 19.1 m-85 -60.95 146.23 47.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -127.6 140.47 52.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.155 0.502 . . . . 0.0 111.766 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.693 HD21 ' HB ' ' A' ' 109' ' ' VAL . 2.8 tm? -111.89 120.94 43.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -112.64 113.05 25.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.072 0.463 . . . . 0.0 111.176 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 19.8 m -106.55 131.74 21.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.171 171.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 94.1 Cg_endo -81.75 146.14 65.72 Favored 'Cis proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.762 -1.349 . . . . 0.0 111.369 -4.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.34 161.22 34.77 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.897 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.01 -35.55 11.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.111 0.481 . . . . 0.0 109.746 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -94.99 -40.24 9.76 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.16 -157.98 9.66 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.39 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -74.49 -34.61 63.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.948 0.374 . . . . 0.0 110.839 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.693 ' HB ' HD21 ' A' ' 100' ' ' LEU . 6.5 m -135.96 124.05 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.987 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 124.58 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.658 HG23 HD23 ' A' ' 100' ' ' LEU . 8.7 pt -106.29 126.55 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.278 173.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 11.7 p90 -150.31 160.58 43.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.204 0.526 . . . . 0.0 111.643 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 m -108.48 126.72 53.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.6 -31.23 72.02 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 123.804 0.69 . . . . 0.0 110.748 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.575 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 78.99 -154.09 38.84 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.0 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.36 -27.41 34.13 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.233 2.622 . . . . 0.0 113.629 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.551 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.2 p-10 -87.34 -13.46 43.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.642 -173.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.36 13.27 73.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.238 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.797 ' O ' ' OG ' ' A' ' 122' ' ' SER . 77.9 t -119.03 121.23 30.56 Favored Pre-proline 0 C--O 1.247 0.93 0 CA-C-O 120.712 0.292 . . . . 0.0 111.084 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.659 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 71.9 Cg_endo -76.06 146.97 29.55 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.508 2.805 . . . . 0.0 112.983 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 121' ' ' GLU . 5.5 tp10 65.19 25.15 12.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.074 0.94 . . . . 0.0 110.338 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.797 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -93.22 172.42 8.31 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.451 172.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -76.14 -0.41 21.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.811 0.338 . . . . 0.0 111.671 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -103.56 -13.84 16.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.185 0.517 . . . . 0.0 109.964 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.659 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -65.76 134.76 53.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.582 -174.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.17 108.44 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.908 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -110.7 176.49 18.8 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.542 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.509 ' HB2' HG13 ' A' ' 111' ' ' ILE . 63.3 t30 -65.14 -28.87 69.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.364 0.602 . . . . 0.0 110.473 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -77.11 -19.44 56.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.803 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 -40.34 62.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.63 -34.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.018 0.437 . . . . 0.0 110.244 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.894 171.016 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.67 0.271 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.73 -48.01 82.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 110.397 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.08 -36.63 72.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.377 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -63.2 -47.1 83.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.109 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 37' ' ' VAL . 35.8 ptt180 -67.67 -34.79 77.63 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.662 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.15 -34.15 75.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.69 -40.37 92.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 92.6 t -60.78 -44.88 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.415 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 33' ' ' ARG . 60.7 t -58.76 -38.41 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.513 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -61.9 -45.93 91.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.09 -34.84 73.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 0.0 110.649 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.411 HD21 ' HA ' ' A' ' 128' ' ' ASN . 17.7 tp -63.41 -45.1 92.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.92 -34.86 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.709 0.29 . . . . 0.0 110.315 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.92 89.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.539 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.82 -43.08 98.68 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.984 0.421 . . . . 0.0 110.047 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.41 ' HG2' HD11 ' A' ' 111' ' ' ILE . 5.5 mm-40 -56.7 -36.78 70.05 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 172.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.82 -44.75 94.14 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.948 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -62.48 -43.67 98.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.798 0.332 . . . . 0.0 110.711 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.91 -43.14 93.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.5 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.01 -41.15 82.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.894 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 86.7 mmm -67.87 -44.05 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.176 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.4 ' HE2' ' NE ' ' A' ' 56' ' ' ARG . 81.7 t80 -62.57 -40.31 96.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.05 -32.16 70.14 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.71 0.291 . . . . 0.0 110.262 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.6 -49.07 79.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.752 0.311 . . . . 0.0 110.422 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -77.2 -47.03 21.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -100.4 -3.49 30.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -169.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.9 m 61.38 28.93 18.27 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 2.0 ppt_? -156.58 154.87 30.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.668 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.511 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 76.0 m-85 -77.4 131.86 70.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 147.08 45.01 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.521 2.147 . . . . 0.0 112.729 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 176.8 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.518 175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.437 ' HA ' HD23 ' A' ' 100' ' ' LEU . 6.5 t -50.15 -44.44 52.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -77.44 -43.77 31.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.059 0.457 . . . . 0.0 110.785 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.22 -36.78 84.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.106 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.45 -45.05 25.24 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.547 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.568 HD21 ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -69.37 -44.65 71.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.412 ' NE2' HD11 ' A' ' 89' ' ' LEU . 33.0 mm-40 -71.59 -26.03 62.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.18 -21.86 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 46' ' ' ALA . 4.8 tp -83.24 -13.02 56.19 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.994 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.44 -29.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.565 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 t -157.34 162.88 39.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.2 122.26 87.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.94 136.69 71.36 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.643 2.229 . . . . 0.0 112.042 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -81.99 -29.66 31.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 127.4 31.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 34.0 tt0 -67.22 139.16 94.82 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 18.2 Cg_exo -67.56 131.62 16.69 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.738 -0.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -80.89 129.95 34.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.698 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.48 122.84 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.924 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -111.81 158.42 19.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.017 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 60.89 32.0 20.02 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 110.608 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -72.03 146.61 90.29 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.414 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.78 138.28 31.4 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.981 1.787 . . . . 0.0 111.272 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.81 124.63 22.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.457 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.58 4.94 75.74 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.505 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.34 -150.85 47.67 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.406 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.55 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 62.1 m-85 -101.45 -37.44 8.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.364 0.602 . . . . 0.0 109.901 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 88' ' ' ARG . 13.0 tt -131.92 137.53 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -67.05 -21.87 65.89 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.428 ' H ' HG12 ' A' ' 86' ' ' ILE . 46.9 mtm180 -130.52 154.92 47.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.412 HD11 ' NE2' ' A' ' 65' ' ' GLN . 4.4 mm? -54.43 125.83 53.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.03 137.09 79.05 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.636 2.224 . . . . 0.0 112.142 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -138.4 138.03 37.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.295 0.569 . . . . 0.0 111.327 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.85 153.86 78.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.948 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -19.02 29.14 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.198 2.599 . . . . 0.0 112.704 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -81.96 -12.75 58.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.09 30.72 7.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.198 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.3 m -103.52 149.46 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.962 0.41 . . . . 0.0 111.021 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.81 143.5 29.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.844 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.568 ' O ' HD21 ' A' ' 64' ' ' LEU . 83.7 m-85 -83.67 148.53 27.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.476 ' NE2' HD21 ' A' ' 114' ' ' LEU . 27.0 mp0 -118.22 152.96 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 110.932 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 60' ' ' THR . 13.4 tp -131.94 140.16 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.077 171.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.405 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 2.8 tm? -135.38 115.93 13.74 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.815 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 t -106.8 132.56 20.81 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.88 139.77 63.1 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 124.251 -1.145 . . . . 0.0 111.907 -1.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 101' ' ' LEU . . . -68.83 150.91 51.03 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.741 -172.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.69 -26.53 68.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 0.0 110.286 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -131.04 44.88 2.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.246 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 147.08 -165.62 28.54 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.434 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 13.2 mm100 -75.5 -29.55 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.77 0.785 . . . . 0.0 110.607 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 100' ' ' LEU . 2.1 m -134.35 127.36 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.138 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -119.52 118.19 30.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.451 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.41 HD11 ' HG2' ' A' ' 44' ' ' GLU . 13.8 pt -106.6 132.21 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.087 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.68 161.02 43.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.158 0.504 . . . . 0.0 111.428 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.422 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . 18.3 t -116.42 149.29 39.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.179 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.476 HD21 ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -69.57 -27.42 65.11 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 123.52 0.513 . . . . 0.0 109.924 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.09 -162.09 33.51 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.155 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.42 -28.38 32.7 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.951 2.434 . . . . 0.0 113.397 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.566 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.6 p-10 -85.06 -11.56 55.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.6 12.0 80.43 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.853 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.851 ' O ' ' OG ' ' A' ' 122' ' ' SER . 72.0 t -116.94 121.47 32.62 Favored Pre-proline 0 C--O 1.249 1.042 0 CA-C-O 120.637 0.256 . . . . 0.0 111.271 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.743 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 60.3 Cg_endo -75.4 158.33 40.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 113.606 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 62.31 23.97 14.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.219 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 1.127 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -96.93 177.73 5.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.731 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.95 -28.97 43.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.202 0.525 . . . . 0.0 110.496 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 122' ' ' SER . 7.3 p-10 -77.05 -15.2 59.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 1.127 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -65.47 146.06 55.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.358 -177.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.0 mt -113.76 117.87 56.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.884 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.38 161.66 13.49 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.128 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 40' ' ' LEU . 7.9 p30 -59.96 -37.4 79.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.504 0.668 . . . . 0.0 109.867 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -76.67 -28.51 55.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.205 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.2 p -80.91 -29.09 35.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.685 0.278 . . . . 0.0 111.21 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.6 tp -85.96 -31.39 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.217 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.126 178.193 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 120.798 0.332 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 99.5 mttt -67.26 -48.06 68.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.331 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.709 -174.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.24 -40.45 74.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.477 ' O ' HG23 ' A' ' 37' ' ' VAL . 30.8 ptt180 -68.38 -34.15 75.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.388 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 14.8 mm100 -59.32 -31.51 69.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.479 0.18 . . . . 0.0 111.254 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.11 -44.27 97.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.575 HG11 ' HB ' ' A' ' 126' ' ' ILE . 24.7 t -60.71 -45.15 98.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 33' ' ' ARG . 58.3 t -59.9 -38.63 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.403 ' O ' HG22 ' A' ' 41' ' ' VAL . 39.1 t -60.44 -46.8 88.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.866 0.365 . . . . 0.0 110.677 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.532 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.9 m-20 -69.52 -35.4 75.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 109.869 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.462 HD21 ' C ' ' A' ' 127' ' ' GLY . 19.0 tp -60.89 -46.57 90.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.347 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 38' ' ' SER . 28.9 m -65.81 -36.17 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.362 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.17 98.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.397 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.56 ' O ' HD13 ' A' ' 47' ' ' LEU . 98.2 mt -61.32 -49.69 75.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.375 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.3 -39.32 90.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.216 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -63.44 -47.77 84.44 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.215 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.75 84.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.758 0.313 . . . . 0.0 111.343 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.2 mp -57.59 -43.74 84.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.946 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.55 -37.35 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.844 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 20.7 mmt -59.48 -45.23 92.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.567 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 65.6 t80 -67.18 -37.7 84.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.564 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 88.0 tttt -64.92 -35.33 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.308 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.0 tp -68.12 -36.44 79.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.253 0.549 . . . . 0.0 110.385 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.514 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 14.0 t70 -76.0 -47.89 23.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.595 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.55 22.91 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m 71.97 -13.99 0.55 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.446 HH21 ' HD3' ' A' ' 75' ' ' PRO . 7.3 ppt_? -137.15 157.55 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.889 -0.507 . . . . 0.0 111.242 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.4 ' CE1' ' HD2' ' A' ' 51' ' ' LYS . 47.0 m-85 -71.34 148.35 93.51 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 148.3 52.19 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.925 2.417 . . . . 0.0 112.402 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.3 p -79.84 177.99 8.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.999 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.2 t -50.98 -37.29 43.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.827 0.346 . . . . 0.0 111.888 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.06 -45.72 26.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.702 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.04 -27.9 62.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.366 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.19 -51.96 54.92 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.129 -170.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 mp -72.11 -32.9 67.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.412 0.606 . . . . 0.0 111.34 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -72.54 -24.13 61.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.82 -24.9 64.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -103.79 -2.06 26.95 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.65 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.28 -63.04 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.455 0.645 . . . . 0.0 110.742 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 138.19 17.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.35 120.38 25.76 Favored Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.366 0.416 . . . . 0.0 111.153 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.97 141.96 96.39 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 112.602 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -86.64 -9.22 56.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.846 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.3 140.55 52.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.077 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.2 137.67 68.49 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.166 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.567 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 5.2 Cg_exo -79.88 149.84 81.65 Favored 'Cis proline' 0 C--O 1.236 0.378 0 C-N-CA 123.738 -1.359 . . . . 0.0 112.558 -4.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -65.42 128.85 37.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.521 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.0 38.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.377 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.514 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 33.3 mmt180 -111.53 165.14 12.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.94 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 61.79 34.88 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.706 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -94.74 136.65 22.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.853 0.359 . . . . 0.0 110.542 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.72 143.55 56.52 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.637 2.225 . . . . 0.0 111.758 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.07 124.36 20.94 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.21 84.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.824 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.46 -157.93 53.44 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.126 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -92.29 -23.43 19.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.9 128.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.662 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -68.36 -24.46 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.044 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -130.84 171.68 12.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.09 129.91 86.41 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.023 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.09 126.87 15.06 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.063 1.842 . . . . 0.0 110.283 172.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -132.82 145.44 50.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.608 0.242 . . . . 0.0 110.902 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 0.7 OUTLIER -56.3 143.67 64.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.115 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 48.4 Cg_exo -55.69 -25.84 53.0 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.254 2.636 . . . . 0.0 113.111 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.486 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 18.3 m-90 -81.91 -5.08 57.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.648 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.11 15.09 22.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.918 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 43.2 m -95.5 164.37 12.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.723 0.297 . . . . 0.0 110.584 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -111.71 129.32 56.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.118 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.47 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 64.2 m-85 -67.09 161.47 24.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.589 ' NE2' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -129.41 142.76 50.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.499 . . . . 0.0 110.861 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.68 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -112.41 122.77 48.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 101' ' ' LEU . 1.2 tm? -110.24 113.63 26.47 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.66 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 13.7 p -107.16 123.05 39.5 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.555 172.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 1.9 Cg_endo -84.31 140.15 33.17 Favored 'Cis proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.736 -0.943 . . . . 0.0 111.256 -4.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.73 159.62 53.84 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.62 -173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -79.63 -12.05 59.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.128 0.49 . . . . 0.0 109.951 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -121.48 30.51 6.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.02 -157.32 26.83 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 21.5 tp60 -61.2 -45.39 94.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 0.0 110.077 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.68 ' HB ' HD21 ' A' ' 100' ' ' LEU . 15.1 m -136.12 151.09 28.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.32 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -134.61 131.28 37.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.652 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.668 HG23 HD23 ' A' ' 100' ' ' LEU . 4.4 pt -111.32 130.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.781 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -149.08 161.12 42.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.3 p -114.57 139.87 49.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.738 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.589 HD13 ' NE2' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -67.9 -34.43 76.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.746 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.45 -159.68 53.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.45 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 10.8 Cg_exo -70.34 -34.88 11.9 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 123.824 3.016 . . . . 0.0 111.98 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.83 -13.57 50.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.089 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.532 ' C ' ' HG ' ' A' ' 114' ' ' LEU . . . 71.75 11.96 73.86 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.5 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.941 ' O ' ' OG ' ' A' ' 122' ' ' SER . 43.6 t -96.68 113.78 63.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 116.957 0.379 . . . . 0.0 111.233 -176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 145.83 29.45 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.615 2.21 . . . . 0.0 112.462 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 66.98 22.51 10.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.337 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.941 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.3 OUTLIER -91.48 177.46 6.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.654 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.82 -16.78 61.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.23 -15.6 37.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.17 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.806 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -63.49 105.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.201 -173.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.575 ' HB ' HG11 ' A' ' 36' ' ' VAL . 42.4 mm -81.4 107.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.857 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.462 ' C ' HD21 ' A' ' 40' ' ' LEU . . . -114.15 171.26 13.68 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.666 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 40' ' ' LEU . 26.5 p-10 -66.49 -38.39 87.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.989 0.423 . . . . 0.0 110.177 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 56.9 t90 -68.32 -30.53 69.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -72.04 -39.4 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.449 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.98 -40.72 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.752 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.358 0 C-N-CA 119.398 -1.382 . . . . 0.0 114.309 179.024 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.648 0.261 . . . . 0.0 111.36 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 55.4 mtmt -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.411 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.55 -39.85 94.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.807 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -69.17 -39.42 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.807 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.533 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 12.5 ptm85 -66.66 -33.48 75.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.74 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 76.0 mm-40 -59.22 -34.37 72.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.711 0.291 . . . . 0.0 110.882 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -63.3 -39.6 95.03 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.629 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 41.1 t -60.64 -47.65 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.363 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 33' ' ' ARG . 38.6 t -58.82 -37.69 68.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 41' ' ' VAL . 22.6 t -62.53 -47.0 85.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.47 . . . . 0.0 111.044 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.49 ' HB2' ' OH ' ' A' ' 98' ' ' TYR . 63.4 m-20 -70.91 -35.15 72.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.731 -0.606 . . . . 0.0 110.04 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.428 HD21 ' N ' ' A' ' 128' ' ' ASN . 17.6 tp -61.0 -44.93 96.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.076 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 38' ' ' SER . 32.8 m -63.31 -34.54 67.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.507 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 39' ' ' ASP . . . -60.21 -40.07 88.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.589 0.233 . . . . 0.0 110.63 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 47' ' ' LEU . 8.9 mp -60.27 -48.45 81.67 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.262 0.553 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.56 -37.33 85.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.823 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -62.53 -37.06 94.08 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.91 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.16 0.505 . . . . 0.0 110.044 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 43' ' ' LEU . 6.2 mp -61.1 -40.82 95.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.4 -45.52 94.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 25.7 mmt -63.44 -38.52 91.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 77' ' ' ALA . 1.2 t80 -64.2 -44.23 92.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.399 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -70.5 -33.31 71.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.93 -46.3 85.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.01 0.433 . . . . 0.0 110.141 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.99 -46.15 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.215 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -103.57 1.71 32.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m 59.15 31.73 21.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.708 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -164.51 146.21 8.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.844 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.4 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 21.0 m-85 -72.89 144.18 85.14 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 110.466 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 55.5 Cg_endo -71.04 143.26 44.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.843 2.362 . . . . 0.0 112.745 -176.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.567 HG22 ' H ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -73.94 177.45 5.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.591 175.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 100' ' ' LEU . 61.9 m -50.21 -45.82 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.37 -37.58 65.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.236 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -71.92 -43.15 65.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.874 -170.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.443 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -64.37 -49.46 65.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.676 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.4 tp -61.88 -41.68 98.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.941 0.4 . . . . 0.0 111.42 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.41 -22.92 61.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.936 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.24 66.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -168.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.526 HD21 HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -93.95 -3.83 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.986 -178.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.86 -42.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.519 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 p -156.5 130.07 8.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -55.09 121.82 38.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 123.383 0.427 . . . . 0.0 111.324 -177.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 27.1 Cg_exo -64.34 137.56 56.44 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.9 2.4 . . . . 0.0 112.437 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -86.22 -11.45 52.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.1 57.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.474 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -77.5 140.92 64.82 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.81 134.55 36.36 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.719 -1.367 . . . . 0.0 111.931 -2.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.95 128.55 36.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.298 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . . . -63.2 131.33 48.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.526 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -119.32 164.6 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 66.46 32.06 7.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.009 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -91.68 137.18 25.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.694 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.77 139.54 22.46 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.073 1.849 . . . . 0.0 111.843 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 124.77 23.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.711 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -8.89 76.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.73 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 -173.13 55.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.291 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -84.9 -25.7 27.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.26 133.71 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.381 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -70.12 -22.77 62.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.7 mtm180 -131.94 154.59 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.289 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.6 mt -61.73 123.64 77.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.336 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.15 147.95 91.33 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.471 2.114 . . . . 0.0 111.415 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -138.37 145.46 41.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 113' ' ' SER . 53.2 m-20 -57.99 142.99 78.87 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.63 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.38 -19.32 57.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.305 2.67 . . . . 0.0 112.541 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.74 -14.08 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.009 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.0 22.39 7.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.163 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.578 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 19.3 m -104.01 162.5 13.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.535 -0.391 . . . . 0.0 110.613 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -105.64 144.65 32.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.667 0.27 . . . . 0.0 110.341 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 18.6 m-85 -70.31 146.49 50.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.358 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -126.76 142.9 51.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.616 . . . . 0.0 111.751 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 60' ' ' THR . 13.4 tp -121.68 141.99 50.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.934 172.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -134.86 113.07 11.2 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.505 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.7 t -106.9 132.19 21.1 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.374 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.78 150.27 92.35 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.824 -1.323 . . . . 0.0 111.885 -1.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.01 147.25 50.73 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.658 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -75.07 -39.39 60.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.359 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -104.88 -38.88 6.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.897 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.19 -156.79 9.78 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.788 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -73.46 -41.69 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.209 0.528 . . . . 0.0 109.989 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.14 122.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.376 175.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 116.8 33.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.25 0.547 . . . . 0.0 112.15 -173.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.9 pt -107.34 126.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.556 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 30.8 p90 -150.41 146.55 26.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.284 0.564 . . . . 0.0 111.194 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.493 ' HB3' ' OD1' ' A' ' 92' ' ' ASP . 51.2 m -97.83 151.58 20.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.197 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 4.9 mp -75.29 -19.67 59.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.588 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.54 -156.04 53.27 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 123.875 0.734 . . . . 0.0 113.355 171.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.93 -21.01 38.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.675 2.917 . . . . 0.0 112.906 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.77 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 6.6 p-10 -86.23 -14.74 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.484 ' O ' HD23 ' A' ' 114' ' ' LEU . . . 70.7 0.65 33.66 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.178 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.903 ' O ' ' OG ' ' A' ' 122' ' ' SER . 44.6 t -122.47 134.0 24.68 Favored Pre-proline 0 C--O 1.251 1.171 0 CA-C-O 120.56 0.219 . . . . 0.0 110.739 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.4 160.91 41.16 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.81 2.34 . . . . 0.0 111.206 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 69.53 22.64 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 109.311 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.903 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 6.5 m -89.01 170.67 10.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.464 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.18 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 167.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.421 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 14.8 m-20 -96.05 69.12 2.77 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.859 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.27 100.32 7.62 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.799 170.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 64.4 mt -79.98 99.92 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.827 -172.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -104.06 155.21 17.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.218 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 40' ' ' LEU . 22.2 t30 -68.83 -30.96 69.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.596 0.712 . . . . 0.0 109.328 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.96 -30.89 65.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.576 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.6 p -82.32 -32.29 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.002 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.0 tp -74.34 -19.98 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.627 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 119.949 -1.12 . . . . 0.0 114.057 173.237 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.841 0.353 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 48.2 mmtm -68.43 -40.32 81.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.659 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.04 85.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.942 0.401 . . . . 0.0 110.756 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.0 m-20 -65.42 -46.72 78.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.394 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.7 ptm180 -63.85 -35.66 81.37 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.117 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 56.1 mt-30 -59.1 -39.58 82.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.862 0.363 . . . . 0.0 110.256 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -68.32 -38.66 81.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.245 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 32' ' ' ASP . 71.7 t -61.01 -47.9 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.469 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 33' ' ' ARG . 65.6 t -60.09 -37.55 73.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.831 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 41' ' ' VAL . 14.4 t -61.36 -47.47 85.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.99 0.424 . . . . 0.0 111.04 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.6 -33.96 71.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 176.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 15.9 tp -62.5 -44.31 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.211 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 38' ' ' SER . 32.2 m -65.7 -35.29 74.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 O-C-N 122.356 -0.215 . . . . 0.0 110.631 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.44 81.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 78.0 mt -62.04 -47.75 83.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.647 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HG2' HD11 ' A' ' 111' ' ' ILE . 36.6 mm-40 -57.35 -36.69 71.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.28 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.51 99.69 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.689 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.568 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -62.95 -37.83 88.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.223 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 36.3 mt -61.92 -44.99 95.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.449 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -61.34 -45.37 94.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.733 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.78 -38.04 79.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.27 -46.2 74.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.02 -33.26 75.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.686 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -44.57 93.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.436 0.636 . . . . 0.0 110.04 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.64 -41.61 53.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.252 -174.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.503 HD21 ' HA ' ' A' ' 77' ' ' ALA . 48.4 m-80 -118.06 16.04 14.16 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m 72.17 -42.21 0.53 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 176.45 5.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 108' ' ' GLN . 36.8 m-85 -88.78 144.85 33.78 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.418 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.71 152.79 42.77 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.403 2.736 . . . . 0.0 113.697 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 60' ' ' THR . 0.3 OUTLIER -79.46 177.06 9.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.627 173.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 59' ' ' THR . 4.1 t -51.05 -46.02 61.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.1 -39.58 65.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.38 0.609 . . . . 0.0 110.192 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -71.86 -35.43 69.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.812 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.68 70.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.109 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 89' ' ' LEU . 1.2 mm? -70.79 -34.19 71.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.713 0.292 . . . . 0.0 111.657 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.533 ' OE1' ' HA ' ' A' ' 71' ' ' PRO . 28.3 mt-30 -70.28 -23.84 62.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.35 -18.2 36.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.628 ' HB3' HG22 ' A' ' 86' ' ' ILE . 8.5 mt -94.09 -25.07 17.32 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 6.2 p -105.65 -47.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -157.27 143.38 17.8 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.439 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -56.06 121.0 38.33 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.24 0.338 . . . . 0.0 110.283 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.533 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 80.6 Cg_exo -52.87 136.35 59.57 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 123.108 2.539 . . . . 0.0 112.586 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -92.22 41.33 1.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.016 0.912 . . . . 0.0 109.943 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.87 133.87 36.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.636 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.8 140.11 86.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 O-C-N 123.219 0.324 . . . . 0.0 111.175 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.41 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 73.4 Cg_endo -77.45 132.39 26.97 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.922 -1.699 . . . . 0.0 112.957 0.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -66.81 128.02 34.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.704 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.8 126.75 28.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.085 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -108.94 164.46 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 60.14 36.45 21.1 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.513 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 36.1 p90 -94.85 142.01 24.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.94 138.23 28.12 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.224 1.949 . . . . 0.0 111.621 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.39 124.82 23.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.48 -10.14 73.29 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.249 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.17 -164.94 53.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.923 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -91.0 -23.35 20.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.386 0.613 . . . . 0.0 109.385 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.628 HG22 ' HB3' ' A' ' 67' ' ' LEU . 12.1 tt -142.6 138.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -68.98 -26.72 65.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -130.6 166.49 20.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.67 0.271 . . . . 0.0 110.449 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 64' ' ' LEU . 4.1 mm? -62.3 127.63 90.0 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.745 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.6 136.08 64.73 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.556 2.171 . . . . 0.0 112.058 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -128.3 146.9 50.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.268 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.679 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.8 p30 -73.24 153.39 90.39 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.16 -16.93 13.73 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.587 2.858 . . . . 0.0 114.049 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.444 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.7 m-90 -80.63 -25.82 38.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.821 0.344 . . . . 0.0 110.405 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.72 13.91 6.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.041 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.679 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 9.0 m -101.17 143.74 30.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.87 0.367 . . . . 0.0 110.462 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.84 132.65 34.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.332 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -60.34 143.57 52.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.904 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 81.9 mm-40 -118.49 137.86 52.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.907 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 111' ' ' ILE . 3.1 tm? -113.34 123.19 49.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -118.6 113.55 21.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.043 0.449 . . . . 0.0 110.338 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t -106.04 130.8 22.42 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.74 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.48 153.26 94.45 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 124.241 -1.149 . . . . 0.0 111.591 -3.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.59 145.54 49.75 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.247 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -78.26 -24.22 46.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.12 0.486 . . . . 0.0 110.278 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -119.16 -16.2 9.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.59 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.28 -148.84 4.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.461 ' HG2' ' CD2' ' A' ' 57' ' ' TYR . 25.1 tp60 -73.73 -45.68 50.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.956 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.742 ' HB ' HD21 ' A' ' 100' ' ' LEU . 4.3 m -142.81 127.65 15.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.721 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.0 122.07 43.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -174.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 100' ' ' LEU . 10.0 pt -106.54 126.59 62.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -142.07 153.59 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.27 0.557 . . . . 0.0 112.031 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.0 t -99.92 138.29 37.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.241 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.67 -20.19 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.307 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.444 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 64.68 -163.87 35.68 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.221 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.41 -25.93 29.73 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.344 2.696 . . . . 0.0 111.858 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 7.8 p-10 -80.9 -14.63 57.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.186 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.17 12.27 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.381 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 1.089 ' O ' ' OG ' ' A' ' 122' ' ' SER . 41.9 t -109.54 131.19 22.03 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-N 116.734 0.267 . . . . 0.0 111.146 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.574 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 66.2 Cg_endo -76.0 149.47 32.8 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.974 2.449 . . . . 0.0 111.89 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 43.1 mt-10 70.87 15.54 6.78 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.378 0.671 . . . . 0.0 110.793 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 1.089 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -87.39 177.16 7.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.536 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -41.38 98.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.501 0.667 . . . . 0.0 109.638 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.482 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 10.7 m-20 -88.88 65.55 7.63 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.67 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -130.54 91.82 3.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.582 174.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.86 104.62 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.701 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -117.25 174.52 15.26 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.736 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.13 -35.42 73.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -78.98 -31.26 44.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -64.0 -45.23 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.972 0.415 . . . . 0.0 110.767 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 tp -82.65 -26.68 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.811 0.815 . . . . 0.0 109.731 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 CA-C-N 114.771 -1.104 . . . . 0.0 114.083 170.004 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 121.162 0.506 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 96.3 mttt -59.07 -46.04 89.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.18 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.43 97.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.282 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.3 m-20 -63.77 -47.8 79.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.313 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.4 ' NH2' ' HG2' ' A' ' 30' ' ' LYS . 19.6 ptt180 -69.45 -35.22 75.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.307 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 52.4 mt-30 -59.07 -37.57 77.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 110.701 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.01 -37.95 85.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 32' ' ' ASP . 72.0 t -61.16 -47.13 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.669 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -60.35 -37.9 75.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -62.0 -43.53 98.65 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.887 0.375 . . . . 0.0 111.378 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.79 -35.03 74.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.257 0.551 . . . . 0.0 110.088 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.25 -46.26 89.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.344 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -64.6 -34.9 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.36 96.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.681 0.277 . . . . 0.0 110.433 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.512 ' O ' HD13 ' A' ' 47' ' ' LEU . 94.3 mt -61.85 -49.51 75.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.069 0.461 . . . . 0.0 110.631 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -62.41 -40.46 96.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.721 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -62.68 -43.81 98.43 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.916 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -62.69 -38.52 90.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 110.918 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.512 HD13 ' O ' ' A' ' 43' ' ' LEU . 3.2 mp -61.66 -45.82 92.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.416 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.15 -40.39 97.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.1 mtt -65.98 -41.95 90.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.676 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.407 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 50.6 t80 -63.73 -40.99 98.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.268 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 57' ' ' TYR . 83.6 tttt -66.95 -34.68 78.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.854 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.06 -41.89 99.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.177 0.513 . . . . 0.0 110.263 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -76.76 -46.76 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.209 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.1 m-80 -105.79 -1.74 23.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -169.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m 62.99 34.28 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.55 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -170.31 165.85 8.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.449 0.166 . . . . 0.0 110.599 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.55 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 74.9 m-85 -87.4 136.43 33.34 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.05 150.55 60.58 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.87 2.38 . . . . 0.0 112.864 -174.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.422 ' HA ' ' OG ' ' A' ' 102' ' ' SER . 11.4 p -77.59 175.74 9.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.956 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.459 ' HA ' HD12 ' A' ' 100' ' ' LEU . 11.5 t -53.5 -38.59 63.85 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -174.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.97 -46.39 44.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -73.49 -29.72 62.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.134 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.75 67.13 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.146 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.31 -32.46 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -73.08 -25.92 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.115 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.6 65.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -167.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.4 pt? -103.72 -2.28 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -116.15 -45.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 111.62 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -156.69 131.86 9.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -53.79 121.24 27.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.39 0.431 . . . . 0.0 111.137 -176.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 45.2 Cg_exo -57.84 137.04 79.07 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.054 2.503 . . . . 0.0 112.406 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.4 m -79.89 -23.91 41.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.975 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.61 138.75 51.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.677 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -77.85 145.67 70.77 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 11.5 Cg_exo -71.09 135.92 38.99 Favored 'Cis proline' 0 C--O 1.233 0.238 0 C-N-CA 123.32 -1.533 . . . . 0.0 112.003 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -73.48 125.19 27.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.937 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -60.47 123.49 17.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.57 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -112.29 165.23 12.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.765 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 61.73 42.77 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.601 . . . . 0.0 110.221 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.5 145.51 31.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.822 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.63 138.71 19.5 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.988 1.792 . . . . 0.0 111.569 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.9 124.87 23.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.49 76.12 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.182 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.08 -160.75 50.41 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.362 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -96.78 -16.28 20.91 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.82 134.92 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.567 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.6 -21.94 61.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.056 -170.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -130.54 156.31 45.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.537 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.7 mt -55.84 120.98 37.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.718 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.13 134.0 59.13 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -130.49 138.53 50.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.803 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -61.05 152.65 70.26 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.24 -21.34 22.35 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.306 2.67 . . . . 0.0 112.832 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -81.54 -18.18 45.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.84 21.86 8.36 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.992 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 p -101.65 143.55 31.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.897 0.38 . . . . 0.0 111.075 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.97 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -57.51 149.41 21.18 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 0.0 111.508 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -111.56 137.45 49.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.554 -175.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.568 HD23 HG23 ' A' ' 111' ' ' ILE . 3.1 tm? -131.88 122.73 26.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.25 113.95 13.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.655 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 59' ' ' THR . 60.0 p -107.01 129.92 23.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.829 173.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.56 150.72 88.02 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.716 -3.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.51 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -78.41 156.98 43.8 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.278 -172.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.59 -43.05 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 129' ' ' TRP . 91.0 m-70 -92.63 -2.56 56.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.64 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.6 -164.03 26.54 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.874 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.419 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 8.5 mm100 -72.07 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 109.439 175.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -122.3 121.26 63.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.676 169.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.51 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 6.8 t0 -93.39 114.36 26.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -172.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.568 HG23 HD23 ' A' ' 100' ' ' LEU . 12.5 pt -113.6 123.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -151.94 162.24 41.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.2 m -119.31 140.27 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HB3' ' CA ' ' A' ' 118' ' ' GLY . 1.1 mm? -62.69 -32.27 73.33 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.1 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 -170.83 41.23 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.25 -16.16 39.5 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 122.735 2.29 . . . . 0.0 111.757 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.73 -14.12 32.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.232 -173.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.418 ' CA ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.34 8.33 70.35 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.019 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.45 ' O ' ' OD2' ' A' ' 125' ' ' ASP . 41.9 t -94.68 111.26 53.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.194 0.497 . . . . 0.0 111.791 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 119' ' ' VAL . 6.3 Cg_exo -77.08 146.54 25.64 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.403 2.736 . . . . 0.0 112.539 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 62.25 35.5 15.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.405 0.621 . . . . 0.0 111.359 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.602 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.3 p -109.2 172.64 6.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.407 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -66.25 -30.41 70.84 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.96 52.62 2.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.908 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.602 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.8 OUTLIER -126.71 136.06 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 176.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mm -100.59 101.03 11.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.68 157.7 15.8 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.74 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -61.97 -38.03 87.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 110.552 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 106' ' ' HIS . 79.8 t90 -68.49 -31.11 70.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.744 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -78.8 -34.21 45.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.3 tp -87.65 -31.51 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.464 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.259 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.405 176.001 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.537 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 44.6 tt0 . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 110.437 -0.209 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -54.73 -49.29 71.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.378 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -72.45 -44.85 61.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.036 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.94 -46.0 86.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.194 -173.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 36.9 ptt180 -69.1 -33.79 74.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.81 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -59.5 -35.96 75.15 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.21 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 82.6 mttt -62.19 -44.34 96.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.596 0.712 . . . . 0.0 109.287 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.23 -47.09 95.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.179 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.6 t -59.47 -38.73 76.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 t -59.82 -46.53 88.96 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.952 0.406 . . . . 0.0 110.532 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.48 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 89.7 m-20 -68.46 -34.65 76.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.144 0.497 . . . . 0.0 110.197 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.34 -43.37 96.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.591 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 37' ' ' VAL . 26.2 t -62.66 -37.39 78.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.0 91.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.984 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.676 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 95.7 mt -63.9 -49.69 71.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.362 . . . . 0.0 110.561 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.06 -33.95 75.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.76 91.82 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.483 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.32 -43.11 96.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.826 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 45.3 mt -59.64 -42.78 93.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.616 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.42 -44.04 95.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.59 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.503 ' SD ' ' HE2' ' A' ' 85' ' ' TYR . 92.0 mtp -67.66 -42.25 82.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.443 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.521 ' CD2' ' HG3' ' A' ' 58' ' ' PRO . 77.2 t80 -63.87 -43.82 94.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.497 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -69.34 -33.17 72.71 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.067 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.57 -45.92 92.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.158 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.52 -46.97 24.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.552 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -95.21 -6.45 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m 65.54 24.18 11.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 150.0 18.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.568 0.223 . . . . 0.0 110.682 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -75.24 145.25 79.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.779 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 6.2 Cg_exo -75.05 162.37 37.11 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.759 2.306 . . . . 0.0 112.28 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -83.84 177.4 8.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.953 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.408 ' HA ' HD12 ' A' ' 100' ' ' LEU . 9.0 t -51.41 -42.72 61.64 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -175.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.59 -45.0 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.401 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.83 -31.24 70.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.05 -49.38 47.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.177 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.81 -38.52 76.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.864 0.364 . . . . 0.0 111.493 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.57 -24.0 61.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.975 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -25.7 63.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -168.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -103.3 -1.32 28.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.214 -177.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -117.64 -39.99 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.56 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.1 m -156.61 129.18 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -55.42 121.62 39.01 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.642 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 46.4 Cg_exo -57.64 136.93 78.7 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.007 2.471 . . . . 0.0 112.699 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 p -85.13 -16.21 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.597 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.16 137.79 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -77.44 142.63 67.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 -178.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.19 138.11 52.36 Favored 'Cis proline' 0 C--O 1.236 0.39 0 C-N-CA 123.351 -1.52 . . . . 0.0 112.051 -2.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.6 128.67 36.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.87 125.38 23.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.392 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -113.97 163.9 14.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.122 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 56.47 36.36 27.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.343 0.592 . . . . 0.0 110.998 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -98.07 146.11 30.95 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.058 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.36 138.91 28.14 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.752 1.635 . . . . 0.0 110.213 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.37 123.97 21.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.22 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.34 88.12 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.709 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.8 -115.39 7.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.261 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.503 ' HE2' ' SD ' ' A' ' 49' ' ' MET . 60.4 m-85 -134.48 -3.43 2.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.886 0.375 . . . . 0.0 110.786 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.6 136.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -75.43 -22.19 57.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -170.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -130.57 171.16 13.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.814 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.09 127.55 80.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.472 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.77 124.84 11.92 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.533 2.156 . . . . 0.0 112.431 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -130.4 148.75 52.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.761 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.3 p30 -69.4 152.84 96.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.89 -16.22 25.1 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.532 2.821 . . . . 0.0 113.0 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.483 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 5.6 m-90 -80.53 -25.71 38.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.553 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.41 9.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.376 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.585 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 19.3 m -100.18 157.99 16.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.12 0.46 . . . . 0.0 110.786 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.49 138.67 31.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.804 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -68.6 164.36 21.61 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -130.62 146.68 52.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.187 0.518 . . . . 0.0 111.486 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.698 HD23 HG23 ' A' ' 111' ' ' ILE . 2.4 tm? -133.01 122.85 24.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -120.83 112.49 18.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -107.49 131.46 21.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.926 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.43 146.58 68.96 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.43 -1.488 . . . . 0.0 110.998 -5.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.68 159.86 48.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.501 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -92.8 -37.35 12.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 129' ' ' TRP . 97.5 m-70 -76.4 -56.19 4.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.634 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.71 -150.18 7.78 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.791 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -73.35 -36.23 66.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.508 ' HB ' HD21 ' A' ' 100' ' ' LEU . 2.8 m -137.55 131.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.474 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.6 m-20 -104.27 115.0 29.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.777 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.698 HG23 HD23 ' A' ' 100' ' ' LEU . 9.0 pt -106.69 126.51 62.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -145.9 159.55 43.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.818 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 3.0 m -116.15 124.6 50.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.235 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.456 ' HB3' ' C ' ' A' ' 118' ' ' GLY . 62.6 mt -61.39 -34.93 76.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.737 -174.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.483 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 86.79 -166.84 37.82 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.15 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.24 -18.83 44.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.64 -13.53 24.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.912 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.456 ' C ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.54 8.82 72.59 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.781 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.811 ' O ' ' OD2' ' A' ' 125' ' ' ASP . 61.6 t -93.38 114.93 64.21 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -173.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.4 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 82.0 Cg_endo -76.62 154.31 34.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.373 2.715 . . . . 0.0 113.101 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 62.89 16.17 8.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.549 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 1.055 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -89.51 177.03 6.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.444 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -71.69 -37.1 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -88.14 62.63 6.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 1.055 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -138.05 109.14 6.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.721 175.035 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.3 mm -77.17 103.11 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.957 0.408 . . . . 0.0 110.528 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.05 159.49 14.05 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.149 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.421 ' HA ' HG22 ' A' ' 131' ' ' ILE . 25.3 p-10 -67.85 -39.46 83.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.085 0.469 . . . . 0.0 110.521 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.42 ' CG ' ' HB3' ' A' ' 106' ' ' HIS . 93.1 t90 -66.34 -31.04 71.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.656 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.7 p -83.89 -29.52 27.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.714 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 128' ' ' ASN . 11.1 tp -82.7 -27.66 8.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.849 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.951 177.787 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.746 0.308 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.25 -42.2 98.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.987 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.23 73.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.496 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.7 m-20 -60.92 -47.56 85.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.642 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' HG23 ' A' ' 37' ' ' VAL . 32.1 ptt180 -69.5 -35.21 75.31 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.827 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -62.33 -35.17 78.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.634 0.254 . . . . 0.0 110.828 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.14 -41.94 98.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 95.9 t -60.69 -44.46 97.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.99 176.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 33' ' ' ARG . 90.3 t -60.22 -39.37 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.327 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 41' ' ' VAL . 37.9 t -62.18 -46.77 87.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.105 0.479 . . . . 0.0 110.681 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.96 -34.1 71.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.336 0.589 . . . . 0.0 110.311 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 128' ' ' ASN . 17.8 tp -60.65 -44.84 95.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.206 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 38' ' ' SER . 27.7 m -65.68 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.456 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.54 97.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.859 0.361 . . . . 0.0 110.195 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 47' ' ' LEU . 96.1 mt -61.43 -48.95 78.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.776 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.63 -42.53 98.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.33 -38.09 95.67 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.053 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -42.45 96.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.861 0.362 . . . . 0.0 110.277 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.6 mp -62.25 -48.1 81.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.196 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.06 -41.13 97.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.297 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.16 -37.46 72.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.32 -41.19 98.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -68.43 -32.62 72.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.36 -48.9 73.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.905 0.383 . . . . 0.0 110.214 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.66 -39.73 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.0 m-80 -106.69 11.74 30.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.5 m 73.17 -43.19 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.401 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 6.6 ppt_? -117.82 164.53 14.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.712 0.292 . . . . 0.0 111.552 -175.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -71.18 148.16 93.81 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.933 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.73 149.36 48.36 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.031 2.487 . . . . 0.0 112.529 177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.8 p -85.69 179.73 7.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -50.2 -38.89 42.27 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.42 -44.72 34.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.279 0.562 . . . . 0.0 110.677 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.87 -30.29 65.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.323 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.3 -51.17 60.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.645 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 mp -71.28 -33.54 69.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.962 0.41 . . . . 0.0 111.506 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -68.49 -26.69 65.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.809 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -23.53 63.88 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 HD23 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -103.74 -2.2 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.5 p -122.93 -48.33 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.831 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 p -152.08 128.61 10.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.608 0.242 . . . . 0.0 110.484 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.9 121.81 37.35 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.085 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.57 144.45 85.01 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.077 2.518 . . . . 0.0 112.307 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.422 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 25.4 t -94.97 2.51 55.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.17 131.26 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.484 ' OE2' ' HA ' ' A' ' 75' ' ' PRO . 8.1 tp10 -77.79 138.65 62.0 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.208 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 14.3 Cg_exo -67.03 130.84 14.08 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.565 -1.431 . . . . 0.0 112.62 0.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 72' ' ' SER . 3.8 t60 -74.0 131.16 41.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.723 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.403 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -57.48 127.99 34.78 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.524 0.515 . . . . 0.0 111.576 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -114.2 167.09 10.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.844 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.3 p30 52.76 31.39 10.37 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -80.32 139.17 51.99 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.775 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.21 140.5 24.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.551 2.167 . . . . 0.0 111.719 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.36 125.07 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.178 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.54 3.18 86.67 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.45 -161.89 53.45 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.362 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.56 -22.51 24.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' A' ' 67' ' ' LEU . 8.3 tt -139.39 134.08 39.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.769 173.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -60.98 -29.31 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.608 -169.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -133.75 160.24 38.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.51 122.34 59.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.539 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.45 149.45 80.27 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.427 2.084 . . . . 0.0 111.876 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -140.76 140.71 34.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.788 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 1.9 p30 -63.82 152.98 85.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.22 -15.68 15.19 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.816 3.011 . . . . 0.0 113.812 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -79.05 -26.06 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.03 19.6 8.02 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.603 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.584 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 0.7 OUTLIER -95.96 151.35 19.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.417 . . . . 0.0 110.553 -178.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.25 122.6 31.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.494 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 56.6 m-85 -54.66 140.8 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.024 0.44 . . . . 0.0 111.284 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -113.69 137.89 50.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.651 HD23 HG23 ' A' ' 111' ' ' ILE . 2.8 tm? -118.79 122.02 41.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.411 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 1.7 tm? -122.54 113.98 20.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.887 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 p -106.35 130.52 22.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.81 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.5 139.97 63.72 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.385 -1.09 . . . . 0.0 111.93 -1.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 101' ' ' LEU . . . -60.62 143.82 47.99 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.358 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -58.52 -36.24 73.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.887 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -119.45 21.79 11.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.592 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.96 -147.92 11.72 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.816 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -45.44 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.659 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.612 ' HB ' HD21 ' A' ' 100' ' ' LEU . 3.1 m -137.67 146.96 26.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.503 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.48 121.5 30.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.966 -177.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.651 HG23 HD23 ' A' ' 100' ' ' LEU . 7.0 pt -106.59 125.41 62.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.973 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -151.53 156.57 40.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 0.0 111.609 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.436 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 54.6 p -100.04 155.08 17.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -17.77 63.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 110.97 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.24 -172.0 55.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.437 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.01 -22.2 35.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.151 2.567 . . . . 0.0 112.273 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.733 ' OD2' HG12 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -94.91 -14.99 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.333 -173.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.51 -5.54 44.31 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.733 HG12 ' OD2' ' A' ' 117' ' ' ASP . 2.8 p -97.44 128.68 33.9 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.375 1.588 . . . . 0.0 110.683 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.718 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 56.0 Cg_endo -73.13 159.71 46.93 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.749 2.3 . . . . 0.0 113.398 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 69.37 15.83 8.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.296 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 1.003 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 1.3 p -98.97 175.35 5.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -77.9 -22.4 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.987 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -79.88 -11.24 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 1.003 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 1.0 OUTLIER -71.56 89.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.891 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.5 ' HA ' HG21 ' A' ' 130' ' ' THR . 46.6 mm -66.58 105.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.351 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 130' ' ' THR . . . -135.35 -161.8 9.47 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.467 ' HA ' HD21 ' A' ' 40' ' ' LEU . 10.6 t-20 -62.42 -38.11 88.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.618 0.247 . . . . 0.0 111.621 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -79.66 -30.86 41.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 126' ' ' ILE . 5.4 t -69.16 -33.09 72.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.591 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.45 -34.93 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.376 173.379 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 27.6 tt0 . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -64.11 -35.1 79.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -176.125 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.2 -38.21 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.573 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.54 -49.06 79.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 2.5 ptp180 -69.92 -36.63 75.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.484 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -60.89 -35.87 77.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.02 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -68.12 -39.73 82.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.094 0.473 . . . . 0.0 109.966 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 35.4 t -61.04 -47.78 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.716 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 33' ' ' ARG . 58.9 t -62.91 -38.32 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -61.77 -46.22 90.53 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -69.94 -35.34 74.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.107 0.48 . . . . 0.0 110.266 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 ' HA ' ' A' ' 128' ' ' ASN . 45.0 tp -63.93 -46.13 86.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.437 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.1 m -66.02 -36.12 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.13 85.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.47 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 68.2 mt -60.12 -48.26 82.46 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.556 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.92 -36.28 78.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.065 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.06 -46.06 93.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.615 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -62.55 -38.72 91.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.576 0.227 . . . . 0.0 110.617 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 37.4 mt -65.15 -50.42 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.362 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.39 -44.39 97.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.399 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -70.31 -35.76 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.963 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.6 t80 -58.64 -44.75 90.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.43 -33.12 73.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.6 tp -62.82 -51.03 68.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.565 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 78' ' ' ARG . 16.2 t70 -78.51 -46.95 18.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -93.49 -0.07 56.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.861 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m 70.01 7.25 6.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -160.53 157.14 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.591 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 m-85 -74.29 148.22 85.99 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.178 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 60.4 Cg_endo -73.27 155.85 51.24 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.843 2.362 . . . . 0.0 112.456 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -86.06 178.18 7.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.33 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -51.31 -40.33 58.79 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -173.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -76.04 -43.28 44.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.352 0.596 . . . . 0.0 110.733 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -72.6 -27.46 62.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.5 56.12 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.964 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -33.47 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.172 0.486 . . . . 0.0 111.018 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -71.74 -25.18 61.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.677 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.58 -22.88 62.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.498 ' HB3' HG22 ' A' ' 86' ' ' ILE . 9.3 mt -87.75 -19.1 28.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 89' ' ' LEU . 4.2 p -122.25 -48.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 t -144.09 129.95 19.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.44 121.21 41.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.032 -175.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.33 136.91 75.7 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.127 2.551 . . . . 0.0 112.594 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 m -80.07 -16.59 54.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.281 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.89 146.92 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.699 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.05 136.31 69.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.17 131.99 24.43 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.776 -1.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.32 120.94 11.39 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . . . -55.89 121.22 8.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.931 0.396 . . . . 0.0 110.158 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.457 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 22.0 tpt180 -110.38 154.81 23.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.347 -176.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 64.87 43.02 4.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.421 0.629 . . . . 0.0 110.213 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -100.47 140.23 21.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.296 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.7 144.0 58.29 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.744 2.296 . . . . 0.0 111.914 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.31 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.14 4.28 78.15 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.44 -159.58 51.84 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.326 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -88.03 -30.51 19.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.498 HG22 ' HB3' ' A' ' 67' ' ' LEU . 7.6 tt -135.44 124.46 40.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.148 172.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -65.7 -20.25 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.558 ' HD2' ' O ' ' A' ' 89' ' ' LEU . 8.1 tmm_? -129.64 146.53 51.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -174.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.558 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 4.3 mm? -54.28 122.45 37.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 123.292 0.37 . . . . 0.0 111.159 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.38 124.44 15.55 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.945 1.764 . . . . 0.0 110.403 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 89' ' ' LEU . 90.9 mt-30 -134.79 144.38 47.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.989 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.607 ' OD2' ' HB2' ' A' ' 113' ' ' SER . 0.5 OUTLIER -56.34 145.17 59.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.76 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.93 -19.85 41.79 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.97 2.447 . . . . 0.0 112.437 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -80.78 -13.93 58.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.344 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.14 20.16 9.47 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.941 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -99.2 160.69 14.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.569 0.223 . . . . 0.0 110.568 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.66 122.97 48.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.375 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.593 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 52.8 m-85 -53.97 148.04 11.32 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.507 0.67 . . . . 0.0 112.599 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.545 ' HG2' HD21 ' A' ' 114' ' ' LEU . 62.1 mm-40 -112.01 138.6 48.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.036 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.765 HD23 HG23 ' A' ' 111' ' ' ILE . 2.2 tm? -129.39 122.64 29.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.72 113.45 17.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.883 0.373 . . . . 0.0 110.414 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 5.3 m -106.93 128.53 25.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.091 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 1.0 OUTLIER -82.71 137.38 32.35 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.403 -1.082 . . . . 0.0 111.428 -3.205 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -67.35 169.35 36.75 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.768 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.494 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 6.1 tp60 -95.84 -28.08 14.9 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 0.0 109.862 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -93.25 -5.76 49.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.781 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.61 10.57 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.08 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -72.74 -45.32 59.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.971 0.415 . . . . 0.0 110.348 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -127.97 124.56 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 177.335 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -100.01 112.68 24.96 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.874 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.765 HG23 HD23 ' A' ' 100' ' ' LEU . 7.5 pt -112.43 125.5 69.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -151.47 155.08 37.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.607 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 15.9 p -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.358 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.672 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 3.4 mm? -100.98 -12.66 18.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 110.822 -174.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 62.87 -154.9 42.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.275 173.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 124' ' ' ASP . 14.4 Cg_exo -69.05 -33.39 19.39 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.383 2.722 . . . . 0.0 113.135 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.577 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 2.8 p30 -83.7 -14.08 52.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.738 -0.385 . . . . 0.0 112.028 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.97 -3.96 18.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.755 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 1.045 ' O ' ' OG ' ' A' ' 122' ' ' SER . 24.3 m -107.83 139.47 20.66 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-N 117.329 0.565 . . . . 0.0 112.159 -173.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.7 155.31 39.73 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.505 2.803 . . . . 0.0 112.834 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 61.1 25.53 15.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.772 0.796 . . . . 0.0 110.74 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 1.045 ' OG ' ' O ' ' A' ' 119' ' ' VAL . 0.0 OUTLIER -93.49 174.61 7.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.116 -179.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.38 -41.87 98.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.696 0.76 . . . . 0.0 109.19 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.577 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 4.6 m-20 -99.3 75.24 1.98 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.54 1.162 . . . . 0.0 109.248 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.952 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 55.9 m-20 -143.39 112.67 6.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.259 169.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.544 ' HB ' ' OG ' ' A' ' 113' ' ' SER . 44.6 mm -87.34 104.9 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 109.999 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -95.23 157.19 21.93 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.673 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.459 ' HB2' HG13 ' A' ' 111' ' ' ILE . 62.6 t30 -65.89 -28.55 69.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.291 0.567 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -78.36 -23.63 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -81.03 -29.44 35.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 tp -78.37 -21.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.799 0.333 . . . . 0.0 110.938 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 C-N-CA 120.096 -1.05 . . . . 0.0 113.405 176.172 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 4.8 tp10 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.71 0.291 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 53.3 mtmt -58.77 -40.68 84.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.61 -44.96 88.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.345 . . . . 0.0 110.811 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.42 -40.53 77.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.981 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.61 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 13.1 ptm180 -65.9 -33.67 76.36 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.996 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm100 -62.99 -31.59 72.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 87.7 mttt -64.69 -39.22 93.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 31.2 t -60.7 -46.46 95.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.632 175.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 33' ' ' ARG . 82.6 t -58.63 -38.78 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.061 0.458 . . . . 0.0 110.558 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 41' ' ' VAL . 38.9 m -63.4 -43.87 96.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.891 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.9 -35.17 74.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.304 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.39 -45.25 95.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.187 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 38' ' ' SER . 23.7 m -64.64 -35.72 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.26 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.74 85.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.614 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.722 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 87.5 mt -60.55 -48.4 81.92 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.135 0.493 . . . . 0.0 110.101 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.65 -35.96 82.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.586 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.99 -42.92 99.77 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.819 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -60.53 -43.96 96.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.362 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 48.7 mt -59.42 -49.07 79.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.662 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.65 -41.59 97.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.994 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.57 -38.64 74.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.976 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.98 -33.25 73.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.44 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.88 -49.75 76.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.709 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.94 -47.01 17.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.9 10.12 41.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m 70.99 -7.2 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.488 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -139.0 148.7 43.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.829 -0.545 . . . . 0.0 111.455 -175.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.406 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 10.2 m-85 -69.25 142.73 92.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.0 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.69 155.99 49.15 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 123.051 2.501 . . . . 0.0 112.694 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 p -81.89 177.11 9.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.398 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -51.65 -41.39 61.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.4 -45.39 39.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.066 0.46 . . . . 0.0 110.573 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.449 ' HG2' ' HB3' ' A' ' 71' ' ' PRO . 50.4 mt-30 -68.39 -31.61 71.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.189 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.496 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -62.57 -48.85 78.67 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.086 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.44 -32.41 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -72.12 -29.17 63.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.986 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . . . -60.29 -20.83 60.72 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.819 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 7.6 mt -89.95 -9.79 47.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.33 -53.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 p -144.74 139.14 27.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.08 122.24 46.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HB3' ' HG2' ' A' ' 62' ' ' GLN . 52.1 Cg_exo -56.24 137.38 79.6 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.875 2.383 . . . . 0.0 111.776 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -84.64 -16.04 43.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.622 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 135.86 48.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.229 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.413 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 7.9 pt-20 -77.57 140.56 64.2 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.146 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.488 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 57.7 Cg_endo -72.09 132.11 24.22 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.232 -0.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -66.96 129.79 41.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.692 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.6 17.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.687 0.28 . . . . 0.0 110.416 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 29.0 tpt180 -109.26 162.95 13.81 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -177.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.458 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 9.5 p30 47.83 39.75 11.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.902 0.881 . . . . 0.0 111.795 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -85.14 147.29 47.29 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.025 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.19 138.81 48.35 Favored 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.283 1.988 . . . . 0.0 111.446 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.54 124.08 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.24 10.47 86.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.371 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.71 -121.05 21.62 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.764 0.332 . . . . 0.0 112.639 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.526 ' HB2' HD23 ' A' ' 67' ' ' LEU . 51.1 m-85 -114.03 -17.8 11.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.449 0.642 . . . . 0.0 109.553 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 88' ' ' ARG . 6.1 tt -143.15 129.12 16.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.818 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -60.77 -23.12 64.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -167.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.439 ' O ' HG12 ' A' ' 86' ' ' ILE . 59.6 mtp180 -130.42 167.12 19.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -60.74 133.2 91.78 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.69 137.32 63.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.787 2.324 . . . . 0.0 112.46 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -133.48 150.7 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.149 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.437 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 7.7 m-20 -55.88 150.85 26.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.88 -17.96 39.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.181 . . . . 0.0 111.623 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.484 ' CZ3' ' HA2' ' A' ' 115' ' ' GLY . 6.3 m-90 -81.96 -12.3 58.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.315 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.2 10.79 31.1 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.699 -0.762 . . . . 0.0 114.001 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -102.31 143.41 32.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.352 0.576 . . . . 0.0 111.022 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.1 130.7 38.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -61.28 163.13 6.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.772 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -127.93 139.43 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.641 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.517 HD11 ' HB ' ' A' ' 109' ' ' VAL . 13.3 tp -122.89 142.51 50.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.361 173.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.65 112.83 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.481 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 6.0 m -107.55 129.67 23.9 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.144 172.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 108' ' ' GLN . 2.0 Cg_endo -83.09 135.66 26.72 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.465 -1.056 . . . . 0.0 110.956 -5.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -68.85 174.45 32.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.359 -173.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -94.73 -27.67 15.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.172 0.511 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -99.81 21.83 11.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 151.26 -155.26 26.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.514 HE21 ' HA ' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -73.52 -36.83 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.015 0.407 . . . . 0.0 111.21 177.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -132.78 129.05 57.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 -178.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.42 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 0.4 OUTLIER -107.53 114.19 28.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.475 -179.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.434 HG13 ' HB2' ' A' ' 128' ' ' ASN . 5.5 pt -106.88 126.87 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.45 . . . . 0.0 110.025 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -145.02 148.35 33.62 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.417 ' HB3' ' OD1' ' A' ' 92' ' ' ASP . 2.5 m -106.82 137.18 45.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.513 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.46 -35.26 79.85 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.82 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.484 ' HA2' ' CZ3' ' A' ' 94' ' ' TRP . . . 86.69 -177.31 48.28 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.606 -176.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.85 -15.36 40.39 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.012 2.474 . . . . 0.0 112.926 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.61 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 15.9 p-10 -92.37 -12.5 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.723 -174.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.86 67.33 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.679 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.785 ' O ' ' OG ' ' A' ' 122' ' ' SER . 58.9 t -110.76 121.13 41.87 Favored Pre-proline 0 C--O 1.244 0.815 0 CA-C-O 120.744 0.307 . . . . 0.0 111.141 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.658 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 72.0 Cg_endo -76.13 156.5 38.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.411 2.74 . . . . 0.0 113.448 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 62.65 25.94 15.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.75 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.871 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -101.03 172.86 6.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.951 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.48 -32.48 73.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.81 -19.01 60.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.142 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.871 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.7 OUTLIER -62.0 138.71 58.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.986 -174.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -104.87 104.97 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.737 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.71 169.74 13.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.203 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.434 ' HB2' HG13 ' A' ' 111' ' ' ILE . 62.8 t30 -62.38 -33.98 75.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 110.568 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -77.9 -20.24 53.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.271 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -73.48 -46.5 47.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.109 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.95 -22.3 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 110.147 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.048 168.49 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.6 tp10 . . . . . 0 C--O 1.233 0.196 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 87.7 tttt -60.27 -41.85 94.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.01 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.89 -40.32 75.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.677 0.275 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 36' ' ' VAL . 49.4 m-20 -62.49 -47.56 83.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 13.9 ptm180 -68.19 -36.73 80.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.554 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 12.5 mm-40 -63.95 -35.15 79.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -66.44 -37.73 85.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.703 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 32' ' ' ASP . 85.9 t -60.68 -44.01 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.011 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 33' ' ' ARG . 96.7 t -59.94 -40.09 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.972 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.59 -45.65 93.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.4 ' O ' HD13 ' A' ' 43' ' ' LEU . 15.2 m-20 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.116 0.484 . . . . 0.0 110.018 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.5 tp -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.318 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.21 -36.64 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.31 94.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 47' ' ' LEU . 7.5 mp -60.67 -49.03 79.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -63.35 -36.92 85.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.953 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.39 96.89 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.217 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.52 -41.69 94.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.696 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.8 mp -59.75 -39.94 86.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.873 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.14 -36.21 79.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -42.94 77.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -65.7 -38.69 89.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -70.21 -32.79 70.85 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.774 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.4 tp -68.29 -40.98 81.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.032 0.444 . . . . 0.0 110.221 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.14 -44.96 28.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.422 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.58 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.6 m-80 -112.16 5.35 18.45 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -171.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.2 m 66.95 9.24 6.71 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -147.37 167.59 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.966 -0.459 . . . . 0.0 111.016 -177.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.422 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 21.9 m-85 -91.2 142.83 27.56 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.382 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.83 162.18 39.94 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.378 2.719 . . . . 0.0 113.632 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.2 p -88.07 178.87 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.182 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.0 m -50.13 -46.48 53.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.832 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.43 -44.9 61.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.501 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -64.98 -42.43 94.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.444 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.34 -44.49 98.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.702 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD21 ' O ' ' A' ' 98' ' ' TYR . 2.7 mp -69.66 -41.27 75.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.727 0.298 . . . . 0.0 111.39 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -72.52 -24.54 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.36 69.88 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.702 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -96.47 -0.28 49.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.932 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.6 -24.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 111.081 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.1 p -157.66 164.23 37.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.549 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.459 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -75.84 121.81 85.79 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.62 136.89 77.02 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.493 2.128 . . . . 0.0 112.136 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.4 m -82.49 -30.47 29.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.475 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.62 122.07 16.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.517 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -69.85 148.12 96.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.222 -175.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.58 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 14.5 Cg_exo -68.63 136.19 34.97 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.506 1.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -75.97 128.15 34.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.36 126.29 26.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.506 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -106.03 158.16 17.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.477 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.03 43.94 13.87 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.795 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.459 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 34.0 p90 -88.58 139.36 29.73 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.2 140.4 53.51 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.514 2.143 . . . . 0.0 111.38 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -64.31 123.88 20.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.16 86.4 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.927 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.41 -115.05 7.35 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.051 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.3 -21.73 4.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.287 0.565 . . . . 0.0 109.55 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.526 HG12 ' H ' ' A' ' 88' ' ' ARG . 14.0 tt -133.55 138.32 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.43 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 87' ' ' ARG . 38.4 mtp-105 -72.57 -20.8 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.526 ' H ' HG12 ' A' ' 86' ' ' ILE . 74.7 mtp180 -129.38 158.26 39.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.336 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.7 128.39 79.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.69 123.86 14.19 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.56 2.173 . . . . 0.0 112.822 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -127.84 140.39 52.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.635 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 4.8 p30 -68.85 155.58 93.03 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.932 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.53 -31.83 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.836 2.358 . . . . 0.0 113.666 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.445 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 6.5 m-90 -78.03 -19.01 55.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.855 0.359 . . . . 0.0 111.223 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.81 20.97 6.97 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.555 172.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.635 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 4.4 m -103.3 133.23 48.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.106 0.453 . . . . 0.0 110.552 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.79 128.73 37.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.495 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 76.6 m-85 -60.57 168.17 2.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 111.075 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -130.58 137.64 49.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.203 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.616 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -118.09 122.75 43.91 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.11 114.26 20.1 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.126 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.3 t -106.48 135.45 19.5 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.38 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.36 137.83 52.06 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.525 -1.448 . . . . 0.0 111.804 -3.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.83 141.88 47.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.652 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.96 -21.15 65.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.089 0.471 . . . . 0.0 110.262 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -126.89 31.54 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.29 -150.05 21.71 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.852 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -73.27 -40.21 64.77 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.616 ' HB ' HD21 ' A' ' 100' ' ' LEU . 4.5 m -132.84 151.27 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.886 175.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -131.15 123.03 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.604 0.24 . . . . 0.0 110.446 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.538 ' CG2' HD23 ' A' ' 100' ' ' LEU . 13.0 pt -106.87 129.68 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.541 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -151.13 161.05 43.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.287 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.485 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 44.0 p -112.32 150.92 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.471 175.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.35 -22.2 44.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.85 -171.97 54.11 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.553 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 13.4 Cg_exo -68.39 -23.79 37.61 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.045 2.497 . . . . 0.0 112.191 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.41 -12.43 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 111.291 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.21 11.8 79.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.983 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.8 ' O ' ' OG ' ' A' ' 122' ' ' SER . 98.9 t -97.28 116.8 66.02 Favored Pre-proline 0 C--O 1.239 0.526 0 CA-C-N 117.934 0.867 . . . . 0.0 111.747 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.5 151.77 33.31 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.557 2.838 . . . . 0.0 113.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.06 27.23 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.406 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 1.223 ' OG ' ' OD2' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -100.26 177.33 5.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.008 -176.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.28 -41.89 80.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.474 0.654 . . . . 0.0 109.31 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -88.56 65.39 7.81 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.398 1.094 . . . . 0.0 108.319 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 1.223 ' OD2' ' OG ' ' A' ' 122' ' ' SER . 0.4 OUTLIER -136.46 90.55 2.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.41 -1.723 . . . . 0.0 108.823 174.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.54 109.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.571 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.66 -162.98 10.47 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.754 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -63.27 -37.59 87.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.268 -0.466 . . . . 0.0 111.866 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 -78.63 -27.06 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.674 0.273 . . . . 0.0 110.388 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 m -56.83 -49.31 75.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.905 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.7 tt -92.13 -25.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.501 . . . . 0.0 110.632 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.78 176.581 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.751 0.31 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.25 178.95 33.72 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.279 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -85.73 -32.26 21.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.704 0.288 . . . . 0.0 110.68 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.417 ' HG2' ' OD1' ' A' ' 32' ' ' ASP . 4.8 ttpp -52.65 -51.93 57.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.051 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -58.28 -41.48 84.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.198 -175.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -61.72 -45.82 92.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.55 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.98 95.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.07 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.417 ' OD1' ' HG2' ' A' ' 28' ' ' LYS . 12.0 m-20 -66.52 -47.38 73.1 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 37' ' ' VAL . 12.8 ptm85 -69.77 -34.77 74.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.465 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -61.07 -38.52 86.49 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.826 0.346 . . . . 0.0 110.688 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -62.4 -39.3 92.78 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 21.6 t -60.94 -47.52 93.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.801 175.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 33' ' ' ARG . 99.9 t -60.31 -38.84 78.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.996 179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 m -59.02 -47.1 86.41 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.043 0.449 . . . . 0.0 110.765 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.445 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 5.4 m-20 -70.41 -34.8 72.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.699 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.8 tp -59.52 -44.95 93.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.423 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 37' ' ' VAL . 91.4 t -62.41 -41.34 91.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.288 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.04 90.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.085 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.481 ' O ' HD13 ' A' ' 47' ' ' LEU . 88.3 mt -60.25 -48.65 80.85 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.108 0.48 . . . . 0.0 110.316 177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -66.61 -36.05 81.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.166 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -61.73 -39.65 97.73 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.0 176.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.521 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -63.02 -39.81 95.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.232 175.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 43' ' ' LEU . 7.3 mp -60.76 -48.27 82.55 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.763 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.43 -36.83 85.43 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.266 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 24.6 mmt -68.02 -40.17 83.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.882 0.372 . . . . 0.0 110.628 178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -63.63 -38.73 92.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.84 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -67.83 -32.72 73.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.794 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.1 tp -62.96 -48.61 78.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.927 0.394 . . . . 0.0 110.443 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.96 -46.56 23.63 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.445 HD21 ' HA ' ' A' ' 77' ' ' ALA . 38.5 m-80 -101.22 -0.67 35.47 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.4 m 62.3 29.05 17.26 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.544 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.3 OUTLIER -164.15 158.6 19.36 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -82.93 140.94 43.38 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.937 0.398 . . . . 0.0 110.952 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -74.43 157.91 44.75 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.105 2.537 . . . . 0.0 113.771 -175.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.6 p -84.85 179.04 7.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.791 177.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.425 ' HA ' HD23 ' A' ' 100' ' ' LEU . 5.2 t -49.04 -44.78 41.88 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -171.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.17 -45.16 23.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.155 0.503 . . . . 0.0 110.751 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.462 HE22 ' NH2' ' A' ' 56' ' ' ARG . 48.2 mt-30 -64.12 -34.69 78.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.83 -174.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.407 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -65.73 -48.84 63.51 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.922 -177.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.54 -38.33 77.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.903 0.382 . . . . 0.0 111.036 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.435 HE22 HD21 ' A' ' 89' ' ' LEU . 70.4 mm-40 -72.08 -23.49 61.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.242 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.26 -24.48 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -176.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.521 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 11.0 mt -79.4 -18.33 52.52 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.24 176.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.93 -59.14 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.125 0.488 . . . . 0.0 111.905 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 t -152.2 148.39 27.53 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -174.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.94 122.07 50.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.848 -178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HB3' ' HG2' ' A' ' 62' ' ' GLN . 78.2 Cg_exo -53.48 139.83 65.12 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.149 2.566 . . . . 0.0 112.529 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.5 p -81.18 -18.28 46.8 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.91 177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.25 142.61 54.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.444 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.05 141.6 63.16 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.246 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.544 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 73.4 Cg_endo -76.99 143.72 76.42 Favored 'Cis proline' 0 C--N 1.344 0.294 0 C-N-CA 123.241 -1.566 . . . . 0.0 112.588 -4.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -69.88 121.28 17.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.034 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -58.42 130.9 48.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.807 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -112.66 164.72 13.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.863 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 63.03 32.35 15.47 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.397 0.618 . . . . 0.0 110.658 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -88.86 144.05 32.46 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.896 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.33 139.99 43.13 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.37 2.047 . . . . 0.0 111.992 178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.79 125.1 23.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.09 -9.41 60.67 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.789 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.09 -171.41 54.35 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.341 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.403 ' HB2' HD22 ' A' ' 67' ' ' LEU . 83.8 m-85 -83.14 -32.68 26.53 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 175.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.436 HG22 ' HB3' ' A' ' 67' ' ' LEU . 9.5 tt -139.07 126.94 26.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.678 174.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -67.4 -20.59 65.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -170.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -128.82 157.82 40.44 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.435 HD21 HE22 ' A' ' 65' ' ' GLN . 3.7 mm? -59.65 123.69 72.39 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.737 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.38 142.95 97.35 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.444 2.096 . . . . 0.0 111.27 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -138.18 144.7 40.82 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.818 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.49 142.08 52.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 170.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.8 -18.72 13.12 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.349 2.699 . . . . 0.0 113.457 -176.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.405 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 23.1 m-90 -81.65 -14.28 56.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.399 178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.14 25.65 5.51 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.29 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.5 m -103.75 139.6 38.76 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 122.641 -0.329 . . . . 0.0 110.328 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -87.73 119.22 27.84 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.31 -0.244 . . . . 0.0 110.345 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -50.95 145.71 6.97 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.748 0.655 . . . . 0.0 111.839 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.417 ' HG2' HD21 ' A' ' 114' ' ' LEU . 88.3 mm-40 -121.33 143.97 48.9 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.287 0.565 . . . . 0.0 111.625 -175.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.527 HD11 ' HB ' ' A' ' 109' ' ' VAL . 13.1 tp -122.48 142.27 50.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.741 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -128.08 112.57 14.74 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.555 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.8 t -107.4 131.22 21.88 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.438 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.44 143.64 64.9 Favored 'Cis proline' 0 N--CA 1.46 -0.461 0 C-N-CA 124.055 -1.227 . . . . 0.0 111.431 -2.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.24 156.14 34.51 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.711 -0.677 . . . . 0.0 113.985 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -73.4 -27.09 61.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.074 0.464 . . . . 0.0 110.559 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -110.53 -27.01 9.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.65 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -147.51 -144.96 4.09 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.704 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -73.63 -43.17 60.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.085 0.469 . . . . 0.0 110.055 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.527 ' HB ' HD11 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -140.64 128.38 23.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.301 179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.82 127.37 54.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.105 0.479 . . . . 0.0 111.23 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.2 pt -106.69 134.73 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.675 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.32 148.16 37.52 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.138 0.494 . . . . 0.0 111.402 -177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.621 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 4.7 m -103.4 146.68 28.13 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.058 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 114' ' ' LEU . 1.8 mm? -88.3 -20.5 25.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.704 0.288 . . . . 0.0 111.197 -168.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.26 -160.32 54.01 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.492 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.405 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 12.9 Cg_exo -69.95 -23.81 29.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.481 2.787 . . . . 0.0 112.38 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.5 ' OD2' HG22 ' A' ' 119' ' ' VAL . 0.8 OUTLIER -91.9 -14.24 29.95 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.077 -173.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.01 5.84 62.77 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.357 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.5 HG22 ' OD2' ' A' ' 117' ' ' ASP . 22.8 m -93.58 118.79 67.56 Favored Pre-proline 0 C--O 1.239 0.55 0 CA-C-N 117.548 0.674 . . . . 0.0 111.974 -175.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.49 148.06 29.28 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.38 2.72 . . . . 0.0 113.451 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 63.96 24.78 13.73 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.583 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.444 ' OG ' HG23 ' A' ' 119' ' ' VAL . 1.3 p -93.55 176.97 6.17 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.97 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -63.65 -41.88 98.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.159 0.504 . . . . 0.0 110.405 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.51 -22.11 66.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.447 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.621 ' HA ' ' O ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -56.94 104.82 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 O-C-N 123.689 0.618 . . . . 0.0 112.034 -171.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.5 mt -75.18 103.66 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.437 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.12 178.6 19.2 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.89 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -68.21 -25.16 65.08 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.618 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 31.2 t-105 -74.94 -31.3 61.47 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.6 m -66.99 -48.03 69.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.582 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 5.6 tp -75.75 -37.65 36.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.295 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.44 29.8 2.2 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.075 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -100.77 -12.62 18.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.849 0.357 . . . . 0.0 110.766 177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -86.89 76.32 9.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.293 0.568 . . . . 0.0 110.628 -175.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -131.15 -172.42 2.83 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.874 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 40.2 m80 59.65 34.85 22.3 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.364 0.415 . . . . 0.0 111.196 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -148.03 67.77 1.1 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.287 0.565 . . . . 0.0 110.003 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -135.06 115.67 13.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.891 177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -71.42 -16.16 62.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.803 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.528 -0.749 . . . . 0.0 109.587 175.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.78 0.324 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -132.26 172.04 21.26 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.992 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -76.0 101.32 5.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.874 0.369 . . . . 0.0 110.742 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -148.84 20.25 1.01 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.003 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -60.0 -37.0 78.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.715 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -63.2 -37.94 89.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.285 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.93 70.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.871 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -62.88 -47.04 85.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 37' ' ' VAL . 16.8 ptm180 -62.66 -34.8 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.802 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.61 -39.12 83.18 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.718 0.295 . . . . 0.0 111.003 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -68.8 -36.2 77.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.013 0.435 . . . . 0.0 110.035 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 68.2 t -60.36 -46.47 95.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.184 177.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 33' ' ' ARG . 89.2 t -60.04 -38.82 78.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.016 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.8 t -61.09 -46.72 89.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.055 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.81 -34.93 72.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.921 0.391 . . . . 0.0 110.629 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.62 -45.81 91.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.978 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 37' ' ' VAL . 29.3 m -65.32 -34.93 73.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.572 0.225 . . . . 0.0 110.539 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.81 94.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.451 ' O ' HD13 ' A' ' 47' ' ' LEU . 95.2 mt -61.0 -47.68 85.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.005 174.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.13 -43.02 73.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.952 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -65.21 -50.34 57.19 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.94 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -61.24 -38.42 86.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.939 0.399 . . . . 0.0 110.851 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.4 mp -61.77 -50.26 73.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.417 178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -70.9 -31.66 68.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.56 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.9 mtt -66.95 -42.45 85.19 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.727 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -61.42 -38.59 87.67 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 60.2 tttm -65.19 -32.88 74.79 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.0 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -65.71 -41.05 92.75 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.949 0.404 . . . . 0.0 109.952 177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -76.61 -46.48 25.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.329 -177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.514 HD21 ' HA ' ' A' ' 77' ' ' ALA . 45.0 m-80 -111.43 13.56 21.49 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 28.8 p 49.81 35.46 9.25 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.4 OUTLIER -167.08 156.34 10.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.503 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 38.0 m-85 -83.53 142.08 42.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.319 . . . . 0.0 110.874 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.74 145.06 61.85 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.016 2.477 . . . . 0.0 112.891 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -75.87 177.81 6.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.622 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.418 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.9 t -50.55 -40.4 51.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -172.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.0 -45.58 26.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.174 0.512 . . . . 0.0 110.543 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -72.18 -28.11 63.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.273 -171.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.43 -50.3 60.29 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.825 -0.703 . . . . 0.0 113.261 -175.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.73 -31.02 67.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.175 0.512 . . . . 0.0 110.795 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -72.29 -23.44 61.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.776 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.28 -32.44 68.41 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.414 HD13 ' CG2' ' A' ' 86' ' ' ILE . 0.3 OUTLIER -97.86 -3.35 38.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.294 -0.563 . . . . 0.0 112.45 179.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 86.7 t -103.2 -62.83 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.286 0.565 . . . . 0.0 110.554 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -139.58 141.86 37.16 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.377 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.571 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -57.38 121.16 45.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -56.33 135.76 71.83 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.532 2.155 . . . . 0.0 112.231 -177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.7 m -90.45 -9.24 48.17 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.866 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.45 128.8 33.81 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.931 176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 38.9 tt0 -73.82 139.43 76.99 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.097 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.487 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 15.3 Cg_exo -69.14 140.96 61.73 Favored 'Cis proline' 0 C--N 1.352 0.737 0 C-N-CA 124.299 -1.125 . . . . 0.0 113.376 1.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -86.35 136.94 32.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.658 -174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -74.9 122.86 24.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.963 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -104.91 156.02 18.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.334 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 59.45 49.85 8.23 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.507 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.571 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 38.6 p90 -92.17 144.57 29.27 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.03 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.62 138.96 39.53 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.297 1.998 . . . . 0.0 111.663 176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -64.93 125.27 24.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.191 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.45 2.19 90.4 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.997 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.72 -152.75 51.61 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.293 -0.479 . . . . 0.0 112.362 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -100.95 -26.94 13.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 9.1 tt -133.32 133.87 57.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -75.52 -25.82 57.55 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -130.45 172.48 11.84 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 121.038 -0.265 . . . . 0.0 110.607 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 83.2 mt -55.58 124.01 53.85 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.164 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.68 141.08 58.67 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -140.04 139.19 35.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.104 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 43.2 m-20 -58.67 154.43 35.64 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.862 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.58 -25.01 24.3 Favored 'Trans proline' 0 CA--C 1.532 0.412 0 C-N-CA 122.735 2.29 . . . . 0.0 112.839 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -80.71 -12.8 59.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.403 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.11 33.05 5.6 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.628 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.523 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 38.8 m -102.48 133.97 46.56 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.862 0.363 . . . . 0.0 111.572 -176.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -79.12 124.9 28.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.08 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -65.68 138.76 58.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.24 -177.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -112.69 142.35 45.41 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.254 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.675 HD23 HG23 ' A' ' 111' ' ' ILE . 3.4 tm? -126.21 123.28 37.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 176.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.09 113.52 27.17 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.701 -175.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 26.7 p -106.56 119.71 50.79 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.484 171.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 91.6 Cg_endo -84.82 159.69 66.5 Favored 'Cis proline' 0 C--N 1.346 0.398 0 C-N-CA 124.042 -1.233 . . . . 0.0 111.795 -3.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -84.51 163.89 39.28 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.783 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -96.1 -35.64 11.28 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.631 0.729 . . . . 0.0 109.522 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -95.69 14.07 24.31 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.39 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.8 -156.01 27.31 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -72.4 -34.92 68.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.423 0.611 . . . . 0.0 110.867 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.663 ' HB ' HD21 ' A' ' 100' ' ' LEU . 31.6 m -138.02 151.02 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -117.99 121.5 40.81 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.535 -176.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.675 HG23 HD23 ' A' ' 100' ' ' LEU . 7.6 pt -106.75 126.63 62.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 42.6 p90 -148.25 144.44 27.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.297 0.57 . . . . 0.0 111.647 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.3 m -92.16 138.26 31.68 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.409 177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 73.8 mt -66.27 -16.36 63.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.179 -178.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.6 -165.53 49.94 Favored Glycine 0 N--CA 1.44 -1.074 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.683 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.71 -34.54 24.52 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 123.528 2.819 . . . . 0.0 113.053 -176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -90.12 -10.93 42.81 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.646 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.36 4.94 87.48 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.908 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.4 t -86.72 116.1 64.77 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.737 0.268 . . . . 0.0 110.991 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.486 ' O ' ' HG2' ' A' ' 121' ' ' GLU . 47.0 Cg_endo -71.47 153.81 60.61 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.871 2.381 . . . . 0.0 113.042 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 120' ' ' PRO . 11.9 pt-20 55.66 25.05 7.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.911 1.284 . . . . 0.0 111.869 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.6 OUTLIER -94.61 177.9 5.77 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.759 178.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -72.69 -27.4 62.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.991 0.424 . . . . 0.0 110.787 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.16 -17.22 58.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.622 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.445 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -62.74 121.9 14.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.098 -177.111 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 70.5 mt -91.76 105.51 16.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -112.0 179.63 19.61 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.078 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -58.47 -38.78 78.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.786 0.327 . . . . 0.0 111.181 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 24.9 t-105 -74.76 -22.48 58.76 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.784 -178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 41.6 m -64.04 -43.57 95.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.053 0.454 . . . . 0.0 110.695 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -87.0 -38.69 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.959 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 128.72 30.08 0.72 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.361 -0.923 . . . . 0.0 113.176 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -94.51 140.29 30.03 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.02 0.438 . . . . 0.0 110.332 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -163.16 119.65 1.82 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.179 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -72.45 81.54 1.06 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.309 0.576 . . . . 0.0 109.946 -178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -72.76 118.14 15.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.544 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 48.0 m80 -124.75 37.77 4.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.372 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -105.47 154.98 19.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.876 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -128.13 141.14 51.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.577 0.227 . . . . 0.0 110.445 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.542 -0.742 . . . . 0.0 109.961 177.022 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.69 0.281 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.21 -59.08 4.97 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.09 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -129.48 149.81 51.1 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -108.6 22.08 16.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.458 0.647 . . . . 0.0 109.655 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 8.1 tp10 -56.22 -43.26 78.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.934 -176.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -60.77 -41.02 94.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.881 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.04 81.69 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.101 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 36' ' ' VAL . 67.7 m-20 -68.9 -48.11 64.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.197 -179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 12.3 ptm85 -66.9 -35.21 79.5 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.867 -174.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -60.77 -37.81 83.13 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.094 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HD3' ' HG3' ' A' ' 93' ' ' PRO . 30.7 tttp -64.35 -41.94 96.5 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.679 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 60.9 t -61.1 -44.05 97.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.479 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 41' ' ' VAL . 77.4 t -62.91 -38.96 83.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.54 175.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -62.27 -46.01 90.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.885 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.45 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 64.4 m-20 -66.67 -36.31 82.24 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.306 0.574 . . . . 0.0 109.741 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 22.5 tp -61.37 -42.76 99.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.98 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 37' ' ' VAL . 85.1 t -62.62 -38.11 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.025 0.441 . . . . 0.0 110.247 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.83 98.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.618 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 39' ' ' ASP . 96.6 mt -64.47 -47.89 77.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.542 177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.514 ' HG2' HD11 ' A' ' 111' ' ' ILE . 4.2 mm-40 -58.4 -44.95 89.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.281 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.25 -40.94 99.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.619 -0.8 . . . . 0.0 111.924 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -61.21 -42.38 98.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.897 0.38 . . . . 0.0 110.791 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.5 mp -64.27 -45.44 88.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.09 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -61.56 -43.68 98.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.5 mmt -67.02 -43.67 82.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.203 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -63.52 -41.15 98.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.446 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.65 -33.24 74.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.815 178.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 63.5 tp -67.55 -50.42 58.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.73 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -76.71 -44.75 32.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.888 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 56' ' ' ARG . 36.6 m-80 -95.28 2.93 54.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.548 -173.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 13.2 m 68.67 3.78 4.05 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 171.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -159.58 165.52 32.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.727 0.298 . . . . 0.0 111.11 -178.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -74.12 142.02 78.55 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.572 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.49 143.28 42.4 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.189 2.592 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.617 HG22 ' H ' ' A' ' 60' ' ' THR . 1.4 m -72.35 176.82 4.97 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 175.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.617 ' H ' HG22 ' A' ' 59' ' ' THR . 8.8 t -51.34 -43.65 61.82 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -170.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.09 -38.97 51.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.134 0.492 . . . . 0.0 110.348 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -70.82 -31.81 68.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.567 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.43 -49.03 73.21 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.523 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.1 mp -69.58 -35.49 75.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.404 . . . . 0.0 111.093 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -72.54 -24.4 61.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.304 -0.407 . . . . 0.0 112.053 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.1 -29.38 67.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -171.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.2 pt? -103.61 -1.92 27.46 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.672 0.272 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.689 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 74.9 t -109.49 -59.84 3.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.257 0.551 . . . . 0.0 111.074 -175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.0 p -156.68 136.03 12.16 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -53.05 121.57 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.459 0.474 . . . . 0.0 111.34 -172.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 51.1 Cg_exo -56.98 137.07 80.32 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.007 2.472 . . . . 0.0 112.598 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.0 m -89.76 3.84 51.57 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.774 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.23 148.88 22.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.046 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -77.37 137.06 64.2 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.19 131.77 24.56 Favored 'Cis proline' 0 C--O 1.235 0.34 0 C-N-CA 122.957 -1.684 . . . . 0.0 112.247 -0.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -63.6 126.27 26.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.159 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.76 132.32 53.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.685 -178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -118.07 149.94 40.15 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.228 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 59.49 44.23 15.13 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.687 0.617 . . . . 0.0 110.542 177.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -94.84 153.39 40.01 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.274 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.55 140.37 21.29 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.307 2.005 . . . . 0.0 111.222 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.77 125.03 23.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.06 10.32 86.26 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.615 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 59.39 -119.89 20.2 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -126.27 -37.44 2.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.689 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 13.8 tt -124.94 127.45 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.874 172.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -69.29 -21.67 63.86 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -129.39 165.03 22.35 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.405 HD22 HD23 ' A' ' 64' ' ' LEU . 69.5 mt -60.23 126.55 84.39 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.464 ' O ' ' HD2' ' A' ' 98' ' ' TYR . 37.9 Cg_endo -67.07 138.86 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.463 2.108 . . . . 0.0 111.511 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -133.4 138.51 46.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.762 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 4.4 p30 -67.28 152.95 95.61 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.429 ' HG3' ' HD3' ' A' ' 35' ' ' LYS . 27.0 Cg_exo -59.27 -17.82 41.65 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.263 2.642 . . . . 0.0 113.169 -170.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.556 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.5 m-90 -81.27 -26.47 35.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.699 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 127.02 10.87 3.68 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.94 172.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.584 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 14.7 m -103.63 148.38 26.09 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 117.548 0.674 . . . . 0.0 111.038 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.19 133.71 34.59 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.104 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.679 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 78.4 m-85 -60.61 148.65 37.52 Favored 'General case' 0 CA--C 1.517 -0.312 0 O-C-N 123.231 0.332 . . . . 0.0 110.312 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -130.4 143.21 50.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.15 0.5 . . . . 0.0 111.361 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -111.26 121.51 45.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -106.89 112.28 25.17 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.083 0.468 . . . . 0.0 110.783 -172.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.9 p -106.85 130.99 22.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.743 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -82.33 159.77 78.09 Favored 'Cis proline' 0 N--CA 1.462 -0.369 0 C-N-CA 123.678 -1.384 . . . . 0.0 111.125 -4.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -70.96 159.24 53.86 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.569 -0.824 . . . . 0.0 113.136 -174.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -96.2 -36.04 11.08 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -101.97 1.27 36.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.976 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -174.99 -155.88 13.26 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.484 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 11.9 mm100 -74.69 -29.32 61.18 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 117.271 0.535 . . . . 0.0 110.83 176.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.635 ' HB ' HD21 ' A' ' 100' ' ' LEU . 13.5 m -144.78 151.16 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.618 176.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.39 133.02 51.41 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.01 0.433 . . . . 0.0 111.614 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.623 HG23 HD23 ' A' ' 100' ' ' LEU . 6.7 pt -112.3 127.31 69.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.87 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -150.84 160.87 43.6 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.217 0.532 . . . . 0.0 111.884 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 6.2 p -106.85 146.68 30.66 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.651 175.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 7.3 mp -86.61 -20.31 28.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.781 -174.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.556 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 76.53 -159.64 50.09 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.352 -0.84 . . . . 0.0 113.57 170.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -69.28 -23.79 32.57 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 123.64 2.893 . . . . 0.0 112.298 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.68 -13.97 35.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.493 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.5 13.79 74.44 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.697 -0.763 . . . . 0.0 113.068 175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.8 m -111.3 123.64 34.6 Favored Pre-proline 0 C--O 1.242 0.664 0 CA-C-N 117.515 0.657 . . . . 0.0 112.194 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -78.13 157.01 30.15 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.503 2.802 . . . . 0.0 112.128 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 63.73 42.41 6.26 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.085 0.945 . . . . 0.0 109.497 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.6 p -120.86 177.26 5.16 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.881 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -73.73 -31.73 63.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -67.55 -28.42 67.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.753 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 113' ' ' SER . 3.5 m-20 -47.07 112.0 0.47 Allowed 'General case' 0 C--O 1.233 0.203 0 O-C-N 124.282 0.989 . . . . 0.0 112.131 -172.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.587 ' HB ' HG11 ' A' ' 36' ' ' VAL . 4.8 mp -84.62 105.91 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 175.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.505 ' O ' HG22 ' A' ' 130' ' ' THR . . . -130.4 -172.24 13.09 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.324 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -63.89 -37.62 88.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.898 0.38 . . . . 0.0 111.727 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 63.3 t90 -77.3 -19.82 55.89 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.545 -173.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 127' ' ' GLY . 3.4 t -88.68 -22.33 23.47 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.399 -0.521 . . . . 0.0 110.951 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.78 -42.98 13.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.701 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 146.07 -18.43 1.75 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.099 -1.048 . . . . 0.0 113.096 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -69.98 99.78 1.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.9 0.381 . . . . 0.0 111.353 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -101.95 147.18 26.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.222 -0.444 . . . . 0.0 109.867 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -74.38 111.78 9.89 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -67.94 111.92 4.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.044 -172.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -89.24 88.88 7.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.055 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -84.76 23.55 1.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.021 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -113.74 -2.23 13.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.81 0.338 . . . . 0.0 110.729 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.169 -178.243 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.53 20.01 69.93 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.012 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -83.84 91.36 7.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.173 0.511 . . . . 0.0 110.278 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -57.23 -34.29 68.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.501 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -58.79 -43.05 90.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.022 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -59.92 -38.52 82.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.117 -175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.36 -46.48 60.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.944 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 36' ' ' VAL . 62.5 m-20 -69.29 -42.53 75.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.73 -176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.469 ' O ' HG23 ' A' ' 37' ' ' VAL . 14.2 ptm180 -62.17 -34.48 76.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.104 -0.238 . . . . 0.0 111.093 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -58.78 -37.05 75.42 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.8 0.334 . . . . 0.0 111.082 175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -68.58 -39.59 80.9 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 32' ' ' ASP . 46.7 t -61.37 -41.76 91.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.662 ' O ' HG23 ' A' ' 41' ' ' VAL . 96.2 t -60.52 -41.23 86.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.589 176.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.8 t -59.26 -48.23 82.38 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.003 0.43 . . . . 0.0 110.887 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.403 ' HB2' ' OH ' ' A' ' 98' ' ' TYR . 31.1 m-20 -69.86 -34.26 73.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.22 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.13 -39.9 91.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.657 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 37' ' ' VAL . 52.2 t -63.5 -37.73 80.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 110.205 175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.06 -35.63 77.44 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.596 176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.445 ' O ' HD13 ' A' ' 47' ' ' LEU . 9.0 mp -64.08 -47.68 79.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.465 175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -56.29 -37.4 69.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.999 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.49 -45.46 85.17 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.969 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -61.32 -44.62 96.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.793 177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 43' ' ' LEU . 7.9 mp -62.93 -41.88 99.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.653 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -63.11 -44.77 94.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.447 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.9 mmt -65.77 -43.87 87.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.046 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.495 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 67.1 t80 -65.26 -45.22 85.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.03 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -69.6 -33.1 72.21 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.576 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 45.4 tp -64.28 -42.32 96.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.073 0.463 . . . . 0.0 110.313 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -77.32 -48.72 16.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.906 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -98.7 -4.82 32.77 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -169.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 65.9 24.34 11.25 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.448 0.468 . . . . 0.0 111.945 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.31 149.74 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.403 ' HB2' ' OE1' ' A' ' 108' ' ' GLN . 31.2 m-85 -74.4 146.9 84.61 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.797 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.87 142.08 50.91 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.691 2.261 . . . . 0.0 112.295 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.2 p -74.73 177.51 6.11 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.795 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.511 ' HA ' HD12 ' A' ' 100' ' ' LEU . 13.3 t -51.46 -37.17 47.51 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -77.39 -41.18 41.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.086 0.469 . . . . 0.0 111.268 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -72.62 -37.78 67.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.294 -175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -56.59 -49.21 71.27 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.348 -0.453 . . . . 0.0 113.783 -171.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.697 HD21 ' O ' ' A' ' 98' ' ' TYR . 7.4 mp -69.96 -40.22 75.54 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.925 0.393 . . . . 0.0 111.668 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -72.55 -23.98 61.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.234 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -26.46 62.76 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -169.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.7 pt? -104.52 -2.0 25.82 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.47 -38.75 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.4 t -156.44 130.35 8.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.66 121.99 36.91 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.432 -176.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.85 137.47 58.37 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.833 2.355 . . . . 0.0 112.367 178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.0 p -87.45 -19.59 27.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.087 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.23 137.48 57.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.369 176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.04 138.19 92.36 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.495 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 10.7 Cg_exo -73.46 135.12 38.48 Favored 'Cis proline' 0 C--O 1.233 0.272 0 C-N-CA 123.747 -1.355 . . . . 0.0 112.34 -3.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -70.88 121.62 18.42 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.8 124.26 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.736 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -107.46 166.3 10.76 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.372 176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 47.76 40.27 11.96 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 124.192 0.933 . . . . 0.0 111.839 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -89.75 150.17 43.49 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.966 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.93 137.74 32.69 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.025 1.816 . . . . 0.0 111.3 175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.59 124.24 22.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.914 0.387 . . . . 0.0 110.41 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.95 4.95 86.65 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.645 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.45 -142.55 40.94 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.399 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.85 -14.38 13.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.286 0.565 . . . . 0.0 109.594 178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.9 tt -136.83 141.48 40.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.004 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -68.85 -30.97 69.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.886 -172.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -131.18 154.36 48.46 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.294 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.7 tt -62.26 118.8 43.52 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -50.98 128.43 24.77 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.358 2.705 . . . . 0.0 113.206 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -126.37 140.43 52.5 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.672 174.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.2 p30 -71.0 152.5 94.92 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 -15.53 13.66 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.547 2.832 . . . . 0.0 113.683 -177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.422 ' CZ3' HG21 ' A' ' 36' ' ' VAL . 5.4 m-90 -80.57 -19.48 45.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.996 0.427 . . . . 0.0 110.361 177.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 109.16 19.31 8.57 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.918 172.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.496 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 0.9 OUTLIER -103.35 146.24 28.77 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.031 0.443 . . . . 0.0 110.849 -176.317 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.93 126.24 36.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.354 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.697 ' O ' HD21 ' A' ' 64' ' ' LEU . 5.1 m-85 -52.9 151.62 4.5 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.84 0.713 . . . . 0.0 112.692 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -115.68 137.49 52.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.364 -179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.65 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.2 tm? -123.32 122.39 38.22 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -117.1 112.55 21.05 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.787 0.327 . . . . 0.0 110.486 -175.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.484 ' HB3' HG12 ' A' ' 109' ' ' VAL . 20.7 p -107.08 127.97 26.95 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.272 171.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 97.0 Cg_endo -85.06 139.94 29.29 Favored 'Cis proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.907 -1.289 . . . . 0.0 111.648 -5.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.95 161.63 46.92 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.969 -0.559 . . . . 0.0 113.112 -175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -85.15 -20.81 29.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.965 0.412 . . . . 0.0 110.617 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -105.74 -43.98 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.514 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.5 -151.6 8.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.97 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -73.33 -45.64 54.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.65 ' HB ' HD21 ' A' ' 100' ' ' LEU . 16.2 m -128.67 140.48 49.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.413 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.43 125.4 54.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.881 0.372 . . . . 0.0 111.762 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.612 HG23 HD23 ' A' ' 100' ' ' LEU . 11.3 pt -108.35 125.73 65.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.147 176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -151.69 163.09 39.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.057 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 15.5 m -126.81 146.52 50.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.872 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.446 ' HB3' ' HA2' ' A' ' 118' ' ' GLY . 1.8 mm? -66.88 -22.76 65.96 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -169.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.04 -169.16 43.83 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.831 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -68.29 -25.02 36.87 Favored 'Trans proline' 0 C--N 1.337 -0.058 0 C-N-CA 122.891 2.394 . . . . 0.0 112.843 -175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -96.85 -11.08 25.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.115 -173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 114' ' ' LEU . . . 76.09 9.75 85.39 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.406 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.3 t -89.16 112.88 53.8 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.043 0.421 . . . . 0.0 111.448 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.419 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 3.3 Cg_exo -75.86 156.39 39.22 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 123.096 2.531 . . . . 0.0 112.624 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 64.73 16.25 10.28 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.283 176.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 1.9 p -94.27 175.85 6.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.818 -178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -85.73 -23.75 27.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.39 . . . . 0.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -71.43 -22.43 61.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 122' ' ' SER . 1.0 OUTLIER -55.29 132.05 46.99 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.346 -179.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.97 95.75 3.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -106.6 148.96 16.52 Favored Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.301 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.676 ' OD1' ' HB2' ' A' ' 133' ' ' PHE . 64.6 t30 -66.91 -26.03 66.66 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.44 0.638 . . . . 0.0 110.472 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -74.5 -28.43 60.99 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.921 175.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.6 m -74.69 -37.47 62.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.956 -178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.5 tp -78.39 -36.52 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.18 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.27 12.14 14.24 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.106 -1.045 . . . . 0.0 114.474 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.676 ' HB2' ' OD1' ' A' ' 128' ' ' ASN . 51.7 m-85 -69.53 -70.52 0.28 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.26 1.03 . . . . 0.0 110.861 177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.516 ' HB2' ' ND2' ' A' ' 128' ' ' ASN . 3.0 t60 -86.02 66.57 9.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.038 0.447 . . . . 0.0 110.008 -177.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -94.43 149.67 21.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.399 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -99.85 138.16 37.32 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -91.83 82.04 5.2 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.889 0.376 . . . . 0.0 111.089 -176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -149.43 -10.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.735 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -91.03 -29.3 17.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.975 0.417 . . . . 0.0 110.454 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.259 -179.28 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.041 0.448 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.57 19.68 3.35 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.99 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -89.59 73.67 7.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.662 0.744 . . . . 0.0 110.307 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -114.24 34.75 4.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.16 -0.927 . . . . 0.0 108.94 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.9 tp10 -56.04 -43.88 78.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.301 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 36.2 mtmm -69.56 -36.74 76.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.598 -176.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.85 -45.74 77.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.998 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 -44.47 87.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.521 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 37' ' ' VAL . 13.4 ptm180 -67.72 -35.16 78.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.601 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 40.8 mt-30 -63.91 -36.45 83.99 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.97 177.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.71 -39.84 92.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 173.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 76.1 t -61.05 -43.02 95.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.272 174.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 33' ' ' ARG . 88.2 t -60.54 -39.46 81.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.411 ' O ' HG22 ' A' ' 41' ' ' VAL . 50.4 m -61.32 -46.95 88.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.025 0.44 . . . . 0.0 111.055 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.16 -34.42 73.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.277 0.56 . . . . 0.0 110.491 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 128' ' ' ASN . 25.8 tp -65.22 -44.55 87.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.519 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 37' ' ' VAL . 32.8 m -63.53 -35.82 74.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -39.92 90.87 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.79 0.329 . . . . 0.0 110.47 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.5 mt -62.57 -48.54 79.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.685 176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.79 -37.77 88.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.34 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.4 -44.81 97.22 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.769 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.43 -44.13 96.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.735 0.302 . . . . 0.0 110.868 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.54 -44.11 97.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.025 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -63.08 -41.73 99.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.866 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 89.7 mtp -70.7 -38.83 73.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.733 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 77' ' ' ALA . 4.9 t80 -62.25 -42.67 99.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.954 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -69.98 -31.79 69.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.3 -49.1 75.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.924 0.392 . . . . 0.0 110.51 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -76.02 -45.49 34.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -98.32 -1.33 41.98 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -172.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.0 m 63.14 17.34 10.1 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 177.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.86 147.58 21.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -66.74 140.55 96.38 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.956 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.24 149.09 69.77 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.967 2.444 . . . . 0.0 112.439 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.574 HG22 ' H ' ' A' ' 60' ' ' THR . 0.7 OUTLIER -81.71 177.46 8.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.622 176.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.574 ' H ' HG22 ' A' ' 59' ' ' THR . 8.8 t -51.42 -40.53 59.51 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -169.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -77.14 -42.98 35.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.302 0.572 . . . . 0.0 110.2 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -69.37 -33.59 73.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.683 -173.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.9 -49.36 42.36 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.917 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.592 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.3 tp -66.16 -41.01 90.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.963 0.411 . . . . 0.0 111.422 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.449 ' HA ' HG12 ' A' ' 68' ' ' VAL . 34.6 mt-30 -73.03 -23.11 60.56 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.17 -25.66 61.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -170.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.8 pt? -104.65 -2.0 25.63 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 65' ' ' GLN . 7.5 p -117.83 -43.62 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.818 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 65' ' ' GLN . 47.0 m -156.51 129.58 7.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -56.24 121.53 42.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.723 0.297 . . . . 0.0 111.442 -175.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 27.9 Cg_exo -63.15 137.39 61.23 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.739 2.293 . . . . 0.0 112.604 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 10.5 p -86.52 -10.9 53.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.96 176.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.64 138.32 46.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.606 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.48 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 6.1 mp0 -77.03 141.79 68.04 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.92 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 48.2 Cg_endo -69.89 131.33 19.11 Favored 'Cis proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 -1.672 . . . . 0.0 112.532 -0.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -68.96 129.38 39.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.949 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . . . -70.56 125.96 28.28 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.67 -177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -119.34 163.75 16.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.538 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 63.32 39.28 9.61 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.369 0.604 . . . . 0.0 110.229 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -97.83 143.15 25.71 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.58 -176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.45 143.8 35.28 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.595 2.196 . . . . 0.0 111.628 175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -65.08 124.63 22.62 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.809 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.26 10.02 86.48 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.884 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.75 -149.61 51.45 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.2 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -109.95 -5.59 15.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.388 0.613 . . . . 0.0 109.881 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 12.2 tt -142.36 137.06 29.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.694 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -72.18 -22.79 61.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.948 -169.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -138.3 170.16 16.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.896 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.85 128.52 70.43 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 172.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.43 129.11 21.74 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.346 2.031 . . . . 0.0 112.226 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -121.16 140.47 51.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.733 176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.0 p30 -72.91 153.15 91.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 92' ' ' ASP . 13.8 Cg_endo -56.23 -17.89 22.06 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.324 2.683 . . . . 0.0 113.576 -174.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.575 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 7.3 m-90 -81.38 -26.68 35.3 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.697 0.284 . . . . 0.0 110.61 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.94 18.76 4.59 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.871 -0.68 . . . . 0.0 113.718 173.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.65 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 69.5 m -103.68 154.24 19.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 117.489 0.645 . . . . 0.0 111.281 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -92.36 129.88 38.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.218 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.592 ' O ' HD21 ' A' ' 64' ' ' LEU . 19.1 m-85 -60.95 146.23 47.61 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -127.6 140.47 52.09 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.155 0.502 . . . . 0.0 111.766 -177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.693 HD21 ' HB ' ' A' ' 109' ' ' VAL . 2.8 tm? -111.89 120.94 43.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -112.64 113.05 25.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.072 0.463 . . . . 0.0 111.176 -171.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 19.8 m -106.55 131.74 21.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.171 171.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 94.1 Cg_endo -81.75 146.14 65.72 Favored 'Cis proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.762 -1.349 . . . . 0.0 111.369 -4.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.34 161.22 34.77 Favored Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.897 -176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.01 -35.55 11.36 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.111 0.481 . . . . 0.0 109.746 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -94.99 -40.24 9.76 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -127.16 -157.98 9.66 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.39 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -74.49 -34.61 63.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.948 0.374 . . . . 0.0 110.839 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.693 ' HB ' HD21 ' A' ' 100' ' ' LEU . 6.5 m -135.96 124.05 36.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.987 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 124.58 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.378 -178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.658 HG23 HD23 ' A' ' 100' ' ' LEU . 8.7 pt -106.29 126.55 61.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.278 173.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 127' ' ' GLY . 11.7 p90 -150.31 160.58 43.61 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.204 0.526 . . . . 0.0 111.643 -177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.3 m -108.48 126.72 53.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.504 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.6 -31.23 72.02 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 123.804 0.69 . . . . 0.0 110.748 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.575 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 78.99 -154.09 38.84 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.0 173.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.36 -27.41 34.13 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.233 2.622 . . . . 0.0 113.629 -174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.551 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.2 p-10 -87.34 -13.46 43.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.642 -173.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.36 13.27 73.69 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.238 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.551 ' HB ' ' OD2' ' A' ' 117' ' ' ASP . 77.9 t -119.03 121.23 30.56 Favored Pre-proline 0 C--O 1.247 0.93 0 CA-C-O 120.712 0.292 . . . . 0.0 111.084 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.659 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 71.9 Cg_endo -76.06 146.97 29.55 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.508 2.805 . . . . 0.0 112.983 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 121' ' ' GLU . 5.5 tp10 65.19 25.15 12.35 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 122.074 0.94 . . . . 0.0 110.338 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.22 172.42 8.31 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.451 172.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -76.14 -0.41 21.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.811 0.338 . . . . 0.0 111.671 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -103.56 -13.84 16.4 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.185 0.517 . . . . 0.0 109.964 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.659 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -65.76 134.76 53.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.582 -174.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.17 108.44 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.908 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 112' ' ' PHE . . . -110.7 176.49 18.8 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.542 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.509 ' HB2' HG13 ' A' ' 111' ' ' ILE . 63.3 t30 -65.14 -28.87 69.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.364 0.602 . . . . 0.0 110.473 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.8 t-105 -77.11 -19.44 56.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.803 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 21.4 m -74.16 -40.34 62.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.7 tp -81.63 -34.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.018 0.437 . . . . 0.0 110.244 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.76 36.84 3.86 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.894 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.465 ' HB2' ' OD1' ' A' ' 128' ' ' ASN . 39.3 m-85 -87.49 78.43 8.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.505 0.669 . . . . 0.0 110.509 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -101.95 103.4 14.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.874 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -97.94 113.36 25.17 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.27 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -148.12 87.14 1.59 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.226 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -71.22 133.96 46.52 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.136 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 38.5 p-80 -141.77 136.05 30.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.653 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -137.71 21.7 2.89 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.415 0.626 . . . . 0.0 110.029 -176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.548 -0.739 . . . . 0.0 109.919 178.287 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.575 0.226 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.33 -47.76 1.58 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.517 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -70.37 -25.4 63.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.738 0.304 . . . . 0.0 111.412 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -116.87 75.24 0.95 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.942 0.401 . . . . 0.0 110.114 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -58.81 -42.78 89.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.687 -174.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -61.73 -48.01 82.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.987 0.422 . . . . 0.0 110.397 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.08 -36.63 72.31 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.377 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -63.2 -47.1 83.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.109 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.561 ' O ' HG23 ' A' ' 37' ' ' VAL . 35.8 ptt180 -67.67 -34.79 77.63 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.662 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -62.15 -34.15 75.84 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 111.617 0.228 . . . . 0.0 111.617 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.69 -40.37 92.27 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 92.6 t -60.78 -44.88 98.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.415 176.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 33' ' ' ARG . 60.7 t -58.76 -38.41 72.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.513 177.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.0 m -61.9 -45.93 91.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.09 -34.84 73.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.075 0.464 . . . . 0.0 110.649 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.411 HD21 ' HA ' ' A' ' 128' ' ' ASN . 17.7 tp -63.41 -45.1 92.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.141 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.92 -34.86 73.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.709 0.29 . . . . 0.0 110.315 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.92 89.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.539 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.82 -43.08 98.68 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.984 0.421 . . . . 0.0 110.047 174.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.41 ' HG2' HD11 ' A' ' 111' ' ' ILE . 5.5 mm-40 -56.7 -36.78 70.05 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.341 172.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.82 -44.75 94.14 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.948 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -62.48 -43.67 98.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.798 0.332 . . . . 0.0 110.711 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.91 -43.14 93.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.5 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.01 -41.15 82.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.894 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 86.7 mmm -67.87 -44.05 77.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.176 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.4 ' HE2' ' NE ' ' A' ' 56' ' ' ARG . 81.7 t80 -62.57 -40.31 96.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.759 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.05 -32.16 70.14 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 120.71 0.291 . . . . 0.0 110.262 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.6 -49.07 79.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.752 0.311 . . . . 0.0 110.422 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -77.2 -47.03 21.32 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -100.4 -3.49 30.94 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -169.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.9 m 61.38 28.93 18.27 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.511 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 2.0 ppt_? -156.58 154.87 30.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.668 0.27 . . . . 0.0 110.668 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.511 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 76.0 m-85 -77.4 131.86 70.85 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 147.08 45.01 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.521 2.147 . . . . 0.0 112.729 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.71 176.8 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.518 175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.437 ' HA ' HD23 ' A' ' 100' ' ' LEU . 6.5 t -50.15 -44.44 52.53 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -169.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -77.44 -43.77 31.34 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.059 0.457 . . . . 0.0 110.785 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -63.22 -36.78 84.79 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.106 -172.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.45 -45.05 25.24 Favored Glycine 0 C--O 1.229 -0.211 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.547 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.568 HD21 ' O ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -69.37 -44.65 71.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.412 ' NE2' HD11 ' A' ' 89' ' ' LEU . 33.0 mm-40 -71.59 -26.03 62.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -176.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.18 -21.86 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 46' ' ' ALA . 4.8 tp -83.24 -13.02 56.19 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.994 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 p -120.44 -29.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.43 -0.508 . . . . 0.0 111.565 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 t -157.34 162.88 39.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.2 122.26 87.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.94 136.69 71.36 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.643 2.229 . . . . 0.0 112.042 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.1 m -81.99 -29.66 31.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.937 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.76 127.4 31.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.462 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 34.0 tt0 -67.22 139.16 94.82 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.462 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 18.2 Cg_exo -67.56 131.62 16.69 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 123.715 -1.369 . . . . 0.0 112.738 -0.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -80.89 129.95 34.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.698 -178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.48 122.84 18.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.924 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -111.81 158.42 19.41 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.017 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 60.89 32.0 20.02 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.589 0.709 . . . . 0.0 110.608 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -72.03 146.61 90.29 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.414 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.78 138.28 31.4 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 121.981 1.787 . . . . 0.0 111.272 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.81 124.63 22.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.457 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.58 4.94 75.74 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.505 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.34 -150.85 47.67 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.406 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.55 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 62.1 m-85 -101.45 -37.44 8.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.364 0.602 . . . . 0.0 109.901 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.428 HG12 ' H ' ' A' ' 88' ' ' ARG . 13.0 tt -131.92 137.53 54.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -67.05 -21.87 65.89 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.428 ' H ' HG12 ' A' ' 86' ' ' ILE . 46.9 mtm180 -130.52 154.92 47.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.412 HD11 ' NE2' ' A' ' 65' ' ' GLN . 4.4 mm? -54.43 125.83 53.19 Favored Pre-proline 0 C--N 1.33 -0.268 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.03 137.09 79.05 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.636 2.224 . . . . 0.0 112.142 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -138.4 138.03 37.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.295 0.569 . . . . 0.0 111.327 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -62.85 153.86 78.05 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.948 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.75 -19.02 29.14 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.198 2.599 . . . . 0.0 112.704 178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -81.96 -12.75 58.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 110.859 177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.09 30.72 7.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.198 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.3 m -103.52 149.46 24.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.962 0.41 . . . . 0.0 111.021 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -99.81 143.5 29.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.844 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.568 ' O ' HD21 ' A' ' 64' ' ' LEU . 83.7 m-85 -83.67 148.53 27.05 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -175.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.476 ' NE2' HD21 ' A' ' 114' ' ' LEU . 27.0 mp0 -118.22 152.96 34.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.174 0.512 . . . . 0.0 110.932 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 60' ' ' THR . 13.4 tp -131.94 140.16 48.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.077 171.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.405 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 2.8 tm? -135.38 115.93 13.74 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.815 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 t -106.8 132.56 20.81 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 169.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.88 139.77 63.1 Favored 'Cis proline' 0 C--N 1.35 0.613 0 C-N-CA 124.251 -1.145 . . . . 0.0 111.907 -1.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 101' ' ' LEU . . . -68.83 150.91 51.03 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.484 -0.78 . . . . 0.0 113.741 -172.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.69 -26.53 68.42 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.112 0.482 . . . . 0.0 110.286 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 20.4 m80 -131.04 44.88 2.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.246 -178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 147.08 -165.62 28.54 Favored Glycine 0 C--O 1.224 -0.498 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.434 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 13.2 mm100 -75.5 -29.55 59.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 117.77 0.785 . . . . 0.0 110.607 175.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 100' ' ' LEU . 2.1 m -134.35 127.36 50.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.138 176.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -119.52 118.19 30.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.451 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.41 HD11 ' HG2' ' A' ' 44' ' ' GLU . 13.8 pt -106.6 132.21 54.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.087 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.68 161.02 43.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.158 0.504 . . . . 0.0 111.428 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.422 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . 18.3 t -116.42 149.29 39.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.179 173.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.476 HD21 ' NE2' ' A' ' 99' ' ' GLN . 0.7 OUTLIER -69.57 -27.42 65.11 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 123.52 0.513 . . . . 0.0 109.924 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.09 -162.09 33.51 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.155 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.42 -28.38 32.7 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.951 2.434 . . . . 0.0 113.397 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.566 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 10.6 p-10 -85.06 -11.56 55.04 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -171.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.6 12.0 80.43 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.853 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.566 ' HB ' ' OD2' ' A' ' 117' ' ' ASP . 72.0 t -116.94 121.47 32.62 Favored Pre-proline 0 C--O 1.249 1.042 0 CA-C-O 120.637 0.256 . . . . 0.0 111.271 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.743 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 60.3 Cg_endo -75.4 158.33 40.68 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.667 2.911 . . . . 0.0 113.606 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 62.31 23.97 14.23 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.219 176.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.427 ' HB2' ' OD1' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -96.93 177.73 5.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.731 179.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.95 -28.97 43.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.202 0.525 . . . . 0.0 110.496 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 122' ' ' SER . 7.3 p-10 -77.05 -15.2 59.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.135 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.743 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -65.47 146.06 55.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.358 -177.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 75.0 mt -113.76 117.87 56.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.884 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -118.38 161.66 13.49 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.128 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.411 ' HA ' HD21 ' A' ' 40' ' ' LEU . 7.9 p30 -59.96 -37.4 79.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.504 0.668 . . . . 0.0 109.867 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -76.67 -28.51 55.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.205 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 71.2 p -80.91 -29.09 35.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.685 0.278 . . . . 0.0 111.21 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.6 tp -85.96 -31.39 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.468 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 134.73 -15.12 4.38 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.066 -1.064 . . . . 0.0 113.126 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -86.48 56.87 4.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.342 0.591 . . . . 0.0 110.296 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -74.77 156.06 36.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.99 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 106' ' ' HIS . 76.7 m80 -104.1 77.87 1.47 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.478 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -79.39 -18.58 52.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.797 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.9 t60 -87.45 86.49 7.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -132.3 129.45 39.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.775 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -103.03 95.36 6.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.235 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 61.1 tttm . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.775 -0.631 . . . . 0.0 109.963 178.402 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.483 1.176 0 CA-C-O 120.76 0.314 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.41 85.16 1.34 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.396 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -90.32 70.2 7.08 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.176 0.513 . . . . 0.0 109.97 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -82.84 100.24 10.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.267 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -55.95 -43.43 77.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.712 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 99.5 mttt -67.26 -48.06 68.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.331 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.74 -45.92 92.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.709 -174.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -70.24 -40.45 74.45 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.477 ' O ' HG23 ' A' ' 37' ' ' VAL . 30.8 ptt180 -68.38 -34.15 75.54 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.388 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 14.8 mm100 -59.32 -31.51 69.23 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.479 0.18 . . . . 0.0 111.254 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.11 -44.27 97.02 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.575 HG11 ' HB ' ' A' ' 126' ' ' ILE . 24.7 t -60.71 -45.15 98.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 176.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 33' ' ' ARG . 58.3 t -59.9 -38.63 77.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.076 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.403 ' O ' HG22 ' A' ' 41' ' ' VAL . 39.1 t -60.44 -46.8 88.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.866 0.365 . . . . 0.0 110.677 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.532 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 21.9 m-20 -69.52 -35.4 75.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.449 0.643 . . . . 0.0 109.869 177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.462 HD21 ' C ' ' A' ' 127' ' ' GLY . 19.0 tp -60.89 -46.57 90.1 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.347 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 38' ' ' SER . 28.9 m -65.81 -36.17 76.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.362 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.32 -42.17 98.23 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.397 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.56 ' O ' HD13 ' A' ' 47' ' ' LEU . 98.2 mt -61.32 -49.69 75.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.375 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -61.3 -39.32 90.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.216 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.531 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -63.44 -47.77 84.44 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.215 177.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.75 84.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.758 0.313 . . . . 0.0 111.343 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.56 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.2 mp -57.59 -43.74 84.86 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.946 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.636 ' OD2' ' HA ' ' A' ' 139' ' ' HIS . 17.5 t70 -68.55 -37.35 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.844 176.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.531 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 20.7 mmt -59.48 -45.23 92.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.614 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.567 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 65.6 t80 -67.18 -37.7 84.15 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.564 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HD2' ' CE1' ' A' ' 57' ' ' TYR . 88.0 tttt -64.92 -35.33 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.308 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.0 tp -68.12 -36.44 79.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.253 0.549 . . . . 0.0 110.385 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.514 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 14.0 t70 -76.0 -47.89 23.15 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.595 -177.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -123.55 22.91 9.04 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.6 m 71.97 -13.99 0.55 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.446 HH21 ' HD3' ' A' ' 75' ' ' PRO . 7.3 ppt_? -137.15 157.55 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.889 -0.507 . . . . 0.0 111.242 -175.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.4 ' CE1' ' HD2' ' A' ' 51' ' ' LYS . 47.0 m-85 -71.34 148.35 93.51 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.803 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.77 148.3 52.19 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.925 2.417 . . . . 0.0 112.402 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 34.3 p -79.84 177.99 8.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.999 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.2 t -50.98 -37.29 43.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.827 0.346 . . . . 0.0 111.888 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -77.06 -45.72 26.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.209 0.528 . . . . 0.0 110.702 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -73.04 -27.9 62.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.366 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.19 -51.96 54.92 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 121.115 -0.564 . . . . 0.0 114.129 -170.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 mp -72.11 -32.9 67.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.412 0.606 . . . . 0.0 111.34 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -72.54 -24.13 61.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.82 -24.9 64.55 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -103.79 -2.06 26.95 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.65 178.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.3 t -108.28 -63.04 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.455 0.645 . . . . 0.0 110.742 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 47.1 t -152.51 138.19 17.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.35 120.38 25.76 Favored Pre-proline 0 C--N 1.332 -0.162 0 O-C-N 123.366 0.416 . . . . 0.0 111.153 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.97 141.96 96.39 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 123.043 2.495 . . . . 0.0 112.602 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -86.64 -9.22 56.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.846 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.3 140.55 52.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.077 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -76.2 137.67 68.49 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.166 -175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.567 ' HD2' ' OH ' ' A' ' 50' ' ' TYR . 5.2 Cg_exo -79.88 149.84 81.65 Favored 'Cis proline' 0 C--O 1.236 0.378 0 C-N-CA 123.738 -1.359 . . . . 0.0 112.558 -4.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -65.42 128.85 37.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.521 178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.5 129.0 38.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.377 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.514 ' HB2' ' OD1' ' A' ' 53' ' ' ASP . 33.3 mmt180 -111.53 165.14 12.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.94 178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 61.79 34.88 16.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.706 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -94.74 136.65 22.83 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.853 0.359 . . . . 0.0 110.542 -176.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.72 143.55 56.52 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.637 2.225 . . . . 0.0 111.758 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.07 124.36 20.94 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.98 -2.21 84.46 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.824 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.46 -157.93 53.44 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.126 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -92.29 -23.43 19.29 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.7 tt -136.9 128.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.662 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.7 ttt180 -68.36 -24.46 64.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.044 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -130.84 171.68 12.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -59.09 129.91 86.41 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.023 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -68.09 126.87 15.06 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.063 1.842 . . . . 0.0 110.283 172.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -132.82 145.44 50.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.608 0.242 . . . . 0.0 110.902 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 96' ' ' SER . 0.7 OUTLIER -56.3 143.67 64.28 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.115 175.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 92' ' ' ASP . 48.4 Cg_exo -55.69 -25.84 53.0 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.254 2.636 . . . . 0.0 113.111 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.486 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 18.3 m-90 -81.91 -5.08 57.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.648 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 104.11 15.09 22.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.918 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 43.2 m -95.5 164.37 12.83 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.723 0.297 . . . . 0.0 110.584 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -111.71 129.32 56.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.118 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.47 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 64.2 m-85 -67.09 161.47 24.45 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.977 0.417 . . . . 0.0 110.4 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.589 ' NE2' HD13 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -129.41 142.76 50.72 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.499 . . . . 0.0 110.861 -179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.68 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -112.41 122.77 48.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 169.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 101' ' ' LEU . 1.2 tm? -110.24 113.63 26.47 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.66 -175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 13.7 p -107.16 123.05 39.5 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.555 172.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 1.9 Cg_endo -84.31 140.15 33.17 Favored 'Cis proline' 0 N--CA 1.459 -0.517 0 C-N-CA 124.736 -0.943 . . . . 0.0 111.256 -4.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -71.73 159.62 53.84 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.62 -173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -79.63 -12.05 59.84 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.128 0.49 . . . . 0.0 109.951 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -121.48 30.51 6.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.859 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 143.02 -157.32 26.83 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.457 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 103' ' ' PRO . 21.5 tp60 -61.2 -45.39 94.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.212 0.53 . . . . 0.0 110.077 176.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.68 ' HB ' HD21 ' A' ' 100' ' ' LEU . 15.1 m -136.12 151.09 28.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.32 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -134.61 131.28 37.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.652 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.668 HG23 HD23 ' A' ' 100' ' ' LEU . 4.4 pt -111.32 130.08 65.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.781 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -149.08 161.12 42.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 6.3 p -114.57 139.87 49.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.738 -173.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.589 HD13 ' NE2' ' A' ' 99' ' ' GLN . 0.4 OUTLIER -67.9 -34.43 76.63 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.746 -178.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.45 -159.68 53.35 Favored Glycine 0 N--CA 1.435 -1.419 0 CA-C-N 114.79 -1.095 . . . . 0.0 112.45 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.486 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 10.8 Cg_exo -70.34 -34.88 11.9 Favored 'Trans proline' 0 C--N 1.331 -0.352 0 C-N-CA 123.824 3.016 . . . . 0.0 111.98 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.83 -13.57 50.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.089 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.532 ' C ' ' HG ' ' A' ' 114' ' ' LEU . . . 71.75 11.96 73.86 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.5 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.6 t -96.68 113.78 63.33 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-N 116.957 0.379 . . . . 0.0 111.233 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.73 145.83 29.45 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.615 2.21 . . . . 0.0 112.462 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 66.98 22.51 10.04 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.337 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.48 177.46 6.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.654 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -73.82 -16.78 61.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.859 0.361 . . . . 0.0 111.133 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -87.23 -15.6 37.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.17 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.49 105.84 0.83 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.201 -173.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.575 ' HB ' HG11 ' A' ' 36' ' ' VAL . 42.4 mm -81.4 107.37 13.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.857 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.462 ' C ' HD21 ' A' ' 40' ' ' LEU . . . -114.15 171.26 13.68 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.666 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.409 ' N ' HD21 ' A' ' 40' ' ' LEU . 26.5 p-10 -66.49 -38.39 87.17 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.989 0.423 . . . . 0.0 110.177 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.465 ' CE2' ' HD2' ' A' ' 134' ' ' HIS . 56.9 t90 -68.32 -30.53 69.53 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -72.04 -39.4 69.15 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.449 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.0 tp -78.98 -40.72 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 120.921 -0.311 . . . . 0.0 111.752 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 161.08 10.89 0.04 OUTLIER Glycine 0 CA--C 1.52 0.358 0 C-N-CA 119.398 -1.382 . . . . 0.0 114.309 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -95.16 72.09 3.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.705 0.753 . . . . 0.0 109.864 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 129' ' ' TRP . 69.6 m80 -90.2 -12.44 38.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.792 -176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.9 m170 -96.1 156.25 16.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.707 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -127.29 61.5 1.37 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.388 0.613 . . . . 0.0 109.878 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -128.13 25.39 5.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.361 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -75.36 135.12 40.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.636 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 4.3 t-80 179.8 22.82 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.871 0.732 . . . . 0.0 109.457 176.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 140' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.113 -175.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 121.229 0.538 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.28 24.42 76.4 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.351 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -79.52 -44.0 22.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.762 0.315 . . . . 0.0 110.55 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -85.2 -16.29 40.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.478 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -58.26 -32.48 68.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.36 -177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 55.4 mtmt -61.64 -46.55 89.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.411 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.55 -39.85 94.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.837 0.351 . . . . 0.0 110.807 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -69.17 -39.42 78.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.807 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.533 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 12.5 ptm85 -66.66 -33.48 75.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.74 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 76.0 mm-40 -59.22 -34.37 72.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.711 0.291 . . . . 0.0 110.882 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -63.3 -39.6 95.03 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.629 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 41.1 t -60.64 -47.65 92.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.363 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 33' ' ' ARG . 38.6 t -58.82 -37.69 68.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.938 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 41' ' ' VAL . 22.6 t -62.53 -47.0 85.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.47 . . . . 0.0 111.044 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.49 ' HB2' ' OH ' ' A' ' 98' ' ' TYR . 63.4 m-20 -70.91 -35.15 72.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.731 -0.606 . . . . 0.0 110.04 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.428 HD21 ' N ' ' A' ' 128' ' ' ASN . 17.6 tp -61.0 -44.93 96.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.076 -178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 38' ' ' SER . 32.8 m -63.31 -34.54 67.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.507 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 39' ' ' ASP . . . -60.21 -40.07 88.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.589 0.233 . . . . 0.0 110.63 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 47' ' ' LEU . 8.9 mp -60.27 -48.45 81.67 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.262 0.553 . . . . 0.0 109.981 176.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.56 -37.33 85.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.823 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' A' ' 49' ' ' MET . . . -62.53 -37.06 94.08 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.977 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.91 84.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.16 0.505 . . . . 0.0 110.044 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 43' ' ' LEU . 6.2 mp -61.1 -40.82 95.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.723 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -61.4 -45.52 94.01 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 45' ' ' GLY . 25.7 mmt -63.44 -38.52 91.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 77' ' ' ALA . 1.2 t80 -64.2 -44.23 92.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.399 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -70.5 -33.31 71.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.114 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.93 -46.3 85.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.01 0.433 . . . . 0.0 110.141 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.99 -46.15 31.07 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.215 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -103.57 1.71 32.5 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -172.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.9 m 59.15 31.73 21.51 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.708 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -164.51 146.21 8.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.844 -179.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.4 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 21.0 m-85 -72.89 144.18 85.14 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-O 120.911 0.386 . . . . 0.0 110.466 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 55.5 Cg_endo -71.04 143.26 44.27 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.843 2.362 . . . . 0.0 112.745 -176.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.567 HG22 ' H ' ' A' ' 60' ' ' THR . 0.4 OUTLIER -73.94 177.45 5.6 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.591 175.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 100' ' ' LEU . 61.9 m -50.21 -45.82 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -73.37 -37.58 65.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.236 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -71.92 -43.15 65.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.874 -170.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.443 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -64.37 -49.46 65.47 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.676 -172.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.431 HD21 ' O ' ' A' ' 98' ' ' TYR . 1.4 tp -61.88 -41.68 98.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.941 0.4 . . . . 0.0 111.42 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -72.41 -22.92 61.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.936 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.24 66.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -168.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.526 HD21 HD12 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -93.95 -3.83 50.89 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.986 -178.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.86 -42.07 2.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.519 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.2 p -156.5 130.07 8.24 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -55.09 121.82 38.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 123.383 0.427 . . . . 0.0 111.324 -177.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 27.1 Cg_exo -64.34 137.56 56.44 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.9 2.4 . . . . 0.0 112.437 178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.9 m -86.22 -11.45 52.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 138.1 57.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.474 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -77.5 140.92 64.82 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.629 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.81 134.55 36.36 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.719 -1.367 . . . . 0.0 111.931 -2.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -66.95 128.55 36.77 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.298 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.561 ' HB2' ' CE1' ' A' ' 50' ' ' TYR . . . -63.2 131.33 48.06 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.526 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -119.32 164.6 15.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.829 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 66.46 32.06 7.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.577 0.703 . . . . 0.0 110.009 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -91.68 137.18 25.76 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.694 -176.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -75.77 139.54 22.46 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.073 1.849 . . . . 0.0 111.843 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.63 124.77 23.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.711 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.61 -8.89 76.59 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.73 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 -173.13 55.33 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.291 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -84.9 -25.7 27.77 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.26 133.71 34.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.381 173.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -70.12 -22.77 62.98 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -168.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.7 mtm180 -131.94 154.59 49.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.289 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.6 mt -61.73 123.64 77.98 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.336 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -64.15 147.95 91.33 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.471 2.114 . . . . 0.0 111.415 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -138.37 145.46 41.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.71 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 113' ' ' SER . 53.2 m-20 -57.99 142.99 78.87 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.63 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.38 -19.32 57.9 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.305 2.67 . . . . 0.0 112.541 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -81.74 -14.08 56.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.009 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 108.0 22.39 7.26 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.163 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.578 ' HB3' ' HB2' ' A' ' 114' ' ' LEU . 19.3 m -104.01 162.5 13.09 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.535 -0.391 . . . . 0.0 110.613 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -105.64 144.65 32.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.667 0.27 . . . . 0.0 110.341 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 18.6 m-85 -70.31 146.49 50.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.358 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -126.76 142.9 51.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.395 0.616 . . . . 0.0 111.751 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 60' ' ' THR . 13.4 tp -121.68 141.99 50.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.957 -1.02 . . . . 0.0 108.934 172.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -134.86 113.07 11.2 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.189 -0.605 . . . . 0.0 110.505 173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.7 t -106.9 132.19 21.1 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.374 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.78 150.27 92.35 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 123.824 -1.323 . . . . 0.0 111.885 -1.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -64.01 147.25 50.73 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.658 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -75.07 -39.39 60.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.104 -0.548 . . . . 0.0 110.359 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -104.88 -38.88 6.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.897 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.19 -156.79 9.78 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.788 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -73.46 -41.69 62.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.209 0.528 . . . . 0.0 109.989 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.14 122.74 31.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.376 175.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.19 116.8 33.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.25 0.547 . . . . 0.0 112.15 -173.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 14.9 pt -107.34 126.47 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.556 173.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 30.8 p90 -150.41 146.55 26.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.284 0.564 . . . . 0.0 111.194 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.493 ' HB3' ' OD1' ' A' ' 92' ' ' ASP . 51.2 m -97.83 151.58 20.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.197 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 96' ' ' SER . 4.9 mp -75.29 -19.67 59.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.588 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.54 -156.04 53.27 Favored Glycine 0 N--CA 1.444 -0.774 0 O-C-N 123.875 0.734 . . . . 0.0 113.355 171.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.93 -21.01 38.08 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.675 2.917 . . . . 0.0 112.906 -176.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 6.6 p-10 -86.23 -14.74 42.97 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.974 -179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.484 ' O ' HD23 ' A' ' 114' ' ' LEU . . . 70.7 0.65 33.66 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.178 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.6 t -122.47 134.0 24.68 Favored Pre-proline 0 C--O 1.251 1.171 0 CA-C-O 120.56 0.219 . . . . 0.0 110.739 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.4 160.91 41.16 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.81 2.34 . . . . 0.0 111.206 175.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 69.53 22.64 6.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.446 0.641 . . . . 0.0 109.311 -175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 m -89.01 170.67 10.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.464 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -67.18 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 167.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.421 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 14.8 m-20 -96.05 69.12 2.77 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.859 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -117.27 100.32 7.62 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.77 -1.105 . . . . 0.0 108.799 170.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 64.4 mt -79.98 99.92 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.827 -172.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -104.06 155.21 17.65 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.218 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 40' ' ' LEU . 22.2 t30 -68.83 -30.96 69.61 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.596 0.712 . . . . 0.0 109.328 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -71.96 -30.89 65.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.576 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 66.6 p -82.32 -32.29 29.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.002 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.0 tp -74.34 -19.98 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 120.871 0.367 . . . . 0.0 110.627 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.09 -23.59 1.92 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 119.949 -1.12 . . . . 0.0 114.057 173.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -74.48 77.56 1.93 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.239 0.52 . . . . 0.0 111.011 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -73.95 -29.93 62.26 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.487 0.66 . . . . 0.0 109.252 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -155.36 98.53 1.98 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.86 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -61.47 149.09 39.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.385 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -160.64 157.06 26.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.989 -172.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -121.85 26.55 8.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.247 0.546 . . . . 0.0 109.902 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -128.51 144.22 51.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.091 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.765 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.02 -74.47 0.29 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 54.77 60.22 3.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -61.02 -29.38 69.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 172.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -52.51 -42.81 64.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.995 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 48.2 mmtm -68.43 -40.32 81.22 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.659 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.65 -43.04 85.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.942 0.401 . . . . 0.0 110.756 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.0 m-20 -65.42 -46.72 78.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.394 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.528 ' O ' HG23 ' A' ' 37' ' ' VAL . 11.7 ptm180 -63.85 -35.66 81.37 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.117 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 56.1 mt-30 -59.1 -39.58 82.68 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.862 0.363 . . . . 0.0 110.256 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -68.32 -38.66 81.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.245 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 32' ' ' ASP . 71.7 t -61.01 -47.9 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.469 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 33' ' ' ARG . 65.6 t -60.09 -37.55 73.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.831 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.436 ' O ' HG22 ' A' ' 41' ' ' VAL . 14.4 t -61.36 -47.47 85.7 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.99 0.424 . . . . 0.0 111.04 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.6 -33.96 71.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.192 0.52 . . . . 0.0 110.605 176.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 15.9 tp -62.5 -44.31 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.211 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 38' ' ' SER . 32.2 m -65.7 -35.29 74.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 O-C-N 122.356 -0.215 . . . . 0.0 110.631 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -37.44 81.97 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 174.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 78.0 mt -62.04 -47.75 83.33 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.647 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HG2' HD11 ' A' ' 111' ' ' ILE . 36.6 mm-40 -57.35 -36.69 71.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.28 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.51 99.69 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.689 176.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.568 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -62.95 -37.83 88.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.223 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 36.3 mt -61.92 -44.99 95.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.449 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -61.34 -45.37 94.71 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.733 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.78 -38.04 79.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.195 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -67.27 -46.2 74.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -64.02 -33.26 75.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.007 0.432 . . . . 0.0 110.686 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.5 -44.57 93.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.436 0.636 . . . . 0.0 110.04 175.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -75.64 -41.61 53.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.252 -174.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.503 HD21 ' HA ' ' A' ' 77' ' ' ALA . 48.4 m-80 -118.06 16.04 14.16 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -172.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m 72.17 -42.21 0.53 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 174.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.21 176.45 5.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -171.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' ' HG2' ' A' ' 108' ' ' GLN . 36.8 m-85 -88.78 144.85 33.78 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.418 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.71 152.79 42.77 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.403 2.736 . . . . 0.0 113.697 -174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 60' ' ' THR . 0.3 OUTLIER -79.46 177.06 9.14 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.627 173.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 59' ' ' THR . 4.1 t -51.05 -46.02 61.53 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -172.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.1 -39.58 65.69 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.38 0.609 . . . . 0.0 110.192 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -71.86 -35.43 69.81 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.812 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -62.77 -49.68 70.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.109 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 89' ' ' LEU . 1.2 mm? -70.79 -34.19 71.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.713 0.292 . . . . 0.0 111.657 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.533 ' OE1' ' HA ' ' A' ' 71' ' ' PRO . 28.3 mt-30 -70.28 -23.84 62.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.35 -18.2 36.3 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -173.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.628 ' HB3' HG22 ' A' ' 86' ' ' ILE . 8.5 mt -94.09 -25.07 17.32 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 6.2 p -105.65 -47.67 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.9 m -157.27 143.38 17.8 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.439 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -56.06 121.0 38.33 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 123.24 0.338 . . . . 0.0 110.283 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.533 ' HA ' ' OE1' ' A' ' 65' ' ' GLN . 80.6 Cg_exo -52.87 136.35 59.57 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 123.108 2.539 . . . . 0.0 112.586 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.0 p -92.22 41.33 1.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.016 0.912 . . . . 0.0 109.943 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.87 133.87 36.26 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.636 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -70.8 140.11 86.24 Favored Pre-proline 0 C--N 1.319 -0.741 0 O-C-N 123.219 0.324 . . . . 0.0 111.175 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.41 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 73.4 Cg_endo -77.45 132.39 26.97 Favored 'Cis proline' 0 CA--C 1.533 0.427 0 C-N-CA 122.922 -1.699 . . . . 0.0 112.957 0.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -66.81 128.02 34.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.704 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.8 126.75 28.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.085 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -108.94 164.46 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.521 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 60.14 36.45 21.1 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.513 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.439 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 36.1 p90 -94.85 142.01 24.09 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.21 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.94 138.23 28.12 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.224 1.949 . . . . 0.0 111.621 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.39 124.82 23.79 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.48 -10.14 73.29 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.249 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.17 -164.94 53.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.923 177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -91.0 -23.35 20.42 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.386 0.613 . . . . 0.0 109.385 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.628 HG22 ' HB3' ' A' ' 67' ' ' LEU . 12.1 tt -142.6 138.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 174.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -68.98 -26.72 65.17 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -170.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -130.6 166.49 20.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.67 0.271 . . . . 0.0 110.449 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.425 HD12 HD12 ' A' ' 64' ' ' LEU . 4.1 mm? -62.3 127.63 90.0 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.745 174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.6 136.08 64.73 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.556 2.171 . . . . 0.0 112.058 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -128.3 146.9 50.62 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.268 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.679 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 2.8 p30 -73.24 153.39 90.39 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.16 -16.93 13.73 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.587 2.858 . . . . 0.0 114.049 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.444 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 11.7 m-90 -80.63 -25.82 38.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.821 0.344 . . . . 0.0 110.405 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.72 13.91 6.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.041 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.679 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 9.0 m -101.17 143.74 30.89 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.87 0.367 . . . . 0.0 110.462 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -87.84 132.65 34.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.332 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -60.34 143.57 52.67 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.904 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 81.9 mm-40 -118.49 137.86 52.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.907 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 111' ' ' ILE . 3.1 tm? -113.34 123.19 49.52 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -118.6 113.55 21.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.043 0.449 . . . . 0.0 110.338 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.5 t -106.04 130.8 22.42 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.74 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.48 153.26 94.45 Favored 'Cis proline' 0 C--N 1.343 0.277 0 C-N-CA 124.241 -1.149 . . . . 0.0 111.591 -3.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.59 145.54 49.75 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.247 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -78.26 -24.22 46.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.12 0.486 . . . . 0.0 110.278 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -119.16 -16.2 9.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.59 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -150.28 -148.84 4.87 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.448 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.461 ' HG2' ' CD2' ' A' ' 57' ' ' TYR . 25.1 tp60 -73.73 -45.68 50.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 109.956 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.742 ' HB ' HD21 ' A' ' 100' ' ' LEU . 4.3 m -142.81 127.65 15.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.721 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.0 122.07 43.86 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.052 0.389 . . . . 0.0 112.052 -174.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 100' ' ' LEU . 10.0 pt -106.54 126.59 62.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 171.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -142.07 153.59 44.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.27 0.557 . . . . 0.0 112.031 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.0 t -99.92 138.29 37.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.241 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -73.67 -20.19 60.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.307 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.444 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 64.68 -163.87 35.68 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.612 -0.722 . . . . 0.0 113.221 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.41 -25.93 29.73 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 123.344 2.696 . . . . 0.0 111.858 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 7.8 p-10 -80.9 -14.63 57.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.186 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.68 -5.17 12.27 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.307 -0.473 . . . . 0.0 113.381 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 117' ' ' ASP . 41.9 t -109.54 131.19 22.03 Favored Pre-proline 0 C--O 1.248 0.99 0 CA-C-N 116.734 0.267 . . . . 0.0 111.146 -174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.574 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 66.2 Cg_endo -76.0 149.47 32.8 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.974 2.449 . . . . 0.0 111.89 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 120' ' ' PRO . 43.1 mt-10 70.87 15.54 6.78 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.378 0.671 . . . . 0.0 110.793 -176.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.0 OUTLIER -87.39 177.16 7.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.536 178.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.49 -41.38 98.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.501 0.667 . . . . 0.0 109.638 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.482 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 10.7 m-20 -88.88 65.55 7.63 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.574 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.2 OUTLIER -130.54 91.82 3.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.582 174.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 67.8 mt -84.86 104.62 13.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.701 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -117.25 174.52 15.26 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.736 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -59.13 -35.42 73.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.866 0.365 . . . . 0.0 111.517 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -78.98 -31.26 44.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.8 m -64.0 -45.23 89.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.972 0.415 . . . . 0.0 110.767 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 tp -82.65 -26.68 8.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.811 0.815 . . . . 0.0 109.731 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 68.09 38.82 88.65 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 114.771 -1.104 . . . . 0.0 114.083 170.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -77.63 6.41 7.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.485 0.643 . . . . 0.0 111.896 -178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -78.1 -30.31 49.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.091 0.472 . . . . 0.0 109.892 176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -102.56 135.98 43.22 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -113.58 156.51 23.52 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.935 0.397 . . . . 0.0 110.727 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -126.36 173.98 8.93 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.541 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 35.4 m80 63.06 80.2 0.24 Allowed 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.64 0.588 . . . . 0.0 110.869 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -75.57 93.8 3.08 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.273 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.1 mttm . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.488 -0.768 . . . . 0.0 110.306 -179.874 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 121.018 0.437 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.37 133.08 4.57 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.885 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -68.7 -32.64 72.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.954 0.406 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -67.39 -33.89 76.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.387 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -58.48 -38.65 78.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.263 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 34' ' ' GLN . 96.3 mttt -59.07 -46.04 89.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.18 178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -41.43 97.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.282 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.3 m-20 -63.77 -47.8 79.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.313 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' NH2' ' HG2' ' A' ' 30' ' ' LYS . 19.6 ptt180 -69.45 -35.22 75.43 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.307 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 30' ' ' LYS . 52.4 mt-30 -59.07 -37.57 77.4 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.684 0.278 . . . . 0.0 110.701 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -67.01 -37.95 85.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 32' ' ' ASP . 72.0 t -61.16 -47.13 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.669 178.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 63.5 t -60.35 -37.9 75.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.052 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.8 m -62.0 -43.53 98.65 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.887 0.375 . . . . 0.0 111.378 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.79 -35.03 74.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.257 0.551 . . . . 0.0 110.088 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.4 tp -62.25 -46.26 89.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.344 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.9 m -64.6 -34.9 72.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.22 -41.36 96.72 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.681 0.277 . . . . 0.0 110.433 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.512 ' O ' HD13 ' A' ' 47' ' ' LEU . 94.3 mt -61.85 -49.51 75.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.069 0.461 . . . . 0.0 110.631 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -62.41 -40.46 96.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.721 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 49' ' ' MET . . . -62.68 -43.81 98.43 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.916 177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -62.69 -38.52 90.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.84 0.352 . . . . 0.0 110.918 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.512 HD13 ' O ' ' A' ' 43' ' ' LEU . 3.2 mp -61.66 -45.82 92.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.416 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -63.15 -40.39 97.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.039 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.51 ' HG3' ' O ' ' A' ' 45' ' ' GLY . 66.1 mtt -65.98 -41.95 90.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.676 178.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.407 ' OH ' ' HD2' ' A' ' 75' ' ' PRO . 50.6 t80 -63.73 -40.99 98.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.268 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 57' ' ' TYR . 83.6 tttt -66.95 -34.68 78.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.854 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.06 -41.89 99.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.177 0.513 . . . . 0.0 110.263 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -76.76 -46.76 23.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.209 -177.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.1 m-80 -105.79 -1.74 23.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -169.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m 62.99 34.28 14.13 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.55 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.3 OUTLIER -170.31 165.85 8.79 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.449 0.166 . . . . 0.0 110.599 178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.55 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 74.9 m-85 -87.4 136.43 33.34 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.05 150.55 60.58 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.87 2.38 . . . . 0.0 112.864 -174.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.422 ' HA ' ' OG ' ' A' ' 102' ' ' SER . 11.4 p -77.59 175.74 9.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.956 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.459 ' HA ' HD12 ' A' ' 100' ' ' LEU . 11.5 t -53.5 -38.59 63.85 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -174.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -73.97 -46.39 44.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.323 0.582 . . . . 0.0 110.389 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -73.49 -29.72 62.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.134 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.55 -49.75 67.13 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.146 -176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.31 -32.46 70.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.908 0.385 . . . . 0.0 111.163 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -73.08 -25.92 61.08 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.115 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.56 -28.6 65.67 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -167.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.713 HD23 ' H ' ' A' ' 67' ' ' LEU . 2.4 pt? -103.72 -2.28 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 p -116.15 -45.45 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 120.793 0.33 . . . . 0.0 111.62 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.1 t -156.69 131.86 9.15 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -53.79 121.24 27.23 Favored Pre-proline 0 C--N 1.33 -0.282 0 O-C-N 123.39 0.431 . . . . 0.0 111.137 -176.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 45.2 Cg_exo -57.84 137.04 79.07 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.054 2.503 . . . . 0.0 112.406 179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.4 m -79.89 -23.91 41.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.975 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.61 138.75 51.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.677 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -77.85 145.67 70.77 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.046 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 74' ' ' GLU . 11.5 Cg_exo -71.09 135.92 38.99 Favored 'Cis proline' 0 C--O 1.233 0.238 0 C-N-CA 123.32 -1.533 . . . . 0.0 112.003 -1.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -73.48 125.19 27.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.937 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -60.47 123.49 17.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.57 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -112.29 165.23 12.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.765 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 61.73 42.77 10.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.361 0.601 . . . . 0.0 110.221 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -106.5 145.51 31.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.822 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -76.63 138.71 19.5 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 121.988 1.792 . . . . 0.0 111.569 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.9 124.87 23.65 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.91 -5.49 76.12 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.182 -175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.08 -160.75 50.41 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.362 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -96.78 -16.28 20.91 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.82 134.92 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.567 172.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -72.6 -21.94 61.05 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.056 -170.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -130.54 156.31 45.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.731 -0.213 . . . . 0.0 110.537 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 39.7 mt -55.84 120.98 37.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.718 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.13 134.0 59.13 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.69 2.26 . . . . 0.0 112.449 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -130.49 138.53 50.3 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.803 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -61.05 152.65 70.26 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -54.24 -21.34 22.35 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.306 2.67 . . . . 0.0 112.832 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -81.54 -18.18 45.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.379 . . . . 0.0 111.295 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.84 21.86 8.36 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.992 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 p -101.65 143.55 31.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.897 0.38 . . . . 0.0 111.075 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -84.97 128.21 34.53 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -57.51 149.41 21.18 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.37 0.419 . . . . 0.0 111.508 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.458 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 0.5 OUTLIER -111.56 137.45 49.39 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.554 -175.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.568 HD23 HG23 ' A' ' 111' ' ' ILE . 3.1 tm? -131.88 122.73 26.16 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.25 113.95 13.86 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.655 -176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 59' ' ' THR . 60.0 p -107.01 129.92 23.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.829 173.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.56 150.72 88.02 Favored 'Cis proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.2 -1.167 . . . . 0.0 110.716 -3.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.51 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -78.41 156.98 43.8 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.278 -172.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.59 -43.05 17.5 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 173.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 129' ' ' TRP . 91.0 m-70 -92.63 -2.56 56.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.64 -178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.6 -164.03 26.54 Favored Glycine 0 C--O 1.224 -0.487 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.874 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.419 ' HA ' ' NE2' ' A' ' 108' ' ' GLN . 8.5 mm100 -72.07 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 0.0 109.439 175.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -122.3 121.26 63.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.676 169.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.51 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 6.8 t0 -93.39 114.36 26.75 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.662 -172.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.568 HG23 HD23 ' A' ' 100' ' ' LEU . 12.5 pt -113.6 123.82 69.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 173.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -151.94 162.24 41.38 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.999 -177.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 49.2 m -119.31 140.27 50.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.4 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HB3' ' CA ' ' A' ' 118' ' ' GLY . 1.1 mm? -62.69 -32.27 73.33 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.1 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.39 -170.83 41.23 Favored Glycine 0 N--CA 1.438 -1.178 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.25 -16.16 39.5 Favored 'Trans proline' 0 C--N 1.332 -0.317 0 C-N-CA 122.735 2.29 . . . . 0.0 111.757 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.73 -14.12 32.73 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.232 -173.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.418 ' CA ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.34 8.33 70.35 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.019 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 41.9 t -94.68 111.26 53.47 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 117.194 0.497 . . . . 0.0 111.791 -174.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 119' ' ' VAL . 6.3 Cg_exo -77.08 146.54 25.64 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 123.403 2.736 . . . . 0.0 112.539 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 62.25 35.5 15.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.405 0.621 . . . . 0.0 111.359 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 1.3 p -109.2 172.64 6.73 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.407 177.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -66.25 -30.41 70.84 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.669 ' OD2' 'CA ' ' A' ' 201' ' ' ' CA' . 1.6 p30 -85.96 52.62 2.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.908 176.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 122' ' ' SER . 0.8 OUTLIER -126.71 136.06 51.95 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.354 176.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 41.1 mm -100.59 101.03 11.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.68 157.7 15.8 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.74 -177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -61.97 -38.03 87.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.975 0.417 . . . . 0.0 110.552 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 106' ' ' HIS . 79.8 t90 -68.49 -31.11 70.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.744 178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.2 m -78.8 -34.21 45.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.108 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.3 tp -87.65 -31.51 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.464 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.35 39.76 0.46 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.226 -0.988 . . . . 0.0 113.405 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -131.14 48.27 2.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.329 0.585 . . . . 0.0 110.377 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -103.99 -25.55 12.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.925 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -93.4 54.19 2.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.659 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -137.3 113.71 10.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.372 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -175.37 114.86 0.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.08 0.467 . . . . 0.0 110.532 177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.5 m80 -117.59 139.08 51.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.208 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -86.07 -23.18 26.82 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.5 ptpp? . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.642 -0.694 . . . . 0.0 109.691 172.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . 0.669 'CA ' ' OD2' ' A' ' 124' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 120.69 0.281 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -83.19 -147.21 7.07 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.693 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 53.05 47.08 25.38 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.212 0.529 . . . . 0.0 110.706 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -85.28 70.05 10.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.702 -175.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.537 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 44.6 tt0 -57.86 -32.59 67.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.437 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -54.73 -49.29 71.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.378 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -72.45 -44.85 61.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.036 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -63.94 -46.0 86.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.194 -173.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 36.9 ptt180 -69.1 -33.79 74.06 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.81 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -59.5 -35.96 75.15 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.58 0.229 . . . . 0.0 111.21 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 82.6 mttt -62.19 -44.34 96.8 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.596 0.712 . . . . 0.0 109.287 173.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 70.7 t -61.23 -47.09 95.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 114.724 -1.125 . . . . 0.0 111.179 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.605 ' O ' HG23 ' A' ' 41' ' ' VAL . 57.6 t -59.47 -38.73 76.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.673 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 t -59.82 -46.53 88.96 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 120.952 0.406 . . . . 0.0 110.532 178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.48 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 89.7 m-20 -68.46 -34.65 76.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.144 0.497 . . . . 0.0 110.197 178.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 16.7 tp -60.34 -43.37 96.5 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.591 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 37' ' ' VAL . 26.2 t -62.66 -37.39 78.87 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.3 -39.0 91.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.984 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.676 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 95.7 mt -63.9 -49.69 71.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.859 0.362 . . . . 0.0 110.561 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -68.06 -33.95 75.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.563 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.76 91.82 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.382 -0.827 . . . . 0.0 111.483 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.32 -43.11 96.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 110.826 175.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 45.3 mt -59.64 -42.78 93.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.616 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.42 -44.04 95.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.59 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.503 ' SD ' ' HE2' ' A' ' 85' ' ' TYR . 92.0 mtp -67.66 -42.25 82.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.443 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.521 ' CD2' ' HG3' ' A' ' 58' ' ' PRO . 77.2 t80 -63.87 -43.82 94.96 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.497 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -69.34 -33.17 72.71 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.067 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 57.2 tp -61.57 -45.92 92.09 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.158 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.52 -46.97 24.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.552 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -95.21 -6.45 41.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.8 m 65.54 24.18 11.79 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 150.0 18.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.568 0.223 . . . . 0.0 110.682 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -75.24 145.25 79.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.779 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HG3' ' CD2' ' A' ' 50' ' ' TYR . 6.2 Cg_exo -75.05 162.37 37.11 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.759 2.306 . . . . 0.0 112.28 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.8 p -83.84 177.4 8.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.953 173.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.408 ' HA ' HD12 ' A' ' 100' ' ' LEU . 9.0 t -51.41 -42.72 61.64 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -175.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.59 -45.0 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.943 0.401 . . . . 0.0 110.808 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -67.83 -31.24 70.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.165 -174.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -68.05 -49.38 47.74 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.177 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mp -69.81 -38.52 76.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.864 0.364 . . . . 0.0 111.493 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.57 -24.0 61.05 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.975 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -25.7 63.55 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -168.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -103.3 -1.32 28.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.214 -177.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.7 p -117.64 -39.99 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.56 177.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.1 m -156.61 129.18 7.63 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -55.42 121.62 39.01 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.642 -176.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 46.4 Cg_exo -57.64 136.93 78.7 Favored 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.007 2.471 . . . . 0.0 112.699 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 p -85.13 -16.21 41.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.597 177.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.16 137.79 57.26 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -77.44 142.63 67.3 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.747 -178.157 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -72.19 138.11 52.36 Favored 'Cis proline' 0 C--O 1.236 0.39 0 C-N-CA 123.351 -1.52 . . . . 0.0 112.051 -2.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -71.6 128.67 36.59 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.87 125.38 23.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.392 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -113.97 163.9 14.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.122 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 56.47 36.36 27.43 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.343 0.592 . . . . 0.0 110.998 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -98.07 146.11 30.95 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.058 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.36 138.91 28.14 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.752 1.635 . . . . 0.0 110.213 171.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.37 123.97 21.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.866 0.365 . . . . 0.0 110.22 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.34 88.12 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.709 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.8 -115.39 7.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.282 -0.485 . . . . 0.0 112.261 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.503 ' HE2' ' SD ' ' A' ' 49' ' ' MET . 60.4 m-85 -134.48 -3.43 2.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.886 0.375 . . . . 0.0 110.786 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.6 136.35 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -75.43 -22.19 57.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -170.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.4 mtp180 -130.57 171.16 13.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.814 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.09 127.55 80.14 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.472 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.77 124.84 11.92 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.533 2.156 . . . . 0.0 112.431 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -130.4 148.75 52.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.761 177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.585 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 3.3 p30 -69.4 152.84 96.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.89 -16.22 25.1 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.532 2.821 . . . . 0.0 113.0 -176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.483 ' CE3' ' HA2' ' A' ' 115' ' ' GLY . 5.6 m-90 -80.53 -25.71 38.51 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.553 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 122.11 4.41 9.32 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.685 -0.769 . . . . 0.0 113.376 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.585 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 19.3 m -100.18 157.99 16.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.12 0.46 . . . . 0.0 110.786 -178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -90.49 138.67 31.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.804 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -68.6 164.36 21.61 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -130.62 146.68 52.18 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.187 0.518 . . . . 0.0 111.486 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.698 HD23 HG23 ' A' ' 111' ' ' ILE . 2.4 tm? -133.01 122.85 24.81 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -120.83 112.49 18.88 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.946 0.403 . . . . 0.0 110.338 -177.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.0 m -107.49 131.46 21.7 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.926 175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.43 146.58 68.96 Favored 'Cis proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.43 -1.488 . . . . 0.0 110.998 -5.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -66.68 159.86 48.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.501 -173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -92.8 -37.35 12.37 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 129' ' ' TRP . 97.5 m-70 -76.4 -56.19 4.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.634 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.71 -150.18 7.78 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.791 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -73.35 -36.23 66.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.508 ' HB ' HD21 ' A' ' 100' ' ' LEU . 2.8 m -137.55 131.81 44.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.474 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 43.6 m-20 -104.27 115.0 29.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.777 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.698 HG23 HD23 ' A' ' 100' ' ' LEU . 9.0 pt -106.69 126.51 62.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -145.9 159.55 43.06 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.818 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 125' ' ' ASP . 3.0 m -116.15 124.6 50.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.235 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.456 ' HB3' ' C ' ' A' ' 118' ' ' GLY . 62.6 mt -61.39 -34.93 76.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.737 -174.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.483 ' HA2' ' CE3' ' A' ' 94' ' ' TRP . . . 86.79 -166.84 37.82 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.15 177.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -68.24 -18.83 44.84 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 123.107 2.538 . . . . 0.0 111.968 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.64 -13.53 24.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.912 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.456 ' C ' ' HB3' ' A' ' 114' ' ' LEU . . . 72.54 8.82 72.59 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.781 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.38 114.93 64.21 Favored Pre-proline 0 C--O 1.237 0.414 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -173.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.4 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 82.0 Cg_endo -76.62 154.31 34.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.373 2.715 . . . . 0.0 113.101 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 62.89 16.17 8.92 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.549 175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -89.51 177.03 6.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.444 -177.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -71.69 -37.1 70.74 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -88.14 62.63 6.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -138.05 109.14 6.78 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 113.527 -1.67 . . . . 0.0 108.721 175.035 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.3 mm -77.17 103.11 4.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.957 0.408 . . . . 0.0 110.528 -177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -109.05 159.49 14.05 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.149 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.421 ' HA ' HG22 ' A' ' 131' ' ' ILE . 25.3 p-10 -67.85 -39.46 83.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.085 0.469 . . . . 0.0 110.521 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.42 ' CG ' ' HB3' ' A' ' 106' ' ' HIS . 93.1 t90 -66.34 -31.04 71.58 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.656 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.7 p -83.89 -29.52 27.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.714 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' A' ' 128' ' ' ASN . 11.1 tp -82.7 -27.66 8.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.813 0.34 . . . . 0.0 110.849 -178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 149.79 -40.06 0.87 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.951 177.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -71.52 99.5 2.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.82 0.343 . . . . 0.0 111.57 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -134.97 111.67 10.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.233 0.54 . . . . 0.0 111.006 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -78.78 78.84 5.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.69 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -100.87 -14.44 17.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.087 0.47 . . . . 0.0 110.265 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -90.63 31.5 1.04 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.147 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -76.68 95.66 4.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.591 -176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.2 p-80 -141.92 147.0 36.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.376 177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.739 -0.648 . . . . 0.0 109.818 -179.595 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.45 139.48 5.91 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.654 -0.784 . . . . 0.0 111.883 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -138.67 16.19 2.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.072 0.463 . . . . 0.0 110.656 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -120.88 112.25 18.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.228 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -57.58 -30.97 65.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.925 -178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.5 mtmt -61.25 -42.2 98.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.987 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.85 -37.23 73.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.496 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.7 m-20 -60.92 -47.56 85.82 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.642 176.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.524 ' O ' HG23 ' A' ' 37' ' ' VAL . 32.1 ptt180 -69.5 -35.21 75.31 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.827 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -62.33 -35.17 78.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.634 0.254 . . . . 0.0 110.828 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -62.14 -41.94 98.76 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 172.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 95.9 t -60.69 -44.46 97.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.99 176.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 33' ' ' ARG . 90.3 t -60.22 -39.37 80.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.327 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.481 ' O ' HG22 ' A' ' 41' ' ' VAL . 37.9 t -62.18 -46.77 87.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.105 0.479 . . . . 0.0 110.681 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.96 -34.1 71.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.336 0.589 . . . . 0.0 110.311 176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 128' ' ' ASN . 17.8 tp -60.65 -44.84 95.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.206 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 38' ' ' SER . 27.7 m -65.68 -35.32 74.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.184 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.456 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.54 97.93 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.859 0.361 . . . . 0.0 110.195 173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 47' ' ' LEU . 96.1 mt -61.43 -48.95 78.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.776 177.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -63.63 -42.53 98.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.334 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -62.33 -38.09 95.67 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.053 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.28 -42.45 96.42 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.861 0.362 . . . . 0.0 110.277 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.6 mp -62.25 -48.1 81.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.196 177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.06 -41.13 97.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.297 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.7 mmt -71.16 -37.46 72.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -63.32 -41.19 98.9 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -68.43 -32.62 72.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.677 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 53.1 tp -64.36 -48.9 73.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.905 0.383 . . . . 0.0 110.214 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.66 -39.73 51.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.328 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.0 m-80 -106.69 11.74 30.0 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -171.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.5 m 73.17 -43.19 0.55 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 175.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.401 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 6.6 ppt_? -117.82 164.53 14.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.712 0.292 . . . . 0.0 111.552 -175.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -71.18 148.16 93.81 Favored Pre-proline 0 N--CA 1.465 0.276 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.933 -177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.73 149.36 48.36 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.031 2.487 . . . . 0.0 112.529 177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.8 p -85.69 179.73 7.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.988 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.0 t -50.2 -38.89 42.27 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.42 -44.72 34.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.279 0.562 . . . . 0.0 110.677 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.87 -30.29 65.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.323 -172.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -59.3 -51.17 60.75 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.078 -0.582 . . . . 0.0 113.645 -173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.9 mp -71.28 -33.54 69.83 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.962 0.41 . . . . 0.0 111.506 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -68.49 -26.69 65.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.809 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -23.53 63.88 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 HD23 ' A' ' 43' ' ' LEU . 0.6 OUTLIER -103.74 -2.2 26.82 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -179.153 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.5 p -122.93 -48.33 2.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.831 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 p -152.08 128.61 10.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.608 0.242 . . . . 0.0 110.484 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -54.9 121.81 37.35 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.085 -172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.57 144.45 85.01 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.077 2.518 . . . . 0.0 112.307 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.422 ' HA ' ' CE1' ' A' ' 76' ' ' HIS . 25.4 t -94.97 2.51 55.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.17 131.26 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.251 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.484 ' OE2' ' HA ' ' A' ' 75' ' ' PRO . 8.1 tp10 -77.79 138.65 62.0 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.208 -178.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HA ' ' OE2' ' A' ' 74' ' ' GLU . 14.3 Cg_exo -67.03 130.84 14.08 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.565 -1.431 . . . . 0.0 112.62 0.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 72' ' ' SER . 3.8 t60 -74.0 131.16 41.12 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.856 -1.066 . . . . 0.0 109.723 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.403 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -57.48 127.99 34.78 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.524 0.515 . . . . 0.0 111.576 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -114.2 167.09 10.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.844 177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.3 p30 52.76 31.39 10.37 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.263 1.025 . . . . 0.0 111.901 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -80.32 139.17 51.99 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.775 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.21 140.5 24.97 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.551 2.167 . . . . 0.0 111.719 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -64.36 125.07 23.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.178 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.54 3.18 86.67 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.45 -161.89 53.45 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.362 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -87.56 -22.51 24.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.437 ' CG2' HD13 ' A' ' 67' ' ' LEU . 8.3 tt -139.39 134.08 39.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.769 173.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -60.98 -29.31 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.608 -169.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -133.75 160.24 38.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 69.5 mt -58.51 122.34 59.69 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.539 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.45 149.45 80.27 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.427 2.084 . . . . 0.0 111.876 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -140.76 140.71 34.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.788 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.584 ' OD2' ' HB2' ' A' ' 96' ' ' SER . 1.9 p30 -63.82 152.98 85.52 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.22 -15.68 15.19 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.816 3.011 . . . . 0.0 113.812 -175.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -79.05 -26.06 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.03 19.6 8.02 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.603 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.584 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 0.7 OUTLIER -95.96 151.35 19.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.977 0.417 . . . . 0.0 110.553 -178.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.25 122.6 31.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.494 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 56.6 m-85 -54.66 140.8 34.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.024 0.44 . . . . 0.0 111.284 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -113.69 137.89 50.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.775 -178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.651 HD23 HG23 ' A' ' 111' ' ' ILE . 2.8 tm? -118.79 122.02 41.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 174.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.411 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 1.7 tm? -122.54 113.98 20.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.887 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.4 p -106.35 130.52 22.83 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.81 169.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.5 139.97 63.72 Favored 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.385 -1.09 . . . . 0.0 111.93 -1.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 101' ' ' LEU . . . -60.62 143.82 47.99 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.757 -0.656 . . . . 0.0 113.358 -176.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -58.52 -36.24 73.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.521 -0.339 . . . . 0.0 110.887 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -119.45 21.79 11.99 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.592 -177.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 168.96 -147.92 11.72 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.816 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -45.44 65.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.923 0.392 . . . . 0.0 110.659 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.612 ' HB ' HD21 ' A' ' 100' ' ' LEU . 3.1 m -137.67 146.96 26.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.503 178.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -127.48 121.5 30.93 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.966 -177.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.651 HG23 HD23 ' A' ' 100' ' ' LEU . 7.0 pt -106.59 125.41 62.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.973 176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -151.53 156.57 40.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.099 0.476 . . . . 0.0 111.609 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.436 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 54.6 p -100.04 155.08 17.91 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -70.19 -17.77 63.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.761 0.315 . . . . 0.0 110.97 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 77.24 -172.0 55.14 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.437 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.01 -22.2 35.86 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 123.151 2.567 . . . . 0.0 112.273 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.733 ' OD2' HG12 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -94.91 -14.99 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.333 -173.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.51 -5.54 44.31 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.892 1.117 . . . . 0.0 115.892 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.733 HG12 ' OD2' ' A' ' 117' ' ' ASP . 2.8 p -97.44 128.68 33.9 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.375 1.588 . . . . 0.0 110.683 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.718 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 56.0 Cg_endo -73.13 159.71 46.93 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.749 2.3 . . . . 0.0 113.398 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 69.37 15.83 8.38 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.296 177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 1.3 p -98.97 175.35 5.96 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.217 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -77.9 -22.4 49.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.987 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -79.88 -11.24 59.82 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.718 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 1.0 OUTLIER -71.56 89.79 0.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.891 178.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.5 ' HA ' HG21 ' A' ' 130' ' ' THR . 46.6 mm -66.58 105.79 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.351 -177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.439 ' O ' HG22 ' A' ' 130' ' ' THR . . . -135.35 -161.8 9.47 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.486 -178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.467 ' HA ' HD21 ' A' ' 40' ' ' LEU . 10.6 t-20 -62.42 -38.11 88.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.618 0.247 . . . . 0.0 111.621 -173.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -79.66 -30.86 41.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.5 HG21 ' HA ' ' A' ' 126' ' ' ILE . 5.4 t -69.16 -33.09 72.86 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.591 -177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.45 -34.93 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 176.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.95 83.74 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.376 173.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -73.64 -22.89 59.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -130.85 91.48 3.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.382 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -72.43 96.46 1.91 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.824 -178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -74.92 102.3 4.72 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -81.07 135.42 35.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.143 0.497 . . . . 0.0 111.561 -173.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -138.17 91.01 2.52 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.63 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -99.76 138.19 37.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.541 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.836 -0.602 . . . . 0.0 109.948 179.191 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.958 0.409 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.59 167.68 40.12 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.908 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 66.52 98.44 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.493 0.663 . . . . 0.0 110.732 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -98.25 47.93 1.0 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.809 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 27.6 tt0 -53.68 -39.17 64.89 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.421 -175.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 30' ' ' LYS . 0.4 OUTLIER -64.11 -35.1 79.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -176.125 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.2 -38.21 72.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.573 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -60.54 -49.06 79.05 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.157 0.503 . . . . 0.0 110.506 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 2.5 ptp180 -69.92 -36.63 75.52 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.484 -176.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -60.89 -35.87 77.76 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 111.02 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -68.12 -39.73 82.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.094 0.473 . . . . 0.0 109.966 175.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.593 ' HA ' ' OH ' ' A' ' 98' ' ' TYR . 35.4 t -61.04 -47.78 92.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.716 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 33' ' ' ARG . 58.9 t -62.91 -38.32 81.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.049 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -61.77 -46.22 90.53 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.8 0.334 . . . . 0.0 111.139 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -69.94 -35.34 74.45 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.107 0.48 . . . . 0.0 110.266 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD21 ' HA ' ' A' ' 128' ' ' ASN . 45.0 tp -63.93 -46.13 86.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.437 -178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.1 m -66.02 -36.12 76.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.734 0.302 . . . . 0.0 110.359 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.13 85.29 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.47 175.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.708 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 68.2 mt -60.12 -48.26 82.46 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.556 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -60.92 -36.28 78.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.065 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -58.06 -46.06 93.1 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.793 -0.717 . . . . 0.0 111.615 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -62.55 -38.72 91.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.576 0.227 . . . . 0.0 110.617 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 37.4 mt -65.15 -50.42 66.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.362 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -61.39 -44.39 97.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.399 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 65.2 mtt -70.31 -35.76 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.963 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' HB2' ' O ' ' A' ' 46' ' ' ALA . 4.6 t80 -58.64 -44.75 90.16 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 175.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.43 -33.12 73.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.897 0.38 . . . . 0.0 110.634 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.6 tp -62.82 -51.03 68.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.565 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 78' ' ' ARG . 16.2 t70 -78.51 -46.95 18.36 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -93.49 -0.07 56.53 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.861 -170.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.3 m 70.01 7.25 6.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.1 OUTLIER -160.53 157.14 26.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 0.0 111.027 -177.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.591 ' O ' ' HD3' ' A' ' 56' ' ' ARG . 51.1 m-85 -74.29 148.22 85.99 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.178 178.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD3' ' HB3' ' A' ' 50' ' ' TYR . 60.4 Cg_endo -73.27 155.85 51.24 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.843 2.362 . . . . 0.0 112.456 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -86.06 178.18 7.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.33 176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -51.31 -40.33 58.79 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -173.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -76.04 -43.28 44.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.352 0.596 . . . . 0.0 110.733 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -72.6 -27.46 62.18 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.852 -173.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -65.26 -50.5 56.12 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.964 -174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.59 -33.47 71.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.172 0.486 . . . . 0.0 111.018 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -71.74 -25.18 61.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.677 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.58 -22.88 62.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -173.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.498 ' HB3' HG22 ' A' ' 86' ' ' ILE . 9.3 mt -87.75 -19.1 28.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.448 HG11 HD22 ' A' ' 89' ' ' LEU . 4.2 p -122.25 -48.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -171.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.5 t -144.09 129.95 19.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.44 121.21 41.61 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.032 -175.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.33 136.91 75.7 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.127 2.551 . . . . 0.0 112.594 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.7 m -80.07 -16.59 54.71 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.281 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.89 146.92 41.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.699 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -76.05 136.31 69.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.903 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.17 131.99 24.43 Favored 'Cis proline' 0 C--N 1.345 0.355 0 C-N-CA 123.41 -1.496 . . . . 0.0 112.776 -1.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -61.32 120.94 11.39 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HB2' ' CE2' ' A' ' 50' ' ' TYR . . . -55.89 121.22 8.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.931 0.396 . . . . 0.0 110.158 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.457 ' HB3' ' OD1' ' A' ' 53' ' ' ASP . 22.0 tpt180 -110.38 154.81 23.02 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.347 -176.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 64.87 43.02 4.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.421 0.629 . . . . 0.0 110.213 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -100.47 140.23 21.26 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.296 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.7 144.0 58.29 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.744 2.296 . . . . 0.0 111.914 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.31 124.1 20.87 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.14 4.28 78.15 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.44 -159.58 51.84 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.344 -0.455 . . . . 0.0 112.326 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -88.03 -30.51 19.89 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.498 HG22 ' HB3' ' A' ' 67' ' ' LEU . 7.6 tt -135.44 124.46 40.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.148 172.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -65.7 -20.25 66.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -169.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.558 ' HD2' ' O ' ' A' ' 89' ' ' LEU . 8.1 tmm_? -129.64 146.53 51.42 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -174.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.558 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 4.3 mm? -54.28 122.45 37.11 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 123.292 0.37 . . . . 0.0 111.159 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -59.38 124.44 15.55 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.945 1.764 . . . . 0.0 110.403 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 89' ' ' LEU . 90.9 mt-30 -134.79 144.38 47.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.989 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.607 ' OD2' ' HB2' ' A' ' 113' ' ' SER . 0.5 OUTLIER -56.34 145.17 59.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.76 178.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -57.93 -19.85 41.79 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.97 2.447 . . . . 0.0 112.437 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 24.9 m-90 -80.78 -13.93 58.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.344 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.14 20.16 9.47 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.941 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.8 m -99.2 160.69 14.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.569 0.223 . . . . 0.0 110.568 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -108.66 122.97 48.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.375 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.593 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 52.8 m-85 -53.97 148.04 11.32 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.507 0.67 . . . . 0.0 112.599 -175.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.545 ' HG2' HD21 ' A' ' 114' ' ' LEU . 62.1 mm-40 -112.01 138.6 48.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.036 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.765 HD23 HG23 ' A' ' 111' ' ' ILE . 2.2 tm? -129.39 122.64 29.84 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.72 113.45 17.99 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.883 0.373 . . . . 0.0 110.414 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 5.3 m -106.93 128.53 25.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.091 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 102' ' ' SER . 1.0 OUTLIER -82.71 137.38 32.35 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 C-N-CA 124.403 -1.082 . . . . 0.0 111.428 -3.205 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.431 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -67.35 169.35 36.75 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.768 -173.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.494 ' HA ' ' OE1' ' A' ' 105' ' ' GLN . 6.1 tp60 -95.84 -28.08 14.9 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.239 0.542 . . . . 0.0 109.862 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -93.25 -5.76 49.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.781 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 178.7 -151.61 10.57 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.08 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -72.74 -45.32 59.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.971 0.415 . . . . 0.0 110.348 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.444 ' HB ' HD21 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -127.97 124.56 63.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.814 177.335 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -100.01 112.68 24.96 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.874 -176.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.765 HG23 HD23 ' A' ' 100' ' ' LEU . 7.5 pt -112.43 125.5 69.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -151.47 155.08 37.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.607 ' HB2' ' OD2' ' A' ' 92' ' ' ASP . 15.9 p -91.49 158.41 16.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.358 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.672 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 3.4 mm? -100.98 -12.66 18.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 110.822 -174.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 62.87 -154.9 42.82 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.275 173.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 124' ' ' ASP . 14.4 Cg_exo -69.05 -33.39 19.39 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 123.383 2.722 . . . . 0.0 113.135 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.577 ' OD1' ' HB2' ' A' ' 124' ' ' ASP . 2.8 p30 -83.7 -14.08 52.57 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.738 -0.385 . . . . 0.0 112.028 -176.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.97 -3.96 18.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.755 173.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 122' ' ' SER . 24.3 m -107.83 139.47 20.66 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-N 117.329 0.565 . . . . 0.0 112.159 -173.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.7 155.31 39.73 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.505 2.803 . . . . 0.0 112.834 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 61.1 25.53 15.53 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.772 0.796 . . . . 0.0 110.74 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.408 ' HB3' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -93.49 174.61 7.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.116 -179.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -63.38 -41.87 98.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.696 0.76 . . . . 0.0 109.19 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.577 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 4.6 m-20 -99.3 75.24 1.98 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 122.54 1.162 . . . . 0.0 109.248 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.672 ' OD1' ' HA ' ' A' ' 114' ' ' LEU . 55.9 m-20 -143.39 112.67 6.79 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.336 -1.756 . . . . 0.0 109.259 169.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.544 ' HB ' ' OG ' ' A' ' 113' ' ' SER . 44.6 mm -87.34 104.9 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.033 0.444 . . . . 0.0 109.999 -179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -95.23 157.19 21.93 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.673 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.459 ' HB2' HG13 ' A' ' 111' ' ' ILE . 62.6 t30 -65.89 -28.55 69.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.291 0.567 . . . . 0.0 110.499 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -78.36 -23.63 46.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.98 175.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 3.7 m -81.03 -29.44 35.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.39 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.8 tp -78.37 -21.67 13.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.799 0.333 . . . . 0.0 110.938 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 130.17 -6.14 6.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.096 -1.05 . . . . 0.0 113.405 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -86.31 165.53 16.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.935 0.368 . . . . 0.0 110.638 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 58.34 32.22 21.82 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.795 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -91.06 56.36 3.15 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 28.2 t60 62.09 71.53 0.53 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.494 -177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -116.44 143.7 45.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.738 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -152.51 129.75 11.23 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.889 0.376 . . . . 0.0 111.235 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -83.25 -13.34 55.47 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 172.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.851 174.079 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.726 0.298 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 30' ' ' LYS . . . -156.76 79.54 0.18 Allowed Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.112 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -59.17 -41.29 88.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.956 0.407 . . . . 0.0 110.603 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -78.73 -34.69 45.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.701 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 4.8 tp10 -61.4 -38.19 86.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.394 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 53.3 mtmt -58.77 -40.68 84.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 35' ' ' LYS . . . -64.61 -44.96 88.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.823 0.345 . . . . 0.0 110.811 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.42 -40.53 77.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.981 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.61 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 13.1 ptm180 -65.9 -33.67 76.36 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.996 178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 30' ' ' LYS . 15.4 mm100 -62.99 -31.59 72.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 174.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 87.7 mttt -64.69 -39.22 93.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 172.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 33' ' ' ARG . 31.2 t -60.7 -46.46 95.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.632 175.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 33' ' ' ARG . 82.6 t -58.63 -38.78 73.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.061 0.458 . . . . 0.0 110.558 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 41' ' ' VAL . 38.9 m -63.4 -43.87 96.3 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.891 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -69.9 -35.17 74.4 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.092 0.472 . . . . 0.0 110.304 176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 36.9 tp -61.39 -45.25 95.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.187 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 38' ' ' SER . 23.7 m -64.64 -35.72 75.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.26 176.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.24 -36.74 85.07 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.614 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.722 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 87.5 mt -60.55 -48.4 81.92 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 121.135 0.493 . . . . 0.0 110.101 175.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.65 -35.96 82.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.586 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.99 -42.92 99.77 Favored Glycine 0 N--CA 1.451 -0.337 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 174.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.819 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . . . -60.53 -43.96 96.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.362 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 48.7 mt -59.42 -49.07 79.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.662 177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.65 -41.59 97.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.994 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 72.7 mtp -70.57 -38.64 74.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.976 -177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -65.48 -42.99 91.59 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -68.98 -33.25 73.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.44 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.6 tp -59.88 -49.75 76.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.709 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.94 -47.01 17.18 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -100.9 10.12 41.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -170.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.6 m 70.99 -7.2 1.14 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.488 ' NH2' ' HD2' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -139.0 148.7 43.79 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.829 -0.545 . . . . 0.0 111.455 -175.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.406 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 10.2 m-85 -69.25 142.73 92.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.0 177.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.69 155.99 49.15 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 123.051 2.501 . . . . 0.0 112.694 -177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.1 p -81.89 177.11 9.05 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.398 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -51.65 -41.39 61.29 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.4 -45.39 39.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.066 0.46 . . . . 0.0 110.573 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.449 ' HG2' ' HB3' ' A' ' 71' ' ' PRO . 50.4 mt-30 -68.39 -31.61 71.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.189 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.496 ' HA3' HD22 ' A' ' 100' ' ' LEU . . . -62.57 -48.85 78.67 Favored Glycine 0 CA--C 1.516 0.111 0 C-N-CA 120.711 -0.756 . . . . 0.0 113.086 -177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -69.44 -32.41 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.935 0.398 . . . . 0.0 111.384 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -72.12 -29.17 63.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.986 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB3' ' HB1' ' A' ' 46' ' ' ALA . . . -60.29 -20.83 60.72 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -173.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.819 ' HG ' ' HB2' ' A' ' 46' ' ' ALA . 7.6 mt -89.95 -9.79 47.46 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 p -128.33 -53.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 29.3 p -144.74 139.14 27.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -173.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.08 122.24 46.62 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.137 -176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.449 ' HB3' ' HG2' ' A' ' 62' ' ' GLN . 52.1 Cg_exo -56.24 137.38 79.6 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.875 2.383 . . . . 0.0 111.776 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -84.64 -16.04 43.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.622 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 135.86 48.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.229 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 7.9 pt-20 -77.57 140.56 64.2 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.146 -178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.488 ' HD2' ' NH2' ' A' ' 56' ' ' ARG . 57.7 Cg_endo -72.09 132.11 24.22 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 123.304 -1.54 . . . . 0.0 113.232 -0.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -66.96 129.79 41.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.692 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.61 122.6 17.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.687 0.28 . . . . 0.0 110.416 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.458 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 29.0 tpt180 -109.26 162.95 13.81 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -177.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.458 ' N ' ' HG3' ' A' ' 78' ' ' ARG . 9.5 p30 47.83 39.75 11.22 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.902 0.881 . . . . 0.0 111.795 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -85.14 147.29 47.29 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.025 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.19 138.81 48.35 Favored 'Trans proline' 0 N--CA 1.464 -0.265 0 C-N-CA 122.283 1.988 . . . . 0.0 111.446 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.54 124.08 21.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.24 10.47 86.23 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.371 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.71 -121.05 21.62 Favored Glycine 0 N--CA 1.447 -0.581 0 O-C-N 123.764 0.332 . . . . 0.0 112.639 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' HB2' HD23 ' A' ' 67' ' ' LEU . 51.1 m-85 -114.03 -17.8 11.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.449 0.642 . . . . 0.0 109.553 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 88' ' ' ARG . 6.1 tt -143.15 129.12 16.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.818 178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -60.77 -23.12 64.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -167.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.439 ' O ' HG12 ' A' ' 86' ' ' ILE . 59.6 mtp180 -130.42 167.12 19.1 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -60.74 133.2 91.78 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.69 137.32 63.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.787 2.324 . . . . 0.0 112.46 -176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -133.48 150.7 51.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.149 -178.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.437 ' HB3' ' CE3' ' A' ' 94' ' ' TRP . 7.7 m-20 -55.88 150.85 26.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.88 -17.96 39.65 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.572 2.181 . . . . 0.0 111.623 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.484 ' CZ3' ' HA2' ' A' ' 115' ' ' GLY . 6.3 m-90 -81.96 -12.3 58.44 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.315 178.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.2 10.79 31.1 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.699 -0.762 . . . . 0.0 114.001 173.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -102.31 143.41 32.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.352 0.576 . . . . 0.0 111.022 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.1 130.7 38.72 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -61.28 163.13 6.76 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.117 0.484 . . . . 0.0 110.772 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -127.93 139.43 52.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.641 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.517 HD11 ' HB ' ' A' ' 109' ' ' VAL . 13.3 tp -122.89 142.51 50.71 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.361 173.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.65 112.83 14.67 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.481 175.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' PRO . 6.0 m -107.55 129.67 23.9 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.144 172.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 108' ' ' GLN . 2.0 Cg_endo -83.09 135.66 26.72 Favored 'Cis proline' 0 N--CA 1.458 -0.563 0 C-N-CA 124.465 -1.056 . . . . 0.0 110.956 -5.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 110' ' ' ASP . . . -68.85 174.45 32.8 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.359 -173.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -94.73 -27.67 15.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.172 0.511 . . . . 0.0 109.797 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -99.81 21.83 11.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.403 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 151.26 -155.26 26.04 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.514 HE21 ' HA ' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -73.52 -36.83 65.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 117.015 0.407 . . . . 0.0 111.21 177.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -132.78 129.05 57.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.786 -178.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.42 ' HB2' ' CA ' ' A' ' 104' ' ' GLY . 0.4 OUTLIER -107.53 114.19 28.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.475 -179.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.434 HG13 ' HB2' ' A' ' 128' ' ' ASN . 5.5 pt -106.88 126.87 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.046 0.45 . . . . 0.0 110.025 175.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -145.02 148.35 33.62 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.799 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.417 ' HB3' ' OD1' ' A' ' 92' ' ' ASP . 2.5 m -106.82 137.18 45.35 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.513 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.46 -35.26 79.85 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.82 -169.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.484 ' HA2' ' CZ3' ' A' ' 94' ' ' TRP . . . 86.69 -177.31 48.28 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.253 -0.975 . . . . 0.0 111.606 -176.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.85 -15.36 40.39 Favored 'Trans proline' 0 C--N 1.334 -0.224 0 C-N-CA 123.012 2.474 . . . . 0.0 112.926 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.61 ' OD2' ' HB ' ' A' ' 119' ' ' VAL . 15.9 p-10 -92.37 -12.5 32.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.723 -174.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.17 5.86 67.33 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.679 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.61 ' HB ' ' OD2' ' A' ' 117' ' ' ASP . 58.9 t -110.76 121.13 41.87 Favored Pre-proline 0 C--O 1.244 0.815 0 CA-C-O 120.744 0.307 . . . . 0.0 111.141 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.658 ' HA ' ' OD1' ' A' ' 125' ' ' ASP . 72.0 Cg_endo -76.13 156.5 38.03 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.411 2.74 . . . . 0.0 113.448 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 62.65 25.94 15.39 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.75 177.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -101.03 172.86 6.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.951 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -66.48 -32.48 73.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.085 0.469 . . . . 0.0 111.313 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -74.81 -19.01 60.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.142 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.658 ' OD1' ' HA ' ' A' ' 120' ' ' PRO . 0.7 OUTLIER -62.0 138.71 58.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.986 -174.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mp -104.87 104.97 17.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.737 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -112.71 169.74 13.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.203 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.58 ' OD1' ' HB2' ' A' ' 133' ' ' PHE . 62.8 t30 -62.38 -33.98 75.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.301 0.572 . . . . 0.0 110.568 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 44.4 t-105 -77.9 -20.24 53.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.271 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -73.48 -46.5 47.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.109 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.8 tp -79.95 -22.3 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 110.147 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.54 42.91 7.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.048 168.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.58 ' HB2' ' OD1' ' A' ' 128' ' ' ASN . 28.6 m-85 -83.85 62.09 6.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.537 0.684 . . . . 0.0 110.373 174.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -142.87 92.29 2.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.454 178.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -79.05 142.78 36.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.197 0.522 . . . . 0.0 111.303 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 55.2 t60 -142.6 75.25 1.48 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.463 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -74.17 -32.53 63.13 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.806 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 55.8 m80 -76.76 84.01 3.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.236 0.541 . . . . 0.0 110.172 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.1 p-80 -94.56 46.03 1.14 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.973 -176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.993 179.652 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.22 -28.18 6.14 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.294 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -93.78 82.76 4.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.101 0.477 . . . . 0.0 110.056 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -113.25 75.09 0.9 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.423 0.63 . . . . 0.0 109.391 176.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 33' ' ' ARG . 7.6 tp10 -53.4 -40.14 64.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.805 -1.089 . . . . 0.0 111.789 -175.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 34' ' ' GLN . 87.7 tttt -60.27 -41.85 94.16 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.01 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.89 -40.32 75.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.677 0.275 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 36' ' ' VAL . 49.4 m-20 -62.49 -47.56 83.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.494 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 29' ' ' GLU . 13.9 ptm180 -68.19 -36.73 80.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.554 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 34' ' ' GLN . 12.5 mm-40 -63.95 -35.15 79.73 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.954 0.407 . . . . 0.0 110.531 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -66.44 -37.73 85.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.703 175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 32' ' ' ASP . 85.9 t -60.68 -44.01 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.011 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 33' ' ' ARG . 96.7 t -59.94 -40.09 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.972 177.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.2 t -61.59 -45.65 93.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.4 ' O ' HD13 ' A' ' 43' ' ' LEU . 15.2 m-20 -69.51 -37.29 77.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.116 0.484 . . . . 0.0 110.018 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 26.5 tp -59.94 -46.12 90.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.318 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.1 m -65.21 -36.64 78.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.54 -40.31 94.21 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.873 175.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 47' ' ' LEU . 7.5 mp -60.67 -49.03 79.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.308 0.575 . . . . 0.0 110.549 177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -63.35 -36.92 85.29 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.953 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.39 96.89 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.217 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . . . -60.52 -41.69 94.91 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.152 0.501 . . . . 0.0 110.696 176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 43' ' ' LEU . 5.8 mp -59.75 -39.94 86.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.873 177.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -68.14 -36.21 79.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.689 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.71 -42.94 77.01 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -65.7 -38.69 89.93 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -70.21 -32.79 70.85 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.774 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 43.4 tp -68.29 -40.98 81.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.032 0.444 . . . . 0.0 110.221 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.14 -44.96 28.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.422 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.58 ' OD1' ' HB2' ' A' ' 75' ' ' PRO . 36.6 m-80 -112.16 5.35 18.45 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -171.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.2 m 66.95 9.24 6.71 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 173.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -147.37 167.59 23.96 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.966 -0.459 . . . . 0.0 111.016 -177.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.422 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 21.9 m-85 -91.2 142.83 27.56 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.145 0.497 . . . . 0.0 111.382 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.83 162.18 39.94 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.378 2.719 . . . . 0.0 113.632 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.2 p -88.07 178.87 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.182 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.0 m -50.13 -46.48 53.89 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.934 0.397 . . . . 0.0 111.832 -176.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.43 -44.9 61.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.501 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -64.98 -42.43 94.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.444 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.34 -44.49 98.0 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.702 -177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD21 ' O ' ' A' ' 98' ' ' TYR . 2.7 mp -69.66 -41.27 75.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.727 0.298 . . . . 0.0 111.39 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -72.52 -24.54 61.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.36 69.88 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -169.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.702 HD23 ' H ' ' A' ' 67' ' ' LEU . 1.5 pt? -96.47 -0.28 49.28 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.932 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.7 p -118.6 -24.28 3.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 111.081 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.1 p -157.66 164.23 37.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.549 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.459 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . . . -75.84 121.81 85.79 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 170.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.62 136.89 77.02 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.493 2.128 . . . . 0.0 112.136 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.4 m -82.49 -30.47 29.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.475 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.62 122.07 16.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.517 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' HA ' ' C ' ' A' ' 75' ' ' PRO . 43.0 mt-10 -69.85 148.12 96.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.222 -175.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.58 ' HB2' ' OD1' ' A' ' 54' ' ' ASN . 14.5 Cg_exo -68.63 136.19 34.97 Favored 'Cis proline' 0 C--N 1.345 0.362 0 C-N-CA 123.413 -1.495 . . . . 0.0 112.506 1.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -75.97 128.15 34.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.404 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HA ' HD21 ' A' ' 54' ' ' ASN . . . -62.36 126.29 26.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.506 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -106.03 158.16 17.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.477 178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.03 43.94 13.87 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.795 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.459 ' CG ' ' HB2' ' A' ' 70' ' ' ALA . 34.0 p90 -88.58 139.36 29.73 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.464 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.2 140.4 53.51 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.514 2.143 . . . . 0.0 111.38 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -64.31 123.88 20.3 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.0 10.16 86.4 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.927 -176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.41 -115.05 7.35 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.051 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -126.3 -21.73 4.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.287 0.565 . . . . 0.0 109.55 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.526 HG12 ' H ' ' A' ' 88' ' ' ARG . 14.0 tt -133.55 138.32 51.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.43 -179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 87' ' ' ARG . 38.4 mtp-105 -72.57 -20.8 61.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -173.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.526 ' H ' HG12 ' A' ' 86' ' ' ILE . 74.7 mtp180 -129.38 158.26 39.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.336 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.7 128.39 79.96 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.69 123.86 14.19 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.56 2.173 . . . . 0.0 112.822 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -127.84 140.39 52.05 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.256 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.635 ' OD1' ' HB2' ' A' ' 96' ' ' SER . 4.8 p30 -68.85 155.58 93.03 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.932 177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.53 -31.83 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.836 2.358 . . . . 0.0 113.666 -178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.445 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 6.5 m-90 -78.03 -19.01 55.15 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.855 0.359 . . . . 0.0 111.223 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 110.81 20.97 6.97 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.836 -0.697 . . . . 0.0 113.555 172.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.635 ' HB2' ' OD1' ' A' ' 92' ' ' ASP . 4.4 m -103.3 133.23 48.73 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.106 0.453 . . . . 0.0 110.552 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.79 128.73 37.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.495 ' OH ' ' HA ' ' A' ' 36' ' ' VAL . 76.6 m-85 -60.57 168.17 2.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.172 0.511 . . . . 0.0 111.075 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -130.58 137.64 49.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.203 -176.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.616 HD21 ' HB ' ' A' ' 109' ' ' VAL . 3.3 tm? -118.09 122.75 43.91 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 174.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -123.11 114.26 20.1 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.126 -176.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.3 t -106.48 135.45 19.5 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.38 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.36 137.83 52.06 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.525 -1.448 . . . . 0.0 111.804 -3.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.83 141.88 47.81 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.652 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.96 -21.15 65.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.089 0.471 . . . . 0.0 110.262 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -126.89 31.54 5.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.086 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 153.29 -150.05 21.71 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.852 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -73.27 -40.21 64.77 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.616 ' HB ' HD21 ' A' ' 100' ' ' LEU . 4.5 m -132.84 151.27 34.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.886 175.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -131.15 123.03 27.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.604 0.24 . . . . 0.0 110.446 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.538 ' CG2' HD23 ' A' ' 100' ' ' LEU . 13.0 pt -106.87 129.68 60.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.541 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -151.13 161.05 43.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.287 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.485 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . 44.0 p -112.32 150.92 30.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.471 175.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.35 -22.2 44.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.707 -173.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.85 -171.97 54.11 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.553 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HG3' ' CE2' ' A' ' 94' ' ' TRP . 13.4 Cg_exo -68.39 -23.79 37.61 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.045 2.497 . . . . 0.0 112.191 -179.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.41 -12.43 40.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 111.291 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.21 11.8 79.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.983 174.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.28 116.8 66.02 Favored Pre-proline 0 C--O 1.239 0.526 0 CA-C-N 117.934 0.867 . . . . 0.0 111.747 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.5 151.77 33.31 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 123.557 2.838 . . . . 0.0 113.399 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 62.06 27.23 16.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.406 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 125' ' ' ASP . 0.9 OUTLIER -100.26 177.33 5.09 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.087 -0.961 . . . . 0.0 112.008 -176.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -68.28 -41.89 80.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.474 0.654 . . . . 0.0 109.31 173.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -88.56 65.39 7.81 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 122.398 1.094 . . . . 0.0 108.319 174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 122' ' ' SER . 0.4 OUTLIER -136.46 90.55 2.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.41 -1.723 . . . . 0.0 108.823 174.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 65.4 mt -70.54 109.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.571 -175.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -132.66 -162.98 10.47 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.754 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -63.27 -37.59 87.85 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.268 -0.466 . . . . 0.0 111.866 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 43.0 t-105 -78.63 -27.06 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.674 0.273 . . . . 0.0 110.388 -177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 23.9 m -56.83 -49.31 75.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.905 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.7 tt -92.13 -25.9 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.151 0.501 . . . . 0.0 110.632 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.23 35.45 52.91 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.78 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -84.39 129.33 34.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.893 0.378 . . . . 0.0 110.167 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -171.75 135.83 0.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.574 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 60.91 26.97 16.84 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.469 0.652 . . . . 0.0 109.806 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -102.15 70.7 1.21 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.576 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -131.7 42.94 3.12 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.575 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 47.1 m170 -83.39 114.05 21.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.525 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -143.48 33.17 1.3 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.234 0.54 . . . . 0.0 110.935 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.341 -0.838 . . . . 0.0 109.826 176.818 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_